Production of antibodies for use in a biosensor-based assay for Listeria monocytogenes by Leonard, Paul
Production of antibodies for use in a biosensor- 
based assay for Listeria monocytogenes
A  thesis subm itted for the degree o f  Ph.D.
By
Paul Leonard B.Sc. (H ons),
August 2003.
Based on research carried out at 
School o f B iotechnology, 
Dublin City University, 
D ublin 9,
Ireland,
Under the supervision o f Professor R ichard O ’K ennedy.
This thesis is dedicated to my parents for all their encouragement and 
support over the last number of years.
“I am not discouraged, because every wrong attempt discarded is another
step forward”
-Thom as Edison.
Declaration
I hereby certify that this material, which 1 now submit for assessment on the programme 
of study leading to the award o f Doctor o f Philosophy, is entirely my own work, and has 
not been taken from the work o f others, save and to the extent that such work is cited and 
acknowledged within the text.
Signed
Date:
Acknowledgements
Sincere thanks to Prof. Richard O'Kennedy for his constant support and guidance over the 
past few years, in particular for sharing his wealth o f experience and knowledge 
throughout my studies. Thanks to all the lab group, past and present and all my friends at 
DC’U for their companionship and some unforgettable (and more often than not better 
forgotten) nights out! Special thanks goes to Steve, a great scientist and friend, for his 
support, knowledge and overall enthusiasm over the last few years. To Monty, Macker, 
Ryaner and the rest of the “Finian's lads” for their continual ‘good humoured harassment’ 
and alcohol-based support! Cheers! I would like to thank all my family for their 
unequivocal support from start to finish, I owe you so much! Finally, 1 would like to 
reserve a very special thanks to Nerea, my source o f inspiration, for her patience, 
companionship and constant love and support.
IV
Table of contents:
Declaration iii
Acknowledgements iv
Table of contents v
Abbreviations xiv
Publications & Presentations xviii
Summary xx
Chapter 1: In tro d u c tio n  1
1.1 Section overview 2
1.2 Introduction to Listeria monocytogenes 2
1.3 A pathogenic life-cyclq. Listeria monocytogenes 4
1.4 Virulence factors involved in the entry o f Listeria monocytogenes
into host cells 7
1.5 Intracellular spread o f Listeria-. An actin-based process 14
1.6 Recent outbreaks o f listeriosis 17
1.7 Current detection techniques for Listeria 19
1.8 Antibody structure 23
1.9 The generation o f diversity in the humoral response 31
1.10 Polyclonal and monoclonal antibodies 34
1.11 An introduction to  recombinant antibodies 3 6
1.12 Phage display technology 37
1.13 The Krebber system for the isolation o f specific scFv 38
1.14 The Vaughan naive human antibody library 41
1.15 Recent innovations in phage display technology 42
1.15.1 Selectively infective phage 43
1.15.2 Affinity maturation of antibodies 45
1.15.2.1 Chain shuffling 45
1.15.2.2 Error prone PCR 45
1.15.2.3 Site-directed mutagenesis 46
1.15.2.4 Mutagenesis using random or ",spiked” PCR primers 46
1.15.2.5 Selection and screening o f  favourable affinity maturated 
antibodies 47
1.15.3 Antibody multimer formation 4 8
1.15.4 Ribosomal and mRNA display 51
1.16 The use o f biosensors for the detection o f bacteria 54
v
1.17 Surface plasmon resonance biosensors
1.18 Detection o f bacteria using SPR
1.19 Thesis Outline
55
58
59
Chapter 2: M ateria ls  a n d  M eth o d s  61
2.1 General formulations 62
2.1.1 Materials 62
2.1.2 Equipment 63
2.1.3 Culture media formulations 64
2.1.4 Buffer formulations 65
2.1.4.1 Phosphate buffered saline (PBS) 65
2.1.4.2 PBS-Tween (PBST) 65
2.1.4.3 Tris buffered saline (TBS) 65
2.1.4.4 Tris-acetic acid-EDTA buffer (TAE) 65
2.1.4.5 Hepes buffered saline (HBS) 65
2.1.5 Bacterial strains used 66
2.2 Production and characterisation of polyclonal antibodies 67
2.2.1 Antibody and antigen preparation 67
2.2.1.1 Preparation o f  bacterial stocks 67
2.2.1.2 Preparation o f  InlB Extract 67
2.2.1.3 Production o f  polyclonal antibodies 67
2.2.2 Purification o f polyclonal antibody from whole serum 68
2.2.2.1 Saturated ammonium sulphate precipitation 68
2.2.2.2 Protein G affinity chromatography 68
2.2.3 Non-competitive ELISA for determination o f polyclonal
antibody titre 69
2.2.4 Checkerboard ELISA for determination o f  optimal
concentrations o f immobilised interactant 69
2.2.5 Inhibition ELISA for polyclonal antibody characterisation 69
2.2.6 SDS polyacrylamide gel elcctrophoresis 70
2.2.7 Western blotting 71
2.3 Cloning of the gene sequences encoding InlB and p60 into E. coli 73
2.3.1 Preparation o f Listeria monocytogenes genomic DNA 7 3
2.3.2 Agarose gel electrophoresis for DNA characterisation 73
2.3.3 Design o f p60 and InlB primers 74
2.3.4 PCR of p60 and InlB protein gene sequences 74
VI
2.3.5 TA cloning o f p60 and InlB PCR products into E. coli
INV a F  cells 75
2.3.5.1 Ligation o f  PCR Products into a pCR 2.1 Vector 75
2.3.5.2 Transformation o f  pCR 2.1 into E. coli IN V aF' cells 76
2.3.5.3 Plasmid purification 76
2.3.5.4 Restriction analysis o f  white colonies from theX-Gal
agar plates 77
2.3.6 Cloning of p60 and InlB gene sequences into a QIAGEN 
pQE-60 plasmid 78
2.3.6.1 Preparation ofpQE-60 plasmid 78
2.3.6.2. Restriction o f  both pQE-60 and the pCR 2.1 plasmid
containing the inserts 78
2.3.6.3 Purification ofDNA from an agarose gel 78
2.3.6.4 Ligation ofpurified cut pQE-60 plasmid with purified
protein inserts 79
2.3.6.5 Preparation o f high efficiency competent cells 79
2.3.6.6 Transformation o f  pQE-60 into E  coliXL-10 Gold 
competent cells 79
2.3.7 Protein expression time course experiment 79
2.3.8 Determination of protein solubility 80
2.3.9 Purification o f recombinant protein by immobilised
metal affinity chromatography 80
2.3.10 Identification of recombinant protein by W estern blotting 81
2.3.11 Conjugation o f HRP to the anti-InlB polyclonal antibody 81
2.3.12 Identification o f recombinant protein by ELISA 81
2.3.13 Alignment o f protein gene sequences 81
2.4 Production o f murine scFv antibody libraries 82
2.4.1 Isolation o f murine antibody genes from immunised mice 82
2.4.1.1 Immunisation procedure ofBALB/c mice for the 
production o f  single chain Fv antibodies to Listeria 
monocytogenes cells and invasion-associated proteins 82
2.4.1.2 Total RNA extraction from the spleen ofBALB/c mice82
2.4.1.3 Reverse transcription o f  mouse spleen mRNA 83
2.4.2 Amplification o f  antibody light and heavy chain genes 84
2.4.2.1 PCR primers 84
2.4.2.2 Components o f PCR reaction fo r  amplification o f
antibody light and heavy chain genes 85
2.4.2.3 PCR conditions for amplification o f  antibody light
and heavy chain genes 86
vii
2.4.2.4 Purification ofPCR reaction products 86
2A.2.5 Quantification o f  PCR-purifiedproducts 87
2.4.2.6 Components o f  splice by overlap extension (SOE) PCR 87
2.4.2.7 Preparation and purification ofpAKlOO vector using
Wizard miniprep system (Promega) 88
2.4.2.8 Digestion o f  pAKlOO and antibody light and heavy
chain genes SOE PCR products 88
2.4.2.9 Ligation o f  antibody light and heavy chain genes into
the pAK l 00 vector 89
2.4.2.10 Preparation o f  high efficiency competent cells 89
2.4.2.11 Transformation ofE.coliXLl-Blue supercompetent cells 
with pAK l 00 vector containing light and heavy chain
genes and measurement o f  transformation efficiencies 89
2.4.3 Production o f  scFv antibodies to Listeria monocytogenes 90
2.4.3.1 Rescue o f  scFv displaying phage 90
2.4.3.2 PEG/NaClPrecipitation 90
2.4.3.3 Phage titre 90
2.4.3.4 Selection o f  antigen binders by bio-panning on Nunc 
immunotubes 91
2.4.3.5 Re-infection o f  phage displaying scFv antibodies 91
2.4.3.6 ELISA o f  phage displaying scFv antibodies 91
2.4.3.7 Preparation o f  bacterial glycerol stocks 92
2.4.3.8 Bioinformatics tools fo r  analysis o f  variable domain genes 92
2.4.3.9 Expression o f  soluble scFv antibodies from  E. coli 
harbouring the pAK400 vector with scFv gene inserts 93
2.4.3.10 ELISA fo r  the determination o f  soluble scFv 93
2.4.3.11 Cross-reactivity studies o f phage-scFv clones 93
2.4.4 Bio-panning o f  a naive human antibody library against 
H T-Listeria monocytogenes cells and invasion-associated 
proteins 94
2.4.4.1 Preparation ofphage from library glycerol stocks 94
2.4.4.2 PEG/NaCl Precipitation 94
2.4.4.3 Selection o f  phagemid-antibody libraries by panning in 
immunotubes 94
2.4.4.4 Phage ELISA o f phage displaying scFv antibodies 95
2.4.4.5 Inhibition ELISA o f positive clones 95
2.4.4.6 Preparation o f SDS-extracts o f Listeria monocytogenes 95
2.4.4.7 SDS-PAGE and Western blot analysis o f  phage displaying 
scFv clones 95
2.4.4.8 ScFv gene sequence alignment and CDR region 
Determination 95
viii
2.4.4.9 Expression o f  soluble scFv antibodies 95
2.4.4.10 Purification o f recombinant InlB and p60 proteins 96
2.4.4.11 Preparation o f  bacterial cytoplasmic extracts 96
2.4.4.12 Time course study for the expression scFv antibodies 96
2.4.4.13 Preparation ofTris-Cl extracts from bacterial cells 96
2.4.4.14 Inter- and Intraday assay reproducibility studies 96
2.4.4.15 Cross reactivity ofscFv antibody clone G7 against Tris-Cl 
extracts from various bacterial cells 97
2.5 Development o f SPR-based immunoassays using a BIAcore 3000™
instrument 98
2.5.1 Preconcentration studies 98
2.5.2 General immobilisation conditions 98
2.5.3 Regeneration studies 98
2.5.4 Subtractive inhibition assay for the detection o f Listeria
monocytogenes cells using an anti-Listeria monocytogenes 
polyclonal antibody 99
2.5.5 Inhibition assay for the detection o f Listeria monocytogenes
cells using an anti-InlB extract polyclonal antibody 99
2.5.6 Inhibition assay for the indirect detection o f Listeria  
monocytogenes cells using an anti-InlB protein scFv antibody 100
Chapter 3: Characterisation of polyclonal antibodies against
L is te r ia  m o n o c y to g en es  101
3.1 Introduction 102
3.2 Production and characterisation of polyclonal antibodies to heat-treated
(HT) Listeria monocytogenes cells and the invasion-associated protein 
intemalin B (InlB) 104
3.2.1 Purification o f polyclonal antiserum 104
3.2.2 Characterisation o f purified antibody by SDS-PAGE and
Western blotting 105
3.2.3 Development o f an inhibition enzyme-linked immunosorbent
assay (ELISA) for the detection of heat treated -Listeria 
monocytogenes 4b in phosphate buffered saline (PBS) 108
3.2.4 Checkerboard ELISA for determination o f optimal loading 
ratios o f cell coating and optimal antibody dilution for
the anti-InlB extract polyclonal antibody 108
ix
3.2.5 Intra- and interday inhibition assay variability studies o f each 
polyclonal antibody in PBS
3.2.6 Intra- and interday inhibition assay variability studies o f each 
polyclonal antibody in chocolate milk
3.2.7 Cross reactivity studies
3.3 Discussion
Chapter 4: Cloning, expression and purification of L isteria
m onocy togenes  invasion-associated protein gene 
sequences in E. co li
4.1 Introduction
4.2 Cloning of the InlB and p60 gene sequences into E. coli
4.2.1 Amplification o f the InlB and p60 gene sequences by PCR
4.2.2 TA cloning o f amplified gene sequences
4.2.3 Cloning o f amplified inserts into the pQE-60 expression vector
4.2.4 Time course experiments to determine the expression o f gene 
products
4.2.5 Determination o f protein solubility and cellular location
4.2.6 Sequencing o f the cloned InlB and p60 gene sequences
4.2.7 Determination o f the optimum IPTG concentration
4.2.8 Purification o f the InlB and p60 gene products by IMAC
4.2.9 Immunoreactivity o f the recombinant p60 and InlB proteins
4.3 Discussion
Chapter 5: Selection of recombinant scFv antibodies to
L isteria  m onocy togenes
5.1 Introduction
5.2 Production o f murine antibody libraries for the selection o f
anti -Listeria monocytogenes single chain Fv antibodies
5.2.1 Immunisation o f mice with heat-treated Listeria  
monocytogenes cells and InlB extract
5.2.2 Selection of primers for the amplification o f murine heavy and 
light chain genes
5.2.3 Amplification o f variable heavy (VH) and variable Light 
( V l )  antibody domains
116
121
125
110
128
129
131
131
131
132
137
137
141
141
145
148
152
155
156 
158 
158 
158 
160
x
5.2.4 Assembly o f VH and VL genes by splice by overlap extension 
(SOE) PCR
5.2.5 Digestion o f pAKlOO vector and SOE-PCR products formed 
by linking antibody light and heavy chain genes
5.2.6 Transformation o f E. coli XLl-Blue competent cells with 
pAKlOO vector containing light and heavy chain genes
5.3 Production o f single chain Fv antibodies to Listeria  
monocytogenes cells
5.3.1 Pre-panning selection and screening o f functional scFv 
sequences to Listeria monocytogenes cells and characterisation 
by ELISA
5.3.2 Selection and screening o f functional scFv sequences 
to Listeria monocytogenes cells by bio-panning
5.3.3 Alignment o f phage-scFv gene sequences and determination 
of antibody complementarity determining regions
5.3.3.1 Alignment o f  the three clones selected from the InlB extract 
library prior to bio-panning
5.3.3.2 Alignment o f  the three clones selected from the InlB extract 
library after bio-panning
5.3.3.3 Alignment o f  the three clones selected from the 
HT-Listeria monocytogenes library after bio-panning
5.3.3.4 Alignment o f  all nine clones selected from  both antibody 
libraries
5.3 .4 Homology modelling o f scFv sequences using Swiss-Model
and Swiss-PDB viewer
5.3.5 Expression o f soluble scFv with the pAK400 vector
5.3.6 Cross reactivity studies o f phage-scFv clones
5.4 Selection o f scFv antibodies from a naive human antibody library by 
bio-panning on Nunc immunotubes
5.4.1 Screening of scFv sequences to Listeria monocytogenes 
cells by phage ELISA
5.4.2 Determination o f antigen specificity o f clones F12 and B5 
by Western blotting
5.4.3 Sequencing and alignment o f positive phage-scFv clones
5.4.4 Expression of soluble scFv antibodies and characterisation 
by ELISA and Western blotting
5.4.5 Evaluation o f clone F12 phage-scFv antibodies for use in 
an Inhibition ELISA
160
160
163
163
166
170
170
171
172
173
178
183
185
187
187
190
190
193
160
196
xi
5.5 Selection o f scFv sequences against purified recombinant InlB and 
p60 from a naive human antibody library by bio-panning on Nunc 
immunotubes
5.5.1 Screening o f supernatant and periplasmic extracts of 
selected clones against recombinant protein and Listeria 
monocytogenes cells
5.5 .2 Development o f an ELISA-based immunoassay for the
indirect detection of Listeria monocytogenes cells using the 
anti-InlB clone G7 scFv antibody
5.5.3 Intra- and interday studies
5.5.4 Sequencing o f the scFv clone G7 and determination o f the 
antibody complementarity determining regions
5.5.6 Cross-reactivity studies of the scFv
5.6 Discussion
Chapter 6 : D eve lo p m en t o f  a b iosensor-based  assay f o r  the
detec tion  o f  L is te r ia  m onocy togenes u s in g  
su r fa ce  p la sm o n  resonance
6.1 Introduction
6.2 Indirect detection o f Listeria monocytogenes with an anti -Listeria
monocytogenes polyclonal antibody using a subtractive inhibition 
assay
6.2.1 Preconcentration o f the goat anti-rabbit Fab antibody on to 
the CM5 sensor chip surface
6.2.2 Immobilisation o f antibody on to the CM dextran sensor 
chip surface
6.2.3 Regeneration studies o f the immobilised anti-Fab antibody 
surface
6.2 .4 Development o f a subtractive inhibition assay for the 
detection o f Listeria monocytogenes cells
6.3 Direct detection o f Listeria monocytogenes with an anti-InlB extract 
polyclonal antibody
6.3.1 Preconcentration of the purified recombinant InlB protein on 
to the CM dextran sensor chip surface
6.3.2 Immobilisation o f the recombinant InlB protein on to the 
CM dextran sensor chip surface
198
203
203
206
206
209
213
214
216
216
219
222
222
227
227
198
230
xii
6.3.3 Regeneration studies o f a rlnlB immobilised surface
with a polyclonal anti-InlB antibody 230
6.3.4 Development o f  a BIAcore inhibition assay for the detection
o f Listeria monocytogenes 230
6.4 Indirect detection o f  Listeria monocytogenes with an anti-InlB
recombinant single chain Fv fragment antibody 237
Evaluation o f various sensor chip surface chemistries 237
6 .4. 1. 1 Evaluation o f a CM5 sensor chip 237
6.4.1.2 Evaluation o f a  NTA sensor chip 238
6.4.1.3 Evaluation o f  a C l sensor chip 243
6.4.1.4 Evaluation o f a HP A sensor chip 243
6.4.1.5 Reduction o f the overall negative charge o f  a CJ sensor chip 
surface by over-activation o f the surface carboxyl groups
and capping with ethylene diamine 244
6.4.2 Immobilisation o f recombinant InlB protein on to a BIAcore
C 1 sensor chip surface 248
6.4.3 Regeneration studies o f the anti-InlB scFv antibody 248
6.4.4 Development o f  a BIAcore inhibition assay for the indirect
detection o f Listeria monocytogenes using an anti-InlB scFv 
antibody 248
6.5 Discussion 255
Chapter 7: O verall co n c lu sio n s 260
Chapter 8 R e feren ces  26 7
xiii
Abbreviations
Ab antibody
A/Abs absorbance
ABS antigen binding site
ActA Actin A (Actin Assembly protein)
Ag antigen
AO AC Association o f Analytical Communities
Arp actin related protein
BHI brain heart infusion media
BIA biomolecular interaction analysis
BNL Brookhaven National Laboratories
bp base pairs
BSA bovine serum albumin
Cam chloramphenicol
CAT Cambridge Antibody Technology
cDNA complementary DNA
CDC Center for Disease Control and Prevention
CDR complementarity determining region
cfu colony forming units
Ch heavy chain constant domain
CL light chain constant domain
CM carboxymethylated
conc (c) concentration
CV coefficient o f variation
DNA deoxyribonucleic acid
dNTP deoxynucleotidyl triphosphates
dTNB 5,5'-dithio-bis(2-nitrobenzoic acid)
dTT Dithiothreitol
EB enrichment broth
E. coli Escherichia coli
EDC N-ethyl-N'-(dimethylamiopropyl) carbodiimide
EDTA ethylencdiaminetetra-acetic acid
ELISA enzyme-linked immunosorbent assay
Fab antigen binding region o f an antibody above the hinge
region
Fc constant region o f an antibody molecule
FCA Freunds’s Complete Adjuvant
xiv
FDA Food and Drug Administration
FLA Flow injection analysis
FITC fluorescein isothiocyanate
10Fn3 tenth fibronectin type III domain
FSAI Food Safety Authority o f Ireland
Fv variable binding region o f an antibody
GW glycine-tryptophan
g3p gene-3-protein
HACCP Hazard Analysis o f Critical Control Points
HAT Hypoxanthine aminopterin thymidine
HGF-R hepatocytes growth factor receptor
HGPRT hypoxanthine-guanine phosphoribosyl transferase
HT heat-treated
HBS Hepes buffered saline
HRP Horse radish peroxidase
IDF International Dairy Federation
IFR Institute for Food Research, Norwich
Ig immunoglobulin
IgG immunoglobulin class G
IMAC immobilised metal affinity chromatography
Ini Intemalin (series o f L. monocytogenes surface proteins)
InlA lntemalin A
InlB Intemalin B
InlC Intemalin C
IPTG isopropyl-p-D-galactopyranoside
ISO International Organisation for Standardisation
Kan Kanamycin
LB Luria Bertani media
LE low expression
LLO listeriolysin 0
Log logarithmic
LPS lipopolysaccharides
LRR leucine rich repeat
mAb monoclonal antibody
Mpl metalloprotease
mRNA messenger RNA
MW molecular weight
XV
NCTC UK national collection o f type cultures
NE non-expression
NHS N-hydroxysuccinimide
NTA nitrilotriacetic acid
OD optical density
OPD o-phenylenediamine dihydrochloride
PAGE polyacrylamide gel electrophoresis
PBS phosphate buffer saline
PBST PBS-Tween
PCR polymerase chain reaction
PDB Protein Data Bank
PEG polyethylene glycol
PLC phospholipase C
RCSB Research Collaboratory for Structural Bioinformatics
RI refractive index
rlnlB recombinant InlB
RIDS ribosomal-interaction display systems
RPM revolutions per minute
RT room temperature
RTA ricin A-subunit
RU response units
scFv single chain Fv antibody derivative
SDS sodium dodecyl sulphate
SIP selectively infective phage
SOC super optimal catabolites
SPR surface plasmon resonance
TBS Tris buffer saline
Tet tetracycline
TIR total internal reflection
TK thymidine kinase
TY yeast-tryptone
UY ultraviolet
VASP vasodilator-stimulated phosphoprotein
VH variable region o f heavy chain
v L variable region o f  light chain
X-Gal 5-bromo-4-chloro-3-indolyl-P-D-galactoside
XVI
Units
(k)Da (kilo) Daltons
1^ 1 microlitre
|o.M micromoles
°C degrees Celcius
cm centimetres
g grams
h hours
kg kilogram
1 litre
m metre
M molar
mg milligram
min minute
ml millilitre
mm millimetres
nM nanomolar
mol molar
pg picograms
rpm revolutions per minute
RU response units
sec, s seconds
v/v volume per unit volume
w/v weight per unit volume
(xg microgram
Publications
Leonard, P., Hearty, S., Quinn, J. and O ’Kennedy, R. (2003). Development o f a surface 
plasmon resonance-based immunoassay for the direct detection o f Listeria 
monocytogenes. Submitted to Applied and Environmental Microbiology.
Leonard, P., Hearty, S., Quinn, J. and O’Kennedy, R. (2003). A generic approach for the 
detection o f whole Listeria monocytogenes cells in contaminated samples using surface 
plasmon resonance. Biosens. Bioelectron., accepted 18th November.
Leonard, P., Hearty, S., Brennan, J., Dunne, L., Quinn, J., Chakraborty, T., and 
O'Kennedy, R. (2003). Advances in biosensors for the detection o f pathogens in food and 
water. Enzyme Microb. Tech., 32:3-13
Fitzpatrick, J., Fanning, L., Hearty, S., Leonard, P., Manning, B.M., Quinn, J.G., and 
O'Kennedy, R. (2000). Applications and recent developments in the use o f antibodies for 
analysis. Anal. Lett., 33(13):2563-2609
Leonard, P., Hearty, S., Quinn, J.G., and O'Kennedy, R. (2001). A pathogenic life cycle 
o f Listeria monocytogenes. INCO COPER1NICUS News, 3:1-2
Hearty, S., Leonard, P., Quinn, J.Q. and O ’Kennedy, R. (2002). Background to new rapid 
technology in detection of pathogens, part II: Book o f abstracts, New methods for the 
detection of Listeria monocytogenes. INCO COPERNICUS project ERBIC 15 CT98- 
0902. May 2002.
Pres entations/co u rs es
Leonard, P., Hearty, S. and O'Kennedy, R. (2003). Development o f an immunoassay to 
detect Listeria monocytogenes using a scFv antibody selected against purified 
recombinant Intemalin B protein. V llth International Conference on Agri-Food 
Antibodies, Uppsala, Sweden, September 10-13.
Completed the EMBO, NUI Maynooth Bioinformatics Summer School, 28th April to 3rd 
May 2003.
x v m
L eonard, P. (2003). Bioinformatics and antibody modelling. Antibody training course. 
DCU. February 12th.
L eonard, P. (2002). Introduction to Antibodies and the Immune System. CTYI guest
lecture. DCU 1st Dec.
L eonard, P. and O’Kennedy, R. (2002). Development o f a  biosensor based assay to  detect 
Listeria monocytogenes in “real time”. PhD Transfer meeting. DCU.
Leonard, P. and O’Kennedy, R. (2002). The generation o f  recombinant antibodies to
Listeria monocytogenes. The National Centre for Sensor Research cluster seminar. DCU 
23rd M ay 2002.
Leonard, P., Hearty, S., Quinn, J.G., and O'Kennedy, R. (2001). Listeria monocytogenes: 
antibody characterisation, biosensing developments and recombinant studies, lnco 
Coperinicus PL 979012project meeting, 10th-11th May, Zivkov, Czech Republic.
Hearty, S., Leonard, P., Quinn, J.G., and O'Kennedy, R. (2000). Rapid, specific detection 
o f Listeria monocytogenes by antibody techniques and on-line sensor technology; 
development o f improved control o f food safety for industry and the consumer, lnco 
Coperinicus PL 979012 project meeting, 22nd-24th Nov., Solvak Technical University, 
Bratislava, Solvakia.
Leonard , P., Hearty, S., Quinn, J.G., and O'Kennedy, R. (2000). Characterisation of anti-
Listeria monocytogenes polyclonal antibodies by ELISA and BIAcore. lnco Coperinicus 
PL 979012 project meeting, 25th-26th May, DCU, Dublin.
x ix
Summary
The inclusion of L. monocytogenes in the list of organisms subject to HACCP has recently 
driven the search for detection methods suitable for on-line monitoring. The aim of the 
work presented in this thesis was the development o f a biosensor-based immunoassay for 
the detection o f Listeria monocytogenes using SPR.
Two polyclonal antibodies were generated from Listeria monocytogenes M B  extract and 
heat-treated Listeria monocytogenes cells. Both antibodies were purified and characterised 
by ELISA, SDS-PAGE and W estern blotting. An inhibition ELISA-based immunoassay 
was developed with each antibody for the detection o f Listeria monocytogenes. Intra- and 
interday studies were performed to evaluate the accuracy and intermediate precision of the 
assays. The feasibility of detecting Listeria monocytogenes cells in chocolate milk, a  food 
matrix which has been reported to have been the cause o f a well known Listeria 
monocytogenes-&ssoc\atQ<\ food poisoning outbreak, was also examined. To determine the 
potential cross reactivity o f each antibody, inhibition ELISAs were performed with a 
number o f bacterial strains. It was concluded that both antibodies can be used as valuable 
tools for the genus-specific detection o f Listeria cells, but were severely limited for the 
species-specific detection o f Listeria monocytogenes cells.
Expressing Listeria monocytogenes invasion-associated proteins in E. coli allows the safe 
and efficient production o f high quantities of pure protein for use in the generation of 
Listeria monocytogenes specific antibodies and immunoassay development. Two Listeria 
monocytogenes invasion-associated proteins, Intemalin B (InlB) and p60 (also known as 
iap), were cloned and expressed in E. coli X L -10 Gold cells. Expressed protein was 
purified by immobilised affinity chromatography (IMAC) and used for the selection of 
specific antibodies (Chapter 5) and for the development a  biosensor-based immunoassay 
for the detection o f Listeria monocytogenes (Chapter 6).
The emergence o f recombinant antibody phage display technology has transformed the 
way we generate antibodies for the specific detection o f a chosen analyte. Chapter 5 
describes the development o f two combinatorial antibody libraries from mice immunised 
with Listeria monocytogenes cells and InlB protein extract. Phage scFv antibodies were 
selected from both murine antibody libraries and from a large naive human antibody 
library against Listeria monocytogenes cells and invasion associated protein. A number of 
the selected phage-scFv antibodies could not be expressed as soluble scFv and also 
showed tendencies to cross react with various bacterial strains tested. A soluble scFv
xx
antibody was selcctcd that recognised the Listeria monocytogenes invasion-associated 
protein, Internalin B, but did not recognise Listeria monocytogenes cells. An inhibition 
ELISA was developed with this antibody to indircctly detect Listeria monocytogenes.
The two polyclonal antibodies and the selected anti-InlB scFv antibody were used in 
development o f three biosensor-based immunoassays using a  BIAcore 3000 instrument 
(chapter 6 ). Various assay formats and sensor chip surfaces were evaluated. Intra- and 
interday assay variability studies performed to determine the precision and reproducibility 
of each assay. The assay developed with the polyclonal anti-InlB polyclonal proved to be 
most sensitive and cost effective while the assay developed with the anti-InlB scFv 
antibody fragment proved most specific for the detection o f  Listeria monocytogenes.
x x i
Chapter 1
Introduction
i
1.1 Section overview
The aim of this thesis was to develop a rapid biosensor-based immunoassay for the 
detection of the food pathogen, Listeria monocytogenes. This chapter reviews the 
important human pathogen, Listeria monocytogenes and its pathogenicity life-cycle. The 
main Listeria monocytogenes pathogenicity-relatcd proteins and recent Listeria 
monocytogenes associated food poisoning outbreaks are discussed in detail. The current 
methods o f Listeria monocytogenes detection are examined and the use o f antibody-based 
assays for the detection of bacteria discussed. A detailed description of the structure and 
characteristics o f antibodies is given and the rapidly expanding area o f antibody 
engineering introduced and explained. The use o f surface plasmon resonance (SPR)-based 
biosensors for the detection o f bacteria is also reviewed. Finally, a thesis outline is 
presented, highlighting the strategy pursued for the development o f a biosensor-based 
immunoassay for the detection o f Listeria monocytogenes.
1.2 Introduction to Listeria monocytogenes
The bacterial genus Listeria  consists o f a group o f facultatively anaerobic, asporogenous 
Gram-positive rods closely related phylogenetically to Bacillus, Streptococcus, 
Enterococcus, Staphylococcus and Clostridium (Vazquez-Boland et al., 2001). O f the six 
currently recognised species o f Listeria, (L. innocua, L. ivanovii, L. monocytogenes, L. 
grayi, L. seeligeri, and L. welshimeri), L. monocytogenes is the principal human pathogen, 
with only a few known cases o f human listeriosis due to the animal pathogen L. ivanovii 
(Wyatt, 1999). Since its discovery by E.G.D. Murray in 1926 (Murray, et al., 1926), 
Listeria monocytogenes has become regarded as an important food borne pathogen and 
was the cause of many recent well-publicised food poisoning outbreaks (Schlech, 2000; 
Donnelly, 2001). Even though L. monocytogenes was frequently associated with sepsis and 
meningoencephalitis in immunocompromised patients in the 1950s and 1960s (Nieman 
and Lober, 1980), it was not until the 1980s that L. monocytogenes was recognised as an 
important food borne pathogen. Prior to the 1980s, listeriosis was primarily o f veterinary 
concern but as a result of its wide distribution in the environment and its ability to grow at 
refrigeration temperatures, L. monocytogenes can be readily isolated from soil, dust, 
fertilizer, sewage, water, plants, and even processed foods stored at 4°C (Southwick and 
Purich, 1996).
L. monocytogenes is a Gram-positive facultatively anaerobic rod-shaped bacterium that 
grows between 1-45°C. Optimal growth occurs between 30-37°C within the pH range o f
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pH 5.0 and 9.0, in a NaCl concentration o f 10% (Jones and Seeliger, 1992). So far, Listeria 
monocytogenes is the only Gram-positive organism that has been found to contain 
authentic lipopolysaccharides (LPS). The LPS of Listeria monocytogenes and those o f all 
Gram-negative species arc also called endotoxins, thereby distinguishing these cell-bound, 
heat-stable toxins from heat-labile, protein exotoxins secreted into culture media. In 
addition to causing endotoxic shock, LPS is pyrogenic, can activate macrophages and 
complement, is mitogenic for B lymphocytes, induces interferon production, causes tissue 
necrosis and tumour regression, and has adjuvant properties (Peake et al., 1996 and 
Murray et al., 1998). Most food-borne outbreaks o f listeriosis have been caused by L. 
monocytogenes serotype 4b, although no distinct correlation between this serotype and 
greater virulence has been observed (Schlech, 1997). Pregnant women and newborns, 
elderly people and people with weakened or suppressed immune systems caused by 
chemotherapy, AIDS, diabetes and kidney disease are especially at risk to listeriosis. 
Indeed, immunocompromised patients can be up to 500-1000 times more susceptible to 
listeriosis than the general population (Jensen et al. 1994 and Hof, 2003). In the majority 
of cases, infection by L. monocytogenes results in symptoms such as mild fever, diarrhoea, 
nausea or vomiting accompanied by a slight headache. However, in more severe cases 
Listeria  infection can cause septicaemia, meningitis and meningo-encephalitis. Listeriosis 
can also cause stillbirths and spontaneous abortions (Doganay, 2003). The number o f food 
poisoning cases due to L. monocytogenes may be very few (Table 1) compared to that o f 
other bacteria such as Salmonella (1/3 o f all cases in the U.S), Staphylococcus aureus 
(25% o f all cases in the U.S), Clostridium perfringens (17% of all cases) and Escherichia 
coli 0157:H7, (Anonymous, 1997), but the fatality rate is far greater. According to the 
Center for Disease Control and Prevention (CDC) in the US, approximately 25% of the 
people (1 in 4 people) who contract listeriosis die as a result o f the illness. However, other 
reports on the disease claim that the fatality rate could be as high as 29% (Fleming et al. 
1985) or 30% (Cossart et al., 2003).
The outbreaks of listeriosis in late 80s and 90s (discussed later) in both the EU and the 
United States has lead to the recognition o f  the hazard caused by this organism and has 
resulted in tightening o f the control o f hygiene during the production o f food associated 
with Listeria  food poisoning, namely soft cheeses and milk. In the United States the Food 
and Drug Administration has adopted a policy o f “zero tolerance” for the presence o f 
Listeria in food. Also the food industry, in both the EU and U.S., have introduced a 
program called Hazard Analysis o f Critical Control Point (HACCP) which aims to 
effectively eliminate Listeria monocytogenes from food processing environments and, 
therefore, processed food products (Schlech, 1997; Anonymous, 1997, and Donnelly,
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2001). Due to the increase in the number o f human listeriosis cases between 1987 and 
1989 in England and Wales, the Dairy Products (Hygiene) Regulations for England and 
Wales, based on the European Council Directive 92/46/EEC as amended, became law on 
9th May 1995. According to these regulations, L. monocytogenes should be absent from lg  
samples o f hard cheese and from 25g samples o f certain soft cheeses. Pasteurization still 
remains the first line of defence against the transmission o f  foodbome disease through milk 
and other dairy products contaminated on the farm (Schlech, 1997).
Table 1.1: A summary o f  estimated foodborne illnesses, hospitalisations and deaths caused by 
selected pathogens in the US annually as calculated by the USDA's Economic Research Service.
Bacteria
Estimated
annual
cases
Estimated
annual
hospitalisations
Estimated
annual
deaths
Onset
Infectious
dose
(CFUs)
Salmonella 1,342,532 16,102 556 6 hours to 28 days 104to 107
Listeria
monocytogenes
2,493 2,298 499 A few days to 3 weeks
400 to 103
Campylobacter
spp.
1,963,141 10,539 99 2 to 5 days 400 to 106
E. coli (0157:H7 
and other types)
173,107 2,785 78 12 hours to 3 days
101 to 102
Clostridium
perfringens 248, 520 41 7
18 to 36 
hours
> 108
Staphylococcus 
food poisoning
185,060 1,753 2 1 to 7 hours > 106
1.3 A pathogenic life cycle: L. monocytogenes
To cause infection, many bacteria must first adhere to a mucosal surface such as the 
alimentary tract mucosa. The alimentary tract mucosa is continually cleansed by the 
release o f mucus from goblet cells and by the peristaltic flow o f the gut contents over the 
epithelium. Similarly, ciliated cells in the respiratory tract sweep mucus and bacteria 
upward. In addition, the turnover of epithelial cells at these surfaces is fairly rapid. The 
intestinal epithelial cell monolayer is continually replenished, and the cells are pushed 
from the crypts to the villar tips in about 48 hours. To establish an infection at such a site, a 
bacterium must adhere to the epithelium and multiply before the mucus and extruded 
epithelial cells are swept away. To accomplish this, bacteria have evolved attachment 
mechanisms, such as pili and colonisation factors that recognise and attach the bacteria to 
cells (Peake et al., 1996).
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Listeria monocytogenes has the amazing capacity to cross three tight barriers in humans, 
that is the intestinal, the blood-brain and the fetoplacental barriers (Cossart, 2002). During 
infection, it enters, survives and multiples inside phagocytic and non-phagocytic cells and 
also spreads directly from cell to cell. These features are considered to be central to the 
pathophysiology o f listeriosis (Vasquez-Boland et al., 2001). Listeria-induced 
internalisation, like all phagocytic processes, is a complex phenomenon that is driven by a 
finely controlled rearrangement o f the actin cytoskeleton coupled to membrane extensions 
that lead to engulftnent o f the bacterium (Machesky and May, 2001 and Cossart et a l,  
2003). Invasive bacteria have been classified into two groups according to the type of 
morphological change that occurs at the site o f entry (Finlay and Cossart, 1996). Bacteria 
such as Salmonella  and Shigella  belong to a group o f bacteria that enter cells by a process 
known as a “trigger mechanism”. In the trigger mechanism, a bacterium in contact with a 
cell delivers virulence factors directly into the host cytoplasm and these virulence factors 
activate both the cytoskeleton machinery and several signal transduction pathways, 
resulting in the formation of large membrane ruffles that internalise the bacterium in a type 
of macropinocytosis (reviewed by Cossart el al., 2003). Alternatively, internalisation can 
result from the tight apposition o f the plasma membrane over the entering bacterium. This 
process, also called the “zipper mechanism” is used by Listeria monocytogenes and 
appears different from the above mentioned “trigger mechanism” (Cossart, 2002). In the 
zipper mechanism a bacterial ligand interacts with a surface molecule on the host cell, 
which is generally a protein involved in cell adhesion and/or activation of the cytoskeleton 
machinery. Interaction o f this receptor with the bacterial ligand induces local 
rearrangements in the actin cytoskeleton and other signals that culminate in the tight 
envelopment o f the bacterial body by the plasma membrane (reviewed by Cossart et al., 
2003).
As discussed, L. monocytogenes has been observed to have a very unusual life-cycle with 
only a few species o f bacteria like Shigella flexneri (Bemardini et a l ,  1989) and Rickettsia 
(Heinzen et al. 1993) using the same method o f intra- and intercellular spread through 
interaction with f-actin. A family o f bacterial cell-wall surface proteins, called intemalins 
(described later), are present at the cell surface o f L. monocytogenes which promote entry 
into epithelial cells and hepatocytes (Gaillard et al. 1991; Dramsi et al. 1995 and Cossart 
and Bieme, 2001). L. monocytogenes also uses the body’s own defence systems to gain 
entry into the cytoplasm of infected cells. Phagocytosis encloses the bacterium in a 
subcellular organelle called a phagolysosome, which is a toxic and hostile environment for 
most bacteria. The pH  inside the phagolysosome drops which in turn activates listeriolysin 
O (LLO) and the bacterial metalloprotease (Mpl) resulting in lysis of the organelle within
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30 minutes (Cossart, 2002), allowing the bacterium to escape into the cytoplasm. All 
pathogenic strains o f Listeria produce listeriolysin O as entry o f the bacteria into the 
cytoplasm o f the host cell is required for pathogenesis (Kathariou et al., 1987).
Figure 1.1: Cell cycle distribution o f ActA protein (black dots) and actin filaments (black lines) in 
L. monocytogenes (adapted from Maddock et al. 1993). When free in the cytosol, Listeria starts to 
replicate while inducing the recruitment and the polymerisation o f cellular actin. ActA, requiredfor 
the bacterial-induced actin assembly, is distributed around the cell except at the pole following cell 
division (Knock et al., 1993). The direction o f movement o f the new cells is therefore in opposite 
directions as indicated by the arrows.
Within the cytoplasm, L. monocytogenes can proliferate and becomes surrounded by a high 
density o f cytoplasmic actin. Actin is the most abundant protein in the cytoplasm o f 
mammalian cells, accounting for 10 to 20% o f the total cytoplasmic protein. It exists either 
as a globular monomer (G-actin) or a filament (F-actin), the latter formed by head to tail 
polymerisation o f asymmetric monomers (Southwick and Purich, 1996). As the cell 
divides or proliferates, ActA protein (Figure 1.1) and actin filaments are distributed around 
the cell with the exclusion o f the new pole. As the septation region is devoid o f  ActA, the 
movement o f the progeny is usually in opposite directions to each other (Maddock et al. 
1993).
Using this actin-based motility process, the bacterium migrates to the peripherary o f the 
cell where it creates a protrusion or "filopod" into the adjacent cell. This filopod can be
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ingested into the adjacent cell forming a now double membraned phagolysosome (Figure
1.2) where the life cycle begins over again (Southwick and Purich, 1996).
Figure 1.2: Life cycle o f L. monocytogenes in host cells (Adapted from Southwick and Purich, 
1996). The Listeria intracellular life cycle involves a number o f stages (indicated) starting with the 
entry of the bacterium into the host cells using the virulence factors discussed below. Phagocytosed 
Listeria monocytogenes survives within the phagocytic vacuole and within less than 30 minutes 
disrupts the phagosomal membranes and escapes into the cytosol. In the cytosol, the Listeria 
monocytogenes cells replicate and utilise actin-based motility to direct cell-to-cell spread.
1.4 Virulence factors involved in the entry o f  Listeria monocytogenes into host cells
Listeria monocytogenes is able to efficiently invade normally non-phagocytic cells by 
triggering an induced phagocytosis involving a number o f specific proteins (listed in Table
1.2). Actin A (ActA) and p60 (iap gene product) are involved in the invasion o f some cell 
types (discussed later), but clearly the most important listerial factors involved in uptake 
by host cells are the intemalin proteins. These proteins are encoded on a multi-gene family, 
the first two, Intemalin (InlA) and Intemalin B (InlB) (discussed below), have been 
detected in the inlAB operon and are the most extensively studied (reviewed by Kreft et al.,
2002). The function o f other intemalins during infection has not yet clearly been 
elucidated, although a mutant lacking the inlE, inlG and inlH genes is avirulent in a mouse 
infection model (Schubert et al., 2001). The products o f all these genes (Intemalin multi­
gene family) are rather larger proteins with a characteristic structure. The primary structure 
o f intemalins is characterised by a modular architecture (see Figure 1.3) essentially
tr■
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comprising two repeat regions separated by an inter-repeat (IR)-region (Schubert et al, 
2001). At their N-terminus, a canonical export-mediating sequence, the signal peptide, is 
found, followed by a stretch of 6-16 leucine-rich repeats (LRRs) (depending on the 
respective protein and also on the definition o f the LRR; Kreft et al, 2002). Leucine-rich 
repeats (LRRs) are 20-29 residue sequence motifs present in a number o f proteins with 
diverse functions. The primary function o f these motifs appears to be to provide a versatile 
structural framework for the formation o f protein-protein interactions (Kobe and Kajava, 
2001). In the case o f Listeria, these are blocks o f 22 amino acids with a characteristic 
signature o f leucines; the repeat units together forming a right-handed parallel beta-helix 
(Kreft et al, 2002).
Table 1.2: Summary o f the main Listeria monocytogenes invasion-associated proteins and their 
receptors.________________________ ____________________________________ ______________________________
Listeria monocytogenes 
associated protein Protein function
Host receptor/ligand
Listeriolysin O (LLO)
Lysis o f phagolysosome in 
conjunction with the 
bacterial metalloprotease 
(Mpl)
Activated by drop in pH
Actin A (ActA)
Intracellular movement by 
polymerisation o f host 
cellular actin
Actin
Intemalin (InlA)
Invasion associated protein 
promoting phagocytosis in 
cells expressing its receptor
E-Cadherin
Intemalin B (InlB)
Invasion associated protein 
promoting phagocytosis in a 
broad spectrum of cells by 
activation of 
phosphatidylinositol-3 - 
kinase
Hepatocytes growth factor 
receptor (HGF-R/Mct) and a 
glycoproteins called gC lq- 
R
p60 (also known as iap)
Invasion associated secreted 
protein required for invasion 
into non-phagocytic host 
cells
Unknown
The receptor for InlA is the cell adhesion molecule E-cadherin (Mengaud et al., 1996a). E- 
cadherin is a  calcium-dependent cell adhesion molecule composed o f five extracellular 
domains and a  cytoplasmic tail (Takeichi, 1990). It plays a key role in embryogenesis by 
mediating the sorting o f cells in tissues (Larue et a l, 1994). In adult life, it contributes to 
cell cohesion and tissue architecture (Hermistion and Gordon, 1995 and Cossart, 2001b). 
E-cadherin mediates adhesion between epithelial cells through homophilic interactions 
which require the first extracellular domain (EC1). Both lateral dimérisation o f the 
ectodomain and connection o f the cytoplasmic tail o f  E-cadherin to the actin cytoskeleton 
via catenins are required for strong homophilic interactions and formation o f “adherens 
junctions” between epithelial cells (Lecuit et a l, 1999). InlA is an 80kDa protein that
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promotes phagocytosis in cell lines expressing its receptor, E-cadherin (Mengaud e t al., 
1996a). Expression o f InlA in the non-invasive bacterium L. innocua renders the organism 
capable o f invading caco-2 cells suggesting that InlA may be sufficient for entry (Gaillard,
1991). Recently, InlA was shown to promote the translocation of L isteria monocytogenes 
through the intestinal barrier (Lecuit et al., 2001). By using anti-E-cadherin antibodies in a 
microtiter plate binding assay, Mengaud et al, (1996b) demonstrated that binding of Caco- 
2 cells to intemalin was strictly E-cadherin-dependent. The nature o f the amino acid at 
position 16 of E-cadherin is crucial for InlA-E-cadherin interaction and is species-specific 
(Lecuit et al., 1999). The primary structure o f intemalin can be characterised by two 
different regions of repeats. The first region is made o f fifteen 22 amino acid leucine-rich 
repeats (LRRs) (Cossart, 2001b). The second region is formed of three consecutive repeats, 
two o f 70 amino acids and one of 49 amino acids (Mengaud et al., 1996a,b). The carboxy- 
terminal region o f InlA contains an LPXTG motif (where X  can be any amino acid), a 
signature sequence necessary for sorting and cell wall anchoring o f many surface proteins 
of gram positive bacteria (Lecuit et al., 1997 and Cabanes et al., 2002). LPXTG surface 
proteins are anchored to the cell wall by transpeptidases named sortases (Navarre and 
Schneewind, 1999). It has been suggested that intemalin is anchored to the cell wall of 
Listeria monocytogenes by covalent linkages via the threonine residue o f the conserved 
m otif LPXTG (where X is any amino acid), (Fischetti et a l ,  1990 and Schneewind el al., 
1995).
While InlA promotes the infection o f human cnterocyte-like cell lines, InlB shows a much 
broader host cell spectrum and promotes invasion by activation o f  phosphatidylinositol-3- 
kinase (Ireton and Cossart, 1997 and Schubert et al., 2001). InlB is an agonist o f  the 
hepatocyte growth factor receptor (HGF-R/Met), a widely expressed receptor tyrosine 
kinase involved in complex cellular processes, such as cell proliferation, dissociation, 
migration and differentiation (Shen et al., 2000). InlB also interacts with gClq-R , a 
ubiquitous glycoprotein (Braun et al., 2000), and with proteoglycans (Jonquieres et al., 
2001) that might potentiate interactions with Met. InlB is a 630 amino acid protein that is 
one of the 24 member L. monocytogenes intemalin-related protein family (Glaser e t al., 
2001 and Bieme and Cossart, 2002). It has been shown to mediate entry into cultured 
hepatocytes (Dramsi et al. 1995), and some epithelial, endothelial and fibroblast cell lines, 
including HeLa, HEP-2, CHO, L2, and Vero (Dramsi et al. 1997 and Parida et al., 1998). 
InlB contains leucine rich repeats (LRRs) similar to those in InlA, (Dramsi et al. 1997). As 
shown in Figure 1.3, most Intemalin-like proteins have a short N-terminal conserved cap 
region, followed by several leucine-rich tandem 22-residue repeats (LRR) and an inter 
repeat (IgG-like) region. In some cases, a  second repeat region o f up to three repeats of
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-7 0  residues, the B-repeats are present (Bierne and Cossart, 2002). According to Parida et 
al. (1998) and Schubert et al. (2001), InlB possess 7 LRRs and one B repeat. However, 
InlB has also been reported to contain 6 (Cabancs et al., 2002) and 8 (Bierne and Cossart, 
2002 and Cossart, 2001b) leucine-rich repeat units (see Figures 1.3 and 1.4). The C- 
terminal region o f InlB contains three tandem ~80-rcsidue repeats, which are highly basic 
and start with the dipeptide glycine-tryptophan (GW) (Braun et al., 1997). The mechanism 
of association o f InlB with the bacterial surface is different from that o f InlA. InlB protein 
does not contain any known cell-surface anchoring region, such as a hydrophobic C- 
terminal region or an LPXTG motif. Instead InlB is attached to the bacterial surface via the 
232 amino acid GW repeat region beginning with the sequence glycine-tryptophan (GW) 
that is also present in a  newly identified surface-associated bacteriolysin o f L. 
monocytogenes, called Ami (Cabanes et al., 2002). These repeats mediate a loose 
association of the protein with the bacterial surface, mainly through non-covalent 
interactions with lipoteichoic acid, a membrane-anchored polymer present on the surface 
of Gram-positive bacteria (Jonquieres et al., 1999).
10
11
Cap domain
In lB 36_32j
/  LRR dom ain 
showing 8 repeats
(7  strictly  in the L R R  region)
IgG-like dom ain
Figure 1.3: Structures ofInlA36.496 (PDB code 106T), InlH36_343 (PDB code 1H6U) and InlB¡6.32i (1H6T) 
viewed using Swiss-PDB viewer. Panel A shows the 3D structures oflnlA, InlH and InlB in a view towards 
the concave surface o f the leucine rich repeat (LRR) region, a-helices are coloured in red, loops in solid 
grey and (3 strands as yellow arrows pointing in a N-terminus to C-terminus direction. Panel B shows the 
structures presented in panel A coloured according to domain structure. The area coloured in green 
represents the cap domain, the LRR region is coloured in red and the IgG-like domain coloured in orange. 
The final ¡3 strand (coloured purple) o f the LRR region is simultaneously the first strand o f the IgG-like 
domain. Panel C shows the structures coloured in grey with the leucine rich repeats coloured in red. 
Generally LRRs are 20-29 residues long and contain a conserved 11 -residue segment with the consensus 
sequence LxxLxLxxxxL where x can be any amino acid and L positions can also be occupied by valine, 
isoleucine and phenylalanine (Kobe and Kajava, 2001). In Listeria, the internalin family o f LRR proteins 
have varying numbers o f repeats o f 22 amino acid residues. In the diagram only the two repeat residues 
(i.e. LxxLxLxxxxL) present on the ¡3-strands are coloured in red. InlA has 15 tandemly arranged leucine- 
rich repeats, InlH has 8 repeats and InlB has 7 repeats. Panel D shows an enlarged view o f the InlB 
structure shown in C with the leucine-rich repeat residues coloured in red. As shown in panel B, the last ¡3- 
strand o f the LRR region simultaneously forms the first strand o f  the IgG-like domain. Depending on the 
classification o f the LRR region (i.e. inclusion of the last /3-strand) the InlB structure presented can be 
classified as having 7 or 8 repeats. In the literature InlB have been reported to have between 6 and 8 
repeats (see text).
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Internalin B protein domains
Cap LRR region m B GW GW GW
Figure 1.4: Diagram of the Internalin B protein (PDB code 1M9S) domain structure (adaptedfrom Bierne 
and Cossart, 2002 and Cossart et al., 2003). The Internalin domain o f InlB contains four domains; a cap 
region, leucine rich repeats (LRRs), an IgG-like domain also known as an inter-repeat (IR) region and a B- 
repeat region. The amino terminal part encompassing the LRR and IR regions is involved in Met 
recognition. The protein is anchored to the cell surface via it carboxy-terminal GW repeat domains. The 
InlB protein tertiary structure shown was taken from the Protein data bank (1M9S) and viewed using the 
Swiss-PDB viewer program. The white dotted line represents the B-repeat region which could not be 
modelled.
GW domains
IgG-like 
domain
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L. monocytogenes requires a 60-kDa major extracellular housekeeping protein for normal 
cell division (Bubert et al., 1994 and Rowan et al., 2000). This major extracellular 60 kDa 
protein (pi 9.5) was originally reported by Kuhn and Goebel (1989) and termed as p60. 
This p60 protein is transcribed independently o f the central virulence regulator PrfA, and it 
is also involved in the attachment o f L. monocytogenes to certain eukaryotic cells (Rowan 
et al., 2000). The gene coding for p60 is called iap (invasion-associated protein) and its 
expression is controlled at the posttranscriptional level (Bhunia, 1997). P60 is a modular 
protein containing two LysM domains, a bacterial Src homology 3 (SH3) domain and a 
carboxy-terminal NLPC/P60 domain (Cabanes et al., 2002). The LysM domain (40 
residues long) is found in a variety o f enzymes involved in degradation of the bacterial cell 
wall and is thought to have a general peptidoglycan-binding function. It has been shown 
that the p60 protein is among the strongest antigens in listeriae for B- and T-cell responses
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(Geginat et a l ,  1999 and Kolb-Maurer et a l,  2001). It has also been shown that p60 
possesses murein hydrolase activity without which cells tend to form long chains, where 
septum formation between individual cells was intact but cells do not separate (Kuhn and 
Goebel, 1989). Further studies revealed that the lack o f p60 protein was responsible for the 
loss o f cell invasion ability (Kuhn and Goebel, 1989 and Park et a l ,  2000b) and only the 
addition o f purified p60 into culture media restored the cell internalisation capacity o f 
these mutant cells. The addition o f purified p60 also conferred increased cellular uptake 
when expressed in Salmonella typhimurium  (Hess et al., 1995) and, therefore, it was 
evident that p60 is an essential factor in the invasion into non-phagocytic host cells (Park 
eta l., 2000b).
Intracellular movement o f Listeria monocytogenes requires the expression o f a surfacc 
protein called “actin assembly” or ActA (Bhunia, 1997), and the two-membrane vacuole is 
lysed by Listeriolysin O and a lecithinase (PC-PLC) (Cabanes et al., 2002). Listeriolysin 
O, a 58 kDa protein encoded by hly, is a  member of a  large family o f oxygen-labile, 
sulphydryl-activated cytolysins present in many Gram-positive bacteria (Golfine and 
Wadsworth, 2002). When inside the cell, the cell recognizes the endocytosed vacuole as a 
target for degradation. How this recognition occurs is not fully understood, but the sudden 
drop in pH activates listeriolysin O (LLO) and metalloprotease (Mpl), the latter cleaving 
the bacterial-secreted phospholipase C (proPC-PLC) to its active form with vacuolar lysis 
occuring rapidly (Robbins et al. 1999).
1.5 Intracellular spread o f  Listeria: An actin-based process
Once escaped from the phagolysosome, the bacterium resides within the host cytoplasm 
where it harnesses the host machinery required for actin assembly, generating a comet-like 
tail (Figure 1.5) which propels the bacterium within the host cell (Sanger et al., 1992 and 
Theriot et al., 1992). It is this actin-based motility that enables L isteria  to spread infection 
from one cell to the next via a membrane-bound protrusion. ActA, a 639 amino acid 
protein with a C-terminal hydrophobic region (Laurent et al. 1999) involved in anchoring 
to the membrane, is needed for polymerization o f host actin and movement (Domann et a l ,
1992). Genetic studies have shown that ActA possesses two regions important for motility. 
The NH2-terminal region (1-262) appears solely responsible for actin nucleation, a low- 
probability process in which three actin monomers combine simultaneously to form a 
thermodynamically unstable trimer, the first step in the formation o f filaments. The central 
domain (263-390), which contains four proline rich repeats, controls the rate o f movement 
(Pistor et a l ,  1995; Lasa et al., 1997 and Goldberg, 2001). The proline-rich repeats of 
ActA form the binding site for vasodilator-stimulated phosphoprotein (VASP) (Laurent et
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al, 1999) one of the many cellular proteins including alpha-actinin, profilin, cofilin, 
vinculin and the Arp2/Arp3 complex, which is involved in actin-based movement (Ireton 
and Cossart, 1997; Cossart, 2000; Bieme et al, 2001 and Merz and Higgs, 2003).
VASP is associated with microfilaments in focal contacts and lamellae in spreading cells 
(Goldfine, 2001). This tetramer o f identical 40-kDa subunits binds to profilin, a host cell 
component which binds to  actin monomers in a one-to-one complex, alters the 
confirmation o f  the actin monomer, and accelerates the exchange o f  ATP for actin-bound 
ADP (Goldschmidt-Clermont, 1992) and ActA. ActA has four potential VASP-binding 
sites and VASP has 16 potential profilin-binding sites. As a result, this two-step binding- 
mechanism allows one ActA molecule to concentrate up to 64 profilin molecules, strongly 
amplifying the ability of Listeria to promote the assembly o f actin filaments (Southwick 
and Purich, 1996).
ActA protein also contains a positively charged amino acid sequence thought to be 
involved in promoting actin nucleation by attracting negatively charged actin monomers 
(Southwick and Purich, 1996). The multiprotein complex isolated from platelet extracts, 
containing the actin-related proteins Arp2 and Arp3 (Cooper and Schafer, 2000 and 
Cossart, 2000), is sufficient to initiate actin polymerization at the surface o f Listeria, most 
likely by interacting with ActA (Welch et al., 1998). The Arp2/3 complex has been 
observed to remain bound to the pointed ends of nucleated filaments and is uniformly 
distributed throughout the actin tail while the bacterium is moving (Welch et al., 1997). 
Although the direct binding of Arp2/3 to ActA has not been demonstrated, the domain of 
ActA that was found to synergize with Arp2/3 in nucleating actin assembly in-vitro, maps 
to the N-terminus o f the protein, the same region of ActA that has been shown to be 
essential for nucleation o f actin assembly on the surface o f the bacterium within the 
cytoplasm o f the mammalian cell (Beckerlc, 1998). Indeed, when ActA and Arp2/3 are 
mixed together with monomeric actin, the nucleation phase o f actin assembly which is 
normally slow, is essentially instantaneous (Beckerle, 1998 and W elch et al., 1998). It is 
thought that Arp2/3-dependent capping o f actin filaments may also enhance their stability 
by slowing disassembly from the pointed end o f the polymers (Berkerle, 1998).
Other proteins such as capping proteins, ADF/cofilin and alpha-actinin play an important 
role in enhancing filament turnover, i.e. in increasing the site-directed barbed end-growth 
(Carlier, 1998). Alpha-actinin, a homodimer with an actin-binding site on each monomer, 
has the ability to cross-link actin filaments (Ireton and Cossart, 1997). It has been shown 
that microinjection o f infected cells with a 53-kDa proteolytic fragment o f this protein,
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causes the disappearance o f bacteria-containing filopodia and an arrest in movement (Dold 
et al., 1994), indicating that this fragment acts as a dominant negative protein and that 
cross-linking o f actin filaments is important for growth. Cofilin(ADF), a small G- and F- 
actin binding protein, increases the rate o f actin depolymerization and shortens actin tails 
in human platelet extracts, while addition to highly diluted platelet extracts increased the 
rate o f bacterial movement (Carlier, 1997). From these results it was suggested that cofilin 
may affect bacterial motility by stimulating the rate o f actin filament turnover.
^  a -a c tin in « g l ^ l  A ctin  filam ent ■ ■ ■ ■  A ctA
A rp2/3 com plex •  V A SP
C apping 
^  pro tein V  C ofilin Profilin
Figure 1.5: Model o f the Listeria monocytogenes actin-based motility process adapted from Cossart and 
Bierne (2001). The network o f  elements known as the actin cytoskeleton provides the supportive framework 
of the three-dimensional structure o f eukaryotic cells (Goldberg, 2001). Intracellular microbial pathogens 
such as Listeria, have evolved mechanisms to utilise pre-existing pathways o f actin cytoskeleton 
rearrangements to generate their own motility within cells. ActA binds the Arp2/3 complex at its Arp2/3 
binding domain and an actin monomer at its actin-binding domain. ActA also binds VASP at its proline- 
rich repeat region with VASP in turn binding profilin. The actin nucleation activity of the Arp2/3 complex 
is stimulated by its binding to ActA and mediates the addition o f actin monomers to the barbed end and 
caps the pointed end o f a new actin filament. As the filament extends, the original Arp2/3 complex is 
released from ActA and another Arp2/3 complex binds both ActA and the side o f the existing actin filament. 
Repeated rounds o f filament branching, filament nucleation, filament extension, and Arp2/3 complex 
release generate a network o f actin filaments linked at 70° angles (Goldberg, 2001). At a distance from the 
bacterial surface, filament barbed ends are capped, thereby halting the addition of more actin monomers. 
Also filaments debranch and, with the assistance o f the actin severing protein cofilin, depolymerise,
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thereby maintaining a local pool o f  actin monomers (Goldberg, 2001). The continuous assembly o f an actin 
tail provides sufficient force to propel the organisms through the cytoplasm o f the infected cell and into 
adjacent cells (see Figure 1.2 for a diagram o f the intracellular spread o f Listeria).
1.6 Recent outbreaks o f  listeriosis
Although usually associated with soft cheeses and unpasteurised milk (Harvey and 
Gilmour, 1992 and Rea et al., 1992), L. monocytogenes can be found in a wide variety of 
foods. Listeriosis outbreaks in the United States and the UK, have been linked to  foods 
such as hot dogs, pâté, cheese and chocolate milk. A survey o f ready-to-eat (RTE) foods 
in Northern Ireland reported that high numbers o f L. monocytogenes were also found in 
foods such as chicken and fish (Wilson, 1995). The isolation o f L. monocytogenes from a 
wide variety o f foods and recently reported Listeria-associated food poisoning outbreaks, 
have prompted the recognition of Listeria monocytogenes as a potentially very dangerous 
food-borne pathogen.
Cheese, milk, pâté and luncheon meats contaminated with L. monocytogenes all have a 
history o f causing listeriosis. In January 2000, the Food Safety Authority o f Ireland (FSAI) 
ordered the withdrawal o f two French pâtés by retailers throughout the country. The pâtés 
were Rillettes (goose, duck or pork) and Langotine (pork tongue in aspic) and were 
manufactured under the brand name Paul Predault by Société Coudray in France. An 
advertisement placed in the Irish Times newspaper on Monday 10th January 2000 by the 
FSAI warned consumers not to consume these pâtés following a number o f  cases of 
Listeria  poisoning in France (de Valk et al., 2001) which have been associated with the 
pâtés. While there were no reported cases o f such poisoning here in Ireland, a 75-year-old 
man and a baby contaminated in the womb died from Listeria  suspected to have come 
from the company’s Rillettes. Four other cases o f Listeria  poisoning were also reported in 
France with one victim in a coma. In a large epidemic in California in 1985, soft Mexican- 
style cheese was implicated as the vehicle (Schlech, 1997), in which at least 142 cases of 
listeriosis including 48 deaths, were reported. According to the Institute of Food Science 
and Technology (UK), an outbreak in Switzerland between 1983 and 1987, involving at 
least 122 cases (including 34 deaths) was eventually reported to be due to contamination of 
Vacherin M ont d ’Or cheese (Bille, 1990). In 1989 samples o f pâté imported into the UK 
were found to contain high numbers o f L. monocytogenes and the pâté was withdrawn 
from sale. L. monocytogenes isolated from the pâté and comparison with strains from 
patients with listeriosis during the outbreak from 1987-1989 provided strong evidence that 
many cases o f listeriosis, in that period, were attributable to the consumption o f the pâté 
(Mclauchlin et al., 1991). Due to the potentially long incubation period o f L.
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monocytogenes and because o f the “flu-like” symptoms caused by mild listeriosis, most 
cases of listeriosis go undiagnosed or the vehicle for transmission goes undiscovered. An 
outbreak of gastroenteritis and fever among people at a picnic, in Illinois, on July 9th 1994, 
was later traced to chocolate milk consumed at the picnic (Dalton et a l ,  1997). A 
subsequent examination o f the production plant showed no defects in the pasteurization 
process. It later emerged that there was a breach in the lining o f a holding tank, which 
allowed pasteurized milk to leak into the insulation jacket, creating a pool o f sequestered 
milk. As the tank was drained, sequestered milk containing L. monocytogenes could re­
enter through the breach (Dalton et al., 1997).
L. monocytogenes was the cause o f one o f the biggest and most recent recalls o f food in the 
United States. On the 22nd December 1998, Bil M ar Foods a meat processing subsidiary of 
the Sara Lee Corp, announced a 15million lb. recall o f hot dogs and deli meats with an 
estimated cost o f $50-70 million (Hollingsworth, 1999). As o f February 4th 1999, the 
outbreak had allegedly caused 16 deaths and three miscarriages, and sickened about 72 
people.
In Ireland, food poisoning statistics arise from notifications by the Health Boards under the 
Infectious Disease Regulations, 1981. Under the regulations statutory notifications are 
made by the attending clinician who is then obliged to notify the Department o f Health and 
Children. But according to the Food Safety Authority o f Ireland, there is a large variation 
throughout the country in the investigating and reporting procedures used for identifying 
cases o f food poisoning. In 1998 the Food Safety Authority o f Ireland conducted a survey 
in collaboration with the Public Health Infections Working Group with a view to 
developing a standard system for investigating and reporting cases o f food poisoning 
throughout the country. With a new and more sophisticated system for investigating and 
reporting cases o f food poisoning, food poisoning cases due to Listeria  and other bacteria 
will become more apparent (1273 cases notified in '98 compared to 448 cases in '97), 
increasing the need for stricter production processes and rapid detection systems.
The availability o f records and statistical data is very poor in the Republic o f Ireland. This 
contrasts with other nations such as the U.S. and EU member states which keep accurate 
records o f listeriosis and food contamination and such information is made available to the 
general public. Such records are essential for the implementation of effective preventive 
measures to reduce incidences o f listeriosis. The work undertaken in this project will 
provide a rapid detection system for the presence o f pathogenic Listeria. This technology if  
implemented by the relevant food safety authority and health services would greatly
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facilitate the recording of both the prevalence o f Listeria  in food and in the environment, 
giving realistic measure of the dangers o f contracting listeriosis. It is important that this 
information is conveyed between the Public Health Services, the Food Safety Authority, 
and the general public. The lack of documented cases in the Republic o f Ireland, does not 
necessarily reflect the true rate o f infection. Many cases remain undetected due to the 
similarity o f symptoms with flu and because the general incidence o f food poisoning 
caused by L. monocytogenes remain undiagnosed and are recorded as general bacterial 
food poisoning. The lack of a rapid assay for the detection o f Listeria  spp. may account for 
the absence o f documented cases o f human listeriosis in Ireland.
1.7 Current detection techniques for Listeria
In recent years, the hazard analysis critical control point (HACCP) concept has been 
proposed as the best approach to assure food safety (Silva et a l ,  2003). HACCP is a 
methodical and systematic application o f science and technology to evaluate, plan, control, 
and document the safe and efficient manufacture o f products, from raw materials to end 
use (Vega-Mercado et al., 2003). The goal of HACCP is to ensure product safety before, 
during, and after manufacture. The inclusion o f L. monocytogenes in the list o f organisms 
subject to HACCP has recently driven the search for detection methods suitable for on-line 
monitoring (Almeida and Almeida, 2000).
Given the severity o f Listeria  infections and its ability to grow at refrigeration 
temperatures, the US FDA has adopted a ‘zero-tolerance’ policy for the presence o f the 
bacterium in food and with the use o f HACCP strategies aims to effectively eliminate 
Listeria monocytogenes from food processing environments and, therefore, processed food 
products (Donnelly, 2001). The critical issue facing the implementation o f any “zero 
tolerance” policy relates to the lack o f reliable procedures for the detection o f low numbers 
of Listeria  in foods. The U.S Food and Drug Administration (FDA), the International 
Organization for Standardization (ISO), and the International Dairy Federation (IDF) have 
formulated methods for the detection and identification o f L. monocytogenes  in dairy 
products. The ISO method 11290 and the IDF Standard 143A:1995 method for the 
detection and enumeration o f Listeria monocytogenes in foods are used in most countries, 
including the Republic of Ireland (Scotter et al., 200 la,b). According to these standards, in 
general, the detection o f Listeria  spp. necessitates at least three successive stages.
Enrichment in selective liquid medium is the first stage o f the process. As the numbers of 
Listeria monocytogenes present in food, especially in dairy products, are usually low,
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attempts to directly isolate Listeria monocytogenes usually fail (Doyle and Schoeni, 1987). 
Selective medium (enrichment broth (EB)) is usually inoculated with the test portion of the 
sample and incubated at 30 ± 1°C for 48 ± 2 h (Vlaemynck and Moermans, 1996). The 
second stage, isolation and presumptive identification, involves the inoculation from the 
culture, obtained in the enrichment medium, into the isolation medium (Oxford agar). The 
inoculated medium is incubated at 37 ± 1°C and examined after 48 ± 2 h to check for the 
presence o f colonies which are considered to be presumptive Listeria  spp. In the third stage 
of the process colonies o f presumptive Listeria  spp. are subcultured onto a non-selective 
solid medium for confirmation of identity by means o f appropriate morphological, 
physiological and biochemical tests.
While cultural methods provide the “gold standard” for the detection o f L. monocytogenes 
(Golsteyn Thomas, 1991), these are labour intensive and time-consuming, taking up to a 
week with some methods, and hence present difficulties in the quality control o f semi­
perishable foods. Detection ofZ,. monocytogenes by DNA amplification has been shown to 
be more suitable (see Table 1.3). The polymerase chain reaction (PCR) can be used to 
enhance the sensitivity o f nucleic acid-bascd assays. Target nucleic segments o f defined 
length and sequence are amplified by repetitive cycles o f strand denaturation, annealing, 
and extension o f oligonucleotide primers by the thermostable DNA polymerase, Thermus 
aquaticus (Taq) DNA polymerase. PCR has provided the basis for many assays developed 
for the detection o f L. monocytogenes in recent years with the listeriolysin O (hlyA) 
(Deneer and Boychuk, 1991; Golsteyn Thomas, 1991; Johnson et al., 1992; Bsat el al., 
1994 and Norton and Batt, 1999), the p60 (iap) (Hein et al., 2001 and Schmid et al., 2003), 
the Actin A (ActAJ (Longhi et al., 2003) and the intemalin (InlAB) (Ingianni et al., 2001; 
Kaclikova, et al., 2003 and Jung et a l ,  2003) genes being frequent targets. Also with the 
advent of microarray technology, microarrays have been coupled with PCR, serving as a 
set o f parallel dot-blots for enhanced product detection and identification o f Listeria  spp. 
(Volokhov et al., 2002; Borucki et al., 2003 and Call et al., 2003). Use o f selective 
enrichment media overcomes the difficulties that may arise in direct PCR by increasing the 
amount of target DNA and decreases the amount o f  inhibitors o f PCR that may be present 
in samples. From an industrial point o f view, detection o f L. monocytogenes using PCR 
can be a time consuming technique with enrichment broth required to ensure that only 
DNA from viable cells is detected. Nucleic acid-based amplification systems can still have 
severe limitations due to the complexity o f sample handling and processing, especially 
when the detection o f PCR products are achieved by such methods as Southern blot, gel 
electrophoresis or dot blot hybridization.
20
Table 1.3: List o f recent nucleic acid-based detection assays for Listeria monocytogenes 
highlighting the format used, limit of detection achieved and source o f the assay.
Assay format Limit of detection Reference
Direct PCR (InlB) 104 cfii/ml Pangallo et al. (2001)
PCR (M B) <10 cfii/25g Kachkova et al. (2003)
Competitive PCR (hlyA) 103 cfu/0.5ml Choi and Hong (2003)
Real-time PCR 103 cells/ml Bhagwat (2003)
Real-time PCR (iap) lO'-lO2 cfii/ml Hein et al. (2001)
PCR/DNA probe 1-10 cfu/25ml O ’Connor et al. (2000)
PCR/blot 103 cfii/ml Li et al. (2000)
IMS/PCR 25 cells/25g (ham) Hudson et al. (2001)
IMS/PCR 102 cfu/ml Hsih and Tsen (2001)
Immunological detection with antibodies (see sections 1.8 and 1.9 for a  description of 
antibody structure and diversity) is perhaps the only technology that has been successfully 
employed for the detection o f cells, spores, viruses and toxins alike (Iqbal et al., 2000). 
Polyclonal antibodies (section 1.10) can be raised quickly and chcaply and do not require 
the time or expertise associated with the production o f monoclonal antibodies (Cahill et a l,
1995). However, polyclonal antibodies are limited both in terms o f  their specificity and 
abundance. Since the development of hybridoma techniques (Kohler and Milstein, 1975) 
and the emergence o f recombinant antibody phage display technology (section 1 .11), 
developed during the past decade, immunological detection o f microbial contamination has 
become more sensitive, specific, reproducible and reliable with many commercial 
immunoassays (Table 1.4) available for the detection o f a wide variety o f  microbes and 
their contaminants. W hile nucleic acid-based detection may be more specific and sensitive 
than immunological-based detection, the latter is faster, more robust and has the ability to 
detect not only contaminating organisms but also their biotoxins that may not be expressed 
in the organism’s genome (Iqbal et al., 2000).
Other methods such as using Phospatidylinositol-specific Phospholipase C activity as a 
marker to distinguish between pathogenic and non-pathogenic Listeria  spp. (Notermans et 
al., 1991) and immunomagnetic capture on beads to recover Listeria  from environmental 
samples (Mitchell et a l ,  1994), have failed to remove the time-consuming culture step, 
although the latter proved more rapid and more sensitive than a standard culture method 
for detection of Listeria  in environmental samples.
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Table 1.4: Table o f  commercially available antibody-based tests fo r  Listeria and L. monocytogenes. 
Adaptedfrom  the University o f  Californa Davis,
(httn:/'/seafood.ucdavts.edu/HACCP/Compendiuin/Chapt.l 5.htm)
Test
Analytical
Technique
Approx. 
Total Test 
Time
Supplier
Assurance Listeria EIA' 
Used to identity Listeria 
spp. including L.
monocytogenes
Enzyme
immunoassay
50 h
BioControl Systems, Inc.
www.rapidmethods.com
Transía Plate
Used to identify L.
monocytogenes
Sandwich-type
enzyme
immunoassay
45 h
Diffchamb
www.diffchamb.com
Dynabeads m ti-L isteria
Used to identify L. 
monocytogenes
IMS3 48 h
Dynal, Inc.
www.dvnal.no/
EIA Foss Listeria
Combination of 
ELISA and IMS3
48 h
Foss N. America, Inc.
www.Fossnorthamerica.com
Listeria  Rapid Test
Used to identify Listeria 
spp. including L.
monocytogenes
EIA 42 h
Oxoid, Inc. 
E-mail: jbell@oxoid.ca
Listeria- Tek™2 ELISA 48 h
Organon Teknika Corp. 
E-mail: casey@orgtek.com
ListerTest ™2 IMS3 24 h
Vicam, L.P.
www.vtcani.com
MICRO-ID Listeria
Used to identify Listeria  
spp.
Latex agglutination 24 h
Remel, Inc.
www.remelinc.com
Reveal* for Listeria 
Used to identify Listeria  spp
Sandwich ELISA 48 h
Neogen Corporation
www.neoaen.com
VIDAS LMO
Used to identify L. 
monocytogenes
Enzyme linked 
fluorescent assay
48 h
(Sewell et al., 2003) 
BioMerieux Inc.
www.biomerieux.com
VIP for Listeria 
Used to identify Listeria 
spp. including L.
monocytogenes
Visual
immunoprecipitate
48 h
BioControl System, Inc
www.repidmethods.com
Includes enrichment. AOAC Approved (Web: www.aoac.org). Immunomagnetic separation.
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1.8 Antibody Structure
As presented in Table 1.4, a number of commercially available antibody-based tests for the 
detection of Listeria have been developed, To understand the fundamental principles o f 
antibody-based detection systems a comprehensive knowledge o f antibody structure and 
function is required. This section describes the structure o f antibodies and antibody 
fragments and discusses the antibody components involved in binding to a target analyte.
Antibodies are highly soluble serum glycoproteins involved in the defense mechanism of 
the immune system. The basic structure of all antibody molecules comprises o f two 
identical light chains and two identical heavy chains linked together by disulphide bonds 
(Figure 1.6). All antibodies are constructed in the same way from paired heavy and light 
polypeptide chains, and the generic term immunoglobulin (Ig) is used for all such protein 
molecules. Determination o f the amino acid sequences o f many immunoglobulin heavy 
and light chains has revealed, that each chain consists o f a  series o f similar, although not 
identical amino acid sequences, each about 110 amino acids in length (Branden and Tooze, 
1991). The light chain comprises of two such sequences (domains), whereas the heavy 
chain o f IgG contains four. This suggests that the immunoglobulin chains have evolved by 
repeated duplication o f an ancestral gene corresponding to one folded domain o f the 
protein (Janeway et a l,  1999). The amino-terminal sequences of both the heavy and light 
chains vary greatly between different antibodies and arc responsible for antigen binding.
Five classes o f immunoglobulin IgM, IgD, IgG, IgA and IgE can be distinguished 
biochemically as well as functionally, whereas more subtle differences confined to the 
variable region account for the specificity o f antigen binding (Janeway et al., 1999). IgG, 
IgD and IgE are monomeric immunoglobulin molecules built up from two copies each of 
two different polypeptide chains, heavy (H) and light (L). The light chain folds into two 
domains, a VL domain with variable sequence between different immunoglobulin 
molecules and a CL domain with constant sequence between different immunoglobulin 
molecules. The heavy chain folds into four domains, one variable (VH) and three constant 
domains (four in the case o f IgE), ChI, Ch2 and CH3 (Ch4 also present in IgE). An 
additional polypeptide chain, the J chain, is associated with the immunoglobulins A and M, 
allowing the linking o f two immunoglobulin units to form the dimeric IgA and five 
immunoglobulin units to form the pentamer, IgM. IgGs are the major components o f the 
five different classes o f immunoglobulins with serum concentrations o f up to 13.5 mg/ml 
(Shantha Raju, 2003). There are four isotypes o f IgGs, classified as IgG l, IgG2, IgG3 and 
IgG4, each having different numbers and arrangements o f interchain disulphide bonds. In
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IgGl the disulphide bond linking the heavy and light chains goes to the hinge region, 
whereas in IgG2, IgG3 and IgG4 subclasses the disulphide bond goes to the junction 
between the variable and constant regions (Shantha Raju, 2003).
The IgG antibody molecule (with a molecular weight o f approximately 150 kDa) is 
composed o f two heavy (50 kDa) and two light (25 kDa) polypeptide chains. Proteolytic 
enzymes (proteases) that cleave polypeptide sequences have been used to dissect the 
structure o f antibody molecules and to determine which parts o f the molecule are 
responsible for its various functions. Figure 1.6, panel B, shows that the IgG molecules 
comprise o f three equally-sized globular portions (Fc and two Fab portions) joined by a 
polypeptide chain known as the hinge region, forming a  crude Y shaped molecule. The 
hinge region that links the Fc and Fab portions o f the antibody molecule is in reality a 
flexible tether, allowing independent movement o f the two Fab arms, rather than a rigid 
hinge. Genetic engineering techniques (discussed in detail in sections 1.11-1.15) also now 
permit the construction o f a truncated Fab fragment comprising only the V region o f the 
heavy chain linked by a stretch of synthetic peptide to a V region o f a light chain (known 
as a single chain Fv fragment antibody).
The discrete globular domains of immunoglobulin chains fall into two distinct structural 
categories, corresponding to V and C domains. The similarities and differences between 
the two domains can be seen in Figures 1.7 and 1.8, which show the characteristic tertiary 
structure of the immunoglobulin domains. Each immunoglobulin domain is connected in 
tandem and has a characteristic “immunoglobulin fold” composed o f two roughly parallel 
layers o f anti-parallel p-pleated sheets connected with an intrachain disulphide bond. The 
positions of the two cysteine residues in the p-strands that form the disulphide bond are 
highly conserved (Mayforth, 1993). Linking the p-strands are loops o f amino acids that are 
more variable in sequence. The amino acids comprising the p-strands are arranged so that 
the interior o f the domain is hydrophobic and exterior is hydrophilic. The C domains have 
seven p-strands, while the V domains have an extra p-strand pair and loop (the extra loop 
forming the second hypervariable regions as shown in Figure 1.8). The tertiary structure of 
the homology domains promotes interaction between the faces o f the p-sheets and 
subsequently allows the correct folding into a functional antibody molecule.
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Figure 1.6: Structure o f  an antibody and antibody fragments. Immunoglobulin G (IgG) antibodies are 
made up o f  fo u r  polypeptide chains, comprising o f  two identical light chains and two identical heavy 
chains, and can be thought o f  as form ing a flexib le Y-shaped structure. Each o f  the fo u r  chains has a 
variable (V) region at its amino terminus, which contributes to the antigen-binding site (ABS) and a 
constant (C) region, which in the heavy chain determines the isotype and hence the functional properties o f  
the antibody. The light chains are bonded to the heavy chains by many non-covalent interactions and by 
disulphide bonds, and the paired V regions o f  the heavy and light chain domains generated two identical 
antigen-binding sites (ABS), which lie at the tips o f  the Y  -shaped antibody structure. (A) Ribbon structure 
o f  an IgG antibody showing the various polypeptide domains, region o f  gylcosylation, hinge region
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(flexible region) and the antigen binding sites, ff-strands are coloured in yellow, a-helices in red  and loops 
in solid grey. (B) Ribbon structure o f  an IgG antibody indicating the constant fragments (Fc), antigen 
binding fragm ents (Fab), variable fragments (Fv) and the complementarity determining regions (CDR). 
The heavy chain CDR regions are coloured in purple and the light chain CDR regions in green. (C) Ribbon 
structure o f  an enlarged view o f  the Fab fragm ent indicated in panel B. A Fab antibody fragm ent consists 
o f  the constant light (C[) and variable light (Vi) domains associated with variable heavy (VH)  and constant 
heavy domain 1 (CH1). The fi-strands o f  the light chain constant domain are coloured in salmon fo r  clarity. 
(D) Ribbon structure o f  a Fv fragm ent antibody with CDR loops indicated. (E) Diagrammatic 
representation o f  the antibodies and antibody fragm ents presented in panels A-D. The fragm ents presented  
above may be produced by genetic, enzymatic or chemical manipulation. The whole antibody may be 
initially broken up into either Fab (antigen-binding fragment) or F(ab%  (two antigen-binding fragm ents 
linked) and Fc (constant domain fragments) regions. Fab fragm ents may be further broken up into Fv 
(variable fragments) and scFv (single chain Fv), which are all capable o f  antigen binding. A scFv antibody 
contains a synthetic 15-20 amino acid linker peptide (usually a glycine-serine repeat linker) which acts to 
stabilise the antibody fragm ent without interfering with domain association. The complementarity-binding 
regions (CDR) or hypervariable regions located on both the variable heavy and light chains are 
responsible fo r  antigen binding (Branden and Tooze, 1991).
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Figure 1.7: Structure of the immunogolubulin constant domain. All constant domains are built up 
from seven 0  strands arranged so that four strands form one (5 sheet and remaining three strands 
form a second sheet. The sheets are closely packed against each other and joined together by a 
disulphide bridge from /3 strand 6 in the three strand sheet to (3 strand 2 in the four strand sheet. 
Most of the invariant residues of the constant domain, including the disufide bridge, are found in 
the sheets of the framework region. These invariant residues have two important functions. One is 
to form and stablise the framework by packing the ¡3 sheets through hydrophobic interactions to 
give a hydrophobic core between sheets. Their second function involves interactions between 
constant domains of different chains to form a complete immunoglobulin molecule. Panel (A) 
shows a ribbon structure of the constant light domain of an IgGl antibody (PDB code 11GY). [5 
strands are coloured in yellow, loops in grey and a-helices in red The (3 strand arrows point from
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the N terminus to the C terminus and are numbered in black. From the view presented, the P  sheets 
consisting o f  strands 3,6 and  7, and strands 1,2,4 and 5 can be clearly differentiated. Panel (B) 
shows a simple diagramatic representation o f  the direction and layout o f  each p  strand. The 
p  strands are coloured orange and grey representing the two p  sheets consisting o f  4 and 3 
strands, respectively. The disulphide bond between strands 2 and 6 is indicated by the horizontal 
broken line. The veritical broken line indicates the axis on which both sheets can be fo lded  together 
form ing a solid 3D antiparalled P  barrel consisting o f  the 3 stranded p  sheet packed tightly against 
the fo u r  stranded P  sheet (Branden and Tooze, 1991).
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Figure 1.8: Structure o f  the immunogolubulin variable domain. The overall structure o f the 
variable domain is very similar to that o f  the constant domain but there are nine (i strands instead 
o f  seven. The two additional ¡3 strands are inserted into the loop region that connects ¡3 strand 3 
and 4 (labelleled 3a and 3b). Functionally, this part o f  the polypeptide chain is important since it 
contains the hypervariable region CDR 2. The two extra ¡3 strands provide the framework that 
positions CDR 2 close to the other two hypervariable regions in the domain structure. The CDR 1 
and 3 loops are found between ¡3 strands 2 and 3, and 6 and 7, respectively. Panel (A) shows a
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ribbon structure o f  the variable light domain o f  an IgGl antibody (PDB code 1IGY). f t  strands are 
coloured in yellow, loops in grey and the CDR regions indicated by green arrows. The ft strand 
arrows point from the N  terminus to the C terminus and are numbered in black. From the view 
presented, the ft  sheets consisting o f  strands 3, 3 a, 3 b, 6 and 7, and strands 1,2,4 and 5 can be 
clearly differentiated. Panel (B) shows a simple diagramatic representation o f  the direction and 
layout o f each ft strand. The ft strands are coloured orange and grey representing the two ft sheets 
consisting o f 4 and 5 strands, respectively. The two additional ft  strands are numbered 3a and 3b 
(shown in the shaded area o f  the diagram). The disulphide bond between strands 2 and 6 is 
indicated by the horizontal broken line. The veritical broken line indicates the axis on which both 
sheets can be folded together forming a solid 3D antiparalled /3-barrel consisting o f  the 5 stranded 
ft-sheet packed tightly against the four stranded ft sheet.
1.9 The generation o f  diversity in the humoral response
The immune repertoire is remarkably diverse, expressing as many as 10H antibodies with 
different specificities. It has been estimated that a  human body generates 50 million new 
antibody-producing B cells every day (Branden and Tooze, 1991). The size o f the immune 
repertoire makes it impossible for each antibody to be coded for by its own germline DNA. 
Rather, unique genetic mechanisms generate the diversity in the variable regions of 
antibodies.
The germline genes encoding immunoglobulins are located at three different loci on the 
human chromosomes. The heavy-chain locus is on chromosome 14, the k  light-chain locus 
is on chromosome 2, and the X light chain locus is on chromosome 22 (Mayforth, 1993). 
Each immunoglobulin gene locus contains gene segments (exons) that code for the V and 
C domains. The germline DNA that codes for the V regions is further divided into two or 
three groups of gene segments, each group containing anywhere from four to hundreds of 
gene segments. One gene segment from each group is rearranged or assembled together to 
form the DNA that codes for the variable region. In the light chain, each V domain is 
encoded in two separate DNA segments. The first segment encodes the first 95-101 
(approximately) amino acids o f the light chain and is termed a V gene segment because it 
makes up most o f the V domain. The second segment encodes the remainder o f the V 
domain (up to 13 amino acids) and is termed a joining or J gene segment. The process of 
rearrangement that leads to the production o f an immunoglobulin heavy and light-chain 
genes is shown in Figure 1.9. The joining o f a V and a J gene segment creates a continuous 
piece of DNA encoding the whole of the light chain V region. The J gene segments are 
separated from the C region genes by non-coding DNA, and are joined to them by RNA
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splicing after transcription, not by DNA recombination (Janeway et ah, 1999). The heavy 
chain V regions are encoded in three gene segments. In addition to the V and J gene 
segments, there is a third gene segment called the diversity or D gene segment, which lies 
between the V and J gene segments. The process o f recombination that generates a 
complete heavy chain V segment occurs with the joining o f a D gene segment to a J gene 
segment, followed by a  V gene rearrangement to DJ completing the heavy chain V region 
exon (Figure 1.9).
Further diversity can be generated in the areas where the gene segments join. The positions 
where the gene segments are fused together are not constant and so imprecise DNA 
recombination can lead to changes in the amino acids at these sites, called junctional 
diversity. Bases can be inserted, deleted, copied or altered at the sites o f combination and 
these can be part o f the hypervariablc regions that produce the antigen-binding site leading 
to greater diversity in the immunoglobulin specificity (Tonegawa, 1983).
Point mutations occur at a much higher frequency in the V(D)J gene structure than normal. 
This is referred to as somatic hypermutation and it is antigen-driven mechanism. It allows 
the secondary and further immune responses to produce antibodies with increased affinity 
for the antigen o f interest. Somatic hypermutation occurs in the germinal centers of 
lymphoid tissue and is a critically timed process (Mayforth, 1993). In the primary response 
the antibodies produced are usually o f low affinity and are close to gcrmline sequence but 
as the response matures the amino sequence diverges from the germline. This gives the 
immune system the ability to provide more active and specific antibodies.
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Figure 1.9: Construction o f the variable regions by somatic recombination o f  separate gene segments. 
Light chain V-region genes are constructed from two segments as shown on the left hand side o f  the 
presented diagram. A variable (V) and joining (J) gene segment in the genomic DNA are joined to form a 
complete light-chain V-region exon. The C region is encoded in a separated exon and is joined to the 
variable region exon by splicing o f  the light-chain RNA to remove the J  to C introns. Heavy chain V 
regions are constructed from three gene segments as shown on the right hand side o f  the diagram. First the 
diversity (D) and J  gene segments join, then the V gene segment joins to the combined D J sequence, 
forming a complete V,r exon. The heavy chain C-region genes (only one shown here) are each encoded by 
several exons (the exon encoding the hinge region is shaded in a pale yellow). The C-region exons are 
spliced to the V-domain sequence during processing o f  the heavy chain RNA transcript. Light chain and 
heavy chain genes are translated into large polypeptide chains that associat to form the antibody molecule. 
The diagram present here was adaptedfrom Janeway et al. (1999).
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1.10 Polyclonal and monoclonal antibodies
It is possible to obtain antibodies against a very broad range o f  antigens including 
conformationally intact or denatured proteins, short peptides, carbohydrates, drugs, 
hormones and small chemicals (Delves, 1997). An antigen is traditionally defined as any 
substance that can be bound by the antigen-combining site o f an antibody molecule, 
whereas an immunogen is any antigen capable o f eliciting an immune response. Antigens 
used for immunization may be highly purified preparations containing a single molecular 
species, a mixture o f molecules, or an extremely complex “antigen” such a microorganism 
or cell. All of the antibodies that a given B-cell clone secretes have exactly the same 
specificity and avidity for antigen and are called monoclonal antibodies. However, when 
the immune system is challenged with antigen, many different B cells respond and secrete 
antibodies. They all recognise the antigen but in slightly different ways and comprise 
different specificities, avidities, and cross-reactivities. This is called a polyclonal response 
and antibodies derived from the challenged immune system are known as polyclonal 
antibodies (Mayforth, 1993),
Monoclonal antibodies (mAb) provide reagents with a single epitope specificity and 
potentially limitless amounts o f identical antibody. On the other hand, polyclonal antibody 
mixtures usually contain multiple epitope specificities and are limited in quantity to the 
amount o f serum that can be obtained from the immune animal. For commercial purposes 
larger animals such as sheep, pigs and goats can be used for antibody production. 
However, for laboratory-scale production o f polyclonal antibodies medium-sized species 
such as rabbits provide perfectly adequate amounts o f serum and can yield high-titer 
antibodies which will last, for most applications, for several years (Delves, 1997).
Paradoxically, a polyclonal antibody antiserum can sometimes provide greater specificity 
than a mAb raised against the same antigen. This is because undesirable cross-reactions 
can not be removed from a mAb because all o f the molecules have identical specificity. 
The specificity of a polyclonal antiserum can also be improved by affinity chromatography 
using purified antigen.
Hybridoma technology was first described by Milstein and Kohler in 1975 and 
revolutionized the production o f antigen specific antibodies. Primed B cells obtained from 
experimental animals (such as mice and rats) immunized with the desired antigen can be 
fused to myeloma cells, forming hybridoma cells capable o f producing antibody o f the 
desired specificity. The myeloma variants that are chosen as fusion partners for hybridoma
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technology, do not secrete any antibodies, fuse well, carry a selectable trait(s) and give rise 
to stable hybrids (Mayforth, 1993). The hybrid cell (hybridoma) inherits antigen specificity 
from the normal B cell and immortality from the tum or B cell. Unfused normal B cells are 
not immortal and die in culture. The myeloma cell lines used are mutants lacking either of 
the enzymes hypoxanthine-guanine phosphoribosyl transferase (HGPRT) and thymidine 
kinase (TK) and they are unable to use the salvage pathways o f nucleic acid synthesis. The 
mutant myeloma therefore dies if  the pathway for purine and pyrimidine synthesis is 
blocked using the folic acid analog aminopterin since neither pathway for DNA synthesis 
is then available to it. The hybridoma, however, inherits the salvage pathway genes from 
the normal B cell and is able to utilize hypoxanthine and thymidine, thus surviving in HAT 
(hypoxanthine-aminopterin-thymidine) medium (Kohler and Milstein, 1975; Kohler and 
Milstein, 1976 and Delves, 1993).
The production o f mAbs of either murine or rat origin is now a  routine procedure easily 
within the capabilities of most investigators. However, it is a time-consuming and 
expensive process and serious thought should therefore be given to the necessity of 
embarking upon a program o f mAb production. The emergence o f recombinant antibody 
phage display technology, developed during the past decade, has revolutionized the 
approaches available to generate specific antibodies. In theory, phage display technology 
(discussed later) allows the generation o f high affinity antibodies and antibody fragments 
and provides a direct link between the expressed phenotype and encapsulated genotype.
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1.11 An Introduction to Recombinant Antibodies
As part of our immune system, antibodies identify and attack foreign particles that enter 
our body. Antibodies and antibody fragments (Figure 1.6) have the ability to detect 
antigens ranging from illicit drugs and hormones to pathogenic bacteria such as Listeria 
monocytogenes. In recent years, the emergence o f recombinant antibody phage display 
technology, has transformed the way in which we generate antibodies for the specific 
detection o f a chosen analyte. Phage display is a molecular diversity technology that 
allows the presentation o f  large peptide and protein libraries on the surface o f filamentous 
phage. Having a direct link between the experimental phenotype and its encapsulated 
genotype, phage display allows the evolution o f selected binders into optimised molecules 
(Maynard and Georgiou, 2000 and Azzazy and Highsmith, 2002). Moreover, modifications 
are easily introduced in the primary antibody sequence leading to affinity maturations, 
often resulting in higher affinity for binding to the antigen, generation o f fusion proteins 
and addition o f detection and purification tags. The power o f phage selection to choose 
those ligands having the desired biological properties, permits us to mimic the immune 
system and synthesise “tailor-made” antibodies for use in diagnosis, immunotherapy or for 
immunoassay development.
pIX phage
pVI phage coat protein
Single-stranded plasmid 
containing scFv gene sequence
pVII phage coat protein
Recombinant 
scFv Fragment
I
p ill phage 
coat protein
pVlII phage coat protein
Figure 1.10: Display o f a scFv antibody on a filamentous bacteriophage particle. The location o f  the 
capsidproteins and the scFv antibody are clearly indicated by arrows. Filamentous phage particles are 
covered by approximately 3000 copies o f  the small major coat protein pVIII. Few copies o f  the minor 
coat proteins p ill  and pVI are displayed at one extremity o f  the phage particle, while pV ll and p IX  
proteins are located at the other extremity. The scFv is displayed as a fusion to g3p (pill) protein at the 
tip o f the phage. The phage particles may incorporate either p i l l  derived from the helper phage or from  
the scFv fusion protein and therefore in reality, the scFv is not fused to all p ill  protein molecules, 
allowing the phage to retain its ability to infect bacteria.
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1.12 Phage display technology
Phage display was first introduced in 1985 by Smith, who described the use of non-lytic 
filamentous bacteriophage fd for the display of specific binding peptides on the phage coat. 
The filamentous bacteriophagcs (genus Inovirus) are a  group o f viruses containing a 
circular single-stranded DNA (ssDNA) genome encapsulated in a long flexible protein 
capsid cylinder. The F f  class of filamentous phages (fl, fd and M13) use the tip o f the F 
conjugative pilus as a receptor and are, therefore, specific for E. coli containing the F 
plasmid. The three F f  class of filamentous phages are 98% homologous with respect to the 
DNA sequences and consequently, the protein sequences o f the gene products are 
practically the same (Barbas et al., 2001). Filamentous phage does not produce a lytic 
infection in E. coli, but rather induces a state in which the infected bacteria produce and 
secrete particles without undergoing lysis. The filamentous phage fd can infect strains of E. 
coli containing the F conjugative plasmid by attaching to the tip o f the F pilus that is 
encoded by genes on this plasmid, and translocating the phage genome, a circular single­
stranded DNA molecule into the host cytoplasm (Hoogenboom et al., 1998). Filamentous 
phage (Figure 1.10) are covered by approximately 3000 copies o f a small major coat 
protein (pVIII), with few copies o f the minor coat proteins p in  (the product o f gene III) 
and pVI displayed at one extremity o f the phage particle, while pVII and pIX are present at 
the other extremity (reviewed by Nilsson et al., 2000). The principle o f phage display 
involves displaying certain ligands, usually an antibody, fused with the carboxy terminal to 
a phage coat protein (pill or pVIII). Initially, complete phage vectors or bacteriophage, 
which carried all the genetic information required for the phage life cycle were used as the 
display vector (Barbas et al., 2001). Now small plasmid vector or phagemids, which 
contain the appropriate packaging signal and cloning sites, have become a more popular 
type o f vector for display (Daly et al., 2001). Phagemids are hybrids o f phage and plasmid 
vectors designed to contain the origins o f replication for both the M13 phage and E. coli in 
addition to gene III. They also contain appropriate multiple cloning sites, and an antibiotic- 
resistance gene, but lack all other structural and non-structural gene products required for 
generating a complete phage, (reviewed by Azzazy and Highsmith, 2002). Phagemids have 
high transformation efficiencies, making them ideal for generating large repertoires. Many 
phagemids also utilize the lacZ promoter as a means of controlling expression. For display 
of scFv-pIII fusion product, the catabolic repressor (glucose) is removed and expression 
induced using isopropyl-p-D-galactopyranoside (IPTG). The phagemid encoding the scFv- 
pIII fusion product will be preferentially packaged into phage particles using a  helper 
phage such as M13 K 07  or VCS-M13, which supplies all the structural proteins.
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1.13 The Krebber system for the isolation of specific scFv
Recombinant antibodies can be generated by PCR from cDNA isolated from hybridoma 
cells or from the spleens o f immunised animals and assembling scFv or Fab fragments by 
genetic engineering or by a combinatorial approach. This is usually achieved by 
constructing an antibody gene library by PCR-amplification o f the rearranged antibody 
genes from B-lymphocytes. The combinatorial libraries can be generated from the B cells 
o f immunised animals (immune libraries) or from non-immunised animals (naive libraries) 
(Burmester and Pliickthun, 2001 and Dubel and Kontermann, 2001). Due to the random 
light and heavy chain combinations, combinatorial antibody libraries may contain antibody 
fragments not found in nature, and therefore libraries can be used to isolate antibodies 
directed against antigens not suited for immunisation, e.g. recognising highly toxic 
substances or self-antigens.
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Figure 1.11: Illustration o f  the production o f  antibody fragments using the Krebber system. RNA is 
extracted from spleen cells or hybridomas and cDNA synthesised with random hexamer primers by 
reverse transcription PCR. Vi and VH genes are amplified from the cDNA template using primer mixes 
designed for the amplification o f mouse antibody variable genes. VL and VfI PCR products are assembled 
into the scFv format (Splice Overlap Extension PCR) and purified product digested with the Sfil 
restriction enzyme. Restricted scFv PCR product is ligated into the pAKlOO vector and transformed into 
E. coli. With the addition o f  helper phage, the scFv insert is displayed on the tip o f  the phage whereas the 
genetic information encoding fo r  the particular scFv fragment is packaged as single stranded DNA in the 
phage interior. By subcloning the scFv gene into pAK300-600 plasmids the scFv can be expressed in 
soluble form.
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A prerequisite for the use o f recombinant antibody technologies starting from hybridomas 
or immune repertoires as the source o f DNA, is the reliable cloning o f  functional light and 
heavy chain genes. For this purpose, Krebber developed a standard phage display system 
optimized for robustness, vector stability, tight control o f scFv-Agene III expression, 
primer usage for PCR amplification o f  variable region genes, scFv assembly strategy and 
subsequent directional cloning using a single rare cutting restriction enzyme. The Krebber 
(Krebber et al., 1997a) system allows the rapid harvesting o f antigen binding single chain 
Fv fragment (scFvs) antibodies derived from spleen cell repertoires o f mice immunised 
with antigens such as intemalin protein or whole Listeria monocytogenes cells. ScFv 
antibodies (Figure 1.6 panels D and E) generally retain the same affinity as the parent Fv 
module and have been observed to express to higher levels than Fabs in bacteria (Hudson,
1998). To maximize soluble expression o f functional scFvs subsequent to cloning, Krebber 
and colleagues also constructed a compatible vector series (pAK100-600) (Figure 1.12) to 
simplify modification, detection, multimerisation and rapid purification of recombinant 
antibody fragments. An outline o f the Krebber system is shown in Figure 1.11. Antibody 
mRNA (containing the full repertoire o f antigen specificities) is isolated from hybridoma 
or spleen cells and undergoes reverse transcription using random hcxamer primers 
converting mRNA to cDNA. This cDNA is then used as a template for the PCR 
amplification o f heavy and light chain genes encoding a  restriction site for cutting with 
Sfil. The amplified heavy and light genes are then joined together by splice overlap 
extension (SOE) PCR and this product is purified and digested along with pAKlOO vector 
with the Sfil restriction enzyme. The scFv genes are then ligated into the digested vector 
and transformed into E. coli. Packaging of the scFv into phage (known as Phage rescue) 
involves the packaging o f phagemid DNA as recombinant M l3 phage with the aid of 
helper phage that contains a slightly defective origin o f replication (such a M 13K 07 or 
VCSM13) and supplies, in trans, all the structural proteins required for generating a 
complete phage, (reviewed by Azzazy and Highsmith, 2002).
Affinity selection of scFv by panning (Figure 1.13) and subsequent reinfection into E. coli 
greatly enhances the number o f specific strong binding scFvs. During panning the phage 
library is incubated in an immunotube coated with specific antigen, unbound phage 
particles are washed away and the bound phages are then removed under strict elution 
conditions. Successive rounds o f panning are carried out to enrich antigen binders and 
ensure antibody fragments with the strongest binding affinities are isolated.
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Figure 1.12: Schematic diagram o f  the pAK vector series used by Krebber et al. (1997a). The phage 
display vector pAKlOO and related vectors can be used to build modifications into antibody 
fragments cloned by the strategy outlined in Figure 1.3. Vectors pAK300-600 contain the same 
elements as in vector pAKlOO except fo r  the modifications shown. The pAKlOO vector allows fusion  
o f the scFv gene to the g3p protein fo r  antibody production by phage display. The vectors pAK300 
and 400 allow the soluble expression o f  scFv antibody. pAK400 contains a modification (SDT7gl0) 
in the ribosome binding sequence (known as a Shine-Dalgarno sequence named after the workers 
who first recognised its significance), which results in a significant enhancement o f  protein 
expression. PAK500 allows dimérisation o f  antibody and pAK600 allows both dimérisation o f  
antibody and direct detection through fusion o f  the scFv with alkaline phosphatase (AP).
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Figure 1.13: Illustration o f  the affinity-selection bio-panning process. Phage displaying scFv antibodies 
are incubated in immunotubes coated with the antigen o f  interest. Non-binding phage scFv are washed 
away and antigen-specific phage eluted and subsequently re-infected into E. coli fo r  amplification. The 
process (bio-panning) is repeated several times, with an enrichment o f  antigen-specific phage scFv 
antibodies observed after each round o f  bio-panning.
1.14 The Vaughan naive human antibody library
A naive human antibody library, donated by Cambridge Antibody Technology (CAT) was 
used to select for scFv antibodies against Listeria monocytogenes cells and invasion 
proteins Intemalin B and p60. The antibody library was developed by Vaughan et 
al. (1996), from the functional V gene segments o f 43 non-immunised human donors 
resulting in a repertoire o f 1.4 x  1010 single-chain Fv (scFv) fragments displayed on the 
surface o f phage. Fragments were cloned in a phagemid vector (pCantab 6), which allows 
both phage displayed and soluble scFv antibodies to be produced without the need for 
subcloning. The library was designed similar to the library described by Marks et al. 
(1991), except that a more efficient two fragment PCR assembly process was used (Figure 
1.6). Here, the library was made 1000-fold larger by performing several hundred 
electroporations into E. coli TGI cells. All scFv genes cloned in this vector incorporate a 
C-terminal stretch o f six histidines (EUS) for immobilised metal affinity chromatography
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(IMAC) and a sequence derived from c-myc enabling detection with the monoclonal 
antibody 9E10. An amber codon (A UAG stop codon named “amber”, a literal translation 
o f the German word “Bernstein”, the name o f one o f the investigators who discovered it; 
Dale, 1998) is present between the c-myc tag and gene III sequence, enabling switching 
between soluble scFv expression induced by the addition o f IPTG and phage display using 
M 13K07 helper phage.
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Figure 1.14: Simplified schematic outline o f  the cloning scheme used to construct the naïve human 
scFv repertoire described by Vaughan et al. (1996). The variable heavy and light chain genes were 
amplified by PCR and assembled by overlap o f  the glycine linker resulting scFv antibodies o f  the 
orientation Vir linker- VL which is different from  that described by Krebber et al. (1997a). The 
positions o f  the Cambridge Antibody Technology (CAT) leader sequence and the His and c-myc 
tags used for purification and/or detection are clearly shown. The position o f  the amber codon 
allows switching from phage displayed scFv antibodies to soluble scFv antibodies without the need 
fo r  subcloning.
1.15 Recent Innovation in phage display technology
The last decade has seen remarkable developments in the techniques used to generate and 
isolate antibody fragments o f desired specificity. Recombinant DNA techniques now 
enable us to alter the affinity, valency or size o f antibodies and allow us to improve the 
antibody-antigen interaction introducing novel biological functions, thus extending the 
antibodies abilities beyond nature.
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1.15.1 Selectively infective phage
Selectively infective phage (SIP) consist of a filamentous phage particle made non- 
infective by replacing its gene-3-protein (g3p) N-terminal domains with a ligand-binding 
protein (e.g. antibody) and an “adapter molecule” in which the ligand is linked to the N- 
terminal domains o f the g3p that are missing from the phage particle (Spada et al., 1997). 
In SIP, in contrast to phage display, the desired specific protein-ligand interaction is itself 
directly responsible for restoring infectivity in an otherwise non-infective display phage 
(Figure 1.15). SIP has the advantage o f directly coupling the productive protein-ligand 
interaction with phage infectivity and amplification, without the need o f an elution step 
from a solid matrix (Jung, et al., 1999), SIP exploits the modular structure o f the gene-3 - 
protein, which consists o f three domains o f 68 (N l), 131 (N2) and 150 (CT), connected by 
glycine-rich linkers of 18 (G l) and 39 (G2) amino acids, respectively (Spada et al., 1997). 
The N-terminal N l domain o f g3p is involved in penetration o f the bacterial membrane 
and is absolutely essential for infection into E. coli while the N2 domain forms a complex 
with N l on the phage and specifically interacts with the E. coli F-pilus (Jakes et al., 1988; 
Stengele et al., 1990 and Krebber et al., 1997b). In the phage particles, the C-terminal 
domain (CT) is part o f the phage coat structure and thereby anchors the N-terminal 
domains to the phage (Davis et al., 1985). A library displayed in the SIP phage can be 
constructed by fusing it N-terminally either to CT or to N2-CT. In general, the N2-CT 
fusions give higher infectivities (Krebber et al., 1997b). Both types can be combined with 
either an N l-ligand or an Nl-N2-ligand, thereby having zero, one or two copies of N2 in 
each reassembled g3p (Jung, et al., 1999). Phage displaying a protein (e.g. antibody) and 
the N l adaptors or N1-N2 adaptors with coupled ligand, can be separately purified and 
combined in defined amounts in vitro to yield infective phages, provided the ligand 
interacts with the protein. Alternatively, specific protein antigen can be fused to the adapter 
encoded on an expression plasmid and both phage and adapter produced in the same cell 
(in vivo SIP). In vivo SIP, the specific protein does not have to be first expressed and 
purified as in phage display. Instead, its DNA is all that is needed, and only very small 
quantities have to be functionally expressed in the selection system (Jung, et al., 1999). 
Some of the tasks of conventional phage display are to minimize adsorption o f non­
specific phage to the ligand and to enrich phage displaying high-affinity molecules over 
abundant low affinity binders. In SIP, phage infectivity is restored only when the non- 
infective phage displaying protein or peptide, specific for the ligand, comes in contact with 
adapter molecule. SIP technology is therefore a low background procedure that eliminates 
the need for inefficient physical separation o f specific from non-specific binders.
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Figure 1.15: Diagram showing a comparison o f  the conventional phage display and SIP display systems. 
(A) 3-5 copies o f  the minor M l 3 phage coat protein gene-3-proteins (g3p) are present at the tip o f wild type 
phage. The gene-3-protein consists o f  three domains, Nl, N2 and CT, which are connected by glycine rich 
linkers (G1 and G2). (B,C) In conventional phagemid/helper phage systems, infectivity is maintained by the 
presence o f  wild type (wt) g3p, encoded on the helper phage. Displayed proteins (e.g. antibodies) can be 
(A) fused to all three g3p domains (long fusion) or (C) fused only to the C-terminal domain o f  the g3p 
(short fusion). (D,E) The N-terminal N l domain o f  g3p is essential fo r  infection into E. coli and in the 
selectively infective phage, all copies o f  g3p lack the N l domain that is replaced by a specific protein, 
usually an antibody (Ab) fragment. Proteins can be (D) fused to the N2 domain (long fusion) or (E) fused  
directly to the CT domain (short fusion). Such phages are totally non-infectious, but infectivity can be 
restored when the missing domain(s) are supplied in an adapter-linked protein, usually an antigen (Ag). 
The adapter protein connects the missing domains o f  g3p to the phage by a non-covalent interaction such 
as the binding o f  an antibody (Ab) to a specific antigen (Ag). The diagram presented here was adapted 
from Spada et al. (1997).
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1.15.2 Affinity maturation of antibodies
Recent advances in antibody engineering and phage display technology allow cloned 
antibody variable domain genes to be further engineered producing antibody variants with 
lower immunogenicity (Thompson et al. , 1998), higher affinity (Schier el al., 1996a,b) 
altered antigenic specificity (Ohlin et al., 1996), enhanced stability (Worn and Pliickthun,
1999) or increased solubility and expression (Pini et al., 1997). Recombinant antibodies 
can be easily expressed with a number o f fusion proteins and affinity tags for the rapid and 
efficient detection and purification o f the desired antibody. The affinity o f recombinant 
antibody fragments for their antigen can be affinity maturated by processes such chain 
shuffling, error prone PCR and mutagenesis, resulting in the formation o f new antibody 
fragments with enhanced sensitivity and specificity.
1.15.2.1 Chain Shuffling
Chain shuffling relies on the natural mutation o f V-genes that occurs in vivo in response to 
antigens that the host has been exposed to for the generation o f sequence diversity. For 
chain shuffling o f scFv antibodies, the gene for one o f the variable domains (e.g. Vh) is 
cloned into a repertoire for the second chain (VL) resulting in a library o f  scFv antibodies 
containing the Vh domain gene o f the parent antibody and random V l genes. The new 
library is then panned against the target antigen to identify clones with improved binding 
characteristics. The new V l gene o f the scFv antibody with the desired binding 
characteristics is then cloned into a repertoire o f Vh chains and the process o f selection 
repeated (Adams and Schier, 1999 and Nielsen and Marks, 2001). However, chain 
shuffling is dependent on the availability o f large highly diverse variable domain libraries 
in order to supply sufficient sequence variation to improve binding, which is usually not 
obtained from hybridoma-derived antibody libraries.
1.15.2.2 Error prone PCR
Error prone PCR involves the random introduction of nucleotide substitutions (errors) 
throughout a  gene by reducing the fidelity o f Taq polymerase. The number of errors 
incorporated is usually kept low ( 1-2 substitutions) as introducing large numbers o f 
mutations can be counterproductive in that highly defective antibodies (frameshifts, etc.) 
may bind non-specifically and out-compete improved variants (Johnson and Hawkins,
1996). Controlling the level o f substituted errors can be difficult to optimise and often
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be further enhanced by sequential mutagenesis o f  the remaining CDR regions also known 
as “CDR walking” (Takkinen etal., 2001).
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Figure 1.16: Schematic illustration o f  an scFv sequence showing the primer positions fo r  randomisation in 
the variable heavy chain CDR 3 region. Two PCR reactions are needed. The first reaction uses a primer 
homologous with the beginning o f  the variable light domain (primer 1) which incorporates the restriction 
enzyme site (e.g. Sfil) fo r  subsequent cloning o f  the gene and the random primer (red arrow) introduces 
errors in the CDR 3 region and amplifies the rest o f  the VH gene (minus the framework 4 region). A second 
PCR reaction is carried out using the new randomised PCR product as a template in which primer 1 
amplifies the VL gene and primer 3, encoding the Sfil site and Framework 4 region, attaches to the end o f  
the primer 2 sequence and amplifies up the whole scFv gene including the newly introduced errors.
1.15.2.5 Selection and screening o f favourable affinity maturated antibodies
As stated in section 1.15.2.4 above, mutagenesis using “spiked” PCR primers homologous 
with the variable domain CDR 3 regions, in conjunction with selection by phage display, 
possibly offers the greatest potential for the affinity maturation o f recombinant scFv 
antibody fragments. In order to minimise the number o f non-viable structures and to 
identify the amino acid residues which tend to have solvent accessible side chains from 
those with buried side chains (see section 5.3.4), molecular modelling o f the most similiar 
variable domains (to that o f the chosen antibody sequence(s)) in the PDB database should 
be carried out. The Protein Data Bank (PDB), established at Brookhaven National 
Laboratories (BNL) in 1971, is the single worldwide archive o f structural data of 
biological macromolecules, which is now managed by the Research Col laboratory for 
Structural Bioinformatics (RCSB) (Berman et al., 2000). The Protein Data Bank contains 
thousands (21,390 structures at the time o f printing) o f protein structures deposited from 
research groups throughout the world. Identifying important residues in the CDR regions 
will increase the chances o f beneficial mutations and minimise selecting for the wild type 
antibody sequence. Designing random primers to different regions o f  the CDR sequences 
(varying the number and placement o f targeted amino acids) can further enhance the 
potential for selecting favourable clones.
47
Independent o f the affinity maturation technique used, selection o f  phage displaying scFv 
antibodies can be achieved on soluble or immobilised antigen. Antigen can be coated on 
immunotubes and randomised phage scFv antibodies allowed bind. Specific phage scFv 
antibodies can then be eluted from the tube and re-infected into E. coli for further 
amplification and selection. Alternatively specific phage scFv with improved affinities can 
be selected in solution using biotinylated antigen and recovered with streptavidin-coated 
magnetic beads. This method makes it easier to control the amount o f antigen used (as the 
coating o f certain antigen on plastic can be unpredictable) and, by lowering the 
concentration o f antigen used, can allow improvements in the selection o f high affinity 
antibodies. The choice of selection procedure will depend on the type o f antigen and both 
methods should be evaluated.
Mutated phage-scFv antibodies can be screened by ELISA using 96 well plates coated with 
the desired antigen. Thorough screening o f selected clones is o f utmost importance in order 
to avoid re-selecting the wild type sequence and maximise the possibility o f selecting the 
most favourable mutation. After selection, the most favourable clones should be sequenced 
to examine the diversity of the mutations and avoid wild type sequences. Affinity studies 
o f selected clones can be performed by competition ELISA and by studying the 
dissociation rates using a BIAcore 3000™ instrument. The clone(s) displaying the most 
improved affinities can then be used for the template for further mutagenesis (Nielson and 
Marks, 2001).
1.15.3 Antibody multimer formation
The Fv antibody fragment, (Figure 1.17) consisting of only the Vh and VL domains, is the 
smallest immunoglobulin fragment containing the whole antigen-binding site. However, 
Fv antibodies appear to have a lower interaction energy between their two chains than Fab 
antibody fragments, which are also held together by the CH1 and CL constant domains 
(reviewed by Little et al., 2000). To stabilise the association o f the VH and VL domains, 
the domains have been linked with peptides (Huston et a l, 1988), disulphide bridges 
(Glockshuber et al., 1990) and “knobs into holes mutations” (Zhu et a l, 1997). Peptide 
linkers o f about 3.5 nm are required to span the distance between the C terminus of one 
domain and N terminus of the other (Hudson, 1998 and Huston, et a l,  1988). The most 
common scFv linker designs contain a combination of glycine and serine residues (usually 
15 residues) providing flexibility and protease resistance (reviewed by Todorovska et al., 
2001). By shortening the peptide linker, monovalent scFv antibody fragments can be
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forced to form antibody multimers (diabodies, triabodies and larger multimers). The most 
important advantage o f multivalent scFvs over monovalent scFv and Fab fragments is the 
gain in functional binding affinity (avidity) to target antigens (Todorovska el al., 2001). 
Intact antibodies are polyvalent molecules with generally enhanced functional affinity 
(avidity) relative to monovalent Fab fragments, particularly in the case o f pentameric IgM 
molecules (Hudson, 1998). There is, therefore, a similar increase in functional affinity 
when Fab or scFv fragments are engineered into dimers, trimers or larger aggregates 
(Pliickthun and Pack, 1997). Holliger et al. (1993a,b) have demonstrated that VH and VL 
domains within a  scFv with a short polypeptide linker (0-10 amino acid residues) cannot 
pair to form a  monomeric antibody fragment, but rather homodimerise to form a  small 
bivalent antibody fragment termed “diabody”. According to Todorovska el al. (2001), 
linkers greater than 12 residues in length provide enough flexibility for the V l and VH 
domain to assemble in natural Fv orientation (Figure 1.7). An scFv molecule with a linker 
of 3-12 residues cannot fold into a functional Fv domain and instead associates with a 
second scFv molecule to form a bivalent dimer (diabody, ~60 kDa). Reducing the linker 
length below 3 residues can force the scFv to associate into trimers (triabodies, -9 0  kDa) 
or tetramers (tetrabodies, -120  kDa) depending on linker length, composition and V- 
domain orientation. Also, the association o f two different scFv molecules, each comprising 
a VH and VL domain derived from different parent immunoglobulin, can form a fully 
functional bispecific diabody (Holliger et al., 1993a,b). Bispecific antibodies are hybrid 
molecules that are comprised of two specificities. Bispecific diabodies can be synthesised 
using a bicistronic expression vector that enables the two scFvs to associate in situ, in the 
E. coli periplasm (Todorovaska et al., 2001). Although most applications o f bispecific 
antibodies are aimed at therapeutic applications, they also show great potential as 
diagnostic and imaging reagents. Bispecific antibodies with a  first binding specificity to a 
target antigen and a second to an enzyme (e.g. alkaline phosphatase) have great potential in 
improving and refining immunoassays as well immunohistochemical applications that 
employ antibodies that are chemically linked to radio-isotopes, enzymes or fluorochromes 
(Nolan and O’Kennedy, 1990; Azzazy and Highsmith, 2002 and Brennan et al., 2003).
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Figure 1.17: Representation o f  various recombinant antibody constructs. As discussed in section 1.15.3, 
peptide linkers greater than 12 residues in length provide enough flexibility fo r  the VL and VH domain to 
assemble in natural Fv orientation. Panel A shows the structures o f  two scFv antibodies with different 
linker lengths viewed as ribbon structures using the Swiss-PDB (Protein Data Bank) viewer program. The 
CDR regions o f  both antibodies are coloured red and yellow representing the light and heavy chain CDR 
regions, respectively. The linker region is coloured in black fo r  both antibodies and shows the importance 
o f  linker length fo r  the proper association o f  the heavy and light chain domains. The top antibody (labelled 
I), a homology model o f  the anti-lnlB scFv antibody described in section 5.5.4, has a 15 amino acid linker 
which permits proper folding o f  the scFv into a functional antibody. The bottom antibody (labelled 2), a
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scFv antibody obtained from the Protein Data Bank (accession code llmke), has only a 6 amino acid linker 
which does not allow the heavy and light chain domains to associate properly. Panel B is a representation 
o f  the structure o f a diabody consisting o f  two identical scFv antibody molecules (scFv 1 and scFv 2). The 
scFv structure presented in the lower part o f  panel A was manually manipulated using the Swiss-PDB 
viewer program to form the possible diabody structure shown. The diagram shows how two scFv 
antibodies with short peptide linkers can associate to form a functional bivalent antibody. Using the Swiss- 
PDB viewer program the scFv antibody was further manipulated to form a triabody consisting o f  three 
scFv antibodies (Panel C). The associated scFv fragments form  a trivalent functional antibody with the 
antigen binding sites (ABS) facing in opposite directions. Panel D shows a copy o f  the triabody presented 
in Panel C, binding a theoretical peptide antigen (Ag). The diagram illustrates how the increased valency 
o f  the scFv fragments can allow the binding o f  three antigens (shown here as a short peptide sequencej 
simultaneously, resulting in higher functional affinity (avidity). Note, the structures shown in Panels B, C 
and D were manually manipulated using the Swiss-PBS viewer fo r  the purpose o f  illustration and, 
therefore, the exact orientation o f  the possible multimeric structures formed by the presented scFv (llmke) 
may vary slightly. Panel E  shows a diagram o f the simplified structures o f  the various antibody fragments 
indicated.
1.15.4 Ribosomal and mRNA Display
As discussed in section 1.12, phage display offers a sophisticated method for the rapid 
identification, characterisation, and potential improvement o f interaction partners. 
However, phage display is limited by the involvement o f living cells in the process of 
library generation and screening. In vitro technologies, such as ribosomal and niRNA 
display technologies, are not limited by cellular transformation efficiencies and, thus, very 
large libraries o f up to 1014 members can be built (reviewed by Amstutz etal., 2001). Both 
methods also facilitate directed evolution o f polypeptides as they have the potential for the 
generation o f large libraries, contain fewer o f the biases caused by cellular expression and 
allow the more facile application of round-by-round mutagenesis techniques (reviewed by 
Dower and Mattheakis, 2002). Ribosomal display, first developed by Matthcakis et al.
(1994), relies on non-covalent ternary complexes o f mRNA, ribosome and nascent 
polypeptide, ensuring the coupling of genotype and phenotype. For the display o f proteins 
complexed with ribosomes, a DNA library is constructed with the gene o f interest (usually 
an antibody fragment) fused to a C-terminal spacer region, allowing the peptide region to 
fold and be displayed clear o f the ribosome (Figure 1.18). In ribosomal display this fusion 
construct lacks a stop codon at the mRNA level, thus preventing release of the mRNA and 
the polypeptide from the ribosome. Alternatively, the DNA construct can be fused to a 
sequence encoding the ricin A-subunit (RTA) via a spacer. Once translated, the nascent 
RTA will depurinate a specific site in the 28S rRNA o f the large subunit o f the nearby 
ribosome, blocking further elongation and producing a stable complex that is used for
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selection on the immobilised target (Dower and Mattheakis, 2002). The related technology 
of mRNA display, predominately developed by Robert and Szostak (1997), relies on the 
covalent coupling o f mRNA to the nascent polypeptide. The mRNA is first covalently 
linked to a short DNA linker carrying a puromycin moiety. As translation proceeds, the 
ribosome stalls at the RNA-DNA junction and the puromycin moiety enters the 
peptidyltransferase site o f the ribosome. The ribosome catalyses the formation o f an amide 
bond between puromycin and the carboxy-terminal residue o f the nascent chain, forming a 
covalent bridge between RNA and protein (reviewed by Amstutz et a l, 2001 and Dower 
and Mattheakis, 2002).
In vitro display technologies have great potential for the maturation o f high affinity 
protein binders. Hanes et al. (2000), described a process, performed entirely in vitro, for 
the affinity maturation o f antibodies, resulting in the recovery o f anti-insulin antibodies 
with Ka values as low as ~10'10 M. Xu et al. (2002), constructed a library o f >1012 unique, 
covalently coupled mRNA-protein molecules by randomising three exposed loops o f an 
immunoglobulin-like protein, the tenth fibronectin type III domain (10Fn3). According to 
the authors, the large library size made possible by in vitro mRNA display technology 
allowed the randomisation o f all three CDR-like loops o f 10Fn3 and the sampling o f 104- 
fold more sequences than was possible in the phage-display selection reported by Koide et 
al. (1998). Using mRNA display, the authors selected 10Fn3-based antibody mimics with 
higher affinity, increased specificity and with larger population variants with comparable 
properties. A common requirement for most biotechnological and medical applications of 
proteins is that they possess an intrinsic high stability against denaturation (Amstutz et al.,
2001). In  vitro technologies have also shown great promise for the stability engineering of 
desired proteins. Matsuura and Pluckthun (2003) used ribosome display to study the 
folding properties o f proteins by selecting proteins on the bases o f increased sensitivity to 
proteolysis and greater exposure of hydrophobic area. By targeting these properties the 
authors showed that compactly folded and soluble proteins can be enriched over insoluble 
and random coil proteins. Various evolutionary methods to perform stability engineering 
of proteins using ribosomal display were also described in the excellent review by Worn 
and Pluckthun (2001). Selection for scFv stability by simply using a destabilising strategy 
(adding increasing concentrations of DTT) o f reducing the disulphide bonds during in vitro 
protein folding and antigen binding, and selection for scFv stability by functional 
cytoplasmic expression, were discussed. The work present in this review and in the more 
recent publication by Matsuura and Pluckthun (2003) highlight the importance of in vitro 
technologies as sophisticated methods for the rapid identification, characterisation, and 
potential improvement of interaction partners
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Figure 1.18: Diagram showing different display formats adapted from Dower and Mattheakis (2002). For 
both the ribosomal display and the ribosomal-interaction display systems (RIDS), the DNA library is 
constructed with the gene o f  interest fused to a C-terminal spacer region, allowing the peptide product to 
fo ld  and be displayed clear o f  the ribosome. A strong transcriptional promoter is installed upstream o f  the 
gene and in vitro transcription and translation performed. During translation, as one or more ribosomes 
travel down the RNA, the nascent polypeptide folds and becomes exposed. The release o f  the RNA and 
peptide from the ribosome can be prevented by (A) the absence o f  stop codons or by (B) by fusing a 
sequence encoding the ricin A-subunit (RTA) to the C-terminus o f  the gene o f  interest. Translated nascent 
RTA acts on the nearby ribosome to depurinate a specific site in the 28S rRNA o f  the large subunit. This 
modification blocks further elongation and as with the absence o f stop codons method (A) produces a 
stable complex that is then used fo r  selection on immobilised target. I f  nascent peptides bind to the target
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with sufficient affinity, they are not washed away. Bound complexes can be dissociated and cDNA reverse 
transcribed from the recovered mRNA. Recovered sequences can be sequenced or retranscribed, translated 
and screened in a subsequent selective round o f  enrichment. (C) In mRNA display, the transcription and 
translations steps are performed separately as modification o f  the RNA is required prior to translation. A  
segment o f  DNA carrying a 3'-puromycin moiety, is attached to the 3 '-end o f  the RNA and the hybrid 
translated in vitro. When the transiting ribosome reaches the RNA/DNA junction, the ribosome stalls and 
the tethered puromycin enters the ribosomal A-site. The ribosome catalyses the covalent incorporation o f  
the puromycin into the peptide chain, forming a covalent link between the RNA and peptide. The displayed 
peptides are then screened for binding to immobilised target and recovery, identification and amplification 
performed as described in the methods shown in (A) and (B) above.
1.16 The use o f  biosensors fo r  the detection o f  bacteria
Even though both traditional antibody-based and nucleic acid-based detection have greatly 
decreased assay time after sample pre-enrichment compared to traditional culture 
techniques, they (with the exception o f real-time PCR) still lack the ability to detect 
microorganisms in “real-time” taking up to several hours in some cases to yield 
confirmation o f results. The need for a more rapid, reliable, specific and sensitive method 
o f detecting a target analyte, at low cost, is the focus o f a great deal o f research, especially 
for applications outside the laboratory environment. Since its inception in the 1970's,
Hazard Analysis at Critical Control Point (HACCP) methodology has evolved as the 
leading food safety strategy used by the food industry. HACCP identifies where potential 
contamination, time and temperature problems can occur (the critical control points). 
However, key technologies needed to successfully implement any HACCP program are 
“real-time” microbial detection, trace-ability and source identification. Biosensors offer the 
potential o f detecting pathogens in “real time” (the microbial-antibody binding event is 
observed as it happens) but however still require the time consuming pre-enrichment in 
order to detect low numbers o f pathogens in food and water. Advances in antibody 
production and the recent emergence o f phage-displayed peptide biosensors (Chaplin and 
Bucke, 1990; Goldman et al., 2000; Benhar et a l ,  2001, and Goodridge and Griffiths,
2002) offer increased possibilities for the rapid detection o f pathogens.
Biosensors use a combination o f biological receptor compounds (antibody, enzyme, 
nucleic acid etc.) and the physical or physicochemical transducer directing, in most cases, 
“real-time” observation o f a specific biological event (e.g. antibody-antigen interaction).
They allow the detection of a broad spectrum o f analytes in complex sample matrices, and 
have shown great promise in the areas such as clinical diagnostics, food analysis, 
bioprocess and environmental monitoring (Invitski et a l ,  1999 and Fitzpatrick et al.,
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2000J. Biosensors may be divided into four basic groups, depending on the method of 
signal transduction: optical, mass, electrochemical and thermal sensors (Goepel, 1991; 
Seyhi, 1994, and Goepel and Heiduschka, 1995). Optical transducers are particularly 
attractive as they can allow direct “label-free” and “real-time” detection o f bacteria. 
Current studies focusing on optically-based transduction methods aim to achieve a more 
robust, easy to use, portable, and inexpensive analytical system. The phenomenon of 
surface plasmon resonance (SPR) has shown good biosensing potential and many 
commercial SPR systems are now available (e.g. BIAcore™) (Homola et al, 1999 and 
Quinn and O ’Kennedy, 1999).
1.17 Surface plasmon resonance biosensors
Surface plasmon resonance (SPR) is an optical phenomenon which occurs as a result of 
total internal reflection (TIR) o f light at a metal film-liquid interface (Anon., 2001 and 
Quinn and O ’Kennedy, 1999) (Figure 1.19). The detection system o f a  SPR monitor 
essentially consists o f a monochromatic and p-polarised (electrical vector parallel with 
plane o f incidence) light source, a glass prism, a thin metal film in contact with the base of 
the prism, and a photodetector (Stenberg et a l, 1991). Total internal reflection is observed 
where light travels through an optically dense medium such as glass and is reflected back 
through medium at the interface with a less optically dense medium such as buffer, 
provided the angle o f incidence is greater than the critical angle required for the pair of 
optical media (O ’Shannessy et al., 1993). Although light is totally reflected, an 
electromagnetic field component, termed the evanescent wave, penetrates a  short distance 
o f the order o f one light wavelength into the less dense medium (buffer) (Dillon et al.,
2003). The evanescent wave will interact with free oscillating electrons, or plasmons, in 
the metal film surface, and therefore, when surface plasmon resonance occurs, energy from 
the incident light is lost to the metal film, resulting in a decrease in reflected light intensity 
(Leonard et al., 2003). The resonance phenomenon occurs only at a precisely defined angle 
of the incident light which is dependent on the refractive index o f the buffer solution 
(Karlsson et al., 1991; O’Shannessy et al., 1993 and Homola et al., 1999). The effective 
penetration depth o f the evanescent field which arises under conditions o f total internal 
reflection is approximately 300 nm (O ’Shannessy et al., 1993 and Fratamico et al., 1998), 
and therefore, only refractive index changes occurring within this distance from the surface 
will cause a change in the generated SPR signal. The interaction o f macromolecules in the 
buffer solution causes a change in refractive index in close proximity to the metal-film 
surface which translates into a change in the resonance angle which is in turn detected and 
quantitated by the instrument. In the biosensor refractive changes are monitored 
continuously over time and presented in a sensorgram, where the y axis o f  the sensorgram
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is the resonance signal and is expressed in resonance units (RU) (Karlsson et al., 1991). A 
sensor response o f 1000 RU corresponds to a shift o f  0.1° in the SPR angle, which in turn 
correlates to a change o f about 1 ng nun '2 in the surface protein concentration (Alfthan, 
1998). SPR biosensors are potentially useful for environmental and food safety analysis 
because they are relatively easy to use, do not require labelling o f either molecule in the 
reaction, and can assay crude samples without purification (Brigham-Burke et a l, 1992 
and Rasooly, 2001).
Generally, an SPR optical sensor comprises an optical system, a transducing medium 
which interrelates the optical and (bio)chemical domains, and an electronic system 
supporting the optoelectronic components o f the sensor and allowing data processing 
(Homola et al., 1999). Recently, a number o f surface plasmon resonance-sensing 
configurations and detection approaches have been used in SPR sensors. Surface plasmon 
resonance sensors using attenuated total reflection optical prism couplers, particularly the 
Kretschmann geometry o f ATR method (Kretschmann, 1971), have been found to  be very 
suitable for sensing and have become the most widely used geometry in SPR sensors. In 
this configuration a light wave is totally reflected at the interface between a prism coupler 
and the thin metal layer (of thickness o f about 50 nm) and excites an SPW at the outer 
boundary of the metal by evanescently tunnelling through the thin metal layer (Homola et 
al., 1999). All the main detection approaches have been demonstrated in SPR prism-based 
sensors including measurement of the intensity of reflected light wave (Nylander et al., 
1982; Leidberg et a l, 1983 and Leidberg et al, 1995), measurement o f the resonant angle 
o f incidence o f the light wave (Leidberg et a l, 1993), and measurement o f the resonant 
wavelength of the incident light wave (Zhang and Uttamchandani, 1988). Surface plasmon 
resonance sensors using grating couplers and optical waveguides (Homola et al., 1999) 
have also proven suitable for sensing.
The pioneers o f commercial SPR-based biosensing were Pharmacia Biosensor AB, now 
BIAcore AB, who launched the original BIAcore system (see Figure 1.20 for a diagram of 
the detection method used in the BIAcore biosensor) in 1990 (Leidberg et a l, 1995). The 
company now has a large range of biosensors, which includes several generations of the 
original BIAcore (series 1000, 2000 and 3000) as well as the BIAlite™ (1994), BIAcore 
X™ (1996), BIAQuadrant™, BIAcore S51 and BIAcore J (2001) systems, offering varying 
degrees of automation and parameter specifications. Since the introduction o f  the original 
BIAcore in 1990, a number o f commercial SPR based biosensors have become available 
(Table 1.5) utilising various sensing configurations and detection approaches (reviewed by 
Leonard, et al., 2003). Although a number of SPR instruments are widely available, 
BIAcore instruments are the most commonly used with approximately 90% of the 1998
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and 1999 commercial biosensor publications citing the use o f a BIAcore instrument (Rich 
and Myszka, 2000).
A ntigen passed over 
sensor su rface
A ntibody-coated sensor 
chip surface
Buffer Flow —► • * (#| FlowCeH | • *
Minimum observed in 
reflected light at angle (II)
Incoming light Detector Array
D ata acqu isition  and 
p rocessing
5=
£
Angle Tim e
Figure 1.20: Basis o f the detection principle in the BLAcore biosensor instrument. Monochromatic
and p-polarised light is focused onto a gold chip surface immobilised with an antibody (Y), by 
means o f a prism under conditions o f  total internal reflection. Buffer is passed over the surface and 
the dip in reflected light intensity (blue line) recorded at an angle (I). As antigen is injected over the 
antibody immobilised surface, a change in refractive index near the sensor chip surface, results in a 
shift in the resonant angle o f reflected light (II) which is measured and recorded. The shift in 
rejlected light is measured constantly and the results presented as a sensorgram o f  the change in 
measured response over time. As changes in the resonant angle are a direct result o f  changes in the 
mass or concentration on the surface o f  the chip, the mass o f  the analyte specifically binding to the 
chip surface may be determined.
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Table 1.5: List o f six companies currently manufacturing a variety ofSPR biosensor hardware.
Company W ebsite
BIAcore AB 
Affinity Sensors 
Texas Instruments 
BioTul AG 
Windsor Scientific Limited 
Nippon Laser and Electronics Lab 
Fairfield
http://www.biacore.com 
http://www. afíinitv-sensors. com 
httn://www. ti. cotn/spr 
littp://ww\\<. biotul com 
http./Avww. Windsor-ltd. co. tik 
http://www. rikei. com 
http://www. fairfields. co. uk
1.18 D e te c t io n  o f  b a c te r ia  u s i n g  S P R
Biosensors offer the possibility of rapid and “real-time” detection o f pathogens, and 
therefore a number o f sensors and assay formats (Table 1.6) have recently been reported in 
the literature (Invitski et al., 1999 and Leonard et al., 2003). However, the vast majority of 
surface plasmon resonance-based biosensor publications have involved the detection of 
small molecules such as proteins (Nieba et al., 1997), hormones (Gillis et al., 2002 and 
Fitzpatrick et al., 2003), toxins (Daly et al., 2000) and drugs (Dillon et al, 2003). One of 
the earliest attempts to use SPR for direct detection o f microbes (Fratamico et al., 1998) 
achieved a detection limit for E. coli 0157:H 7 of 5-7 x 107 CFU/ml. Fratamico and co­
workers used a sandwich assay format in which they immobilised an anti-is. coli 0157:H7 
monoclonal antibody on the surface o f the sensor chip. They then passed various 
concentrations o f cells over the surface and amplified the signal with the injection of 
polyclonal anti-E. coli antibodies. Perkins and Squirrel (2000), described the detection of 
bacteria using light scattering in combination with a BIAcore 2000 surface plasmon 
resonance and reported that they could detect 107 bacterial spores ml"1. Koubova et al. 
(2001) later described the detection of Salmonella enter itidis and Listeria monocytogenes 
at concentrations down to 106 cells/ml. Koubova and co-workers used a surface plasmon 
resonance biosensor-based on prism excitation o f surface plasmons and spectral 
interrogation to directly detect cells on antibody immobilised surfaces. Various cell 
concentrations were injected over the surface and the shift in resonant wavelength 
recorded. Recently, Bokken et al. (2003) described the detection of Salmonella with a 
BIAcore surface plasmon resonance-based biosensor. Anti-Salmonella antibodies
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immobilised to the biosensor surfacc were allowed bind injected bacteria followed by a 
pulse with soluble anti-Salmonella immunoglobulins to intensify the signal. The target 
organism was successfully detected at 1.7 x 105 CFU m l'1. These recently reported 
publications highlight the potential of SPR-based biosensors for the detection of 
pathogens. Other sensor formats such as electrochemical sensors (listed in Table 1.6 below 
and reviewed more extensively by Leonard et al., 2003) have been reported in the literature 
with limits o f detection as low as approximately 103 cells/ml (Susmel et al., 2003 and 
Benhar et al., 2001). However, further characterisation o f these formats have not been 
evaluated and therefore the reproducibility o f these assays and regeneration o f the sensor 
surfaces would need to be determined before an accurate limit of detection can be assessed.
Table 1.6: List o f  biosensor-based immunoassays fo r  the detection o f  Listeria monocytogenes.
F orm at Lim it of detection Reference
SPR (IAsys) Failed Lathrop et al. (2003)
SPR (miniature prism) 106 cells/ml Koubova et al. (2001)
SPR (BIAcore) 104 cells/ml Haines and Patel (1995)
Modified electrochemical 105 cells/ml Minett et al. (2003)
Electrochem. Redox probe 103-104/ml Susmel et al. (2003)
Piezoelectric 107 cells/ml Vaughan et al. (2001)
Piezelectric 1 O'/crystal Minunni et al. (1996)
Electrochemical 2 .5xl03/ml Benhar et al. (2001)
1.19 Thesis Outline
As previously stated, the aim of this project was to develop a rapid immunoassay for the
detection Listeria monocytogenes cells using the BIAcore optical biosensor.
The strategy presented in this thesis involved the generation o f  polyclonal and recombinant 
scFv antibodies to Listeria monocytogenes cells and invasion-associated proteins. Two 
polyclonal antibodies (described in chapter 3) were generated against heat-treated Listeria 
monocytogenes cells and intemalin B (InlB) protein extract. Both antibodies were 
characterised by ELISA, SDS-PAGE and Western blotting. In order to safely generate 
large quantities of purified Listeria monocytogenes specific protein, the invasion associated 
Intemalin B and p60 proteins were cloned into E. coli XL 10 Gold cells (chapter 4). Both 
InlB and p60 arc well characterised (see section 1.4), species specific, surface exposed 
(p60 is secreted) and are constitutively expressed making them excellent targets for 
antibody production. Expressed protein was purified by immobilised metal affinity
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chromatography (IMAC) and the immunoreaetivity of each protein determined with anti- 
Listeria monocytogenes derived monoclonal and polyclonal antibodies. Two combinatorial 
antibody libraries were developed from mice immunised with Listeria monocytogenes cells 
and InlB protein extract. Phage scFv antibodies were selected from both murine antibody 
libraries and from a  large naive human antibody library (chapter 5) against Listeria 
monocytogenes cells and invasion associated protein. A number o f the selected phage-scFv 
antibodies could not be expressed as soluble scFv and also showed tendencies to cross 
react with various bacterial strains tested. A soluble scFv antibody was selected that 
recognised the Listeria monocytogenes invasion associated protein, Intemalin B but did not 
recognise Listeria monocytogenes cells. The two polyclonal antibodies and the selected 
anti-InlB scFv antibody were used in the development o f three biosensor-based 
immunoassays using a BIAcore 3000 instrument (chapter 6). Various assay formats and 
sensor chip surfaces were evaluated and intra- and interday assay variability studies 
performed to determine the precision and reproducibility o f each assay. The assay 
developed with the polyclonal anti-InlB antibody proved to be most sensitive and cost 
effective while the assay developed with the anti-InlB scFv antibody fragment proved most 
specific.
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Chapter 2 
Materials & Methods
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2.0  Materials and Methods
2.1 General Formulations
2.1.1 Materials
All standard laboratory reagents were purchased from Sigma Chemical Co., Poole, Dorset, 
England unless stated otherwise.
Reagent Supplier
Acetic acid 
Hydrochloric acid
Riedel de-Haen AG, Wunstorfer, Strabe 40, D-30926, 
Hannover, Germany.
Bacteriological Agar 
Tryptone 
Yeast Extract 
PBS tablets
Oxoid, Basingstoke, Hampshire, RG24 8PW, England.
DNA ligase Boehringer-Mannheim Ltd., East Sussex, England.
Trizol Gibro BRL, Renfew Rd, Paisley PA49RF, Scotland.
HPLC-grade solvents Lab-Scan, Stillorgan, Co. Dublin, Ireland.
PCR Optimizer kit 
TA cloning kit
Invitrogen, 9704-CH-Groningen, Netherlands.
PCR Primers MWG-Biotech Ltd, Milton Keynes, MK12 5RD, UK.
Restriction enzymes New England Biolabs, Hitchin, Herts., England.
VCSM13 Helper Phage Stratagene, North Torrey Pines Rd. La Jolla, USA.
Wizard Plus Mini-prep kit 
PCR prep DNA purification kit 
Reverse-Transcription kit
Promega Corporation, 2800 Wood Hollow Rd., Madison, 
W I 53711-5399, USA.
Goat anti-rabbit (Fab portion) 
polyclonal antibody
Fitzgerald Industries International, Inc., Concord, MA 
01742-3049, USA.
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2.1.2 Equipment
Equipm ent Supplier
BIAcore 1000™ 
BIAcore 3000™ 
CM5 chips
Pharmacia Biosensor AB, Uppsala, Sweden.
Eppendorf tubes 
Sterile universal containers
Sarstedt, Wexford, Ireland.
Heraeus Christ Labofiige 6000 
Biofuge A Microcentrifuge
Heraeus Instruments Inc, 111-a Corporate Boulevard, 
South Plainfield, New Jersey, USA.
Titretek Twinreader Plus
Medical Supply Company, Damastown, Mulhuddart, 
Dublin 12, Ireland.
NUNC Maxisorb plates NUNC, Kamstrup DK, Roskilde, Denmark.
3015 pH meter Jenway Ltd., Essex, England.
Orbital incubator Gallenkamp, Leicester, England.
RM6 Lauda waterbath 
T-Gradient BIOMETRA-PCR 
Millipore Filtration Apparatus
AGB Scientific Ltd., Dublin Industrial Estate, 
Glasnevin, Dublin 9, Ireland.
SB1 Blood tube rotator Stuart Scientific, London, England.
Sorvall RC-5B refrigerated centrifiige Du Pont instruments, Newtown, Connecticut, USA.
Sterile cell culture lab-wear Brownes, Foxrock, Dublin, Ireland.
Stuart Platform Shaker STR6 Lennox, Naas Rd., Dublin, Ireland.
Ultrafiltration cell 8400 Amicon Inc. Beverly, Massachusetts 01915, USA.
UV-160A spectrophotometer Shimadzu Corp., Kyoto, Japan.
UVP ImageStore 7500 gel 
documentation system
Ultra Violet Products, Upland, CA., USA.
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2.1.3 Culture media formulations
2 x  Tryptone and yeast extract (TY) medium Tryptone 
Yeast Extract 
NaCl
16 g/1
10 g/1
5 g/1
Luria Bertani broth (LB) medium Tryptone 
Yeast Extract 
NaCl
10 g/1
5 g/1 
5 g/1
Non-expression medium (NE) Tryptone 
Yeast Extract 
NaCl 
Glucose
Chloramphenicol
16 g/1 
10 g/1
5 g/1 
1%, v/v 
25 |xg/ml
Low expression medium (LE) Tryptone 16 g/1
Yeast Extract 10 g/1
NaCl 5 g/1
Glucose 1%, v/v
Chloramphenicol 25 f-ig/ml
IPTG 0.5 mM
SOB medium Tryptone 
Yeast Extract 
NaCl 
KC1 
MgCl2
20 g/1
5 g/1 
0.5 g/1 
2.5 mM 
20 mM
Super optimal catabolites (SOC) medium Tryptone
Yeast Extract
NaCl
KC1
MgCl2
Glucose
pH
20 g/1
5 g/1 
0.5 g/1 
2.5 mM 
20 mM 
20 mM 
7.0
Top Agar Tryptone 
Yeast Extract 
NaCl
Bacto agar
10 g/1
5 g/1
10 g/1
7 g/1
Solid medium was made by adding 15 g/l bacteriological agar to the media above.
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2.1.4 Buffer formulations
2.1.4.1 Phosphate buffered saline (PBS)
One Dulbecco’s A tablet (DA, Oxoid) was dissolved per 100 mis o f  distilled water 
according to the manufacturer’s instructions. When dissolved, prepared PBS contained 
0.15 M N aC l, 2.5 mM potassium chloride, 10 mM disodium hydrogen phosphate and 18 
mM sodium dihydrogen phosphate, pH 7.4. This buffer will be referred to  throughout as 
PBS.
2.1.4.2 PBS-Tween (PBST)
Tween 20 surfactant (Sigma) was added to PBS (described in 2.1.2.1 above) to a final 
concentration o f 0.05% (v/v) and mixed.
2.1.4.3 Tris buffered saline (TBS)
Tris buffered saline containing 0.05 M Tris, 0.15 M NaCl, pH 7.4, was prepared using 
distilled water.
2.1.4.4 Tris-acetic acid-EDTA buffer (TAE)
A 50 X stock solution o f TAE buffer was prepared in a final volume of 1 litre by 
dissolving 242 g Tris, and addition o f 57.1 ml glacial acetic acid followed by 100 ml of 
0.5 M EDTA. pH  8.0. All agarose gels were run in 1 X TAE by diluting the stock solution 
1/50 with ultra pure water.
2.1.4.5 Hepes Buffered Saline (HBS)
Hepes buffered saline (BIAcore running buffer) containing 50 mM NaCl, 10 mM HEPES,
3.4 mM EDTA and 0.05% (v/v) Tween-20 was prepared by dissolving 8.76 g o f NaCl, 
2.56 g o f HEPES, 1.27 g o f EDTA and 500 |_il of Tween 20 in 800 ml o f distilled water. 
The pH o f the solution was then adjusted to  pH 7.4, by the addition o f NaOH. The final 
volume was then made up to 1,000 ml in a volumetric flask. The solution was filtered 
through a  0.2 [im filter and degassed prior to use.
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2.1.5 Bacterial strains used
Bacterial stra in Source Com m ents
Heat-treated (HT) 
L. monocytogenes 4b 
(NCTC 4885)
Institute o f Food Research 
(IF R ), Norwich, UK.
Cells were heat-inactivated 
by heating at 76°C for 20 
minutes
L. monocytogenes 4b 
(NCTC 4885)
IFR
Cultured in Brain Heart 
Infusion (BHI) broth
L. monocytogenes 1 /2a 
(NCTC 4886)
IFR
Cultured in Brain Heart 
Infusion (BHI) broth
L. monocytogenes 
EGDpERL3 50-1 prfAEGD
Prof. Chakraborty, Institute of 
Med. Microbiology, University 
of Giessen, D-35392 Giessen, 
Germany
Overproduces PrfA 
regulated proteins
L. innocua 6a 
(NCTC 11288)
IFR Cultured in BHI broth
L. innocua 6b 
(NCTC 11289)
IFR Cultured in BHI broth
L. welshimeri 
(NCTC 11857)
IFR Cultured in BHI broth
L. invanovii 
(-)
IFR Cultured in BHI broth
L. seeligeri 
(ATCC 35957)
IFR Cultured in BHI broth
Bacillus subtilis subsp. 
subtilis (NCTC 1650)
Dublin City University Cultured in 2xTY
E. coli XL-1 Blue Stratagene Cultured in 2xTY broth
E. coli X L -10 Gold Stratagene Cultured in 2xTY broth
E. coli TGI Stratagene Cultured in 2xTY broth
E. coli INV aF ' Invitrogen Cultured in 2xTY broth
Note: NCTC= UK National Collection of Type Cultures. Cells were obtained from Dr. 
Gary Wyatt, at the Institute for Food Research, Norwich, unless otherwise indicated. Cells 
that were not heat-treated will be referred to as “intact” in the remainder o f this thesis. 
Cultures were stored at -80°C with 15-20% (v/v) glycerol.
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2.2 Production and characterisation o f polyclonal antibodies
2.2.1 Antibody and antigen preparation
2.2.1.1 Preparation o f  bacterial stocks
Stocks o f Listeria  cells used in this project (section 2.1.5) were prepared by growing the 
culture overnight in 50 ml BHI at 37°C with constant shaking at 200 rpm, until the 
O.D.600nm value o f between 0.5 and 0.8 was reached. The cultures were then centrifuged at 
4000 rpm for 20 minutes and the pellet resuspended in 2xTY broth to 1/10 the original 
culture volume. Sterile glycerol was then added to the culture to give a final glycerol 
concentration of 20% (v/v). 1.2 ml aliquots o f each stock culture were then placed in 2 ml 
cryovials and these were stored at -80°C.
2.2.1.2 Preparation o fln lB  Extract
Purification of the InlB gene product o f Listeria monocytogenes was performed as 
described by Muller et al. (1998b). Briefly, one 1.2 ml aliquot stock o f Listeria 
monocytogenes EGD l/2a pERL3 50-1 cells was thawed and inoculated into 50 mis o f  
BHI containing 5 (ig/ml erythromycin. The culture was incubated overnight for 12 hours 
at 37°C and 200 rpm. The overnight culture was diluted 1/50 with fresh, filtered media 
and then incubated as above but at a lower rotational speed (120 rpm). When an O.D.600mn 
value o f between 0.8 and 1.0 was reached, cell numbers were calculated by serially 
diluting a culture sample in media and plating the dilutions on BHI agar plates. The 
culture cells were removed by centrifugation at 4000 rpm for 20 minutes. The supernatant 
was decanted and the cell pellet washed x 2 with PBS at 1% (v/v) the original volume. 
The washed pellet was then re-suspended in 1 M Tris-HCl (Sigma), pH 7.5, and incubated 
on ice for one hour. The cells were then removed by centrifuging at 10000 rpm for 10 
minutes. The supernatant (InlB extract) was retained and stored at -80°C.
2.2.1.3 Production o f  polyclonal antibodies
All processes involving animals were licenced by the Department o f Health and Children 
and care was taken to minimise the stress to the animals involved. An antigen solution (1 
mg/ml solution of InlB extract or a 1x10s cells/ml Listeria monocytogenes solution) in 
PBS was added to an equal volume of Freund’s Complete adjuvant. This solution was 
vortexed until an emulsion was formed. New Zealand White female rabbits were injected
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subcutaneously at a number o f sites with 1 ml o f the emulsion. The immunisation was 
repeated 21 days later with Freund’s Incomplete adjuvant. Bleeds were taken from the 
marginal ear vein o f the animals between 10 and 15 days after immunisation, and the re­
boosting and bleeding procedures repeated until an adequate antibody titre was obtained. 
Once a sufficient titre was obtained the animals were sacrificed and the serum removed.
2.2.2 Purification o fpo lyc lonal antibody fro m  w hole serum
Purification o f polyclonal antibody from rabbit serum was carried out by precipitation 
with saturated ammonium sulphate, followed by affinity purification using a protein G 
column.
2.2.2.1 Saturated ammonium sulphate precipitation
The ammonium sulphate precipitation o f antibody from rabbit serum was carried out 
according to the method o f Hudson and Hay (1989). Saturated ammonium sulphate (SAS) 
was prepared by dissolving 500 g o f ammonium sulphate in 500 ml distilled water at 
50°C, leaving the solution overnight at 4°C and adjusting the pH to 7.2. 10 ml o f cold 
saturated ammonium sulphate (100%, w/v) was added dropwise to an equal volume of 
rabbit serum on ice with stirring. The mixture was allowed to stir at room temperature for 
30 minutes, followed by centrifugation at 3,000 rpm for 20 minutes. The supernatant was 
discarded and the precipitate washed twice in 10 ml o f 45% (w/v) ammonium sulphate. 
The washed pellet was dissolved in 5 ml o f PBS and dialysed in 5 L of PBS overnight at 
4°C to remove residual ammonium sulphate.
22.2 .2  Protein G affinity chromatography
A 2 ml protein G-sepharose column was poured and equilibrated with 50 ml o f PBS, pH
7.4, containing 0.3 M NaCl (running buffer). 2 ml of the dialysed ammonium sulphate 
rabbit immunoglobulin fraction was applied to the column and the flow rate adjusted to 1 
ml/min. The sample was then re-applied to the column twice followed by washing the 
column with 20 ml of PBS, pH 7.4, containing 0.5 M NaCl and 0.05% (v/v) Tween (wash 
buffer). Affinity captured-antibody was eluted with 0.1 M glycine/HCl, pH 2.2. 1 ml 
fractions were collected and immediately neutralised to pH 7.0 by addition o f 100 fo.1 of
1.5 M Tris/HCl, pH 8.7, to each fraction, in order to prevent denaturation o f antibody. The 
optical density o f each fraction was recorded at 280 nm, and those fractions containing
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protein were pooled and dialysed overnight in PBS at 4°C, and sodium azide added to 
0.05% (v/v). The sample was aliquoted (0.5 ml fractions) and stored at -20°C.
2.2.3 Non-competitive ELISA for determination ofpolyclonal antibody titre
96 well ELISA plates (Nunc) were coated with antigen (100 (J.1 o f 1x10s cells/ml bacteria 
species, or 10-20 (xg/ml protein) for 1 hour at 37°C or overnight at 4°C. The plates were 
incubated at 37°C for 1 hour, or at 4°C overnight and washed 3 times with PBS. The plates 
were then blocked with 200 |xl o f a 5% (w/v) Marvel milk powder solution in PBS and 
incubated at 37°C for 1 hour and washed as before. Dilutions o f antibody were prepared in 
PBS-Tween (0.05% (v/v) Tween 20) containing 1% (w/v) milk Marvel and 100 (J.1 o f each 
dilution added to the plates in triplicate. The plates were then incubated at 37°C for 1 hour. 
Followed by 3 washes with PBS and 3 washes with PBS-Tween. A 1/3,000 dilution of  
secondary antibody (goat anti-rabbit horse radish peroxidase-labelled antibody) was 
prepared in PBS-Tween containing 1% (w/v) Marvel and 100 p.1 o f  this solution added to 
the plates and incubated at 37°C for 1 hour. The plates were washed 3 times with PBS and 
3 times with PBST as before and 100 |.il o f  freshly prepared OPD substrate added to each 
well. The absorbance was read at 450 nm after 30 minutes using a Titertek Plate Reader 
Plus®.
2.2.4 Checkerboard ELISA for determination o f optimal concentrations o f immobilised 
interactant
ELISA plates (Nunc) were coated with varying antigen concentrations (1 xlO5 to 2 xlO9 
cells/ml) with each antigen concentration added to a different row on the ELISA plate. 
Plates were blocked as described with 5% (w/v) milk Marvel and 100 (xl samples of  
antiserum serially diluted in PBS-Tween containing 1% (w/v) milk Marvel added to each 
well and detected as in section 2.2.3.
2.2.5 Inhibition ELISA for polyclonal antibody characterisation
Nunc ELISA plates were coated with antigen and blocked as described in section 2.2.3. 
Dilutions of cells (Listeria monocytogenes 4b or cells listed in Table 3.10 for cross­
reactivity studies) were made in PBS or chocolate milk and mixed with an equal volume 
of antibody. This mixture was incubated for 30 minutes at 37°C. The plates were washed 
as before and 100 |j.l o f each sample added to the plate in triplicate and incubated at 37°C 
for 1 hour. Plates were washed three times with PBS and 3 times with PBS-Tween and 
100 (j,l o f 1/3000 dilution o f anti-rabbit HRP-conjugated antibody in PBS-Tween
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containing 1% (w/v) Marvel added to each well. After incubation for 1 hour at 37°C, 100 
|xl o f  OPD substrate was added to each well and the plates incubated for 30 minutes to 1 
hour at 37°C. Absorbance was read at 450 nm.
2.2.6 S D S polyacrylam ide g e l electrophoresis
The following stock solutions were prepared: 30% (w/v) acrylamide containing 0.8% 
(w/v) bis-acrylamide, 1.5 M Tris-HCl, pH 8.8 (Tris base, rather than Tris-Cl, should be 
used for buffer preparation and pH adjustment made with HC1 as use o f Tris-Cl will result 
in higher ionic strength, poor migration and diffuse protein bands), 0.4% (w/v) SDS, 0.5 
M Tris-HCl, pH 6.8, 0.4% (w/v) SDS and 10% (w/v) ammonium persulfate. The glass 
plates were washed with acetone and sealed with a gasket and grips. Free radical-induced 
polymerisation o f the resolving gel acrylamide (Table 2.1) was catalysed by addition of 
ammonium persulphate and the accelerator TEMED and the gel added to the space 
between the plates and covered with a layer o f distilled water. Once the gel had 
polymerised, the water was removed and the stacking gel was placed directly onto the 
resolving gel. A plastic comb was placed in this gel to create the wells for sample 
application. Once the gel had fully polymerised, the plates were then placed in an 
electrophoresis chamber, the comb was removed and the chamber and wells filled with 
electrophoresis buffer (25 mM Tris, 250 mM Glycine (electrophoresis grade), pH 8.3 and 
0.1% (w/v) SDS).
Solution Resolving Gel Stacking Gel
Acrylamide (A) 10 ml 1.66 ml
Distilled Water 5.0 ml 5.75 ml
Resolving Gel Buffer (B) 5.0 ml -
Stacking Gel Buffer (C) - 2.5 ml
Ammonium Persulphate (D) 200 m-1 70 pi
TEMED 20 (j.1 14 fxl
Table 2.1: Composition o f  Resolving and Stacking Gels. (A) 30% (w/v) Acrylamide solution 
containing 29.2% (w/v) acrylamide and 0.8% (w/v) Bis-acrylamide, (B) 4X resolving gel buffer 
consisting o f Tris-HCl p H  8.8 (1.5M) and SDS (0.4% w/v) diluted in distilled water, (C) 4X  
stacking gel buffer consisting o f  Tris-HCl p H  8.8 (0.5M) and SDS (0.4%, w/v) diluted in distilled 
water and (D) 100 mg/ml ammonium persulphate diluted in water.
Excess sample buffer (3:1 ratio o f SDS to protein) is essential to maintain reduction of  
protein sulfhydryls and to prevent intramolecular disulfide bond formation through
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oxidised cysteines. Therefore, samples were mixed 4:1 with sample buffer (60 mM Tris- 
HC1 (pH 6.8), 25% (w/v) glycerol, 2% (w/v) SDS, 14.4 mM 2-mercaptoethanol and 0.1% 
(w/v) bromophenol blue) and heated for 4-5 minutes at 100°C. A Sigma wide range 
marker (product code M 4038), Sigma prestained marker (product code MW-SDS-Blue) 
or Pierce Blue Ranger prestained marker (product code 26681), was used for each gel. A 
sample volume of 20 (xl was added to the respective wells on the gel. The gel was run at 
30 mA until the sample had reached the bottom o f  the gel, at which time, the gels were 
stained with Coomassie blue for 1-2 hours followed by destaining in 30% (v/v) 
methanol: 10% (v/v) acetic acid:60% (v/v) distilled water for 2-3 hours.
Protein standard Sigma wide range marker
Sigma prestained 
marker
Pierce Blue 
Ranger marker
Aprotinin 6.5 kDa - -
a-Lactalbumin 14.2 kDa - -
Lysozyme - - 18 kDa
Trysin Inhibitor 20 kDa - 26 kDa
Trvpsinogen 24 kDa - -
Triosephosphate 31 kDaIsomerase
Carbonic Anhydrase 29 kDa - 32 kDa
Glyceraldehyde-3- 36 kDaphosphate dehydrogenase
Lactic Dehydrogenase - 36.5 kDa -
Ovalbumin 45 kDa - 48 kDa
Fumerase - 54 kDa -
Glutamic Dehydrogenase 55 kDa - -
Pyruvate Kinase - 61.5 kDa -
Albumin 66 kDa - 85 kDa
Fructose-6-phosphate 84 kDa 85 kDaKinase
Phosphorylase B 97 kDa - 112 kDa
Galactosidase 116 kDa 116 kDa -
a2Macroglobulin • 185 kDa -
Myosin 205 kDa - 208 kDa
Table 2.2: Molecular weights o f  the protein standards used fo r  SDS-PAGE and Western Blot 
analysis. The molecular weights o f  the Sigma prestained marker and Pierce Blue Ranger 
prestained marker indicate the apparent molecular weights o f each protein after staining.
2.2.7 Western blotting
Following electrophoresis, as outlined above (section 2.3.6), the gel was placed on top of 
three sheets o f Whatman filter paper pre-soaked in transfer buffer. Generally, a Tris- 
glycine-methanol-SDS buffer is used to transfer separated proteins to nitrocellulose. At 
high concentrations, SDS actually seems to inhibit the binding of proteins to
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nitrocellulose, and therefore in many labs, this component is omitted (Caponi and 
Migliorini, 1999). Without the addition o f SDS, however, the gel may swell and partial 
refolding o f protein may occur. Methanol helps to counteract swelling, but can diminish 
the transfer efficiency, since it also tends to fix the proteins on the gel. Therefore the 
composition of the transfer buffer (electrophoresis buffer (section 2.3.6) with 20% (v/v) 
methanol) represents a compromise between different requirements (Caponi and 
Migliorini, 1999). A sheet o f Immobilon P™ PVDF membrane or nitrocellulose 
membrane, also pre-soaked in transfer buffer, was carefully placed on top o f  the gel and 
any air bubbles removed by rolling a clean 10 ml pipette over the sheets. Three more 
sheets of pre-soaked filter paper were added on top of the gel and air bubbles removed. 
Proteins were transferred from the gel to the membrane using a Bio-Rad Wet Transfer 
system for 1 hour at 70V in a 4°C environment.
After transfer, the blotted membrane was washed 3 times with Tris-Buffered Saline (TBS; 
lOmM Tris-HCl, pH 8.0, 150mM NaCl), prior to overnight incubation in blocking buffer 
(5% (w/v) Marvel Milk Powder in TBS). Following blocking, the blot was washed 3 times 
in TBS buffer and then incubated with primary antibody (at the appropriate dilution in 
TBS containing 1% (w/v) Marvel Milk Powder, 0.05% (v/v) Tween-20) for 1.5 hours at 
room temperature. The blot was then washed 3 times in TBS and 3 times in TBS-T (TBS 
containing 0.05% Tween-20) prior to incubation with alkaline phosphatase-labelled 
secondary antibody (diluted 1/3000 in TBS-T containing 1% (w/v) Marvel Milk Powder) 
for 1.5 hours at room temperature. The blot was washed 3 times in TBS-Tween and rinsed 
in TBS, before incubation in substrate solution (175 |xg/ml BCIP, 500 (xg/ml NBT in 
alkaline phosphatase buffer). Colour development was allowed to proceed at room 
temperature until the desired bands were apparent, at which time the reaction was stopped 
by washing extensively with distilled water or by rinsing with lOOmM EDTA.
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2.3 Cloning o f the gene sequences encoding InlB and p60 into E. coli
2.3.1 Preparation o f Listeria monocytogenes genomic DNA
20 ml o f a L  monocytogenes l/2a culture was centrifuged at 4000 rpm for 10 minutes and 
the pellet resuspended in 1.5 ml TES (10 mM Tris-HCl, 1 mM Na2-EDTA, 50 mM NaCl, 
pH 8). The 1.5 ml culture was centrifuged at 13,000 rpm for 5 minutes, the supernatant 
removed and pellet resuspended in another 1.5 ml TES. The 1.5 ml culture was re- 
centrifuged at 13,000 rpm for 5 minutes, the supernatant removed and the pellet 
resuspended in 0.7 ml TE (10 mM Tris-HCl, ImM Na2-EDTA, pH 8). 100 pi o f  lysozyme 
freshly prepared was added and incubated for 45 minutes at 30°C. When the solution 
turned viscous 50 pi of the Sarkosyl solution (10% (v/v) Sarkosyl in TE containing 5 
mg/ml proteinase) was added and incubated at 37°C for 1 hour. After 1 hour 70 pi o f a 3M 
sodium acetate solution was added and mixed. 600 pi o f the Kirby mix (100 ml Phenol, 
100 ml chloroform, 4 ml isoamylalcohol, 0.8 g 8-hydroxy Quinolone, stored under 100 
mM Tris-HCl, pH 7.5 at 4°C) was then added and mixed. The mixture was then spun at 
13000 rpm for 4 minutes and the aqueous phase decanted into a fresh eppendorf tube. A 
further 600 pi o f the Kirby mix was added and mixed. The mixture was spun at 13000 
rpm for 4 minutes and the aqueous phase again removed into a fresh eppendorf. 700 pi of  
chloroform:isoamylalcohol (24:1) was added and mixed. The mixture was then 
centrifuged at 13000 rpm for 4 minutes and the aqueous phase transferred to a fresh 
eppendorf tube as before. An equal volume of isopropanol was added to the aqueous 
phase and re-centrifuged at 13000 rpm (until a pellet was formed). The supernatant was 
removed and pellet was washed twice with 200 pi of 70% (v/v) ethanol and allowed air 
dry for 5 minutes. The pellet was then resuspended in 150-200 pi TE and stored at 4°C.
2.3.2 Agarose gel electrophoresis fo r  DNA characterisation
DNA was analysed by running on agarose gels (containing 0.5 pg/ml ethidium bromide 
for staining o f DNA) in a horizontal gel apparatus. Gels were prepared by dissolving 
agarose (typically 0.7-1.2% (v/v)) in 1 x TAE buffer by heating and 0.5 pg/ml ethidium 
bromide added to the cooled gel prior to setting. The gels were placed in the gel apparatus 
and 1 x TAE used as the running buffer. A tracker dye was incorporated into the sample (1 
pi dye + 5 pi sample) to facilitate loading of samples. Where Sigma red Taq was used no 
tracking dye was added. Mini gels were frequently run at 100 Volts for 1 hour or until the 
tracker dye reached the end o f the gel while maxi gels were frequently run at 40-80 Volts.
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Gels were then visualised on a UV transilluminator and photographed using a UV image 
analyser.
2.3.3 Design o f p60 and InlB Primers
Primers were designed (Table 2.2) for further ligation into the QIAexpress® Type ATG 
construct pQE-60 (QIAGEN). For both the p60 (accession number X52268) and InlB 
(accession number AJO12346) proteins the sequence coding for the signal peptides were 
deleted. The multi-cloning region of the pQE-60 vector contains a N co l site at the N' end 
o f the sequence and a BamHI site at the C1 end. Therefore, forward primers were designed 
to include the N col binding site sequence and the reverse primers were designed to contain 
the BamHI sequence. Forward primers were designed using the same bases found in the 
starter sequence o f the required protein and reverse primers were designed using the 
complementary bases from the 3' to 5' end of the sequences.
N col
P60 forward primer 5'-cca tgg gaa gca ctg tag tag teg aag ctg g
P60 reverse primer 5 '-gga tcc tac geg acc gaa gcc aac tag
BamHI
N col
InlB forward primer 5'-cc<3 tgg gag aga eta tea ccg tgc caa ege
InlB reverse primer 5 '-gga tcc ttt ctg tgc cct taa att age tgc
BamHI
Table 2.3: Sequences o f  both p60 and InlB forward and reverse primers used for the 
amplification o f  p60 and InlB gene sequences by PCR.
2.3.4 PCR o f p60 and InlB protein gene sequences
PCR was used to amplify the DNA sequences for both proteins. A standard PCR reaction 
was set up as follows:
1 pi dTNP mix (lOmM)
5 pi lOx PCR buffer
0.5 pi (each) Primers (0.5nM/pl) (total o f 1 pi)
1 pi Template DNA (approximately 20ng/reaction)
39.5 pi Sterile H20
2.5 pi Taq polymerase
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A negative control was also set up as above except no Template DNA was added. The
following gradient PCR cycle was used to determine the optimum annealing temperature
for each protein:
Stage 1: Step 1: 95 °C for 10 minutes
Stage 2: Step 1: 95 °C for 1 minute
Step 2: 58°C for 30 seconds or
60°C for 30 seconds or 
62°C for 30 seconds or 
65°C for 30 seconds 
Step 3: 72°C for 1 minute
❖ Stage 2 was repeated for 30 cycles 
Stage 3: Step 1: 72°C for 10 minutes
When the correct annealing temperature was optimised, the PCR was repeated as above 
except Stage 2 Step 2, was run only at the correct annealing temperature for 30 seconds.
2.3.5 TA Cloning o f p60 and InlBPCR products into E. coli INV aF' cells
Cloning o f p60 and InlB PCR products into E. coli IN V  aF ' cells was carried out using a 
TA cloning kit (Invitrogen) under the recommended conditions. Taq polymerase has a 
nontemplate-dependent activity that adds a single deoxyadenosine (A) to the 3' ends of 
PCR products. The linearized vector supplied in the kit has 3' deoxythymidine (T) 
residues. This allows PCR inserts to ligate efficiently with the vector. For optimal ligation 
efficiencies, fresh PCR products (< 1 hour old) were used, as the single 3' A-overhangs on 
the PCR products will degrade over time, reducing ligation efficiency.
2 3 .5 A Ligation ofPC RProducts into a pC R  2.1 Vector 
The ligation reaction (10|il) was set up as follows:
Sterile ultra pure water 5 1^
1 Ox ligation buffer 1 .^1
pCR 2.1 vector (25 ng/ fxl) 2 |jl
Fresh PCR product 1 1^
T4D NA Ligase 1 (¿1
Total volume 10 [il
The ligation reaction was incubated at 14°C overnight and then used for transformation (If 
unable to do transformation immediately the ligation reaction can be stored at -20°C).
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2.3.5.2 Transformation o f  pCR 2.1 into E. coli 1NV aF ' cells
The vial containing the ligation reaction was centrifuged briefly and placed on ice. A 50 
fxl vial of frozen One-shot® competent cells was thawed on ice for each 
ligation/transformation. 2 (il o f each ligation reaction was pipetted directly into the vial o f  
competent cells and mixed by stirring gently with the pipette tip. The vial was incubated 
on ice for 30 minutes and the remaining ligation mixture stored at -20°C. Each Vial was 
heat shocked for exactly 30 seconds in a 42°C water bath and placed immediately back on 
ice. 250 (xl o f SOC medium (section 2.1.3) at room temperature was added to each tube. 
The vials were then shaken horizontally at 37°C for 1 hour at 225 rpm in a shaking 
incubator. After 1 hour, 50 |xl or 100 fil from each transformation vial was spread on 
separate, labelled LB agar plates (Luria-Bertani medium: 1% (w/v) Tryptone, 0.5 % (w/v) 
Yeast Extract, 1% (w/v) NaCl and pH 7.0) containing X-Gal (40 (J.1 o f the 40mg/ml X-Gal 
stock solution was pipetted onto LB plates, spread evenly, and let dry for 15 minutes) and 
50 (xg/ml o f kanamycin. The plates were then inverted and placed in at 37°C for 18-24 
hours before being shifted to 4°C for 2-3 hours to allow for proper colour development.
2.3.5.3 Plasm id purification
To determine the presence o f a PCR insert, six (InlB and p60) colonies were picked from 
the plates and grown overnight in 3 ml LB broth containing 50 (J-g/ml kanamycin. A 
Promega Wizard® Plus Minipreps DNA purification system was used to purify the 
plasmid DNA as follows:
A 5 ml overnight bacterial culture was centrifuged for 5 minutes at 4,000 rpm, the 
supernatant decanted and tubes blotted dry on a paper towel. 250 fil of cell resuspension 
solution (50 mM Tris-HCl, pH 7.5, 10 mM EDTA and 10 fig/ml RNase A) was added and 
the cell pellet completely resuspended by vortexing or pipetting. The mixture was 
transferred to sterile 1.5 ml microcentrifuge tube(s), 250 [xl o f cell lysis solution (0.2 M 
NaOH and 1% w/v SDS) added and mixed by inverting the tube 4 times. The suspension 
was incubated for 1-5 minutes before 10 fil o f alkaline protease solution was then added 
and mixed by inverting the tube 4 times (alkaline protease inactivates endonucleases and 
other proteins released during the lysis o f the bacterial cells that can adversely affect the 
quality of the isolated DNA). After 5 minutes incubation at room temperature 350 (j.1 of 
Wizard® Plus SV neutralisation solution (pH 4.2 buffer containing 4.09 M guanidine 
hydrochloride, 0.759 M potassium acetate and 2.12 M glacial acetic acid,) was added and
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immediately mixed by inverting the tube 4 times. The bacterial lysate was then 
centrifuged at 14,000 rpm for 10 minutes at room temperature. The cleared lysate was 
transferred (~ 850 (xl) to the prepared spin column by decanting. The supernatant was 
again centrifuged at 14,000 rpm for 1 minute at room temperature, the spin column was 
removed from the tube and the flow through discarded from the collection tube. 750 |xl of  
column wash solution (162.8 mM potassium acetate, 22.6 mM Tris-HCl, pH 7.5 and 0.109 
mM EDTA), previously diluted with 95% (v/v) ethanol, was then added to the reinserted 
spin column. The supernatant centrifuged at 14,000 rpm for 1 minute at room temperature 
and the flow through again discarded from the collection tube. The wash procedure was 
repeated using 250 (j.1 o f column wash solution. The supernatant was centrifuged at 14,000 
rpm for 2 minutes at room temperature, and the spin column subsequently transferred to a 
new sterile 1.5 ml microcentrifuge tube taking care not to transfer any o f the column wash 
solution with the spin column. The plasmid DNA was finally eluted by addition o f 100 [il 
of sterile ultra pure water to the spin column and centrifuging the supernatant at 14,000 
rpm for 1 minute at room temperature. After eluting the plasmid DNA, the spin column 
was discarded and DNA stored in the microcentrifuge tube at -20°C.
2.3.5.4 Restriction Analysis o f  White Colonies from  theX-G al agar plates
A restriction digest was carried out at 37°C for 1 hour on each o f the twelve colony 
preparations as follows:
Each digest was run on a 1% (w/v) agarose gel (section 2.3.2) and the restricted p60 insert 
and InlB insert cut from the gel using a sharp scalpel and placed in sterile 1.5 ml 
centrifuge tubes (section 2.3.6.3).
NE buffer 2 (lOx)
BSA (10mg/ml)
Plasmid DNA (30ng/reaction) 
Up H20  (sterile)
BamHl
N col
Total volume
5.0 nl 
0.5 nl
10.0 fil 
28.5 nl
2.0 nl
4.0 pi
50.0 (il
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2.3.6 Cloning o f p60 andInlB gene sequences into a QIAGENpQE-60plasmid
2.3.6.1 Preparation ofpQ E-60 plasm id
An E.coli colony was taken from a LB agar plate containing 100 |ig/ml ampicillin and 
grown overnight in 5 ml LB broth containing 50 (i-g/ml ampicillin at 37°C. The pQE-60 
plasmid was then purified using the Promega Wizard® Plus Minipreps DNA Purification 
System (section 2.3.5.3).
2.3.6 .2 Restriction o f  both pQE-60 and the pCR 2.1 plasm id containing the inserts
A restriction digest was carried out on the purified pQE-60 plasmid, purified pCR 2.1- p60 
plasmid and purified pCR 2.1-InlB plasmid as described in section 2.3.5.4.
2.3.6 .3 Purification o f  DNA from an agarose gel
DNA was purified from the agarose gel using a Promega Wizard® PCR Preparation DNA 
Purification System as outlined below:
The DNA band o f interest was excised using a clean, sterile scalpel blade and the agarose 
slice (<300 mg) transferred to a sterile 1.5 ml microcentrifiige tube. The tube was 
incubated at 70°C until the agarose melted (~10 minutes). 1 ml of resin was added to the 
melted agarose slice and mixed thoroughly for 20 seconds before being pipetted into a 5 
ml sterile syringe attached to the Luer-Lok® extension o f a Wizard® Minicolumn. The 
syringe plunger was then reattached and the DNA/resin gently pushed into the 
minicolumn. The syringe barrel was detached from the minicolumn, the plunger removed 
and the barrel reattached to the minicolumn. 2 ml o f 80% (v/v) isopropanol was pipetted 
into the syringe, the plunger reattached and the solution gently pushed through the 
column. The syringe was again removed and the minicolumn transferred to a new sterile
1.5 ml microcentrifuge tube. The minicolumn was centrifuged at 10,000 rpm to dry the 
resin. The minicolumn was again transferred to a new microcentrifuge tube and 50 (4,1 o f 
sterile TE buffer added. After 1-2 minutes the minicolumn was centrifuged for 20 seconds 
at 10,000 rpm to elute the DNA fragment. The minicolumn was then discarded and the 
purified DNA stored at 4°C short term or at -20°C long term.
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I2.3.6.4 Ligation ofpurified cut pQE-60 plasm id with purified protein inserts
The ligation reaction was set up as follows and incubated at 14°C overnight
NcoI/BamHI digested pQE-60 (20ng/rxn) 4 fxl
NcoI/BamHI digested gene insert (lOng/rxn) 4 (xl
Ligase 1 fil
lOx buffer 1 |j.l
Total volume 10 p.1
The ligation mixture was stored at -20°C until needed.
2.3.6 .5 Preparation o f  competent cells
High efficiency competent cells were prepared as previously described by Inoue et al. 
(1990). A stock o f E. coli XL 10 Gold was streaked on 2xTY agar and incubated at 37°C 
overnight. Approximately 10-12 large colonies were removed from the plate and 
inoculated into 250 ml o f SOB medium in a 2L baffled flask. The culture was grown at 
18°C with vigorous shaking (200-250 rpm) until an OD60o o f 0.6 was reached. The culture 
was then placed on ice for 10 minutes before being transferred to two 250 ml centrifuge 
tubes and spun at 4,000 rpm at 4°C for 5 minutes in a Beckman J2-21 centrifuge. The 
pellets were resuspended in 40 ml o f ice-cold TB buffer (10 mM Pipes, 15 mM CaCl2, 150 
mM KC1, pH adjusted to 6.7 with KOH and 55 mM MnCl2, sterile filtered and stored at 
4°C), placed on ice for 10 minutes, pooled and centrifuged as before. The cell pellet was 
gently resuspended in 20 ml o f ice-cold TB buffer and DMSO added slowly with gentle 
swirling to a final concentration of 7%. After incubation in an ice bath for 10 minutes the 
cell suspension was dispensed in 1 ml aliquots into microcentrifuge tubes. The cells were 
then flash frozen in liquid nitrogen and stored at -80°C.
2.3.6 .6  Transformation o f  pQE-60 into E  coliXL-10 Gold competent cells
The transformation was carried out as described in section 2.3.5.2 except no X-Gal was 
added to the LB plates, as pQE-60 contains no lacZa  gene.
2.3.7 Protein expression tim e course experim ent
5 mis o f LB broth containing both ampicillin and kanamycin was inoculated with 100 |j,l 
of stock culture (culture with insert) and grown overnight at 37°C. The 5 ml culture was
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then used to inoculate 50 mis LB broth containing both ampicillin and kanamycin and 
incubated at 37°C until an O.D .600 of 0 .6  was reached. A t this time a 1 ml sample was 
taken and placed at -20°C until needed. The culture was induced with IPTG to a  final 
concentration o f 1 mM and a 1 ml sample taken every hour. Each 1 ml sample was 
centrifuged at 14,000 rpm for 5 minutes and the supernatant discarded. The pellet was 
resuspended in 200 fil o f  appropriate buffer, PBS for native extract and lysis buffer (8 M 
urea, 10 mM Tris-Cl, 100 mM NaH2P 0 4, pH 8.0) for denatured extract. The samples were 
then sonicated for 45 seconds at an amplitude o f 40 using a microtip Vibra Cell™ 
sonicator and the cell debris removed by centrifugation at 14,000 rpm for 5 minutes. The 
supernatant was mixed with SDS-PAGE sample buffer and SDS-PAGE analysis carried 
out as in section 2 .2 .6 .
2.3.8 Determ ination o f  protein  solubility and cellular location
To determine the solubility of each protein, a 5ml aliquot o f a 50 ml induced protein 
culture (section 2.3.7), was centrifuged at 4000 rpm for 20 minutes and the pellet 
resuspended in 500 fj.1 o f PBS and sonicated. The remaining cell debris was resuspended 
in 8M  Urea buffer and the insoluble matter separated by centrifugation. Both the soluble 
(PBS) and insoluble (Urea buffer) protein fractions were analysed by SDS-PAGE. To 
determine the cellular location of each protein 2 x 5 ml aliquots o f a 50 ml induced protein 
culture (section 2.3.7) were centrifuged at 4000 rpm for 20 minutes and the supernatant 
discarded. One o f the cell pellets was resuspended in 1 ml TES (200 mM Tris-HCl (pH 
8.0), 0.5 M sucrose, 0.5 mM EDTA) buffer and left on ice for 1 hour. After 1 hour, the 
culture was centrifuged at 14,000 rpm for 5 minutes and the supernatant (periplasmic 
extract) removed to a fresh tube for further analysis. The remaining two pellets (pellet 
from periplasmic extract and original culture pellet) were resuspended in PBS (native 
extract) and sonicated as described in section 2.3.7. The periplasmic extract (pellet 
resuspended in TES), native cytoplasmic extract (pellet resuspended in PBS and 
sonicated) and cytoplasmic extract minus periplasmic extract (periplasmic lysate pellet 
resuspended in PBS and sonicated) were centrifuged and analysed by SDS-PAGE as 
described in section 2 .2 .6 .
2.3.9 Purification o f  recom binant protein  by im m obilised m etal affinity chrom atography
1 ml o f a Ni+-NTA agarose resin (QIAgen) was added to a 20 ml universal tube and 
equilibrated with 20 ml of running buffer (PBST with 1% (v/v) Tween-20, 500 mM NaCl 
and 10 mM p-mercaptoethanol). The solution was centrifuged at 4000 rpm for 10 minutes
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and the supernatant (running buffer) removed. 2-3 ml of InlB or p60 cytoplasmic extracts 
were added to the pellet (Ni+-NTA resin) and mixed for 1-2 hours at room temperature on 
a rotating table (“belly dancer”). The mixture was then centrifuged at 4000 rpm for 10 
minutes and the supernatant (unbound material) removed. The pellet (resin with bound 
protein) was washed 3 times with 20 ml o f running buffer as before. The proteins were 
eluted with 2-3 ml o f sodium acetate buffer, pH 4.5, and neutralised with 2 M  Tris-base 
purified proteins were stored at -20°C.
2.3.10 Identification o f  recom binant protein  by Western blotting
Purified proteins were analysed by SDS-PAGE and W estern blotting as described in 
sections 2.2.6 and 2.2.7. Purified recombinant protein bands were detected with a mouse 
anti-His tag monoclonal antibody (Sigma) or with a  mouse monoclonal antibody raised 
against the relevant protein, donated by Stephen Hearty, Dublin City University.
2.3.11 Conjugation o fH R P to  the anti-InlB  polyclonal antibody
3 mg of peroxidase was dissolved in 250 [xl freshly prepared 0.1 M  N aH C 03 in a glass test 
tube. 250 (d o f a 8 mM N aI0 4 solution was added to the peroxidase, and incubated at 
room temperature for 2 hours in the dark. After 2 hours, 500 (d o f 1 mg/ml antibody in 
PBS was added to the peroxidase solution and incubate for a further 2 hours in the dark. 
To stabilise the mixture, 100 (0,1 of 100 mM NaBH*, diluted in 100 mM NaOH, was added 
to the mixture and incubated for 1 hour at 4°C. The mixture was then dialysed overnight at 
4°C in 5 L of PBS.
2.3.12 Identification o f  recombinant protein  by ELISA
Recombinant p60 protein was identified by inhibition ELISA as described in section 2.2.5, 
while recombinant InlB was identified by a sandwich ELISA using HRP-conjugated anti- 
InlB polyclonal antibody. The sandwich ELISA was performed by coating an ELISA plate 
with 30 (ig/ml anti-InlB polyclonal antibody for 1 hour at 37°C and blocking with 5% 
(w/v) milk marvel. Dilutions o f purified recombinant InlB protein in PBS were added to 
the anti-InlB polyclonal antibody coated wells (in triplicate) and incubated for 1 hour at 
37°C. Unbound recombinant InlB protein was washed from the plate with 3 washes with 
PBS and 3 washes with PBST. Bound protein was detected with the addition o f 100 fxl per 
well o f HRP-conjugated anti-InlB polyclonal antibody.
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Purified DNA from section 2.3.6.1 was sent to MW G-Biotech Ltd for sequencing and 
linear nucleotide results were received via e-mail. Nucleotide sequences were translated to 
amino acid sequences by using the Expasy Translate tool (see section 2.4.3 .8 for web 
addresses) and aligned with protein amino acid sequences given in EMBL (AJ012346 and 
X52268) using the clustalW program. Aligned sequences were imported into Genedoc for 
further sequence manipulation.
2.4 Production o f  m urine scFv antibody libraries
Recombinant single chain variable fragment production provides an alternative source of 
high affinity Listeria monocytogenes-specific antibodies. Recombinant antibodies can be 
expressed in large quantities in E. coli and easily purified via engineered affinity tags, 
such as the polyhistidine tag or the Flag peptide tag. Antibody phage display has the 
advantage o f a direct link between DNA sequence and protein function allowing 
modifications in the primary antibody sequence, often resulting in altered antigenic 
specificity and enhanced stability (Azzazy and Highsmith, 2002).
2.4.1 Isolation o f  m urine antibody genes fro m  im m unised m ice
2.4.1.1 Immunisation procedure o f  BALB/c mice fo r  the production o f  single chain Fv 
antibodies to Listeria monocytogenes cells and invasion-associated proteins.
Solutions o f 1x10s heat-treated Listeria monocytogenes cells or 1 mg/ml InlB extract were 
prepared in PBS and added to an equal volume of Freund’s Complete adjuvant. This 
solution was vortexed until an emulsion was present. 5-10 week old BALB/c mice were 
immunised subcutaneously with a total volume o f 250 (il over several sites. Further 
intraperitoneal immunisations were carried out after 21 days using Freunds’ Incomplete 
adjuvant. A tail bleed from the mice were taken 7 days later and the antibody titre against 
the specific drug determined. The mice were re-boosted and bleeding procedure repeated 
until an adequate antibody titre was obtained. The animals were then re-immunised 7-10 
days prior to sacrifice. The mice were sacrificed by cervical dislocation and the spleens 
removed.
2.4.1.2 Total RNA Extraction from  the spleen ofBALB/c mice
The spleen from an immunised mouse (immunised with InlB extract or heat-treated 
Listeria monocytogenes cells) was removed aseptically and placed into a pre-weighed 
sterile universal. The spleen was weighed and therefore 1 ml o f Trizol reagent per 50 mg 
of spleen added and homogenized using a sterile homogeniser that had been sterilised at
2.3.13 Alignment o f protein gene sequences
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180°C overnight. The homogenized sample was aliquoted into 1 ml aliquots and placed in 
sterile 1.5 ml centrifuge tubes. These were then left for 5 minutes at room temperature 
before the addition o f 200 fil of chloroform to each tube. The tubes were shaken for 15 
seconds and incubated again at room temperature for 2-3 minutes. After incubation the 
tubes were centrifuged at 14,000 rpm for 15 minutes at 4°C. Three layers were observed, a 
lower red phenol/chloroform phase, a  protein interphase and a colourless liquid upper 
phase containing the RNA. Transferring the aqueous phase to  a fresh tube and adding 0.5 
ml o f isopropyl alcohol per tube precipitated the RNA. Samples were incubated at room 
temperature for 10 minutes and then centrifuged at 14,000 rpm for 10 minutes at 4°C. 
Small brown pellets were observed at the side o f each tube. The supernatant was removed 
and the pellet washed by redissolving in 1 ml o f 75% (v/v) ethanol per tube by gentle 
pipetting and inversion. Each tube was then centrifuged at 10,000 rpm for 5 minutes at 
4°C, the ethanol decanted and the pellet dried at 37°C for 10 minutes. Each pellet was 
redissolved in 50 (j,l nuclease free water and pooled together in a fresh sterile centrifuge 
tube.
2.4.1.3 Reverse transcription o f  mouse spleen mRNA
PCR can be performed directly from RNA but it is more successful to synthesize 
complementary DNA (cDNA) from total RNA for use in PCR. Complementary DNA was 
synthesized using a Promega cDNA synthesis kit containing random hexamer primers. 
Random hexamer primers were used instead o f poly T primers as it is possible that the 
mRNA could be sheared during the extraction process and the use o f the poly T primer 
would reduce the amount of viable cDNA synthesized. The PCR reaction was set up as 
follows:
Com ponent . W orking conc.
MgCl2 
10X Buffer
5mM
IX
ImM
lU/fxl
0 . 2  | i g / r x n *  
15U/rxn*
dNTP mix
RNase Inhib.
Random Primer
A M V RT
Sterile H 20 Made up to 20 (il including RNA 
7-10 |ig RNA/rxn*RNA
* total concentration per reaction (usually 2 0 |xl volume)
* Volume for one reaction (X I) or six reactions (X6 )
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All reaction components, except enzymes, were placed on ice and left to thaw slowly. 
Enzymes were only removed when required and immediately kept at -20°C after use, in 
order to preserve activity. A 6X master mix was made up and the required volume of 
enzymes added before pipetting the mixture in to pre-labelled eppendorfs. Finally the 
required volume of total RNA was added and mixed by pipetting.
2.4.2 A m plification o f  antibody light and heavy chain genes
2.4.2.1PCR Primers
The listed PCR primers were obtained from Sigma-Genosys Ltd and designed to be The 
compatible with the pAK vector system as described by Krebber et al. (1997).
Variable light chain back primers
LB 1 5 'gccatggcggactacaaaGAYATCCAGCTGACTCAGCC3'
LB2 5' sccatggcg eactacaaaG AY ATT GTT CT C WC C C AGTC 3'
LB3 5 'gccatggcggactacaaaGAYATTGTGMTMACTCAGTC3'
LB4 5 'gccatggcggactacaaaGAYATTGTGYTRACAC AGTC3'
LB5 5 'gccatggcggactacaaaGAYATTGTRATGACMCAGTC3'
LB6 5 'gccatggcggactacaaaGAYATTMAGATRAMCCAGTC3'
LB7 5 'gccatggcggactacaaaGAYATTCAGATGAYDCAGTC3'
LB8 5 'gccatggcggactacaaaGAYATYCAGATGAC ACAGAC3'
LB9 5 'gccatggcggactacaaaGAYATTGTTCTCAWCCAGTC3'
LB 10 5 'gccatggcggactacaaaGAYATTGWGCTS ACCCAATC3'
LB 11 5 'gccatggcggactacaaaGAYATTSTRATGACCCARTC3'
LB 12 5 'gccatggcggactacaaaGAYRTTKTGATGACCCARAC3'
LB 13 5 'gccatggcggactacaaaGAYATTGTGATGACBC AGKC3'
LB 14 5 'gccatggcggactacaaaGAYATTGTGATAACYCAGGA3'
LB15 5 'gccatggcggactacaaaGAYATTGTGATGACCCAGWT3'
LB 16 5 'gccatggcggactacaaaGAYATTGTGATGACACAACC3'
LB 17 5 'gccatggcggactacaaaGAYATTTTGCTGACTC AGTC3'
LB A, 5 'gccatggcggactacaaaGATGCTGTTGTGACTCAGGAATC3'
Variable light chain forward primers
L F1 5 'ggagccgccgccgcc(agaaccaccaccacc)2 ACG 1 1 1  GA 1 1 1  CC AGCTTGG3'
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LF2 5 'ggagccgccgccgcc(agaaccaccaccacc)2ACGTTTTATTTCCAGCTTGG3 '
LF4 5'ggagccgccgccgcc(agaaccaccaccacc)2ACGTTTTATTTCCAACTTTG3'
LF5 5'ggagccgccgccgcc(agaaccaccaccacc)2ACGTTTCAGCTCCAGCTTGG3'
LFA, 5 'ggagccgccgccgcc(agaaccaccaccacc)2ACCTAGGAC AGTCAGTTTGG3' 
Variable heavy chain back primers
H B 1 5 'ggcggcggcggctccggtggtggtggatccGAKGTRMAGCTTCAGGAGTTC3'
HB2 5 'ggcggcggcggctccggtggtggtggatccGAGGTBCAGCTBCAGCAGTC3'
HB3 5 'ggcggcggcggctccggtggtggtggatccCAGGTGCAGCTGAAGS ASTC3'
HB4 5'ggcggcggcggctccggtggtggtggatccGAGGTCCARCTGCAACARTC3'
HB5 5 'ggcggcggcggctccggtggtggtggatccCAGGTYCAGCTBCAGC ARTC3'
FIB6 5'ggcggcggcggctccggtggtggtggatccCAGGTYCARCTGCAGCAGTC3'
HB7 5 'ggcggcggcggctccggtggtggtggatccCAGGTCCACGTGAAGCAGTC3'
HB 8 5 'ggcggcggcggctccggtggtggtggatccGAGGTGAASSTGGTGGAATC3'
HB9 5 'ggcggcggcggctccggtggtggtggatccGA VGTGAWGYT GGTGGAGTC3'
HB 10 5 'ggcggcggcggctccggtggtggtggatccGAGGTGCAGSKGGTGGAGTC3'
HB 11 5 'ggcggcggcggctccggtggtggtggatccGAKGTGC AMCTGGTGGAGTC3'
HB 12 5 'ggcggcggcggctccggtggtggtggatccGAGGTGAAGCTGATGGARTC3'
HB 13 5 'ggcggcggcggctccggtggtggtggatccGAGGTGCARCTTGTTGAGTC3'
HB 14 5'ggcggcggcggctecggtggtggtggatccGARGTRAAGCTTCTCGAGTC3'
HB 15 5 'ggcggcggcggctccggtggtggtggatccGAAGTGAARSTTGAGGAGTC3'
HB 16 5 'ggcggcggcggctccggtggtggtggatccCAGGTTACTCTRAAAGWGTSTG3'
HB17 5'ggcggcggcggctccggtggtggtggatccCAGGTCCAACTVCAGCARCC3'
HB 18 5 'ggcggcggcggctccggtggtggtggatccGATGTGAACTTGGAAGTGTC3'
HB 19 5 'ggcggcggcggctccggtggtggtggatccGAGGTGAAGGTCATCGAGTC3'
Variable heavy chain forward primers
H F 1 5 'ggaattcggcccccgaggcCGAGGAAACGGTGACCGTGGT3'
HF2 5 'ggaattcggcccccgaggcCGAGGAGACTGTGAGAGTGGT3'
HF3 5 'ggaattcggcccccgaggcCGC AGAGAC AGTGACCAGAGT3'
HF 4 5 'ggaattcggcccccgaggcCGAGGAG ACGGTGACTGAGGT3'
2.4.2.2 Components o fP C R  reaction fo r  amplification o f  antibody light and heavy chain 
genes
The concentration o f stock primers varied. However, 0.1 nmol concentration o f the 
forward and reverse primers were used per reaction.
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Component
Forward Primers 
Reverse Primers 
10X Buffer 
MgCl2 
dNTP
Working concentration
0.1  nmol o f each primer/reaction 
0.1  nmol o f  each primer/reaction
cDNA
Ultrapure water
Taq polymerase
I X
1.0 mM 
0.4 mM
to 50 (xl including Taq and DNA 
6-8  [ig o f cDNA/50 |xl reaction 
5 U/reaction
2.4.2.3 PCR conditions fo r  amplification o f  antibody light and heavy chain genes
Typical thermal cycling conditions were as follows:
94°C X 5 min ‘Hot-Start’
94°C X 1 min 
63°C X 30 sec 
58°C X 50 sec 
72°C X 1 min 
repeat X 7 cycles
94°C X 1 min 
63°C X 30 sec 
72°C X 1 min 
repeat X  24 cycles 
72°C X 10 min
All ramping rates were at 4°C/sec.
2 A .2 A  Purification o f  PCR reaction products
PCR purification was performed using the Wizard PCR prep DNA purification kit 
(Promega). An Atto AE-6100 gel electrophoresis system was used. The PCR product 
was run on a 1% (w/v) low melt agarose gel containing 0.5 ng/ml ethidium bromide. The 
400 bp fragment was cut from the gel with a sterile scalpel and the DNA purified from the 
low melt agarose as follows. The sample was incubated at 70°C in a waterbath/heating 
block causing the agarose to melt within 5 minutes. 1 ml o f resin was immediately added 
and mixed thoroughly by pipetting for 15 seconds. For each PCR preparation a  plunger 
from a 5 ml syringe was attached to a W izard Minicolumn and the resin was slowly
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pushed through. The column was then washed with 2 ml o f 80% (v/v) isopropanol. The 
column was centrifuged for 2 minutes at 14,000 rpm to remove any residual buffers. The 
minicolumn was placed in a new 1.5 ml eppendorf tube and 20 p,l o f autoclaved ultrapure 
water was applied to the minicolumn and allowed to incubate for 1 minute. The column 
was centrifuged at 14,000 rpm for 20 seconds to elute the DNA fragment and stored at -  
20°C until required.
2.4.2.5 Quantification o f  PCR-purifiedproducts
After purification the fragments were re-electrophoresed on an agarose gel with a 
quantitative M olecular Weight Marker (Promega, 100 bp Molecular W eight Markers), as 
the concentration must be determined prior to splice by overlap extension PCR (SOE- 
PCR). The 500 bp fragment o f this marker was used as a reference for densiometric 
quantitation as 5 (xl contains 150 ng o f the 500 bp fragment and 50 ng o f the other 
molecular weight fragments.
2.4.2 .6 Components o f  Splice by overlap extension (SOE) PCR
Agarose gel-purified light and heavy chains were joined and amplified together to produce 
a 800 bp fragment by SOE PCR using components and PCR conditions outlined below. 
SOE Primers
Single chain back 5 'ttactcgcggcccagccggccatggcggactaccccg3 '
Single chain forward 5'ggaattcggcccccgag3'
SOE PCR components for amplification of joined antibody light and heavy chain genes 
Component Working concentration
10 X buffer
MgCl2
dNTP
Ultrapure water to 50 pi including Taq, DNA and scfor and scback
1 X
1.0 mM 
0.4 mM
VH
VL
scfor
scback
Taq polymerase
10 ng/reaction 
10 ng/reaction 
0,05 nmol /reaction 
0.05 nmol/reaction 
5 U/reaction
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SOE PCR buffer compositions: buffer A (7.5 mM MgCl2, pH  8.5); buffer B (10 mM 
MgCl2, pH  8.5); buffer C (12.5 mM MgCl2, pH 8.5); buffer D (17.5 mM MgCl2, pH  8.5); 
buffer E (7.5 mM MgCl2, pH 9.0); buffer F (10 mM MgCl2, pH 9.0); buffer G  (12.5 mM 
MgCl2, pH 9.0); buffer H  (17.5 mM MgCl2, pH 9.0); buffer I (7.5 mM MgCl2, pH  9.5) and 
buffer J (10 mM M gCl2, pH 9.5).
SOE PCR conditions for amplification o f joined antibody light and heavy chain genes 
92°C X 1 min 
45°C X 50 min 
72°C X 1 min 
repeat X  5 cycles
Add 0.05 mM scfor and scback primers:
5 U Taq Polymerase/rxn
92°C X 1 min
6 8 °C X 30 sec 
72°C X 1 min 
repeat X  25 cycles 
All ramping rates were at 4°C/sec.
2.4.2.7 Preparation and purification o f  pAKlOO vector using Wizard miniprep system 
(Promega).
A single colony o f E.coli XLl-Blue containing pAKlOO (all vectors were kindly donated 
by Andreas Pluckthun, University o f Zurich, Switzerland) was picked off an agarose plate 
and grown overnight at 37°C with vigorous shaking in 5 ml o f 2 x TY supplemented with 
30 fig/ml tetracycline. Purification o f the plasmid was carried out using the W izard 
miniprep system as described in section 2 .3.5.3.
2.4.2.8. Digestion o f  pAKlOO and antibody light and heavy chain genes SOE PCR  
products
Digestion o f pAKlOO and SOE products was performed using S fil restriction enzyme. 
pAKlOO requires digestion with S fil restriction enzyme prior to ligation with light and 
heavy chain genes. Antibody light and heavy chain gene SOE products were also digested 
with S fil  as 4 bp are spliced off from either end. 2 U of S fil  enzyme was used to cut 30-50
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ng/reaction SOE product or 50-100 ng/reaction pAKlOO vector at 50°C overnight in a 
reaction volume of 10 pi.
2.4.2.9. Ligation o f  antibody light and heavy chain genes into the pAKlOO vector
Agarose gel-purified SOE products were ligated into the pAKlOO plasmid vector using a 
reaction mixture containing DNA ligase (Promega), reaction buffer, SOE Vl/V h and 
pAKlOO digests at a ratio of 1.5:1 and sterile ultrapure water to give a final volume o f 10 
(xl. The reaction mixture was incubated at 15°C overnight and then transformed into E.coli 
XL 1-Blue competent cells.
2.4.2.10 Preparation o f  high efficiency competent cells
High efficiency competent E. coli XL-1 Blue and JM83 cells were prepared as previously 
described in section 2.3.6.5
2.4.2.11. Transformation o f  E.coli XLl-B lue supercompetent cells with pAKlOO vector 
containing light and heavy chain genes and measurement o f  transformation efficiencies
High efficiency competent E. coli X Ll-B lue cells (prepared as described in section 
2.4.2.10) were thawed gently on ice. Cells were gently mixed by hand and aliquoted into 
two 2 0  ml sterilin tubes (one tube was for the experimental transformation and the other 
tube was for the control transformation). 1.7 (il o f  p-mercaptoethanol was added to each 
of the two aliquots o f bacteria, giving a final concentration of 25 mM in each tube. The 
contents o f the tubes were stirred gently and incubated on ice for 10 min, swirling gently 
at 2 min intervals. 0.1-50 ng of vector, containing light and heavy chain genes was added 
to one of the tubes and swirled gently. 1 pi o f pUC18 control vector was added to the 
second tube and also swirled. Both tubes were then incubated on ice for 30 min. Cells 
were heat-pulsed for 45 sec at 42°C followed by incubation on ice for 2 min. 0.9 ml of 
SOC medium, preincubated at 37°C, was then added and the tubes incubated at 37°C for 
lh r with shaking at 225-250 rpm. pAKlOO transformants were plated out on LB agar 
supplemented with 25 fig/ml chloramphenicol and 1% (v/v) glucose. Control 
transformants were plated out on LB agar supplemented with 20 (ag/ml o f ampicillin. 
Both sets o f plates were allowed to grow overnight at 37°C. pAKlOO transformed colonies 
were scraped off the plates and used as library stocks. These stocks were suspended in 
15% (v/v) glycerol and stored at -80°C.
89
2.4.3 Production o f scFv antibodies to Listeria monocytogenes
2.4.3.1 Rescue o f  scFv displaying phage
50 ml of non-expression (NE) medium (2xTY broth containing 1% (w/v) glucose and 25 
pg/ml chloramphenicol) was inoculated with 100  pi o f cells from a stock antibody library. 
The culture was shaken at 37°C until the O . D . 5 5 0  = 0.5, at which point it was incubated for 
10 minutes at 37°C without shaking. 10n cfu o f helper phage (VCSM13) and 25 pi of 1M 
IPTG solutions were added to the culture, followed by incubation for 15 minutes at 37°C 
without shaking. The culture was then diluted in 100 ml o f low-expression (LE) medium 
(NE medium containing 0.5 mM IPTG) and then shaken for 2 hours at 26°C to allow 
phage production. After 2 hours 30 pg/ml kanamycin was added to the culture and it was 
then incubated for a  further 8 hours. Phage particles were purified and concentrated using 
PEG/NaCl precipitation and a phage titre carried out.
2.4.3.2 PEG/NaCl Precipitation
150 ml o f the E. coli XL-1 blue/library was transferred to a sterile Sorvall 250 ml 
centrifuge tube and centrifuged at 10 ,000  rpm for 4°C for 10 minutes. Approximately 30 
ml of PEG/NaCl (36.525g NaCl and 50g PEG 10,000 in 250 ml H 20 )  was added to the 
supernatant, mixed and incubated at 4°C (on ice) for at least one hour. The mixture was 
then centrifuged at 10,000 rpm/4°C for 30 minutes. The pellet was re-suspended in 40 ml 
of sterile ultra pure water and 8 ml o f PEG/NaCl, mixed and incubated at 4°C for 20 
minutes. The mixture was then centrifuged at 10,000 rpm at 4°C for 20 minutes. The 
supernatant was removed and the pellet was re-centrifuged at 7,000 rpm at 4°C for a 
further 10 minutes. Any remaining supernatant was removed and the pellet re-suspended 
in 2 ml of sterile filtered PBS. The phage were then micro-centrifuged at 4,000 rpm for 
4°C for 10 minutes to remove any bacterial debris. The phage precipitate was retained and 
stored at 4°C (short term) or at -80°C in a 15% (v/v) glycerol solution.
2.4.3.3 Phage titre
5 mis o f 2xTY containing 30 pg/ml tetracycline was inoculated with a single colony o f 
XL-1-blue overnight at 37°C. The culture was then diluted 1/100 in 5 mis o f 2xTY 
containing 30 pg/ml tetracycline and left to grow shaking at 37°C until O .D .550 =0.5-0.6 . It 
was then allowed stand at 37°C for 15 minutes without shaking. After this time serial 
dilutions (10 ''-10 'u ) o f phage were prepared using the bacterial culture (180 pi E.coli XL-
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1 blue + 20  pi phage) and incubated for 30 minutes at 37°C without shaking. 100 pi of 
each dilution was spread on 2xTY agar plates containing 1% (w/v) glucose and 25 pg/ml 
chloramphenicol. The plates were allowed to grow overnight at 37°C. The colony forming 
units were counted in order to calculate the titre o f the stock phage.
2.4.3.4 Selection o f  antigen binders by bio-panning on Nunc immunotubes
To allow selection, immunotubes were coated overnight at 4°C with Intemalin B extract or 
whole heat-treated Listeria monocytogenes cells. Tubes were washed five times with PBS- 
Tween and five times with PBS. This was then blocked with 5% (w/v) milk marvel in 
PBS and incubated for 1 hour at 37°C. The tube was washed again as above and 1 ml of 
phagemid (1011 phage/ml) particles was added to 3 ml o f PBS, which in total contained 
2% (w/v) milk marvel. This was allowed to incubate, while gently shaking, in the 
immunotube for 2 hours at room temperature. After washing (as before) bound phage 
were eluted from the tube by adding 800 pi 0.1 M  glycine/HCl, pH 2.2, for 10 minutes. 
This was then neutralised using 48 pi of 2 M  Tris. A phage titre was then carried out as 
previously described in section 2.4.3.3, to determine the amount o f phage recovered from 
the panning step. The titre plates were stored at 4°C for use in the phage ELISA.
2.4.3.5 Re-infection o f  phage displaying scFv antibodies
5 ml o f 2xTY containing 30 pg/ml tetracycline was inoculated with 50 pi o f XL-1 blue 
stock overnight at 37°C. The culture was then diluted 1/100 in 5 ml o f 2xTY containing 30 
pg/ml tetracycline and grown shaking until the O.D .550 =0.4-0.5. It was then allowed to 
stand for 10 minutes at 37°C. 700 pi of phage rescued from the panning step was added to 
the culture and allowed stand at 37°C for 30 minutes. This culture was then incubated 
shaking at 37°C for 1 hour before being plated out on 2xTY agar plates containing 25 
pg/ml chloramphenicol and grown overnight at 37°C.
2.4.3 .6 ELISA o f  phage displaying scFv antibodies
96 well culture plates were filled with 200 pl/well of NE medium containing 30 pg/ml 
tetracycline and 25 pg/ml chloramphenicol. Single clones from the phage titre plates were 
taken and put into each well, leaving 1 or 2 wells free as controls. These plates were 
allowed to grow, while shaking at 150 rpm overnight at 37°C. These were the master 
plates and were frozen with 15% (v/v) glycerol. A second set o f plates were prepared with 
180 pl/well o f NE medium. 20 pi from each well on a  master plate were transferred to the
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corresponding well on the second plate and incubated shaking at 37°C for approximately 
6-8  hours. 25 pi o f  solution X (5.75 ml 2xTY, with 1% (w/v) glucose, 25 pg/ml 
chloramphenicol, 1.5 mM IPTG and 5 x 109 phage/ml) was added to each well after 5 
hours. The culture was then allowed to stand for 30 minutes at 37°C followed by shaking 
at 150 rpm for 1 hour. The plate was then centrifuged at 4000 rpm for 10 minutes. The 
supernatants were removed by inversion and the media was replaced with 2 0 0  pi of 
solution Y (20 ml 2xTY, 25 pg/ml chloramphenicol, 30 pg/ml kanamycin, 1% (w/v) 
glucose and 1.5 mM IPTG). The plate was then grown overnight shaking at 150 rpm at 
26°C. An ELISA plate was coated with whole heat-killed Listeria monocytogenes cells 
overnight at 4°C. The following day the culture plates were centrifuged at 4000 rpm for 10 
minutes and 75 pi o f the supernatant was used for the phage ELISA. The coated ELISA 
plates were blocked using 5% (w/v) milk marvel in PBS. The plates were then washed 3 
times with PBS and 75 pi o f supernatant from the culture plates were added to the 
corresponding wells on the ELISA plates. 25 pi o f 5% (w/v) milk marvel-PBS was then 
added in on top of each well and mixed gently. The phage were left to bind for 2 hours at 
room temperature and then washed with PBS-Tween. 100 pl/well of a 1/1000 dilution of 
anti-bacteriophage (Sigma rabbit antibody) polyclonal antibody was added and the plate 
was incubated for 1 hour at 37°C followed by the addition o f anti-rabbit IgG-HRP 
(1/3000). This was again incubated for 1 hour at 37°C and OPD substrate was used. The 
plates were read at 450 nm after 30 minutes.
2.4.3.7 Preparation o f  bacterial glycerol stocks
Bacteria cells were grown in 2 xTY media containing the desired antibiotic at 37°C until 
the O . D 6oo was 0.5-0.8 . The cultures were then spun at 4,000 rpm for 10 minutes and the 
pellet resuspended in 2xTY with 20% (v/v) sterile glycerol to a volume of 1/4 the original 
culture volume. Cell/glycerol cultures were aliquoted into 0.5 ml aliquots in 1.5 ml sterile 
microcentrifuge tubes and flash frozen with liquid nitrogen. Cells stocks were stored at -  
SOT.
2.4.3 .8 Bioinformatics tools fo r  analysis o f  variable domain genes
Antibody heavy and light chain variable genes were analysed using the following web
based programs found a!, the \ v. <v; : !’ t i ,it-:: 1 ivlcd:
Expasy : v  ;•<
ClustalW (http://www.ebi.ac.uk/clusta lw/)
Genedoc (http://www.psc.edu/biomed/genedoc/)
Kabat rules for identifying antibody CDR regions from a linear amino acid sequence 
(http://www.rubic.rdg.ac.uk/abeng/cdrs.html)
The Protein Data Bank (PDB; http ://www.rcsb.org/pdb/)
2.4.3.9 Expression o f  soluble scFv antibodies from  E. coli harbouring the pAK400 vector 
with scFv gene inserts
E. coli JM83 cells harbouring the pAK400 vector with scFv gene inserts were grown in 
2xTY media containing 25 (xg/ml chloramphenicol at 37°C until the O.D .600 = 0.5-0.8 . 
Expression o f the scFv gene product was induced by the addition o f 1 mM IPTG and 
incubated for a further 4-5 hours at 30°C with constant agitation. The cultures were later 
centrifuged at 4000 rpm for 15 minutes and supernatant analysed as described in section 
2.4.3.10. The remaining cell pellets were resuspended in PBS to a volume of 1/10 the 
original culture volume and sonicated as described in section 2.3.7. The remaining cell 
debris and insoluble matter were pelleted by centrifugation at 14,000 rpm for 10 minutes 
and the supernatant analysed by ELISA as described in section 2.4.3.10.
2.4.3.10 ELISA fo r  the determination o f  soluble scFv
A non-competitive ELISA was carried out with scFv antibody supernatants as described in 
section 2.2.3. In brief, dilutions o f  scFv antibody supernatants were added to H T -Listeria 
monocytogenes coated plates and detected using either a mouse anti-FLAG monoclonal 
antibody, a mouse anti-His tag antibody or a mouse anti-c-myc-HRP-labelled secondary 
antibody.
2.4.3.11 Cross-reactivity studies o f  phage-scFv clones
ELISA plates were coated overnight with 1x10s cells/ml bacterial cells at 4°C and blocked 
with 5% (w/v) milk marvel for 1 hour at 37°C. Phage-scFv supernatant was added to each 
well and incubated for 1 hour at 37°C. After washing with three washes o f  PBS-Tween 
followed by three washes with PBS, bound phage-scFv antibodies were detected using a 
rabbit anti-bacteriophage fd antibody. Colour development occurred after the addition of a 
goat anti-rabbit-HRP conjugated antibody followed by the addition of OPD substrate. 
Absorbance values were read at 405 nm and background values subtracted.
93
2.4.4 B io-panning o f  a naïve human antibody library against H T-Listeria  
m onocytogenes cells and invasion-associated proteins
2.4.4.1 Preparation ofphage from  library glycerol stocks
An aliquot o f a glycerol library stock was added to a 2 L flask, containing 500 ml o f 2xTY 
supplemented with 2%  (w/v) glucose and 100 (xg/ml ampicillin (2xTYAG) and grown in a 
shaking incubator at 37°C at 2 0 0 rpm for 1-2 hours or until O.D.fi0o = 0.5 to 1 .0 . M13K07 
helper phage was then added to the culture to a final concentration o f 5x l0 9 pfu/ml. After 
addition o f helper phage, the cells were incubated at 37°C for 30 minutes without shaking 
and then for 30 minutes with moderate shaking (150 rpm) to allow infection. The culture 
was then centrifuged at 4000 rpm for 15 minutes and the cells resuspended in the same 
volume o f  2xTY (no glucose) with kanamycin (50 mg/ml) and ampicillin (100 mg/ml) 
using a fresh 2 L flask. The culture was grown overnight with shaking (200 rpm) at 25°C.
2.4.4.2 PEG/NaCl Precipitation
The phage in the supernatant was concentrated by precipitation with polyethylene glycol 
as described in section 2 .4.3.2.
2.4.4.3 Selection ofphagemid-antibody libraries by panning in immunotubes
An immunotube was coated with 0.5 ml antigen (1x10s cells/ml Listeria monocytogenes 
or 10-15 (xg/ml InlB extract) overnight at 4°C. After coating overnight, the immunotube 
was washed three times with PBS and blocked with 3% (w/v) skimmed milk powder in 
PBS for 1-2 hours at room temperature. Meanwhile a 20 ml culture o f TG I cells in 2xTY 
was setup to provide mid-log phase cells. For the first round o f panning, phage 
concentrated by PEG precipitation was used. However, for subsequent rounds o f panning 
supernatants were used without the need for PEG precipitation and concentration. For 
each round of panning, phage was pre-blocked in 3% (w/v) milk marvel powder in PBS to 
make a volume of 0.5 ml (Note: a few (xl of input phage per round of panning were kept to 
determine the phage titre). Upon removal o f the blocking solution from the immunotube, 
the tube was rinsed three times in PBS, 0.5 ml of pre-blocked phage added and incubated 
for 1.5 hours without agitation. After the 1.5 hour's incubation, the immunotube was 
washed ten times with PBST and ten times with PBS.
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2.4.4.4 Phage ELISA o f  phage displaying scFv antibodies
A phage ELISA of phage displaying scFv antibodies was performed as described earlier in 
section 2 .4.3.6 .
2.4.4.5 Inhibition ELISA o f  positive clones
An inhibition ELISA was carried out as described in section 2.2.5 using a rabbit anti­
bacteriophage Fd antibody for the detection of bound phage displaying scFv particles.
2 A  A .6 Preparation o fSD S-extracts o f  L isteria  monocytogenes
One millilitre o f a 2 x l0 10 cells/ml Listeria monocytogenes 4B solution was centrifuged at
8,000 rpm for 10 minutes. The supernatant was discarded and the pellet resuspended in 
150 (xl o f a 2% (w/v) SDS solution and incubated for 1 hour at 37°C. After 1 hour, the 
cells were again centrifuged at 8 ,0 0 0  rpm for 10 minutes and the supernatant carefully 
decanted into a fresh micro-centrifuge tube. The pellet was discarded and the SDS extract 
(cell supernatant) stored at -20°C.
2.4.4.7 SD S-PAG E and  Western blot analysis o f  phage displaying scFv clones
SDS-PAGE and Western blot analysis o f phage displaying scFv clones were carried out as 
previously described in sections 2.2.6 and 2.2.7.
2.4.4 .8 ScFv gene sequence alignm ent and  CDR region determ ination
Sequence alignments and CDR region determinations were performed using the programs 
and web sites given in section 2 .4.3.8 .
2.4.4.9 Expression o f  soluble scFv antibodies
1 ml from an overnight culture of E. coli TG I cells, containing the desired scFv gene 
sequences, was used to inoculate 50 ml of 2xTY media containing 100 ^.g/ml ampicillin. 
The cultures were grown at 37°C with shaking until the O.D.6oo reached 0.5-0 .8 at which 
time soluble antibody expression was induced with 1 mM IPTG for 4-5 hours at 30°C. 
After 4-5 hours both cell supernatant and cytoplasmic extract were analysed for antibody 
production by ELISA.
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2.4.4.10 Purification o f  recombinant InlB and p60  proteins
Both recombinant proteins were purified by immobilised metal affinity chromatography as 
described in section 2.3.9.
2.4.4.11 Preparation o f  bacterial cytoplasmic extracts
Expression of scFv protein was induced as described in section 2.4.4.9. After 4-5 hours of 
expression, the cells were centrifuged at 4000 rpm for 20 minutes and the supernatant 
decanted into a fresh tube and stored for further analysis. The pellet was resuspended in 
PBS (native cytoplasmic extract) or denaturing buffer (8 M urea, 100 mM NaH2 P O 4 , 10 
mM Tris-Cl, pH 8.0) to a volume of 1/10 the original culture volume. The resuspended 
pellets were then sonicated (section 2.3.7) and the bacterial debris removed by 
centrifugation at 14,000 rpm for 10 minutes. Cytoplasmic extracts (cell debris 
supernatant) were decanted into a fresh tube and stored at - 2 0 °C.
2.4.4.12 Time course study fo r  the expression scFv antibodies
E. coli TG I cells containing the desired scFv gene sequences were grown in 2xTY (200 
ml with 100  (ig/ml ampicillin) until the O.D.6oo was between 0.5 and 0 .8 . When the 
cultures reached the desired O.D., a 1 ml sample was taken from each culture and stored 
immediately at -20°C. The remaining culture was induced with IPTG at a final 
concentration of 1 mM and scFv antibodies expressed at 30°C. 1 ml aliquots were taken 
from the culture every hour and stored at -20°C. Stored aliquots were later centrifuged at
14,000 rpm for 10 minutes and the supernatant decanted into a fresh tube. Cytoplasmic 
extracts were prepared from the sample pellet as described in section 2.4.4.11. 
Supernatants and cytoplasmic extracts were later analysed by ELISA or SDS-PAGE.
2.4.4.13 Preparation o f  Tris-Cl extracts fro m  bacterial cells
Tris-Cl extracts were prepared from bacterial cells as described by Muller et al. (1998), 
and as outlined in section 2 .2 .1.2 .
2.4.4.14 Inter- a nd  Intraday assay reproducibility studies
An inhibition ELISA was performed as described in section 2.2.5. Briefly, ELISA plates 
were coated with 20 |J.g/ml purified recombinant InlB protein and blocked with 5% (w/v)
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dried milk powder. Clone G7 seFv supernatant, diluted 1/4 in PBS, was added to doubling 
dilutions o f InlB extract diluted in PBST and incubated for 1 hour at 37°C. Antibody and 
InlB extract were added to recombinant InlB-coated ELISA wells (in triplicate) and 
incubated for a further hour at 37°C. After washing with PBS and PBST, bound scFv 
antibodies were detected with a mouse monoclonal anti-c-myc-HRP-labelled antibody and 
colour development observed upon the addition o f OPD substrate. Results were plotted 
with a 4 parameter equation using BIAevaluation software and the plot accuracy observed 
by substituting the actual absorbance values for each standard into the equation o f the line 
and expressing the observed cell concentrations as a  percentage o f the actual cell 
concentrations. The coefficients of variation (CV’s) were determined to assess the 
precision o f the analytical method, expressing the standard deviation as a  percent function 
o f the mean.
2.4.4.15 Cross reactivity o f  scFv antibody clone G 7 against Tris-C l extracts fro m  various 
bacterial cells
Tris-Cl extracts from each o f the bacterial strains to be tested were produced as described 
in section 2.4.4.13 and an inhibition ELISA performed as described in section 2.4.4.14 
except that dilutions o f InlB extracts were replaced with dilutions o f Tris-Cl extracts from 
each bacterial strain tested. The decrease in binding observed for the recombinant InlB- 
coated wells, at a equivalent cell concentration of IxlO 7 cells/ml from each bacterial strain 
was recorded. The observed binding was expressed as a percentage o f  the decrease in 
binding observed at the same cell concentration (concentration at half the maximum 
inhibition observed for InlB extract) for that o f the Listeria  monocytogenes InlB extract.
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I2.5 D evelopm ent o f  SPR -based im m unoassay using a B IA core 3000™  instrum ent
Analysis was carried out on a BIAcore 3000™ instrument using a  range o f available 
sensor chips. The running buffer for all BIAcore experiments was HBS buffer, pH 7.4, 
containing 10 mM HEPES, 150 mM NaCl, 3.4 M  EDTA, and 0.05% (v/v) Tween 20. The 
running buffer was filtered (pore size o f 0 .2 2  |xm) and degassed using a millipore filtration 
apparatus (millipore sintered glass filtration unit) immediately before use.
2.5.1 Preconcentration studies
In order to optimise the conditions needed for the immobilisation o f desired proteins on the 
sensor chip surface, an initial "preconcentration" step, resulting from electrostatic binding of 
protonated amine groups on the biological component to negatively-charged carboxyl 
groups on the chip surface, was performed. Preconcentration o f a desired protein on the 
sensor surface be can be facilitated by adjusting the pH below the isolectric point (pi) o f the 
protein. Therefore, protein solutions were prepared in 10 mM sodium acetate at a range of 
different pHs and these solutions passed over an underivatised chip surface, with the degree 
of electrostatic binding monitored. The pH at which highest preconcentration o f protein on 
to the underivatised surface was observed, was chosen as the pH for immobilisation.
2.5.2 General immobilisation conditions
The carboxymethylated dextran matrix was activated by mixing equal volumes o f 100 
mM NHS (N-hydroxysuccinimide) and 400 mM EDC (N-ethyl-N-(dimethyl- 
aminopropyl) carbodiimide hydrochloride), and injecting the mixture over the sensor chip 
surface for 7 minutes at a flowrate o f 5 fj. 1/minute. The desired protein to be immobilised 
was diluted in 10 mM sodium acetate at the optimised pH, and at a typical concentration of 
50-100 (xg/ml. This solution was then injected over the derivatised chip surface for 30-45 
minutes at 5 |xl/minute. Unreacted NHS groups were capped, and non-covalently bound 
protein removed by injection o f 1 M ethanolamine hydrochloride, pH  8.5, for 7 min.
2.5.3 Regeneration studies
To assess the stability o f immobilised interactant (antibody, peptide or peptide conjugates) 
surfaces, a known concentration of antibody was passed over the chip surface, and the 
surface regenerated by passing over various concentrations o f NaOH and HC1 ranging 
from 1-30 mM. This cycle of regeneration was usually completed for greater than 50
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cycles, and the binding signal measured to assess the stability and suitability o f the 
immobilised surface for the development o f a sensitive and reproducible assay.
2.5.4 iSubtractive inhibition assay fo r  the detection o f  L isteria  m onocytogenes cells 
using an anti-Listeria m onocytogenes polyclonal antibody
Approximately 20,000 RUs of commercial goat anti-rabbit (Fab portion) polyclonal 
antibody (section 2.1.1) was immobilised on a  CM5 sensor chip surface. 300 |xl o f a 1/250 
dilution o f protein-G purified anti -Listeria monocytogenes whole cell polyclonal antibody 
solution diluted in ultra pure water (Millipore) was added to 300 |xl o f decreasing numbers 
Listeria monocytogenes cells diluted in PBS. Each mixture was incubated for 20 minutes 
at 37°C, inverting the mixture occasionally to allow good mixing o f cells and antibodies. 
After incubation, the cells were centrifuged in a stepwise fashion separating cells and 
bound antibody from unbound antibody in the supernatant. Gradually increasing the 
centrifugation speed seemed less abrasive on the antibodies bound to cells, forming 
pelleted layers in which the antibodies would not dissociate from the cells. Centrifugation 
at higher speeds seemed to shear the antibodies from the cells resulting in no inhibition 
being observed. The supernatants from each sample were then randomly passed over the 
sensor surface in triplicate and an average value taken.
2.5.5 Inhibition assay fo r  the detection o f  L isteria  m onocytogenes cells using an anti- 
In lB  extract po lyclon al antibody
Approximately 10,000 response units (RU) o f purified recombinant InlB protein (section
2.3.9) was immobilised on the surface o f a CM5 sensor chip as described in section 2.5.2. 
250 fxl o f a 1/30 dilution o f an anti-InlB extract polyclonal (described in chapter 3) diluted 
in Millipore ultra pure water was added to 250 (xl o f various concentrations o f HT -Listeria 
monocytogenes cells and incubated for 1 hour at 37°C. After 1 hour, the antibody-cell 
solutions were randomly passed over the recombinant InlB surface in four replicates with 
the value obtained from the first replicate discarded (see section 6.3.3). A decrease in 
binding response was observed with increasing cell concentrations and the response at 
each concentration recorded.
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2.5.6 Inhibition assay fo r  the indirect detection o f  L isteria  m onocytogenes cells using an 
anti-InlB  protein  scFv antibody
Approximately 1,100 response units (RU) of purified recombinant InlB protein (section
2.3.9) was immobilised on the surface of a C l sensor chip as described in section 2.5.2 
except the surface was doubly activated with two 7 minute injections o f EDC/NHS and 
“over capped” with a 7 minute injection o f 1M ethylene-diamine, pH 8.5. 250 fil o f a 1/5 
dilution o f an anti-InlB protein scFv antibody supernatant (described in section 5.5.0) 
diluted in PBS was added to 250 (.il of various concentrations o f Listeria monocytogenes 
Tris-Cl extracts and incubated for 1 hour at 37°C. After 1 hour, the antibody-protein 
solutions were randomly passed over the recombinant InlB surface in triplicate. A 
decrease in binding response was observed with increasing extract concentrations and the 
response at each concentration recorded.
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3.1 Introduction
W ith the increased demand on production, in not only the food but clinical and 
pharmaceutical industries, the need for a rapid, reliable, specific and sensitive method of 
detecting a target analyte is o f key significance. Conventional methods for the detection 
and identification o f bacteria mainly rely on specific microbiological and biochemical 
identification. While these methods can be sensitive, inexpensive and give both qualitative 
and quantitative information on the number and the nature o f the microorganisms tested, 
they are greatly restricted by assay time. For example, with some standard methods, such 
as, the NF EN ISO 11290-1 method for the detection o f  Listeria  monocytogenes, up to 
seven days is required to generate results, as such tests rely on the ability of 
microorganisms to multiply to visible colonies (De Boer and Beumer, 1999; Artault el at., 
2001). Immunological detection with antibodies is perhaps the only technology that has 
been successfully employed for the detection of cells, spores, viruses and toxins alike 
(Iqbal et al., 2000). Polyclonal antibodies can be raised quickly and cheaply and do not 
require the time or expertise associated with the production o f monoclonal or recombinant 
antibodies (Stapleton et a l ,  2003). During the past decade, immunological methods for 
detection o f microbial contamination have become more sensitive, specific, reproducible 
and robust with many commercial immunoassays available.
Listeria monocytogenes is regarded as a very important food borne pathogen, due to its 
ability to  grow at refrigeration temperatures, in high salt concentrations and at a wide pH 
range. Listeria monocytogenes has been isolated from a variety o f foodstuffs ranging from 
an array o f dairy products, meat, fish and ready-to-eat-foods stored at 4°C. Rapid detection 
of Listeria  in ready-to-eat-foods such as cheese, coleslaw, and chocolate milk, is o f utmost 
importance, as these foodstuffs are not usually heated before consumption.
The aim o f this chapter was to develop an immunoassay to detect L isteria  monocytogenes 
in food. Two polyclonal antibodies were produced, one raised against heat-treated Listeria  
monocytogenes cells and the other against Listeria  monocytogenes Intemalin B (InlB)- 
protein extracts. These antibodies were crudely purified by saturated ammonium sulphate 
precipitation followed by affinity purification by protein-G affinity chromatography. 
Purified antibodies were characterised by ELISA, SDS-PAGE and W estern blotting. Both 
purified antibodies were used in the development of immunoassays to detect Listeria  
monocytogenes cells in an inhibition ELISA format. Intra- and interday studies were 
performed with both immunoassays to determine the accuracy and precision o f the assays. 
Interday calibration curves were constructed by plotting the mean (3 replicates) change in
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response for each Listeria  monocytogenes cell standard against the known concentration 
of Listeria  m onocytogenes cells over a five separate assay runs. A four parameter equation 
was fitted to each calibration curve and the percentage accuracies calculated to  evaluate if  
the curves provided an accurate representation o f the sigmoidal relationship between the 
measured response and the logarithm o f concentration observed for the immunoassay.
The feasibility o f detecting Listeria monocytogenes cells in chocolate milk, a food matrix 
which has been reported to have been the cause o f a well known Listeria  monocytogenes- 
associated food poisoning outbreak (Dalton el al., 1997), was also examined. An 
inhibition ELISA was developed with each antibody for the detection of Listeria  
monocytogenes in spiked chocolate milk samples. Intra- and interday assay variability 
studies were performed to evaluate the accuracy and reproducibility o f each assay.
To determine the potential cross reactivity o f each antibody, inhibition ELISAs were 
performed with a number o f known bacterial strains. Two strategies for calculating the 
percentage cross reactivity values were compared. Both antibodies showed tendencies to 
cross react with the other bacteria tested from the genus Listeria  but showed little or no 
cross reactivity with B. subtilis or E. coli. It was concluded that both antibodies can be 
used as valuable tools for the genus-specific detection o f Listeria  cells, but were severely 
limited for the species-specific detection o f Listeria  monocytogenes cells.
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3.2 Production and characterisation o f  po lyclon al antibodies to heat-treated  (HT) 
L isteria m onocytogenes cells and the invasion-associated protein  internalin B  (InlB)
The production, purification and characterisation of two polyclonal antibodies raised 
against Listeria monocytogenes 4b cells and Internalin B extract is described in the 
following sections. When the rabbit antibody titre had reached a sufficiently high level 
(Figures 3.1 and 3.2), the blood was harvested by cardiac puncture and the rabbit serum 
purified by saturated ammonium sulphate precipitation followed by protein G affinity 
chromatography (section 3.2.1). SDS-PAGE gel electrophoresis (section 3.2.2) was used 
to assess the purity o f the antibodies. The optimal coating concentration o f Listeria 
monocytogenes cells and optimal working dilution o f the each antibody for use in an 
inhibition assay (section 3.2.3) were calculated by performing a  checkerboard ELISA of 
different antibody dilutions and cell concentrations as described in section 3.2.4.
3.2.1. Purification o f  polyclonal antiserum
Initial purification o f the rabbit serum was performed by saturated ammonium sulphate 
precipitation, as described in section 2.2.2.1. Protein G affinity chromatography (section 
2 .2 .2 .2 ) was then carried out to further purify the antibodies. Protein G  is a cell wall 
protein (originally isolated from type G Streptococci) that binds the Fc region of 
immunoglobulin G (IgG) with high affinity. In addition to the Fc receptor, intact Protein G 
has membrane spanning regions as well as specific binding sites for albumin and for the 
Fab region o f immunoglobins (Bjorck and Kronvall, 1984; Akerstrom et a t, 1985 and 
Akerstrom and Bjorck, 1986). The protein G resin used in this section (Sigma product 
code P-3296) is prepared from a truncated recombinant protein G produced by Pharmacia, 
Inc., that retains the two high affinity Fc binding sites and also binds the Fab region with 
low affinity (Sigma product information sheet). Partially purified saturated ammonium 
sulphate precipitated-antibody was passed through the column allowing IgG to bind to 
protein G. After extensive washing o f the column to remove non-specifically bound 
proteins, the antibodies were eluted with glycine buffer, pH 2.2, and neutralised using 2 M 
Tris base as described in section 2.2.2.2. Fractions were analysed spectrophotometrically 
at 280 nm and the fractions with the highest absorbance pooled. Pooled fractions were 
then dialysed in PBS buffer overnight and the titre o f protein G-purified fractions 
determined by ELISA.
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3.2.2 Characterisation o f purified antibody by SDS-PAGE and Western blotting
The purity o f the anti-L. monocytogenes cells and anti-InlB extract antibodies were 
analysed by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
and by Western blotting using a polyclonal anti-rabbit AP-labelled antibody as described 
in section 2.2.6. SDS-PAGE allows the separation o f proteins according to their size. 
Proteins can be subsequently transferred to a nitrocellulose membrane (Western blotting) 
and probed with a specific antibody, allowing the specific identification o f the sample 
protein. A picture o f the SDS-PAGE gels and Western blots o f  the affinity-purified 
antibodies with molecular weight bands at 50 kDa and 25 kDa representing the antibody 
heavy and light chains, respectively, are presented in Figure 3.3 and 3.4.
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Figure 3.1: A plot showing the titre o f  the anti-lnlB extract polyclonal serum diluted in PBS, added to 
ELISA plate wells coated with 15 pg/ml InlB extract and 1 x  I t f  cells/ml heat-killed Listeria 
monocytogenes 4b cells. Serial dilutions o f  serum was added to the wells and detected with an anti­
rabbit HRP-conjugated antibody. A significant antibody titre o f  over 1/100,000 serum dilution was 
observed against InlB extract, while a lower titre o f approximately 1/25,000 -1/50,000 was observed 
against whole cell-coated surfaces.
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Figure 3.2 A plot showing the litre o f  the anti-Listeria monocytogenes 4b serum added to wells coated 
with I x I f f  cells/ml heat-killed Listeria monocytogenes 4b cells. Serial dilutions o f  serum were added 
to the wells and delected with an anti-rabbit IIRP-conjugated antibody. A significant antibody litre o f  
over 1/1,000,000 serum dilution was observed against whole Listeria monocytogenes cell-coated plate 
wells.
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Figure 3.3: (A) SDS-PAGE gel o f  the protein G sepharose affinity-purified anti-lnlB extract polyclonal 
antibody. Lanes 1 and 9 contain pre-stained markers and lane 8 contains a wide range marker. Lanes 2, 4 
and 6 are blank lam s containing no protein. Lanes 3 contains a 1/5 dilution o f  serum with PBS, lane 5 
contains rabbit serum purified by saturated ammonium sulphate precipitation while lane 7 represents 
affinity purified saturated ammonium sulphate (SAS)-precipitated antibody on a protein G sepharose 
column. (B) Western blot o f  serum, SAS-precipitated antibody and protein G sepharose-purifled antibody. 
Lanes 1 and 8 contain a pre-stained protein marker (Sigma) while lanes 2, 4 and 6 contain no protein 
(blank lanes). Lanes 3, 5 and 7 contain serum (1/5 dilution in PBS), SAS-precipitated antibody andprotein- 
G sepharose purified-antibody, respectively. IgG heavy chain bands were detected using an anti-rabbit AP- 
conjugated antibody as described in section 2.2.7.
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Figure 3.4: (A) SDS-PAGE gel o f  the protein G sepharose affinity-purified anti-Listeria monocytogenes 
polyclonal antibody. Lanes 1 and 9 contain wide range markers. Lanes 2, 4 , 6 and 8 are blank lanes 
containing no protein. Lanes 3 contains a 1/5 dilution o f  serum with PBS, lane 5 contains rabbit serum 
purified by saturated ammonium sulphate-precipitation followed by lane 7 representing affinity-purified 
saturated ammonium sulphate (S.AS)-precipitated antibody on a protein G sepharose column. (B) Western 
blot o f  serum, SAS-precipitated antibody and protein G sepharose-purified antibody. Lanes 1 and 8 contain 
a Pierce pre-stained protein marker while lanes 2, 4, 6 and 8 contain no protein (blank lanes). Lanes 3, 5 
and 7 contain serum (1/5 dilution in PBS), SAS-precipitated antibody and protein G sepharose-purified 
antibody, respectively. IgG heavy chain bands were detected using an anti-rabbit AP-conjugated antibody.
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3.2.3 Development o f  an inhibition enzym e-linked immunosorbent assay (ELISA) fo r  
the detection o f  heat treated-Listeria monocytogenes 4b in phosphate buffered saline 
(PBS)
Inhibition ELISA's were developed for the detection o f free Listeria  m onocytogenes cells 
in solution using both the affinity-purified anti-InlB extract antibodies and the affinity- 
purified anti-HT Listeria  monocytogenes antibodies.
3.2.4 Checkerboard E L ISA  fo r  determination o f  optimal loading ratios o f  cell coating 
and optimal antibody dilution fo r  the anti-InlB  extract polyclonal antibody
In an inhibition ELISA format, the degree o f sensitivity in terms o f detection limits, is a 
function o f the antibody affinity (or range o f affinities as is the case with polyclonal 
antibodies), and the equilibrium between both free and immobilised antigen. 
Consequently, utilising too high a coating concentration o f antigen will shift the binding 
equilibrium in favour o f binding to the ELISA plate and cause reduced sensitivity to free 
antigen in solution. Similarly, utilising too high an antibody concentration, will require 
high concentrations free antigen in solution to inhibit antibody binding to the ELISA plate, 
and therefore result in decreased assay sensitivity.
In order to determine the optimal working dilution of the purified antibody and optimal 
cell coating concentration, a checkerboard ELISA was performed as described in section
2.2.4. Varying dilutions o f a 2 x  1010 cells/ml Listeria m onocytogenes stock were coated 
on a microtitre plate and dilutions o f affinity-purified antibody added to each cell dilution. 
The results were plotted in Figures 3.5 and 3.6. The optimal coating concentration of 
Listeria  monocytogenes cells was approximately a 1/200 dilution representing 1 x 108 
cells/ml o f whole cells. The optimal anti-InlB extract antibody dilution, which gave the 
greatest change in absorbance per change in antibody dilution, was determined to be 
1/300, while the optimal anti-Listeria m onocytogenes antibody dilution determined to be 
approximately 1/12,500.
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Figure 3.5: Checkerboard ELISA fo r  the determination o f  the optimal cell coating concentration and 
antibody dilution for the development o f  an inhibition assay with the anti-InlB polyclonal antibody. 
Dilutions o f  the anti-InlB polyclonal antibody were added to the wells o f  an immunoplate containing 
varying concentrations o f immobilised Listeria monocytogenes cells, as described in section 2.2.4.
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Figure 3.6: Checkerboard ELISA fo r  the determination o f  the optimal cell coating concentration and 
antibody dilution fo r  the development o f  an inhibition assay the anti-L. monocytogenes polyclonal 
antibody. Dilutions o f  antibody were added to the wells o f  an immunoplate containing varying 
concentrations o f  immobilised Listeria monocytogenes cells, as described in section 2.2.4.
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3.2.5 Intra- and interday inhibition assay variability studies o f  each polyclon al antibody 
in P B S
An inhibition ELISA was developed with each antibody as described in section 2.3.5, for 
the detection o f Listeria monocytogenes 4b in solution. A microtitre plate was coated with 
1 x 108 cells/ml heat-killed Listeria monocytogenes cells and blocked with 5% (w/v) milk 
marvel. Listeria monocytogenes cell standards were prepared, mixed with antibody diluted 
in PBST containing 1% (w/v) milk marvel and incubated at 37°C for 30 minutes. The 
number of standards used in assays developed with both antibodies, varied in order to 
obtain the maximum number o f assayed data points (Listeria monocytogenes cell 
concentrations) within the range o f detection o f each assay. Twenty two standards ranging 
from 1 x 1010 to 2 x 106 cells/ml were used with the anti-InlB antibody while 19 standards 
ranging from 1 x 1010 to 3.8 x 104 cells/ml were used with the anti -Listeria monocytogenes 
antibody. The cell-antibody mixtures were then added to the microtitre plates, incubated 
and detected with an anti-rabbit HRP antibody after washing. The observed results were 
plotted using BIAevaluation software and a four parameter equation fitted to the data. The 
four parameter function provides an accurate representation o f the sigmoidal relationship 
between the measured response and the logarithm of concentration observed for many 
immunoassays (Findlay et al., 2000).
hi order to measure the accuracy o f the immunoassay, intra-day assay variability studies 
were performed. Five sets of standards were prepared and incubated with antibody before 
being assayed. The results obtained for the intra-day assay studies for both the anti-InlB 
extract antibody and the mti-Listeria monocytogenes antibody are shown in Tables 3.1 
and 3.2, respectively. The coefficients of variation (CV's) were determined to assess the 
precision o f the analytical method, expressing standard deviation as a percent function o f 
the mean. These values ranged from 0.65 to 9.83% and 0.85 to 5.32% as observed with 
the anti-InlB extract and anti -Listeria monocytogenes antibodies, respectively, indicating 
that both assays had a high degree o f precision.
To measure the intermediate precision (precision o f repeated measurements, taking into 
account sources o f variation such as runs, days, reagents etc.), inter-day assay variability 
studies were performed with each antibody. Three sets o f standards were prepared and 
incubated with antibody before being assayed five times over five days. The inter-day 
assay study for the anti-InlB extract antibody, shown in Figure 3.7, had a limit o f detection 
of approximately 7 x 10s cells/ml (concentration at below which no significant decrease in 
binding could be observed). The coefficients of variation were determined and ranged
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from 1.37 to 15.70% as shown in Table 3.1, where it can be seen that there was a much 
greater degree o f variance with very high concentrations o f cells in solution when 
compared to lower concentrations. The use o f high concentrations o f  Listeria 
monocytogenes can sometimes lead to the formation o f cell aggregates resulting in 
increased inaccuracies, which are not evident at low cell concentrations. A graphical 
representation o f the relationship between the coefficient o f variance and the nominal 
concentration o f Listeria monocytogenes cells is presented in Figure 3.8. From the graph, 
it can be seen that CV's of less than 10% were observed with all cell concentrations less 
than 8 xlO8 cells/ml. A general increase in precision is observed with decreasing cell 
concentrations, with only a slight increase in percentage CV’s observed between 7.76 x 
107 and 3.45 x 107 cells/ml probably due to insufficient sample mixing. The percentage 
accuracies of the curve (Figure 3.7) were good (Table 3.1) especially in the linear range o f 
the assay, which indicates that the curve provides an accurate representation of the 
sigmoidal relationship between the measured response and the logarithm of concentration 
observed for the immunoassay.
The interday assay study for the anti -Listeria monocytogenes antibody, shown in Figure
3.9, had a lower limit of detection of approximately 1 x 106 cells/ml. The coefficients o f 
variation (CV's) were determined and ranged from 2.44 to 10.52% as shown in Table 3.2. 
A graphical representation of the relationship between the coefficient o f variance and the 
nominal concentration of Listeria monocytogenes cells is presented in Figure 3 .10. Unlike 
that observed with the anti-InlB Extract antibody (Figure 3.8) no pattern o f increased 
precision with decreasing cell concentrations was observed. The calculated percentage 
coefficient o f variation values obtained varied throughout the Listeria monocytogenes cell 
range studied. However, all the % CV values obtained were well within the 20% limits 
suggested by Findlay et al. (2000). The percentage accuracies o f the curve (Figure 3.9) 
were good in the linear range o f the assay, while large inaccuracies were observed with 
values found in the non-linear parts of the curve (Table 3.1).
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In traday In terday
Concentration
(cells/ml)*
Back-
calculated
concentration
(cells/ml)
CV's
%
%
Accuracies
Back-
calculated
concentration
(cells/ml)
CV's
%
%
Accuracies
1.00 x 1010 6.88 x 109 7.03 131.15 - 14.28 -
6.67 x 109 7.63 x 109 4.03 85.64 5.29 x 109 15.71 120.64
4.45 x 109 3.92 x lO 9 4.87 111.86 4.20 x 109 15.07 105.54
2.97 x 109 3.45 x 109 9.49 83.81 2.57 x 109 13.86 113.52
1.98 x 109 2.11 x 109 9.83 93.59 1.85 x 109 11.71 106.68
1.32 x 109 1.17 x lO 9 4.13 111.13 1.54 x 109 10.55 83.17
8.81 x 10s 1.11 x lO 8 1.96 74.46 7.41 x 108 9.75 115.81
5.87 x 108 6.49 x 108 2.45 89.49 6.49 x 108 9.27 89.57
3.92 x 10s 3.79 x 108 5.92 103.28 3.74 x lO 8 5.45 104.46
2.61 x 10® 2.75 x 108 2.00 94.85 2.65 x 108 4.76 98.54
1.74 x 10s 1.72 x lO 8 1.13 101.56 1.67 x 108 3.55 103.91
1.16 x 108 9.56 x 107 7.30 117.79 1.19 x lO 8 5.00 97.41
7.76 x 107 8.16 x lO 7 1.34 94.72 9.21 x 107 6.87 81.26
5.17 x 107 4.60 x 107 0.72 111.03 4.88 x 107 4.32 105.70
3.45 x 107 3.65 x 107 1.93 94.18 3.37 x lO7 5.17 102.30
2.30 x 107 2.25 x 107 5.19 102.17 2.09 x 107 3.54 109.16
1.53 x 107 1.64 x 107 0.65 93.13 1.54 x 107 3.57 99.47
1.02 x 107 1.15 x lO 7 2.60 87.19 1.06 x 107 2.68 96.50
6.82 x 106 7.15 x lO 6 3.96 95.28 5.50 x 106 2.10 119.49
4.55 x 106 4.55 x 106 5.42 100.10 4.39 x 106 1.37 103.58
3.03 x 106 2.27 x 106 4.62 125.12 3.77 x lO 6 1.79 76.04
2.02 x 106 2.31x10® 1.43 86.01 1.89 x 106 1.44 106.77
Table 3.1: Intra- and interday assay coefficients o f  variation (CV's) and percentage accuracies for  
the anti-lnlB extract polyclonal antibody in PBS. Intra- and interday studies were performed as 
described in section 2.3.5 and 3.2.5. Coefficients o f  variance (a quantitative measure o f  precision) 
was calculated using the equation % CV  = (S.D./Mean) x 100 where fo r  intraday studies, the 
standard deviation (S.D.) is computed from  replicate (5 replicates) analyses within a single 
validation run and for intermediate precision (interday), the S.D. is computed from  replicate (3 
replicates) analyses over 5 validation runs on 5 separate days. Cells containing a dash indicate 
that no value could be obtained as the data point did not f i t  the calibration curve.
* The cell numbers presented represent the calculated cell concentrations by performing serial cell 
dilutions from  a 1 x  1&° cells/ml Listeria monocytogenes cell stock. 2/3 dilutions were performed 
and the cell numbers calculated to 2 decimal places.
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Figure 3.7: Inter day assay calibration curve for the anti-InlB extract antibody in PBS. A 4-parameter 
equation was fitted to the data set using BIAevaluation 3.1 software. The inter-assay means and 
coefficients o f variance are tabulated in Table 3.1. Each point on the curve is the mean o f five replicate 
measurements analysed over five days.
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Figure 3.8: Precision profile for the interday inhibition ELISA assay using the anti-InlB extract polyclonal 
antibody. This figure denotes a graphical representation o f the relationship between the coefficient o f  
variation (CVJ in analytical measurements and the concentrations o f cells in each sample.
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In traday In terday
Concentration Back-calculated CV's %
Back-
calculated CV’s %
(cells/ml)* concentration
(cells/ml)
% Accuracies concentration
(cells/ml)
% Accuracies
1.00 x 1010 3.17 x lO 9 1.30 168.30 4.87 x 109 5.20 151.27
5.00 x 109 3.66 x 109 1.02 126.81 5.15 x lO 9 6.26 97.03
2.50 x 109 2.34 x 109 3.36 106.48 2.05 x 109 10.52 118.15
1.25 x 109 1.45 x 109 1.20 83.66 1.22 x 109 9.56 102.19
6.25 x 10* 8.37 x 108 3.92 66.01 6.08 x 108 9.02 102.72
3.13 x 108 3.80 x 108 4.10 78.29 3.50 x 108 3.46 87.94
1.56 x 108 1.80 x 10s 4.13 84.86 1.69 x lO 8 7.96 91.84
7.81 x 107 7.52 xlO 7 3.70 103.80 8.47 x 107 8.98 91.63
3.91 x 107 3.42 xlO 7 3.38 112.55 3.73 x 107 9.44 104.49
1.95 x 107 1.47 x 107 4.63 124.76 1.80 x 107 2.97 107.74
9.77 x 106 9.59 x 106 1.70 101.79 8.79 x 106 2.50 110.03
4.88 x 106 6.67 x 106 3.98 63.36 5.03 x 106 2.44 96.99
2.44 x 106 3.99 xlO 6 2.50 36.65 3.49 x 106 3.95 56.90
1.22 x 106 1.19 x 106 2.83 102.40 1.31 x lO 6 5.47 92.70
6.10 x 10s 5.28 x lO 5 4.58 113.47 6.23 x 105 3.47 97.87
3.05 x 10s 5.66 x 105 5.32 14.62 1.18 x 105 5.01 161.17
1.53 x 10s - 0.85 - 2.34 x 105 5.71 46.88
7.63 x 104 1.53 xlO 4 2.80 179.95 2.08 x 104 5.06 172.78
3.81 x 104 - 3.41 - - 6.18 -
Table 3.2: Intra- and interday assay coefficients o f  variation (CV's) and percentage accuracies for 
the anti-Listeria monocytogenes polyclonal antibody in PBS. Intra- and interday studies were 
performed as described in section 2.3.5 and 3.2.5. Coefficients o f  variance (a quantitative measure 
o f  precision) was1 calculated using the equation % CV = (S.D./Mean) x 100 where fo r  intraday 
studies, the standard deviation (S.D.) is computed from replicate (5 replicates) analyses within a 
single validation run and fo r  intermediate precision (interday), the S.D. is computed from  replicate 
(3 replicates) analyses over 5 validation runs on 5 separate days. Cells containing a dash indicate 
that no value could be obtained as the data point did not f i t  the calibration curve.
* The cell numbers presented represent the calculated cell concentrations by performing serial cell 
dilutions from a 1 x  10w cells/ml Listeria monocytogenes cell stock. Serial doubling dilutions were 
performed and the cell numbers calculated to 2 decimal places.
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Figure 3.9: Interday assay calibration curve for the anti-Listeria monocytogenes antibody in PBS. A 4- 
parameter equation was fitted to the data set using BIAevaluation 3.1 software. The inter-assay means and 
coefficients o f variance are tabulated in Table 3.2. Each point on the curve is the mean offive replicate 
measurements analysed over five days.
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Figure 3.10: Precision profile for the interday inhibition ELISA assay using the anti-Listeria 
monocytogenes polyclonal antibody in PBS. This Figure denotes a graphical representation o f  the 
relationship between the coefficient o f variation (CV) in analytical measurements and the concentrations o f  
cells in each sample.
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3.2.6 In tra- and interday inhibition assay variability studies o f  each polyclonal antibody 
in chocolate m ilk
As discussed in section 3.1, an outbreak o f gastroenteritis and fever among people at a 
picnic, in Illinois, on July 9th 1994, was later traced to chocolate milk consumed at the 
picnic (Dalton el al. 1997). To determine the feasibility o f detecting Listeria 
monocytogenes in a  food matrix such as chocolate milk, widely available Yazoo™ 
chocolate milk (Campina UK, Denne Road, Harsham, RH12 1JF) was purchased, 
aliquoted into 10 ml aliquots and stored at -20°C. For each assay, an aliquot was thawed 
and spiked with known cell concentrations of heat-killed Listeria monocytogenes cells.
An inhibition ELISA was developed with each antibody as described in sections 2.3.5 and 
3.2.5, for the detection o f Listeria monocytogenes 4b in chocolate milk. In order to 
determine the accuracy of the immunoassay, intra- and interday assay variability studies 
were performed as discussed in section 3.2.5. The results obtained for the intra- and 
interday assay studies for both the anti-InlB extract antibody and the anti-Listeria 
monocytogenes antibody are shown in Tables 3.3 and 3.4, respectively. The coefficients o f 
variation (CV's) were determined to assess the precision o f the analytical method. These 
values ranged from 0.78 to 5.81% and 1.75 to 12.70% as observed with the anti-InlB 
antibody, for the intra- and interday studies, respectively, indicating that the assay had a 
good degree o f precision. Both intra- and interday precision were increased when the 
assay was carried out in chocolate milk compared to PBS with highest %CV values of 
5.81 and 12.70% (Table 3.3 and Figure 3.12), respectively, compared to 9.83 and 15.70% 
observed in PBS. Also, the sensitivity o f the assay increased in chocolate milk, with a 
limit of detection o f approximately 4-5 x 106 cells/ml (Figure 3.11) compared to 7 x 106 
cells/ml in PBS. The coefficients of variance values obtained with the anti-Listeria 
monocytogenes antibody ranged from 1.30 to 5.72% and 1.41 to 8.69% (Table 3.4) for the 
intra- and interday studies, respectively, which are comparable to those values observed in 
PBS (Table 3.2).
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In traday In terday
Concentration
(cells/ml)
Back-
calculated
concentration
(cells/ml)
CV's
%
%
Accuracies
Back-
calculated
concentration
(cells/ml)
CV's
%
%
Accuracies
1.00 x 1010 8.16 x 109 1.67 118.37 7.77 x 109 12.70 122.34
6.67 x 109 6.88 x 109 3.06 96.86 7.04 x 109 12.58 94.40
4.45 x 109 4.24 x 109 4.96 104.61 6.02 x 109 10.53 64.62
2.97 x 109 2.82 x 109 5.30 104.81 2.99 x 109 8.78 99.31
1.98 x 109 2.68 x 109 2.55 64.83 1.79 xlO 9 8.72 109.53
1.32 x 109 1.17 x 109 4.10 111.29 1.40 x 109 8.49 94.19
8.81 x 108 9.50 x 108 3.09 92.07 8.29 x 108 9.71 105.87
5.87 x 108 6.69 x 108 2.42 86.07 5.54 x 108 6.63 105.62
3.92 x 108 4.15 x 108 4.46 94.10 3.95 x lO 8 6.47 99.29
2.61 x 108 2.22 x 10s 5.73 114.98 2.56 x 108 8.33 101.91
1.74 x 108 1.72 x 108 2.29 101.32 1.81 x 108 5.08 96.23
1.16 x 10s 9.72 x 107 2.03 116.39 1.37 x lO 8 8.63 82.16
7.76 x 107 1.00 x 108 5.79 70.42 7.72 x 107 4.19 100.39
5.17 x 107 4.84 x 107 0.78 106.46 4.97 x 107 8.70 103.95
3.45 x 107 2.79 x 107 5.81 119.22 2.64 x 107 6.07 123.47
2.30 x 107 2.71 x 107 2.63 82.33 2.24 x 107 5.69 102.80
1.53 x 107 1.68 x 107 1.52 90.76 1.83 x 107 4.81 80.47
1.02 x 107 9.27 x 106 1.89 109.43 1.03 x 107 3.35 99.68
6.82 x 106 6.13 x 106 4.40 110.28 8.28 x 106 1.75 78.65
4.55 x 106 5.82 x 10s 1.53 72.20 4.03 x 106 2.49 111.61
3.03 x 106 3.01 x lO 6 2.65 100.82 3.20 x 106 3.89 94.81
2.02 x 106 1.82 x lO 6 3.50 110.18 2.03 x 106 3.16 99.74
Table 3.3: Intra- and interday assay coefficients o f  variation (CV's) and percentage accuracies for  
the anti-InlB extract polyclonal antibody in chocolate milk. Intra- and interday studies were 
performed as described in section 2.3.5 and 3.2.5. Coefficients o f  variance (a quantitative measure 
o f  precision) was calculated using the equation % CV  = (S.D./Mean) x  100 where fo r  intraday 
studies, the standard deviation (S.D.) is computed from replicate (5 replicates) analyses within a 
single validation run and fo r  intermediate precision (interday), the S.D. is computed from replicate 
(3 replicates) analyses over 5 validation runs on 5 separate days.
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Cell concentration (cells/m l)
Figure 3.11: Interday assay calibration curve for the anti-InlB extract antibody in chocolate milk. A 4- 
parameter equation was fitted to the data set using BIAevaluation 3.1 software. The inter-assay means and 
coefficients o f variance are tabulated in Table 3.3. Each point on the curve is the mean o f five replicate 
measurements analysed over five days.
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Figure 3.12: Precision profile for the inter-day inhibition ELISA assay using the anti-lnlB extract 
polyclonal antibody in chocolate milk This figure denotes a graphical representation o f the relationship 
between the coefficient o f variation (CV) in analytical measurements and the concentrations o f cells in 
each sample.
Cell concentration x 106 (cells/ml)
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In traday In terday
Concentration
(cells/ml)
Back-
calculated
concentration
(cells/ml)
CV's
%
%
Accuracies
Back-
calculated
concentration
(cells/ml)
CV's
%
%
Accuracies
1.00 x 1010 6.37 x lO 9 3.76 136.34 5.77 x 109 8.16 142.26
5.00 x 109 5.20 x 109 3.16 96.07 5.27 x 109 7.51 94.65
2.50 x 109 2.50 x 109 3.68 99.87 2.51 x 109 7.66 99.59
1.25 x 109 1.54 xlO 9 3.36 76.93 1.32 x 109 7.28 94.20
6.25 x 108 7.02 x 108 3.97 87.71 6.66 x 108 6.48 93.43
3.13 x 108 2.87 x 108 2.87 108.28 3.04 x lO 8 6.78 102.56
1.56 x 108 1.69 xlO 8 3.81 91.99 1.56 x 108 8.69 100.28
7.81 x 107 6.54 x 107 3.20 116.31 7.87 x 107 4.65 99.21
3.91 x 107 3.99 x 107 5.72 97.91 3.96 x lO 7 5.06 98.60
1.95 x 107 2.35 x 107 3.80 79.84 1.97 x 107 3.60 99.30
9.77 x 106 8.19 x 106 2.83 116.17 8.60 x 106 4.18 111.97
4.88 x 106 5.74 x 106 3.45 82.52 5.14 x lO 6 4.72 94.69
2.44 x 106 2.38 x 106 3.25 102.54 3.20 x lO 6 4.96 68.88
1.22 x 106 6.78 x 105 4.37 144.46 1,29 x l O6 4.04 94.72
6.10 x 10s 6.04 x 105 1.30 101.09 4.01 x 105 3.79 134.28
3.05 x 10s 5.18 x10s 5.11 30.31 4.72 x 10s 3.57 45.23
1.53 x 10s 2.29 x 105 3.11 49.98 4.04 x 104 5.57 173.51
7.63 x 104 6.94 x 104 2.30 199.09 9.47 x 104 3.01 75.90
3.81 x 104 - 1.41 - - 1.41 -
Table 3.4: Jntra- and interday assay coefficients o f  variation (CVs) and percentage accuracies for 
the anti-Listeria monocytogenes polyclonal antibody in chocolate milk. Intra- and interday studies 
were performed as described in section 2.3.5 and 3.2.5. Coefficients o f  variance (a quantitative 
measure o f  precision) was calculated using the equation % CV = (S.D./Mean) x  100 where for  
intraday studies, the standard deviation (S.D.) is computed from replicate (5 replicates) analyses 
within a single validation run and fo r  intermediate precision (interday), the S.D. is computed from  
replicate (3 replicates) analyses over 5 validation runs on 5 separate days. Cells containing a dash 
indicate that no value could be obtained as the data point did not f i t  the calibration curve.
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Figure 3.13: Interday assay calibration curve fo r  the anti-Listeria monocytogenes antibody in chocolate 
milk. A 4-parameter equation was fitted  to the data set using BIAevaluation 3.1 software. The inter-assay 
means and coefficients o f  variance are tabulated in Table 3.4. Each point on the curve is the mean o f  five 
replicate measurements analysed over five  days.
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Figure 3.14: Precision profile fo r  the inter-day inhibition ELISA assay using the anti-Listeria 
monocytogenes polyclonal antibody in chocolate milk. This Figure denotes a graphical representation o f  
the relationship between the coefficient o f  variation (CV) in analytical measurements and the 
concentrations o f  cells in each sample.
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3.2.7 Cross reactivity studies
Cross reactivity may be defined as a measure of the antibody response to structurally 
related molecules, as a result o f shared epitopes. A specific immunoassay should have the 
ability to measure the antigen unequivocally in the presence o f other components, either 
exogenous or endogenous (Findlay, et al., 2000). The degree o f cross reactivity of 
polyclonal antibodies can be assessed by performing the assay (described in section 2.3.5) 
with serial dilutions o f competing antigen in parallel with similar dilutions o f specific 
antigen. The cross-reactivity o f an immunoassay is often conveniently defined as the point 
where the reduction in signal recorded in the presence o f a  particular analyte concentration 
(Cx) gives a 50% reduction in the signal in the presence o f zero analyte (Co) (i.e. 
Cx/C0=50%). Therefore, the antigen concentration value at 50% inhibition (EC50) can be 
expressed as a  percentage o f the cross reactant concentration (Figure 3.15) giving the 
same decrease in signal where the percentage cross reactivity will be defined as:
% cross reactivity = Concentration o f analyte giving 50% decrease in signal xlOO 
Concentration o f cross reactant giving 50% decrease in signal
However, the percentage cross reactivity can also be expressed as a ratio o f the inhibition 
observed with the antigen at the EC50 concentration to the inhibition observed with the 
cross reactant at the same concentration, whereby the percentage cross reactivity will be 
defined as (Figure 3.16):
% cross reactivity = inhibition value o f cross reactant at EC™ concentration xlOO
inhibition value o f antigen at EC5n concentration
Table 3.5 contains the percentage cross reactivity values obtained by both the above 
methods against various bacterial strains. Each antibody was incubated with decreasing 
concentrations of intact bacterial cross reactants and added to ELISA plate wells coated 
with intact Listeria monocytogenes cells. A striking difference is observed between the 
two methods with much lower calculated cross reactivities obtained when using ratio o f 
concentrations rather than ratio o f inhibitions. Figures 3.17 and 3.18 show the actual cross 
reactivity plots obtained with both antibodies against the various bacterial strains. From 
analysing the plots, it can be deduced that both antibodies cross react to various degrees 
with different bacteria tested from the genus Listeria and thus using the ratio o f the 
inhibitions observed is probably a  more accurate method o f determining the percentage 
cross reactivity o f both immunoassays.
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Cell co n c en tra tio n  (Cella/ml)
Figure 3.15: Typical plot showing the potential cross reactivity o f  a particular antibody 
preparation towards a structurally related compound using the ratio o f  concentrations o f  each 
reagent that gives 50% inhibition (EC50) as discussed in section 3.2.7. The % cross reactivity is 
calculated by expressing the antigen concentration (A) as percentage o f  the cross reactant 
concentration (B).
Cell c o n c e n tra tio n  (C ells/m l)
Figure 3.16: Typical plot showing the potential cross reactivity o f  a particular antibody 
preparation towards a structurally related compound using the ratio o f  inhibition values o f  each 
reagent at the concentration o f  specific analyte that gives 50% inhibition (EC5Q) as discussed in 
section 3.2.7. The % cross reactivity is calculated by expressing the cross reactant inhibition value 
(A) as percentage o f  the antigen inhibition value (B).
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Percentage cross reactivity 
with anti-InlB polyclonal 
antibody (%)
Percentage cross reactivity with 
anti-L. monocytogenes 
polyclonal antibody (%)
Bacterial strain
Ratio of 
inhibitions
Ratio of 
concentrations
Ratio of 
inhibitions
Ratio of 
concentrations
L. monocytogenes 100 100 100 100
Listeria innocua 6a 36.7 6.3 14.6 -
Listeria innocua 6b 55.8 4.5 39.3 1.0
Listeria welshimeri 63.8 25.0 61.7 6.7
Listeria ivanovii 36.0 3.5 19.0
Listeria seeligeri 51.8 10.5 29.8 -
Bacillus subtilis 11.2 - 8.3 -
Escherichia coli 6.7 - Neg.
Table 3.5: Cross reactivity o f  the affinity purified rabbit anti-InlB extract and anti-Listeria 
monocytogenes polyclonal antibodies with various bacterial strains. Percentage cross reactivity 
values were calculated using both the ratio o f  concentrations (shown in Figure 3.15) and ratio o f  
inhibition values (shown in Figure 3.16) as discussed in section 3.2.7. From the results tabulated, 
there is a large difference between both methods in defining the % cross reactivity with the ratio o f  
inhibition values method generating much larger % cross reactivity values. Cells containing a dash 
indicate that the cross reactant did not cross react with the antibody (i.e. did not give a decrease in 
inhibition o f  50% over the range o f  concentrations tested). The actual overlay plots fo r  each 
antibody are shown in Figures 3.17 and 3.18.
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Figure 3.17: Overlay plot showing the cross reactivity o f  the anti-lnlB Extract polyclonal antibody 
with various bacterial strains using the inhibition ELISA format described in section 2.2.5. Antibody 
was mixed with decreasing concentrations o f  intact bacterial cells and added to ELISA wells coated 
with intact Listeria monocytogenes 4b cells in triplicate.
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Figure 3.18: Overlay plot showing the cross reactivity o f  the anti-Listeria monocytogenes polyclonal 
antibody with various bacterial strains using the inhibition ELISA format described in section 2.2.5. 
Antibody was mixed with decreasing concentrations o f  intact bacterial cells and added to ELISA wells 
coated with intact Listeria monocytogenes 4b cells in triplicate.
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3.3 Discussion
This chapter describes the production and characterisation o f polyclonal antibodies to 
Intemalin B protein extract and heat-treated Listeria monocytogenes cells. Both antibodies 
were crudely purified by saturated ammonium sulphate precipitation and later further 
purified on a protein G affinity chromatography column. The purity o f each antibody was 
assayed by SDS-PAGE analysis (Figures 3.3 and 3.4) and purified antibody detected by 
Western blotting using an anti-rabbit AP-conjugated antibody. Purified antibody was 
subsequently used in the development o f an inhibition ELISA immunoassay for the 
detection o f heat-treated Listeria monocytogenes cells in solution. Due to the danger of 
using live Listeria monocytogenes cells in an uncontrolled laboratory, optimisation and 
development o f the inhibition ELISA immunoassays were performed with heat-treated 
Listeria monocytogenes cells, obtained from the Institute for Food Research, in Norwich. 
However, intact (not heat-treated) cells were used to determine the cross reactivities of 
each antibody (section 3.2.7) with no obvious decrease in sensitivity observed (Figures 
3.17 and 3.18).
In order to determine the optimal working dilution o f the purified antibody and optimal 
cell coating concentration, a checkerboard ELISA was performed as described in section
2.2.4. Varying dilutions of a 2 x 1010 cells/ml Listeria monocytogenes stock were coated 
on a microtitre plate and dilutions o f affinity purified antibody added to each cell dilution 
on the microtitre plate. The optimal coating concentration o f Listeria monocytogenes cells 
was determined to be approximately 1 x 108 cells/ml and the optimal antibody dilutions 
determined to be 1/300 and 1/12,500, for the anti-InlB extract and anti -Listeria 
monocytogenes polyclonal antibodies, respectively. An inhibition ELISA was developed 
with each antibody as described in sections (2.3.5 and 3.2.5) and a four parameter 
equation fitted to the data using BIAevaluation 3.1 software. Intra- and interday studies 
were carried out with both antibodies to determine the accuracy and precision of repeated 
measurements o f both assays. The coefficients o f variance values o f each assay provide a 
quantitative measure o f precision o f the analytical method. The percentage accuracies 
values obtained in the linear part o f both interday assay plots (Figures 3.7 and 3.7) 
indicate the fitted four parameter curves provide an accurate representation o f the 
sigmoidal relationship between the measured response and the logarithm of concentration 
observed for both immunoassays. Limits o f detection o f approximately 7 x 106 and 1 x  10® 
cells/ml were observed for the anti-InlB extract and anti -Listeria monocytogenes 
antibodies, respectively.
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To assess the feasibility of detecting Listeria monocytogenes in a food matrix such as 
chocolate milk, the widely available Yazoo™ chocolate milk was purchased and spiked 
with known concentrations o f Listeria monocytogenes cells. An inhibition ELISA was 
developed for both antibodies and intra- and interday assay variations analysed (Tables
3.3 and 3.4). Using chocolate milk as a sample matrix increased the precision o f the anti- 
InlB extract antibody assay (section 3.2.6) and seemed to cause a slight shift in the limit of 
detection from approximately 7 x 10s cells/ml in PBS (Figure 3.7) to approximately 4-5 x 
106 cells/ml in chocolate milk (Figure 3.11). These findings suggest the antibody can be 
reliably used for the detection o f Listeria monocytogenes chocolate milk samples without 
the need for prior sample preparation. The m ti-Listeria monocytogenes antibody 
coefficient o f variance values observed in chocolate milk were comparable with those 
observed in PBS, however, the limit o f  detection o f the assay decreased slightly from 1 x 
106 cells/ml in PBS to 2 x 106 cells/ml in chocolate milk. Overall, the results obtained for 
both antibodies in chocolate milk suggest that no sample preparation is required for the 
detection o f Listeria monocytogenes cells in chocolate milk samples.
The level of cross reactivity observed with both antibodies was determined against a 
number o f bacterial cross contaminants. Two strategies for calculating the percentage 
cross reactivity o f each antibody with the bacterial cross contaminants were examined. 
Expressing the antigen concentration value at 50% inhibition (EC50) as a  percentage o f the 
cross reactant concentration giving the same decrease in signal (Figure 3.15) was 
compared to strategy o f expressing the inhibition observed with the antigen at the EC50 
value to the inhibition observed with the cross reactant at the same concentration (Figure 
3.16). The calculated percentage cross reactivity’s observed using both strategies are 
tabulated in Table 3.5 and show a considerable difference between the two methods. The 
ratio o f inhibition values yield a lot higher cross reactivity values which fit the observed 
results (Figures 3.17 and 3.18) more accurately. The calculated ratio o f concentration 
values observed for the anti -Listeria monocytogenes antibody indicate that there is little 
cross reactivity o f the antibody with L. innocua, L. ivanovii, L. seeligeri and B. subtilis 
which is not the case observed in Figure 3.17. Using the ratio o f concentration values of 
each cross contaminant can falsely over exaggerate the specificity o f an immunoassay and 
can lead to the continued detection o f false positive samples. Both the antibodies 
discussed in this chapter cross reacted with the other Listeria strains to different degrees, 
albeit at high cells numbers (no significant cross reactivity observed at less than 5 xlO7 
cells/ml). These findings indicate that neither antibody can be used for the specific 
detection o f Listeria monocytogenes cells from a heterogeneous population o f bacterial 
cells. However, by varying the assay format, and by utilising either o f the antibodies as a
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capture antibody in conjunction with a detection antibody with a more refined specificity 
(monoclonal antibody), both antibodies can be valuable reagents for the development o f  
an immunoassay for the reliable detection o f Listeria monocytogenes cells from a mixed 
population.
Overall the two immunoassays presented in this chapter do not reach the sensitivities for 
Listeria  sp. reported for other assays such as the Listeria Rapid Test; Oxoid, Unipath 
(5xl04 to 10s bacteria/ml, Roberts, 1994), VIDAS Listeria kit (104-105 cfu/ml, Sewell el 
al., 2002) and a microsphere-associated fluorescence assay (<1000 organisms/ml, Dunbar 
et a l,  2003). Both antibodies have been further utilised for the identification o f  Listeria 
monocytogenes recombinant invasion-associated proteins (chapter 4) and for the rapid 
genus specific detection o f Listeria  cells using surface plasmon resonance (SPR) 
described in chapter 6.
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Cloning, expression and purification of Listeria 
monocytogenes invasion-associated protein gene
sequences in E. coli
Chapter 4
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4.1 Introduction
This chapter involves the cloning and expression o f the Listeria monocytogenes invasion 
associated proteins, Intemalin B (InlB) and p60 (also known as iap), gene sequences in E. 
coli XL 10 Gold cells and the purification o f each protein by immobilised metal affinity 
chromatography (IMAC). Expressing Listeria monocytogenes invasion-associated 
proteins in E. coli allows the safe and efficient production o f high quantities of pure 
protein for use in the generation o f Listeria monocytogenes specific antibodies and 
immunoassay development, without the need for culturing large volumes of this important 
food borne pathogen. The fusion o f a polyhistidine tag at the C terminus o f each protein 
also allows the easy purification and detection of the expressed gene products.
The InlB and p60 gene sequences (accession numbers AJO12346 and X52268, 
respectively), lacking the signal sequences for secretion, were amplified from purified 
Listeria monocytogenes genomic DNA and directly cloned into an Invitrogen TA cloning 
vector, pCR 2.1, and ligated into E. coli INV aF ' cells (Figure 4.1 shows an outline of the 
steps involved in the cloning, expression and purification o f each protein). TA cloning 
(section 4.2.2) allows the simple one step cloning of amplified DNA and facilitates the 
screening of positive clones containing the desired PCR products. Most restriction 
enzymes require additional DNA flanking the restriction site in order to sufficiently digest 
DNA. Cloning o f the InlB and p60 gene sequences into a TA cloning vector also provides 
the additional DNA needed for the efficient digestion o f the PCR products. However, TA 
cloning does not allow directional cloning of PCR products which can result in the desired 
genes being present in the wrong orientation or in the wrong reading frame. In order to 
express high levels o f the correct InlB and p60 gene products, the InlB and p60 gene 
sequences were directionally cloned into the QIAgen pQE-60 expression vector (Figure
4.4) as described in section 2.3.6.
In E. coli, the promoter region consists o f a hexanucleotide sequence located 
approximately 35 bp upstream of the transcription initiation base (-35 region) separated by 
a short spacer from another hexanucleotide sequence (-10 region) (Makrides, 1996). The 
ribosome binding site in an optimised-expression vector extends from the -10  region of 
the promoter to the beginning o f the coding sequence. The consensus Shine-Delgamo 
sequence (AGGA) is contained within the ribosome binding site and interacts with the 3' 
terminus o f the ribosomal RNA during translation initiation (Hannig and Makrides, 1998). 
Transcription initiation in E. coli begins with binding o f E. coli RNA polymerase to the 
promoter; however, the successful transition from transcription initiation to transcription
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elongation can be influenced by downstream elements. Many popular bacterial expression 
systems contain components o f the lac operon. Binding o f the lac repressor protein to the 
lac operator, a specific sequence o f DNA to which the lac repressor binds, greatly 
decreases the frequency o f successful transcription elongation events by the RNA 
polymerase (Novy and Morris, 2001). Inducers o f the lac operon, such as IPTG, bind to 
the lac repressor and substantially decrease its binding affinity to the lac operator, thereby 
permitting transcription elongation. However, efficient transcription initiation also 
requires the presence o f cyclic AMP (cAMP) and the cyclic AMP receptor protein, called 
CRP or CAP. The CAP/cAMP complex binds just upstream of the lac promoter and 
directly stimulates transcription by RNA polymerase. However, cAMP levels are strongly 
influenced by the carbon source present in the medium. In the presence o f glucose, (an 
easily metabolised monosaccaride), cAMP levels are low, so transcription from the lac 
promoter is low and this phenomenon is known as the glucose effect or catabolite 
repression (Novy and Morris, 2001). The lac repressor protein can be coded upstream 
from the promoter region or as is the case o f the pQE-60 vector, the lac repressor protein 
can be coded on a separate plasmid (Figure 4.4 shows the major components of the pQE- 
60 plasmid).
QIAgen pQE vectors contain an optimised promoter-operator element consisting o f a 
phage T5 promoter (recognised by E. coli RNA polymerase) and two lac operator 
sequences which increase lac repressor binding and ensure efficient repression of the 
powerful T5 promoter. Each vector also contains a synthetic ribosomal binding site for 
high translation rates, a 6xHis tag (5' or 3' to the multiple cloning site) for convenient 
detection and purification, strong transcriptional terminators to prevent read-through 
transcription and ensure stability of the expression product, a p-lactamase gene (bla) 
conferring resistance to ampicillin and a Col E l origin o f replication (QIAgen Ltd, 2000). 
Regulation of expression from the pQE-60 vector can be controlled by the addition of 
glucose (catabolite repression) and by co-expressing the plasmid in cells containing the 
pREP4 plasmid, a low copy number plasmid that expresses the lac repressor protein 
encoded by the la d  gene (QIAgen Ltd, 2000). Also E. coli strains that harbour the lacF 
mutation, such as XL1 Blue, TG I and XL10 Gold, produce enough lac repressor to 
efficiently block transcription, and are ideal for storing and propagating pQE plasmids 
(QIAgen Ltd, 2000).
Expressed recombinant proteins were extracted from cell cytoplasmic extracts and 
purified by immobilised metal affinity chromatography using a Ni-NTA (nickel- 
nitrilotriacetic acid) agarose resin (QIAgen, UK) and the purity determined by SDS-PAGE
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analysis. The immunoreactivity o f the recombinant antigens with anti-Listeria 
monocytogenes-related antibodies was further examined. Both proteins were probed with 
protein specific monoclonal antibodies by W estern blotting and detected with anti-Listeria 
monocytogenes polyclonal antibodies by ELISA. Both proteins were also used for the 
selection o f specific anti -Listeria monocytogenes antibodies (chapter 5) and for the 
development o f an immunoassay to detect Listeria monocytogenes.
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Figure 4.1: Overview o f the processes involved in the cloning, expression and purification o f the InlB and 
p60 gene sequences.
Cloning: Genomic DNA from Listeria monocytogenes was prepared (described in section 2.3.1) and the 
InlB and p60 gene sequences amplified by specific PCR primers (sections 2.3.3 and 2.3.4). Fresh PCR 
product (PCR A overhangs degrade over time) was ligated into a pCR 2.1 vector (TA cloning) and 
transformed cells spread on agar plates containing 5-bromo-4-chloro-3-indolyl-/3-D-galactoside (X-Gal) 
for the blue-white screening o f positive clones. Plasmid DNA from selected clones was then purified 
(section 2.3.5.3) and the gene insert directionally subcloned into the pQE-60 expression vector by digestion 
with Ncol and BamHI restriction enzymes (section 2.3.5.4). The pQE-60 vectors containing gene inserts 
(pQE-InlB and pQE-p60 vectors) were finally transformed into E. coIiXLlO Gold cells (section 2.3.6). 
Expression: A number o f strategies, such as colony blotting, time course experiments, growth media 
determination and determination of protein solubility by SDS-PAGE, can be utilised to examine and 
optimise the expression o f recombinant protein in E. coli. In this chapter, time course experiments (section 
2.3.7) were performed to determine the expression o f each protein and determination o f protein solubility 
(section 2.3.8) carried out by SDS-PAGE analysis o f  cell lysates.
Purification: Both proteins were purified by immobilised metal affinity chromatography (section 2.3.9) 
using a Ni-NTA agarose resin (QIAgeri) and the purity o f each protein assessed by SDS-PAGE analysis.
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4.2 Cloning of the InlB and p60 gene sequences into E. coli
Due to the obvious dangers o f culturing high numbers o f L isteria monocytogenes cells in 
an uncontrolled environment and with inherent difficulties in extracting large quantities of 
purified invasion-associated protein from Listeria monocytogenes cultures, it was decided 
to clone two Listeria monocytogenes invasion-associated proteins in E. coli. The gene 
sequences (lacking the signal sequences for secretion) coding for the Listeria  
monocytogenes invasion-associated proteins, Intemalin B (InlB) and p60 (discussed in 
Chapter 1), were cloned into E. coli as described in Figure 4.1 above.
4.2.1 Amplification of the InlB and p60 gene sequences by PCR
Listeria monocytogenes l/2 a  (serovar l/2a  was used as the protein sequences obtained 
from accession numbers AJO12346 and X52268 were sequences from Listeria  
monocytogenes l/2a  cells) genomic DNA was extracted as described in section 2.3.1 and 
used as the template for the amplification o f the InlB and p60 genes. Primers were 
designed to incorporate the sequences for N co l and B am H l digestion for the subsequent 
directional cloning into the pQE-60 plasmid (section 2.3.3). The use o f  the N co l  site 
necessitated the incorporation of two additional bases immediately following the N co l site 
in order to maintain the correct reading frame. This resulted in the addition o f a glycine 
codon between the ATG initiation codon and the first codon of the gene. A  standard PCR 
reaction was used to amplify the DNA sequences (section 2.3.4) and the optimum 
annealing temperature determined to be 65°C (Figure 4.2) for each protein.
4.2.2 TA cloning of amplified gene sequences
Thermostable polymerases like Taq DNA polymerase, which lack 3' to 5' exonuclease 
activity, leave 3' A-overhangs in amplified products. Therefore, PCR products generated 
with Taq DNA polymerase have a high efficiency of cloning in the TA Cloning system. 
Cloning in the TA vector allows the distinction between transformants bearing plasmids 
with inserts from transformants bearing recircularised plasmids without inserts by plating 
on media containing X-Gal to test for a-complementation o f P-galactosidase. 
Transformants harbouring plasmids with inserts do not express a  functional lacZ a  gene 
product, which is the a  peptide o f p-galactosidase, and therefore appear white on X-Gal 
plates because a-complementation cannot occur. Transformants harbouring recircularised 
plasmid DNA without any inserts express a functional la cZ a  gene product and thus appear 
blue on X-Gal plates because a-complementation of p-galactosidase can occur resulting in
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the cleavage o f  X-Gal. Figure 4.3 shows a picture o f a X-Gal agar plate containing 
transformants harbouring the InlB gene sequence inserts. From Figure 4.3 it can be seen 
that blue and white colonies can be easily differentiated and the plate contains an even 
spread of blue and white colonies. The high number o f  blue colonies can be the result of 
degradation o f either the plasmid or insert overhangs or be due to the ligation o f  the pCR
2.1 with veiy small or truncated inserts. DNA inserts less than 500 bp in length may 
produce light blue colonies and therefore some blue colonies should be checked.
4.2.3 Cloning o f  am plified inserts into the pQ E -60 expression vector
TA cloning pCR 2.1 plasmids from selected colonies harbouring a PCR product insert 
were purified (section 2.3.5.3) and digested with N col and BamHI as described in section
2.3.5. The InlB and p60 gene sequences were purified from an agarose gel (Figure 4.5) 
and ligated into a QIAgen pQE-60 vector. Ligated vectors were transformed into E. coli 
XL10 Gold cells (section 2.3.6.6) and expression o f  InlB and p60 gene products 
determined as described in section 4.2.4.
Figure 4.2: Gradient PCR to determine the optimum annealing temperature for each protein gene 
sequence. Lanes 1 and 12 contain a Promega 100 bp marker; lanes 2 and 11 are blank wells; lanes 3-6 
contain the p60 amplification products at 58°C, 60°C, 62°C and 65°C annealing temperatures, respectively. 
Lanes 7-10 contain the InlB amplification products at 58°C, 60°C, 62°C and 65°C annealing temperatures, 
respectively. One clear band (no non-specific bands as observed with lower temperatures) was obtained at 
65°C for each protein and therefore this temperature was chosen for subsequent amplification reactions.
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Figure 4.3: Typical X-Gal agar plate used for the identification o f clones containing PCR inserts 
after TA cloning. After transformation E. coli cells were spread on agar plates containing the 
required antibiotics and 40 pi o f a 40 mg/ml X-Gal stock spread evenly over the top o f the plates. 
Colonies with no inserts turned blue on the plate after incubation at 4°C for 3 hours. The picture 
shown here was taken from an agar plate containing transformants with the InlB gene sequence.
Figure 4.4: Diagram o f the pQE-60 vector used for the cloning o f the InlB and p60 gene 
sequences. The plasmid contains a T5 promoter (PT5), lac operators (lac O), a ribosome binding 
site (RBS), ATG start codon, 6xHis tag sequence, multiple cloning site (MCS), stop codons in all 
three reading frames (stop codons), a Col E l origin of replication and an ampicillin resistance 
gene. The expression levels can be regulated by addition of glucose (catabolite repression) and by 
co-expressing the plasmid in cells containing the pREP4 plasmid, a low copy number plasmid that
expresses the lac repressor protein encoded by the lacl gene. Also E. coli strains that harbour the 
lacP mutation, such as XL 1 Blue, TGI and XL 10 Gold, produce enough lac repressor to efficiently 
block transcription, and are ideal for storing and propagating pQE plasmids (QLAgen Ltd, 2000).
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Figure 4.5: Restriction o f pCR 2.1 plasmid clones containing an InlB or p60 gene insert. Plasmid DNA 
was purified as described in section 2.3.5.3 and the purified plasmid digested with Ncol and BamHI 
restriction enzymes as described in section 2.3.5.4. The pCR 2.1 vector contains a Ncol site 1878 bp 
downstream from the promoter and BamHI site 253 bp downstream from the promoter (first base in 
promoter region is base number 1). Digestion with Ncol and BamHI (sites also now present in the MCS as 
amplified with the InlB and p60 genes) results in the generation offour DNA fragments. The first fragment, 
an approximately 2300 bp pCR 2.1 vector fragment, results from digestion from the Ncol site at position 
1878 through the promoter to the BamHI site in position 253. The second fragment, an approximately 1600 
bp pCR 2.1 vector fragment, results from digestion from the MCS, roughly in position 280, to the Ncol site 
in position 1878. The thirdfragment, an insert fragment o f ~1450 bp for the p60 gene sequence and —1900 
bp for InlB gene sequence results, from the digestion o f the PCR product while the fourth fragment, a tiny 
pCR 2.1 plasmid fragment o f  approximately 30 bp, is not present in the gel picture described here. Lanes 1 
and 15 contain a Promega 100 bp marker, with only the 500 bp band visible on the gel. Lanes 2-7 
represent digested pCR 2.1 vector harbouring a p60 gene sequence and lanes 9-14 represent digested pCR
2.1 vector harbouring an InB gene sequence. Lane 8 represents an undigested pCR 2.1 vector harbouring 
no insert. The high band present in lane 12 is probably an InlB gene sequence-pCR 2.1 vector fragment 
(1600 bp) fusion caused by restriction with Ncol only. The InlB and p60 gene fragments indicated were 
purified from the gel and ligated into the pQE-60 expression vector as described in sections 2.3.6.
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4.2.4 Time course experiments to determine the expression gene products
E. coli cells harbouring either the InlB or p60 gene sequences were induced with IPTG as 
described in section 2.3.7 and samples taken every hour. Cell samples were resuspended 
in lysis buffer and sonicated. The resulting denatured cytoplasmic extracts were analysed 
by SDS-PAGE as shown in Figure 4.6 and 4.7. Both the InlB (Figure 4.6) and p60 (Figure 
4.7) gene products were observed at the expected molecular weights (indicated). The level 
of expression o f each protein varied considerably with the expression of the p60 gene 
product being vastly superior. Both gene products showed optimum expression between 5 
and 6 hours of induction.
4.2.5 Determination of protein solubility and cellular location
To determine the solubility o f each protein, E. coli cultures harbouring either an InlB or 
p60 gene sequence were induced with IPTG and grown for 5 hours. Culture cell pellets 
were then resuspended in PBS (referred to as native or soluble cytoplasmic extract) and 
sonicated as described in section 2.3.8. The remaining insoluble matter was resuspended 
in lysis buffer and the cell debris removed by centrifugation. The soluble and insoluble 
extracts were analysed by SDS-PAGE as shown in Figure 4.8. As observed from the gel, 
the majority o f the expression gene products are expressed in the soluble form (lanes 1 
and 3) with some protein expressed an insoluble inclusion bodies (lanes 2 and 4). Running 
both gene products on the same gel indicates the different molecular weights o f each 
protein and highlights the presence of either an InlB or p60 expressed protein band not 
present in the alternative lysate.
By comparing periplasmic and cytoplasmic expression (section 2.3.8) it was determined 
that each protein is expressed mainly in the cytoplasm with small amounts o f  protein 
(mainly p60) being expressed in the periplasm (Figure 4.9). E. coli cell pellets expressing 
either an InlB or p60 gene product were either resuspended in PBS and sonicated (native 
sonicated cytoplasmic extract) or resuspended TES buffer (section 2.3.8) for 1 hour at 4°C 
(native periplasmic extract). The remaining pellet from the periplasmic extract was also 
resuspended in PBS and sonicated (native cytoplasmic extract minus periplasmic extract). 
Each fraction was analysed by SDS-PAGE as shown in Figure 4.9. The large protein 
bands present in lanes 2 and 4 (InlB) and 5 and 7 (p60) indicate that both proteins are 
expressed in the cytoplasm. The expression levels of both proteins were observed to differ 
significantly. The p60 protein was expressed at approximately 18mg/l while InlB was 
observed at approximately 7mg/l.
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Figure 4.6: Time course experiment for the expression of the InlB gene product. Lanes I and 9 represent a 
Pierce Blue Ranger prestained molecular weight marker and lanes 2-8 represent E. coli cell lysates taken 
after induction with IPTG at 0, 1, 2, 3, 4, 5 and 6 hours, respectively. 1 ml samples from the growing 
induced culture were taken at 1 hour intervals, centrifuged and the pellet resuspended in urea buffer as 
described in section 2.3.7. 20 pi o f  each sample was added to each lane.
2 3
Figure 4.7: Time course experiment for the expression o f the p60 gene product. Lanes 1 and 10 represent a 
Sigma wide range molecular weight marker and lanes 2-9 represent E. coli cell lysates taken after 
induction with IPTG at 0, 1, 2, 3, 4, 5, 6 and 18 hours, respectively. I ml samples from the growing induced 
culture were taken at 1 hour intervals, centrifuged and the pellet resuspended in urea buffer as described in 
section 2.3.7. 20 /.tl of each sample was added to each lane.
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Figure 4.8: Determination ofprotein solubility. E. coli cells harbouring each protein were induced for 5 
hours and the cells recovered by centrifugation. Pellets were resuspended in PBS and sonicated (soluble 
fraction). The remaining insoluble matter was separated by centrifugation and resuspended in 8 M urea 
buffer ( insoluble fraction) to solublise the remaining protein aggregates. Lanes 1 and 2 represent E. coli 
InlB soluble and insoluble lysate fractions, lanes 3 and 4 represent E. coli p60 soluble and insoluble lysate 
fractions and lane 5 represents a Pierce Blue Ranger prestained marker with weights indicated. From the 
gel it can be clearly seen that the majority o f each protein is expressed as soluble material.
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Figure 4.9: Determination o f the cellular location o f each protein. E. coli cells harbouring each protein 
were induced with IPTG o f  5 hours and 2 x 5 ml o f each cell culture harvested. The cell pellets were 
resuspended in either PBS and sonicated (native sonicated cytoplasmic extract) or TES buffer (section 
2.3.8) for I hour at 4°C (native periplasmic extract). The remaining pellet from the periplasmic extract 
was also resuspended in PBS and sonicated (native cytoplasmic extract minus periplasmic extract). Lanes 
1 and 9 represent a Sigma wide range marker, lanes 2-4 represent E. coli InlB native cytoplasmic extract, 
periplasmic extract and native cytoplasmic extract minus the periplasmic fraction, respectively. Lanes 5-7 
represent E. coli p60 native cytoplasmic extract, periplasmic extract and native cytoplasmic extract minus 
the periplasmic fraction, respectively. From the gel it can be seen that both the majority o f the InlB and 
p60 gene products are expressed in the cytoplasm with little or no protein being expressed in the 
periplasm (lanes 3 and 6).
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4.2.6 Sequencing of the cloned InlB andp60 gene sequences
Plasmid DNA containing either the InlB or p60 gene sequence was sent to MWG-Biotech 
(UK) Ltd, for sequencing. Sequencing results, received as linear nucleotide sequences, 
were subsequently translated into amino acid sequences and aligned with the known 
amino acid sequence o f each protein using the ClustalW multiple alignment program (see 
section 2.3.13). Aligned sequences were imported into Genedoc, a  program for the 
manipulation o f aligned sequences, and the similarities compared. Figures 4.10 and 4.11 
show the alignments o f both cloned gene sequences with their known protein sequence. 
Both the p60 and InlB cloned gene sequences show 100% identity with their respective 
sequences provided by Genedoc (X52268 and AJ012346 for the p60 and InlB genes, 
respectively).
4.2.7 Determination o f the optimum IPTG concentration
To determine the optimum IPTG concentration for the expression o f each gene product, a 
series o f time course experiments (section 2.3.7) were performed with various IPTG 
concentrations. Figure 4.12 shows the SDS-PAGE time course gels o f the expression of 
both gene products, induced with various IPTG concentrations. Time course experiments 
were performed with IPTG concentrations o f 1 mM (gels labelled A), 0.5 mM (gels 
labelled B), 0.1 mM (gels labelled C) and 0.5 mM (gels labelled D). A time course 
experiment was also performed with no induction (0 mM IPTG, gel labelled E) as a 
negative control. No expressed p60 nor InlB proteins bands were observed with out the 
induction of IPTG which indicate that E. coli strains, such as XL 10 Gold, harbouring the 
laqF gene, produce sufficient quantities o f the lac repressor protein to prevent undesired 
basal expression o f recombinant proteins. Reducing the IPTG concentration from 1 mM to 
0.05 mM had no significant effect on the expression o f the p60 gene product (Figure 4.12, 
gels A-D). Slight variations in the sonication o f each sample can result in the observation 
of unevenly expressed bands on the same gel. This is evident for example in the p60 gel C 
where the p60 band in lane 4 (expression after 3 hours o f induction) is more concentrated 
than in lane 5 o f the same gel (expression after 4 hours o f induction). Decreasing the IPTG 
concentration from 1 mM to 0.5 mM seemed to reduce the expression o f the InlB gene 
product (gels A-D) with an IPTG concentration o f between 1 and 0.5 mM producing the 
highest level o f expression. Again, it is evident that variation in the InlB protein 
concentration between samples has occurred due to the uneven sonication o f the E. coli 
cell samples (gel B, lanes 5 and 6). Due to the type o f sonicator used, exact replication 
(exact position and dept o f the probe) o f sonication conditions were difficult.
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Figure 4.10: Alignment o f the cloned M B  gene sequence with the M B  gene sequence obtained from 
Genebank (accession number AJ012346). As the M B  gene is approximately 1900 bp (630 amino acids) in 
length the cloned gene sequence had to be sequenced in both directions (MWG-InlB-A) and upon receiving 
the sequencing results a primer designed for the sequencing o f the inner region (MWG-InlB-B). The 
nucleotide sequences received from MWG-Biotech Ltd, UK, were translated into amino acid sequences and 
aligned using the ClustalW program. Aligned sequences were then imported into Genedoc for further 
sequence manipulation. The amino acid sequences highlighted in black show 100% identity in all three 
sequences (overlap o f MWG-InlB-A and MWG-InlB-B sequencing results o f the InlB gene with the 
AJ012346 InlB sequence) and the amino acid sequences highlighted in grey show 100% identity between 
the sequenced cloned DNA and the M B  gene sequence provided by Genebank The GW repeats involved in 
the anchoring o f InlB to the cell membrane are highlighted in yellow. The signal peptide in InlB accounts 
for the first 35 amino acids (not highlighted) and the sequence encoding this peptide was not cloned into E. 
coli. No sequencing results were obtained for the last 5 amino acids o f  the M B  sequences (not 
highlighted) possibly due to the nature o f the primers used for sequencing but these amino acids were 
cloned into E. coli and should be present. Overall the sequencing results obtained from MWG-Biotech 
shows 100% identity with the InlB gene sequence obtainedfrom Genebank.
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Figure 4.11: Alignment o f the cloned p60 gene sequence with the p60 gene sequence obtained from 
Genebank (accession number X52268). As the p60 gene is approximately 1450 bp (484 amino acids) in 
length the cloned gene sequence had to be sequenced in both directions (MWG-p60-A) and upon receiving 
the sequencing results a primer designed for the sequencing o f the inner region (MWG-p60-B). The 
nucleotide sequences received from MWG-Biotech Ltd, UK, were translated into amino acid sequences and 
aligned using the ClustalW program. Aligned sequences were then imported into Genedoc for further 
sequence manipulation. The amino acid sequences highlighted in black show 100% identity in all three 
sequences (overlap o f MWG-p60-A and MWG-p60-B sequencing results o f  the InlB gene with the X52268 
p60 sequence) and the amino acid sequences highlighted in grey show 100% identity between the 
sequenced cloned DNA and the InlB gene sequence provided by Genebank. The signal peptide in p60 
accounts for the first 27 amino acids (not highlighted) and the sequence encoding this peptide was not 
cloned into E. coli. No sequencing results were obtained for the last 6 amino acids o f the p60 sequences 
(not highlighted) possibly due to the nature o f the primers used for sequencing. Overall the sequencing 
results obtained from MWG-Biotech shows 100% identity with the p60 gene sequence obtained from 
Genebank. It should be noted that the only the amino acid sequences are aligned and some silent mutations 
or PCR errors may have occurred at the nucleotide level, which are not seen here.
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Figure 4.12: Effect of 1PTG concentration on the expression of the InlB and p60 gene sequences. 
Gels A-E represent p60 (left) and MB (right) gene products induced with 1 mM, 0.5 mM, 0.1 mM, 
0.05 mM and 0 mMIPTG, respectively. Lanes Mrepresent a Pierce Blue Ranger marker, lanes 1-8 
represent 0, 1, 2, 3, 4, 5, 6 and 22 hours of induction, respectively, while lane 9 was left blank 
(some overflow from the marker may have contaminated this lane). The expected InlB or p60 bands 
are indicated by a red arrow. No p60 nor M B band was observed with no induction indicating that 
the expression of both proteins is tightly controlled (E. coliXLlO Gold contain the lacPgene).
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4.2.8 Purification of the InlB and p60 gene products by IMAC
Proteins containing a 6xHis affinity tag, encoded at either the N  or C terminus, can easily 
be purified by binding to Ni-NTA. The pQE-60 vector used to clone both the InlB and p60 
gene sequences encodes a 6xHis tag at the C terminus o f the recombinant protein. The 
6xHis tag is poorly immunogenic, and at pH 8.0 the tag is small, uncharged, and therefore 
does not generally affect secretion, compartmentalisation, or folding of the fusion protein 
in the cell (QIAgen Ltd, 2000). Nitrilotriacetic acid (NTA) is a tetradentate chelating 
adsorbent that occupies four o f the six ligand binding sites in the coordination sphere of 
the nickel ion, leaving two sites free to interact with the 6xHis tag (Ueda et a l, 2003). The 
high surface concentration of the NTA ligand is sufficient for the binding of 
approximately 5-10 mg o f 6xHis tagged protein per millilitre o f resin (QIAgen Ltd, 2000). 
In general, histidine residues in proteins are relatively rare, amounting to approximately 
only 2% o f the amino acid content o f globular proteins; in addition, only half o f them are 
exposed on the protein surface (Ueda et a l, 2003). However, certain proteins from E. coli, 
namely superoxide dismutase (8 histidines, 195 amino acids), chloramphenicol 
acetyltransferase (12 histidines, 219 amino acids) and heat-shock protein (14 histidines, 
624 amino acids), have been identified, which might bind to IMAC columns depending on 
the conditions used (Muller et al., 1998a). Increasing the ionic strength of buffers can lead 
to suppression o f secondary, electrostatically undesirable interactions while augmenting 
protein binding to chelate complexes. Therefore, for the specific purification of 
recombinant proteins from E. coli by immobilised metal affinity chromatography, 
stringent binding and washing conditions should be used. The running buffer used for the 
purification o f the p60 and InlB proteins consisted o f PBS with 1% (v/v) Tween 20, 500 
mM NaCl and 10 mM p-mercaptoethanol. The addition o f Tween 20 to the buffer reduces 
non-specific hydrophobic interactions, while the addition o f 500 mM NaCl reduces non­
specific ionic interactions and the repulsion o f the positively charged recombinant p60 or 
InlB proteins with the positively charged Ni-NTA resin. The addition o f 10 mM p- 
mercaptoethanol reduces the co-purification of host proteins that may have formed 
disulfide bonds with the protein o f interest during cell lysis.
E. coli cells harbouring a gene insert were induced with ImM  IPTG for 5 hours and the 
recombinant gene products purified as described in section 2.3.9. Figure 4.13 shows a 
typical purification o f both recombinant proteins. Lanes 2-5 show the purification of the 
recombinant p60 protein while lanes 6-9 show the purification o f the recombinant InlB 
protein. From lane 2 the rp60 protein is observed to be over expressed in the E. coli lysate 
and binds to the Ni-NTA column resulting in a decrease in the 60 kDa band observed in
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the flow through (lane 3). Limiting the amount o f resin used to purify a recombinant 
protein reduces the purification o f non-specific or weakly bound proteins by introducing 
competition for binding to the resin. Therefore, to improve the quality o f the purified p60 
product, the amount o f resin used for its purification was kept low which resulted in some 
of the recombinant protein remaining in the flow through fraction (lane 2). The 
recombinant p60-Ni-NTA complex was washed (lane 4) with running buffer (section 
2.3.9) and the protein eluted with sodium acetate buffer, pH 4.5 (lane 5). The histidines 
residues in the 6xHis tag have a pKa o f approximately 6.0 and will become protonated if  
the pH is reduced (pH 4.5-5.3). Under these conditions the 6xHis tagged protein can no 
longer bind to the nickel ions and will dissociate from the Ni-NTA resin. Figure 4.13, 
lanes 5 and 9 show the elution o f the recombinant p60 and InlB protein with sodium 
acetate buffer pH 4.5. The elution of each protein resulted in the presence of a 
concentrated protein band at the expected molecular weight. As the concentration o f 
expressed InlB (lane 6) is lower than that o f expressed p60 protein (lane 2), all the 
expressed InlB protein can bind to the Ni-NTA resin as observed with the loss of the InlB 
protein in the flow through (lane 7). However, as can be seen in lane 3, the concentration 
of p60 protein in the cytoplasmic extract is higher than the binding capacity o f the 1 ml of 
Ni-NTA resin used, and therefore a small amount o f p60 protein is present in the flow 
through. The same volume of resin was used to purify both proteins, so the eluted p60 and 
InlB protein bands are observed to be similar in concentration. The presence o f faint 
unknown contaminating protein bands (which are barely visible on the gel) are probably 
the result o f co-purification o f host protein with the InlB or p60 proteins or the slight non­
specific binding o f host proteins to the resin.
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Figure 4.13: Purification o f the InlB and p60 gene products by immobilised metal affinity chromatography 
(IMAC). E. coli cells harbouring a recombinant gene product were induced with 0.5 mMIPTG for 5 hours 
at 30°C. After 5 hours the cells were centrifuged for 20 minutes at 4000 rpm and the pellets resuspended in 
PBS containing 0.5 M  salt to a volume o f 1/10 the original culture volume and sonicated (section 2.3.9). 
Cell lysates were incubated with a Ni-NTA resin (1/3 the lysate volume) for 1 hour at room temperature 
with constant mixing. The mixture was then centrifuged at 4000 rpm for 5 minutes and the supernatant 
decanted into afresh tube (flow through). The Ni-NTA pellet with bound His tagged protein was washed 3 
times with PBST containing 0.5 M salt and 10 mM f}-mercaptoethanol as described in section 2.3.9. Bound 
His tagged proteins were eluted by incubation with sodium acetate buffer, pH  4.5 and neutralised with 2 M  
Tris. Purified proteins were analysed by SDS-PAGE to determine the purity of the protein and stored at — 
20PC until required. Lanes 1 and 10 represent a Pierce Blue Ranger pre-stained molecular weight marker 
with the 48 and 85 kDa bands indicated. Lanes 2-5 represent E. coli pQE-p60 (pQE-60 plasmid with p60  
gene insert) cell lysate after 5 hours o f induction with IPTG, E. coli pQE-p60 flow through after incubation 
for 1 hour with a Ni-NTA resin, bound p60-Ni-NTA resin washed with PBST and p60 protein eluted with 
pH  4.5, respectively. Lanes 6-9 represent E. coli pQE-InlB (pQE-60 plasmid with InlB gene insert) cell 
lysate after 5 hours o f induction with IPTG, E. coli pQE-InlB flow through after incubation for 1 hour with 
a Ni-NTA resin, bound InlB-Ni-NTA resin washed with PBST and recombinant InlB protein eluted with pH  
4.5, respectively.
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4.2.9 lmmunoreactivity of the recombinant p60 and InlB proteins
To determine the potential use o f the rp60 and rlnlB proteins in an immunoassay for the 
detection o f Listeria monocytogenes or for the production o f anti-p60/InlB protein-specific 
antibodies, the immunoreactivity of each protein with anti -Listeria monocytogenes derived 
antibodies was evaluated. Anti-p60 and anti-InlB monoclonal antibodies were used to 
detect the rp60 and rlnlB proteins by Western blotting, while anti-InlB extract and anti- 
Listeria monocytogenes polyclonal antibodies were used to detect the recombinant 
proteins by ELISA.
Figure 4.14, shows the detection o f the rp60 and rlnlB proteins by Western blotting. E. 
coli lysates harbouring the recombinant proteins were probed with a protein-specific 
monoclonal antibody (lanes 1 and 3) or probed with a monoclonal antibody specific for 
the 6xHis affinity tag (lanes 6 and 7) found at the C terminus o f each protein. Both the 
rp60 and rlnlB proteins could be specifically detected with monoclonal antibodies raised 
against the native form o f the protein indicating that both proteins can be used for the 
generation of protein-specific antibodies. The 6xHis tag o f  each protein was easily 
detected with an anti-His tag-specific monoclonal antibody indicating the tag is not hidden 
in the protein structure and no proteolytic activity has occurred at the C-terminus of the 
protein.
Detection of the recombinant proteins under native conditions was performed by ELISA 
using polyclonal antibodies raised against InlB extract and Listeria monocytogenes cells 
(described in chapter 3). The recombinant p60 protein was successfully detected with the 
anti -Listeria monocytogenes polyclonal antibody in an inhibition ELISA format (Figure 
4.15). Decreasing concentrations o f recombinant p60 protein were incubated with the anti- 
Listeria monocytogenes antibody and added to recombinant p60-coated ELISA plates. 
While the anti -Listeria monocytogenes antibody did recognise the rp60 protein, the 
sensitivity of the curve was not good (limit o f detection o f approximately 3 (xg/ml of 
purified protein) and a specific monoclonal or recombinant antibody should be used in 
development of an immunoassay with the rp60 protein. The recombinant InlB protein was 
detected by sandwich ELISA (Figure 4.16) as described in section 2.3.12. The results 
presented in Figure 4.15 and 4.16 show the immunoreactivity o f the recombinant proteins 
in native conditions and indicate that both proteins can be used in the development o f a 
protein-specific immunoassay or for the generation o f protein-specific antibodies by 
immunisation or by bio-panning a combinatorial antibody library.
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Figure 4.14: Detection o f the recombinant p60 and InIB proteins by Western blotting. E. coli lysates 
containing the recombinant p60 or recombinant InIB proteins were separated by SDS-PAGE and 
transferred to a nitrocellulose membrane as described in section 2.2.7. Lanes 2, 4 and 5 represent a Pierce 
Blue Ranger pre-stained marker with molecular weights indicated. Lane 1 represents the detection o f  
recombinant p60 protein with an anti-p60-specific monoclonal antibody, lane 3 represents the detection o f  
InIB with an anti-InlB-specific monoclonal antibody and lanes 6 and 7 represent the detection o f p60 and 
InIB with an anti-His tag monoclonal antibody (Sigma), respectively. The detection o f  both proteins with 
specific monoclonal antibodies confirms the immunoreactivity o f  the recombinant proteins with antibodies 
specific for the native form o f  each protein. The detection o f the His tag o f each protein confirms that the 
His tag is accessible and no cleavage o f the tag has occurred. The anti-p60 and anti-InlB monoclonal 
antibodies used in this blot were donated by Stephen Hearty, Dublin City University.
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Figure 4.15: Inhibition ELISA for the detection o f recombinant p60 (rp60) with an anti-Listeria 
monocytogenes polyclonal antibody. To determine the immunoreactivity o f the rp60 under native 
conditions and to evaluate its use in ELISA, an inhibition ELISA was developed with the anti-Listeria 
monocytogenes polyclonal antibody discussed in chapter 3. The ELISA plate was coated with 30 fug/ml o f  
purified rp60 and blocked with 5% (w/v) milk marvel. Decreasing concentrations o f purified rp60 were 
incubated with a 1/5000 dilution o f the anti-Listeria monocytogenes antibody for 30 minutes before being 
added to the plate in triplicate. The inhibition curve shows a large decrease in binding with increasing 
competing rp60 concentrations.
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Figure 4.16: Sandwich ELISA for the detection o f recombinant InIB (rlnlB) with an anti-InlB Extract-HRP 
conjugated polyclonal antibody. To determine the immunoreactivity o f the rlnlB under native conditions 
and to evaluate its use in ELISA, a sandwich ELISA was developed with the anti-InlB extract and anti- 
Listeria monocytogenes polyclonal antibodies discussed in chapter 3. An ELISA plate was coated with 30 
fig/ml o f purified anti-InlB extract or anti-Listeria monocytogenes antibody and blocked with 5% (w/v) 
milk Marvel. Decreasing concentrations o f purified rlnlB protein were added to the ELISA plate in 
triplicate and incubatedfor 1 hour as described in section 2.3.12. Bound protein was detected with a 1/100 
dilution o f an anti-InlB extract-HRP-labelled polyclonal antibody (section 2.3.11) and the average o f  
triplicate results plotted. The curves shown represent the capture o f the rlnlB protein with either the anti- 
InIB extract or anti-Listeria monocytogenes antibody and the detection o f bound rlnlB with the HRP- 
conjugated anti-InlB extract polyclonal antibody. The absorbance values shown are the absorbance values 
obtained minus the background values. The result shows the immunoreactivity o f  the rlnlB protein in native 
conditions and indicates that either antibody can be used for the capture o f the rlnlB protein on the surface 
of the ELISA plate.
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4.3 Discussion
The aim of this chapter was to generate sufficient quantities o f recombinant InlB and p60 
proteins for use in the development o f an immunoassay for the detection o f Listeria 
monocytogenes cells and for the selection o f protein-specific recombinant antibodies 
(described later in chapter 5). The InlB and p60 gene sequences were successfully 
amplified from genomic DNA extracted from Listeria monocytogenes cells and the 
optimum annealing temperature determined as shown in Figure 4.2. Fresh amplified PCR 
products were cloned into the TA cloning vector, pCR 2.1 and transformed into E. coli 
INV ctF' cells. Transformants containing amplified PCR products were plated on 2xTY 
agar plates containing X-Gal providing blue-white screening for the identification of 
positive clones (Figure 4.3). Plasmid DNA was extracted from selected clones, digested 
with Ncol and BamHI restriction enzymes and run on an agarose gel (Figure 4.5). The 
InlB and p60 gene sequences were then purified from the gel and ligated into the pQE-60 
vector for the over expression and purification of the recombinant InlB and p60 proteins. 
As described in section 4.2.3, the pQE-60 vector contains an optimised promoter-operator 
element consisting o f a phage T5 promoter (recognised by E. coli RNA polymerase) and 
two lac operator sequences which increase lac repressor binding and ensure efficient 
repression o f the powerful T5 promoter. Each vector also contains a synthetic ribosomal 
binding site for high translation rates, a 6xHis tag (located 3' to the multiple cloning site) 
for convenient detection and purification, strong transcriptional terminators to prevent 
read-through transcription and ensure stability o f the expression product and a p- 
lactamase gene (bla) conferring resistance to ampicillin.
A series o f time course experiments were performed to determine the expression o f the 
InlB and p60 gene products. Figures 4.6 and 4.7 show the expression o f the InlB and p60 
proteins upon induction with 1 mM IPTG. Both proteins were easily expressed in E. coli 
XL 10 Gold cells, with the Listeria monocytogenes extracellular protein, p60 being 
expressed at a significantly higher level. Both proteins were mainly expressed in the 
soluble form with little or no protein forming inclusion bodies (Figure 4.8). By comparing 
cytoplasmic lysates and periplasmic lysates from cells harbouring each protein sequence, 
it was determined that both the InlB and p60 proteins were expressed mainly in cytoplasm 
(Figure 4.9). The cloned InlB and p60 gene sequences were sequenced (section 4.2.6) and 
their amino acid sequences compared with the protein amino acid sequences provided by 
Genebank. Both the InlB and p60 cloned amino acid sequences showed 100% identity 
with the protein sequences provided by Genebank (accession numbers AJ012346 and 
X52268). To evaluate the optimum IPTG concentration for the expression o f the InlB and
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p60 gene products, a  series o f time course experiments were performed with various IPTG 
concentrations. Decreasing the IPTG concentration from 1 mM to 0.05 mM  had no 
significant effect on the expression of the p60 and InlB gene products. W ithout the 
induction o f IPTG, no p60 nor InlB expression was evident, which indicates that E. coli 
strains, such as XL 10 Gold, harbouring the laq lq gene, produce sufficient quantities of the 
lac repressor protein to prevent undesired basal expression o f recombinant proteins.
Stringent binding and washing conditions should be used for the specific purification of 
recombinant proteins from E. coli by immobilised metal affinity chromatography 
(discussed in section 4.2.8). The running buffer used to purify the p60 and InlB proteins 
(section 2.3.9) was designed to reduce non-specific hydrophobic interactions by the 
addition o f 1% (v/v) Tween 20. Non-specific ionic interactions and the repulsion of the 
positively charged recombinant p60 or InlB proteins with the positively charged Ni-NTA 
resin were reduced by the addition o f 500 mM NaCl. The co-purification o f host proteins 
that may have formed disulfide bonds with the protein o f interest during cell lysis was also 
reduced by the addition o f 10 mM p-mercaptoethanol. Figure 4.13 shows the purification 
o f the recombinant p60 and InlB proteins as described in section 2.3.9. Ni-NTA bound 
His-tagged proteins were eluted by reducing the pH to 4.5 and analysed by SDS-PAGE. 
Figure 4.13, lanes 5 and 9 shows the elution o f the recombinant p60 and InlB proteins 
resulting in the presence of concentrated protein bands (representing the rp60 and rlnlB 
proteins) at the expected molecular weights. Overall, the purification o f the recombinant 
proteins by IMAC allowed the one step purification o f each protein to good levels of 
homogeneity without the need for subsequent purification steps.
To evaluate the potential use o f the rp60 and rlnlB proteins in an immunoassay for the 
detection o f Listeria monocytogenes or for the production of anti-p60/InlB protein-specific 
antibodies, the immunoreactivity of each protein with anti -Listeria monocytogenes- 
derived antibodies was determined. Both the rp60 and rlnlB proteins could be specifically 
detected with monoclonal antibodies raised against the native form o f the protein and 
against the 6xHis tag (Figure 4.14), indicating that both proteins can be used for the 
generation o f protein specific antibodies and that the 6xHis tag is not hidden in the protein 
structure or no proteolytic activity has occurred at the C-terminus o f the protein. The 
detection o f both recombinant proteins by ELISA (Figure 4.15 and 4.16) shows the 
immunoreactivity o f the recombinant proteins in native conditions and indicates that both 
proteins can be used in the development o f a protein-specific immunoassay or for the 
generation of protein specific antibodies by immunisation or by bio-panning a 
combinatorial antibody library.
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Overall, cloning, expression and purification o f  the Listeria monocytogenes p60 and InlB 
gene sequences in E. coli using the strategy described in this chapter provides a safe (no 
need to handle live Listeria monocytogenes cells), reliable (correct DNA sequences are 
cloned in E. coli) and convenient (bacterial cells can easily be induce to express 
recombinant proteins with IPTG) method for the production o f high levels o f  recombinant 
protein (18 and 7mg/l for p60 and M B , respectively (see section 4.2.5)) and allows the 
simple one step purification (IMAC) o f desired protein. To my knowledge this is the first 
time that both InlB and p60 have been expressed in E. coli.
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Selection of recombinant scFv antibodies to Listeria
monocytogenes
Chapter 5
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5.1. Introduction
As discussed in chapter 1, the emergence o f recombinant antibody phage display 
technology has transformed the way in which we generate antibodies for the specific 
detection o f a chosen analyte (e.g. Listeria monocytogenes). Engineering antibodies and 
antibody fragments in E. coli, allows modifications to be introduced in the primary 
antibody sequence leading to affinity maturations, generation o f fusion proteins and the 
addition of detection and purification tags. The aim of the work described in this chapter 
was to produce a recombinant single chain Fv fragment antibody specific for Listeria 
monocytogenes cells. The selected antibody would be characterised and used to  develop 
an immunoassay to detect Listeria monocytogenes.
The results presented in this chapter involve the generation o f two antibody libraries 
developed from mice immunised with heat-treated (HT) Listeria monocytogenes cells and 
TnlB protein extract. The selection o f phage-scFv antibodies from these libraries and a 
naive human antibody library donated by Cambridge Antibody Technology Ltd, 
Cambridge, UK, is described and selected antibodies characterised. The chapter is set out 
in four sections describing the production o f murine antibody libraries, bio-panning o f the 
murine antibody libraries against Listeria monocytogenes cells, bio-panning o f a  naive 
human antibody library against Listeria monocytogenes cells and finally, bio-panning of a 
naive human library antibody against Listeria monocytogenes invasion-associated 
proteins, Intemalin B and p60.
Antibody variable domain genes were amplified from RNA extracted from the spleens of 
immunised mice according to the protocols described by Krebber et al. (1997a). 
Amplified antibody variable heavy and light chain genes were assembled by splice 
overlap extension PCR and ligated into a  pAKlOO vector for phage display o f  the scFv 
antibodies. Two murine antibody libraries, produced from RNA taken from mice 
immunised with Listeria monocytogenes cells and from mice immunised with InlB 
extract, were screened against HT -Listeria monocytogenes cells using a process known as 
bio-panning. Six phage-scFv antibodies were selected from the anti-InlB extract library 
and three phage-scFv antibodies selected from the anti-Listeria monocytogenes antibody 
library. The scFv genes from each o f the selected antibodies were sequenced and the 
genes aligned using a multiple alignment program. Antibodies were further evaluated for 
soluble expression and reactivity with other non -Listeria monocytogenes strains of 
bacteria. Each o f the nine selected phage scFv-antibodies failed to express scFv antibody 
in soluble form. Also each of the phage-scFv antibodies was observed to  cross-react with
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bacteria from the genus Listeria and therefore were not further characterised for the 
development o f an immunoassay for the specific detection o f Listeria monocytogenes 
cells.
In search o f a species specific recombinant antibody, a naive human antibody library, first 
described by Vaughan et al. (1996), with a diversity o f 1.4 x 1010 clones, was used to 
select for scFv antibodies with the ability to bind Listeria monocytogenes cells. The 
antibody library was bio-panned with HT-Listeria monocytogenes cells and the scFv 
genes o f each o f the selected antibodies sequenced. The antibodies were also further 
evaluated for soluble expression and reactivity with other non -Listeria monocytogenes 
strains o f bacteria. Four rounds o f bio-panning were performed and two phage-scFv 
antibodies selected. Alignment o f the antibody gene sequences revealed that both 
antibodies were identical. However, this antibody was observed to cross react with non- 
Listeria monocytogenes bacterial cells and did not express as soluble scFv antibody.
In order to refine antibody specificity, the naive human antibody library was also bio­
panned with purified recombinant Intemalin B and p60 invasion-associated proteins. A 
number o f antibodies were selected from the library that recognised the Listeria 
monocytogenes invasion-associated protein, InlB. Further examination o f these antibodies, 
revealed that even though the antibodies recognised InlB, none o f the selected antibodies 
reacted with Listeria monocytogenes cells. Intemalin B is a membrane associated protein 
(see chapter 1 for a description of InlB) which is anchored to the cell surface via a 
glycine-tryptophan rich repeat region. Antibodies, binding to this region would react with 
soluble InlB protein but would not be able to bind Listeria monocytogenes cell-associated 
InlB.
A soluble single chain Fv fragment antibody, capable o f binding both the recombinant and 
native forms o f InlB was used to develop an inhibition ELISA-based immunoassay for the 
indirect detection o f Listeria monocytogenes cells. InlB was extracted from Listeria 
monocytogenes cells and rcacted with E. coli anti-InlB scFv antibody culture supernatant. 
Antibody and InlB extract were subsequently added to recombinant InlB-coated ELISA 
plates, with an increase in binding observed with decreasing InlB extract concentrations. 
Intra- and interday assay variability studies were carried out to determine the 
reproducibility o f the immunoassay developed.
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The Krebber system (Krebber et al., 1997a) described in section 1.13, is designed for the 
reliable cloning o f functional antibody variable domains. This system was used to develop 
scFv antibody libraries from spleen cells of mice immunised with heat-treated Listeria 
monocytogenes cells and InlB extract.
5.2.1 Immunisation o f mice with heat-treated Listeria monocytogenes cells and InlB  
extract
Antibody libraries developed from immunised hosts have a distinct advantage over naive 
antibody libraries in that the hosts immune system is primed towards the antigen of 
interest before the antibody variable genes are extracted. To increase the possibility o f 
selecting high affinity antibodies Balb/c mice were immunised with Listeria 
monocytogenes cells or InlB extract as described in section 2 .4.11. Serum from the tail of 
each mouse was analysed by ELISA (section 2.2.3) and the antibody titres observed 
(Figures 5.1 and 5.2). Serial dilutions of mice antiserum were added to ELISA wells pre­
coated with either heat-treated (HT) Listeria monocytogenes cells or InlB extract and 
detected with a rabbit anti-mouse HRP labelled antibody. Mice A and B immunised with 
InlB extract titred out at approximately 1/50,000 and 1/100,000, respectively, when 
assayed over InlB extract-coated wells (Figure 5.1). Mice A and B immunised with HT- 
Listeria monocytogenes cells both titred out between approximately 1/50,000 and 
1/100,000 (Figure 5.2) when assayed over HT -Listeria monocytogenes-coated wells. 
These serum titrations indicated a sufficient response from the host to isolate splenomic 
mRNA as described in section 2.4.1.2.
5.2.2 Selection o f primers for the amplification o f murine heavy and light chain genes
The primers listed in section 2.4.2.1 were based on the primer set described by Krebber et 
al. (1997a), for assembling mouse scFv fragments in the orientation Vl -(G4S)4-Vh, where 
VL and Vh are the variable light and heavy chain domains, respectively, and (G4S)4 is the 
20 amino acid glycine-serine repeat linker. Assembled mouse scFv fragments are 
compatible with all the pAK vector constructs presented in Figure 1.12. The primer set 
incorporates all mouse VH and V*. and VK sequences collected in the Kabat data base 
(Kabat et al., 1991) and combines some extended primer sets (Kettleborough et al., 1993; 
0rum  et al., 1993 and Zhou etal., 1994).
5.2. Production of murine antibody libraries for the selection o f anti-Listeria
monocytogenes single chain Fv antibodies
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Figure 5.1: Titre of tail bleed serum taken from mice immunised with InlB extract. The serum was 
diluted in PBS and added to wells coated with InlB extract. Bound mouse antibodies were detected 
using a rabbit anti-mouse HRP labelled antibody followed by the addition of OPD substrate. 
Absorbance values were read at 450 nm.
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Figure 5.2: Titre of tail bleed serum taken from mice immunised with heat-treated (IIT) Listeria 
monocytogenes cells. The serum was diluted in PBS and added to wells coated with HT-Listeria 
monocytogenes cells. Bound mouse antibodies were detected using an anti-mouse HRP-labelled 
antibody followed by the addition of OPD substrate. Absorbance values were read at 450 nm.
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5.2.3 Amplification of variable heavy (VIf) and variable Light (VJ antibody domains
Reverse transcription of mouse mRNA to cDNA was carried out as described in section
2.4.1.3 and used as a template for the amplification o f mouse variable heavy and light 
chain genes. The amplified PCR products were electrophoresed on a  1% (w/v) agarose gel 
and the expected bands of 375-402 bp (Figure 5.3) for VL or 386-440 bp (Figure 5.4) for 
VH observed. The variable heavy and light chain fragments were purified from the gel as 
described in section 2.4.2.4.
5.2.4 Assembly o f VH and VL genes by splice by overlap extension (SOE) PCR
Purified VH and VL domains were ligated together by SOE PCR as described in section 
2.4.2.6 producing a 800 bp band (Figures 5.5 and 5.6). PCR amplification with different 
templates and primers has a wide range o f optimal reaction conditions. Proper PCR 
amplification usually requires the determination o f optimal conditions for the 
amplification o f  a desired product. A PCR Optimizer™ kit from Invitrogen was used to 
determine the optimal buffer composition for the SOE PCR. A buffer composition o f 7.5 
mM MgCl2, pH 9.0 (buffer E) was optimal for both SOE PCR reactions (lane 6 in Figures
5.5 and 5.6).
5.2.5 Digestion o f pAKlOO vector and SOE-PCR products formed by linking antibody 
light and heavy chain genes
Gel purified pAKlOO vector and SOE PCR products (section 2.4.2.4) were digested with 
Sfil restriction enzyme as described in section 2.4.2.8 overnight at 50°C. Restricted 
products were again purified from an agarose gel and ligated in the presence o f DNA 
ligase (section 2.4.2.9) at 15°C overnight.
5.2.6 Transformation o f E. coli XLl-Blue competent cells with pAKlOO vector 
containing light and heavy chain genes
High efficiency competent E. coli X Ll-B lue cells (section 2.4.2.10), were used for the 
production o f a recombinant antibody libraries to L. monocytogenes and InlB extract using 
the procedure described in section 2.4.2.11. Ligation reactions o f pAKlOO vector and 
SOE-PCR products were transformed resulting in the production o f  recombinant libraries 
consisting o f approximately 5-6 x 103 transformants each.
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Figure 5.3: Light chain PCR amplification. Rows 1 and 8 are Ikb DNA ladder. Lanes 2-4 are light chain 
DNA bands from mice immunised with HT-L. monocytogenes and Janes 5-7 are light chain DNA bands 
from mice immunised with InlB extract.
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Figure 5.4: Heavy chain PCR amplification. Rows 1 and 9 are Ikb DNA ladder. Lanes 2-4 are heavy chain 
DNA bands from mice immunised with HT-L. monocytogenes cells and lanes 6-8 are heavy chain DNA 
bands from mice immunised with InlB extract.
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Figure 5.5: SOE PCR optimisation o f variable domain DNA from mice immunised with HT-Listeria 
monocytogenes. Lanes 1 and 12 represent a Gibco lkb plus DNA ladder and lanes 2-11 represent 
optimisation buffers A -J (see section 2.4.2.6 for buffer compositions). Buffer E (lane 6, 7.5 mM 
MgCl2, pH  9.0) produced the best product (clear band at 800bp).
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Figure 5.6: SOE PCR optimisation o f  variable domain DNA from mice immunised -with InlB extract. 
Lanes 1 and 12 represent a Gibco lkb plus DNA ladder and lanes 2-11 represent optimisation 
buffers A-J. Buffer E (lane 6, 7.5 mM MgCl2, pH  9.0) produced the best product while buffer A (lane 
1, 7.5nmMMgCl2, pH  8.5) also produced a good 800 bp band.
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5.3. Production of single chain Fv antibodies to Listeria monocytogenes cells
The selection o f scFv antibodies to a given target usually requires the enrichment of 
specific antigen-binding clones by bio-panning and the characterisation o f binders by 
ELISA. This section describes the selection o f phage scFv antibodies to WT-Listeria 
monocytogenes cells, the alignment o f antibody genes and the specificity o f  the antibodies 
for their target, H T-Listeria monocytogenes cells.
5.3.1 Pre-panning selection and screening o f functional scFv sequences to Listeria 
monocytogenes cells and characterisation by ELISA
Ninety five colonies from each library were picked from the library stock plates before 
phage rescue and bio-panning. A phage ELISA (section 2.4.3.6) was carried out with each 
clone chosen and the results recorded (Figure 5.7). Three clones from the anti-InlB extract 
antibody library (clones B l, G9 and B12, Figure 5.7, panel A) and three clones from the 
HT -Listeria monocytogenes antibody library (clones H I, H3 and H l l ,  Figure 5.7, panel 
B) showed binding to the immobilised HI-Listeria monocytogenes cells. Positive clones 
were used to inoculate 5 ml 2xTY media and phage produced overnight at 26°C (section 
2.4.3.1). Phage scFv supernatant from each of the chosen clones were further 
characterised by ELISA using an inhibition format (section 2.2.5). Phage scFv supernatant 
was incubated with decreasing concentrations o f HT -Listeria monocytogenes-cells for 30 
minutes at 37°C and then added to WT-Listeria monocytogenes coated ELISA plate wells. 
Bound phage scFv antibodies were detected with a rabbit anti-bacteriophage Fd antibody 
and the results plotted in Figure 5.8. All three clones selected from the anti-InlB extract 
library (clones B l, G9 and B12) recognised HT -Listeria monocytogenes cells in solution 
(Figure 5.8, panel A) showing a  decrease in normalised absorbance with increasing HT- 
Listeria monocytogenes cell concentrations. The three clones selected from the anti HT- 
Listeria monocytogenes library did not recognise HT -Listeria monocytogenes cells in 
solution and showed no decrease in binding with increasing l¥Y-Listeria monocytogenes 
cell concentrations. Glycerol stocks were made o f each positive clone as described in 
section 2 .4.3.7 and stored at -80°C.
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Figure 5.7: Phage EUSA results from the selection of 95 clones from both the InlB and Listeria 
monocytogenes libraries with immobilised L. monocytogenes cells. Panel (A) represents the results for the 
InlB extract antibody library and panel (B) the results for the Listeria monocytogenes antibody library.
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Figure 5.8: Inhibition ELISA curves from phage-scFv clones selected from both libraries. Clones were 
expressed in 5 ml of 2xTY media overnight at 26°C and incubated with decreasing concentrations of 
heat-treated Listeria monocytogenes cells for 30 minutes. Antibody and cells were then added to 
ELISA plate wells that had being coated with lx l (f cells/ml heat-treated Listeria monocytogenes cells 
and blocked with 5% (w/v) milk marvel. Three clones form the InlB extract library (labelled A) and 
three clones from the Listeria monocytogenes library (labelled B) were assayed. Clones Bl, B12 and 
G9 from the InlB library showed competition with free Listeria monocytogenes cells while clones HI, 
H3 and HI 1 from the Listeria monocytogenes library showed no competition.
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5.3.2 Selection and screening of functional scFv sequences to Listeria monocytogenes 
cells by bio-panning
Prior to bio-panning both antibody libraries against HT-Listeria monocytogenes cells, a 
phage rescue was performed as described in section 2.4.3.1 and phage displaying scFv 
antibodies precipitated using PEG/NaCl (section 2.4.3.2) and resuspended in sterile 
filtered PBS. Rescued phage scFv antibodies were pre-blocked with 2% (w/v) milk marvel 
for 20 minutes before being added to immunotubes coated with lx lO 8 cells/ml HT- 
Listeria monocytogenes cells and blocked with 5% (w/v) milk marvel. Phage scFv 
antibodies were incubated in the immunotubes for 2 hours at room temperature (section
2.4.3.4) and eluted phage scFv antibodies re-infected into E. coli XL-1 blue cells as 
described in section 2.4.3.5. A phage titre was carried out with the re-infected phage scFv 
clones and a titre o f lxlO 4 and 5x l0 3 colony forming units (cfu) observed for the InlB 
extract and HT -Listeria monocytogenes antibody libraries, respectively. Ninety five clones 
from each library were characterised by phage ELISA (Figure 5.9) against immobilised 
HT -Listeria monocytogenes cell-coated plates. Five clones from the anti-InlB extract 
library (clones F I, D3, G7, BIO and H I, Figure 5.9, panel A) and five clones from the 
anti- H T -Listeria monocytogenes cell library (clones D2, D 6, D 8, D l l ,  C6, Figure 5.9, 
panel B) showed binding to immobilised HT -Listeria monocytogenes cells. Phage scFv 
antibodies were produced in 5 ml cultures over night at 26°C from all ten positive clones. 
Overnight phage scFv supernatant from each of the chosen clones were further 
characterised by an inhibition ELISA as described in section 2.2.5. Phage scFv 
supernatant was incubated with decreasing concentrations of YYY-Listeria monocytogenes 
cells for 30 minutes at 37°C and then added to Wl-Listeria monocytogenes-coatcd ELISA 
plate wells. Bound phage scFv antibodies were detected with a rabbit anti-bacteriophage 
Fd antibody and the results plotted in Figure 5.10. Three o f the five clones selected from 
the anti-InlB antibody library (clones D3, G7 and BIO, Figure 5.10, panel A) recognised 
HT -Listeria monocytogenes cells in solution showing a decrease in absorbance with 
increasing HT -Listeria monocytogenes cell concentrations. Clones D 6, D 8 and D l l  from 
the anti -HT-Listeria monocytogenes antibody library also recognised HT -Listeria 
monocytogenes cells in solution showing a decrease in absorbance with increasing HT- 
Listeria monocytogenes cell concentrations (Figure 5.10, panel B). Figure 5.11 shows an 
inhibition ELISA curve o f all nine phage scFv clones selected (3 from section 5.3.1 and 6 
from section 5.3.2) form both antibody libraries.
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Figure 5.9: Phage ELISA results after bio-panning both thelnlB and HT-Listeria monocytogenes libraries 
with HT-Listeria monocytogenes cells. Panel (A) represents the results fo r the M B  extract library and 
panel (B) the results for the Listeria monocytogenes library.
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Figure 5.10: Inhibition ELISA curves from phage-scFv clones selected from both libraries. Clones 
were expressed in 5 ml o f  2xTY media overnight at 26°C and incubated with decreasing 
concentrations o f heat-treated (HT) Listeria monocytogenes cells for 30 minutes. Antibody and cells 
were then added to ELISA plate wells that had been coated with lx l  ( f  cells/ml heat-treated Listeria 
monocytogenes cells and blocked with 5% (w/v) milk marvel. Five clones from the M B  library 
(labelled A) were assayed with three clones, D3, G7 and BIO showing competition with free HT- 
Listeria monocytogenes cells. Five clones from the Listeria monocytogenes library (labelled B) were 
also assayed with three clones, D6, D8 and D l l  showing competition with free HT-Listeria 
monocytogenes cells. Slight competition was observed with the negative clones at high cell numbers 
possibly due to non-specific interference with binding due to the sheer high numbers o f  cells present.
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Figure 5.11: Inhibition ELISA curves o f all nine phage-scFv clones. Each clone was grown in 5 ml 2xTY 
media overnight at 26°C. Phage-scFv supernatant way incubated with decreasing concentrations o f HT- 
Listeria monocytogenes cells for 30 minutes at 37°C. Antibody and cells were added to HT-Listeria 
monocytogenes-coated ELISA plates and bound phage-scFv antibodies detected with rabbit anti­
bacteriophage Fd antibody. Clones InlB B1 (InlB library) and Lm D6 (Listeria monocytogenes library) 
showed the greatest levels o f detection of approximately 1x107 cells/ml.
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5.3.3 Alignment o f phage-scFv gene sequences and determination o f antibody 
complementarity determining regions
Bacterial stocks containing the pAKlOO-scFv gene sequences from the clones selected in 
sections 5.3.1 and 5.3.2 were grown overnight in 5 ml 2xTY containing 1% (w/v) glucose 
and 25 |ag/ml chloramphenicol at 37°C. Plasmid DNA was purified according to section 
(2.4.2.7) and vacuum dried. DNA was sent to MWG-Biotech Ltd, UK, for sequencing. On 
receiving the DNA sequence results, the DNA sequences were translated to amino acid 
sequences using the Expasy translate tool (see section 2.4.3 .8 for web addresses o f 
programs used in this section) and the amino acid sequences pasted into the ClustalW 
program, a tool for multiple alignments. The aligned sequences from ClustalW were 
imported into the Genedoc program, which allows easy manipulation o f sequence 
alignments. Using the Genedoc program identical residues were automatically identified 
and the CDR regions manually highlighted according to  the Kabat scheme for the 
identification o f antibody CDR regions (Figures 5.12 to 5.15).
5.3.3.1 Alignment o f the three clones selected from the InlB extract library prior to bio­
panning
Figure 5.12 shows the alignment of the three scFv clones selected from the anti-InlB 
library described in section 5.3.1. Light chain complementarity determining regions are 
highlighted in red while the heavy chain regions are highlighted in yellow. All three 
sequences show variation in amino acid compositions in both the framework and CDR 
regions. However, it can be clearly seen that there are many highly conserved residues 
(highlighted in black) which are present in all three clones and found throughout both the 
heavy and light chain domains. Each complementarity determining region is flanked on 
both sides by conserved residues (CDR LI flanked by a C and W, CDR L3 flanked by a C 
and FGGG etc.). The complementarity determining regions o f  each clone show huge 
variations from the corresponding regions on the other clones, with the CDR L I and H3 
showing the greatest diversity with respect to identity and length. CDR L I o f clone B12 
consists of 19 residues compared to 14 residues from that o f clone G9. Likewise, the CDR 
H3 of B1 consists o f 13 residues compared to 7 residues from that o f clone B12. There 
appears to be a greater diversity in the light chain framework regions compared to  that 
from the heavy chain framework regions as indicated by the lack o f identical (highlighted 
in black if  present in all three sequences and in grey if  present in two sequences) residues. 
The 20 amino acid linker region (highlighted in black and labelled) allows enough
170
flexibility for both chains to associate to each other (see section 1.15.3 for effects o f linker 
chain length on antibody domain association).
5.3.3.2 Alignment o f the three clones selected from the InlB extract library after bio- 
pannmg
The three scFv clones selected from the anti-InlB library after bio-panning (section 5.3.2) 
are aligned in Figure 5.13. The number of conserved sequences (highlighted in black) is a 
lot higher than that observed in Figure 5.12 indicating a lesser degree of diversity between 
the sequences than that observed from the clones selected prior to bio-panning.
The gene encoding the heavy chain variable domain o f an antibody is made up o f three 
types o f segments, V, D and J where V codes for approximately the first 90 residues, D 
mostly for the CDR 3 region and J for the remaining approximately 15 residues o f the 
variable domain. These segments are randomly assembled (combinatorial joining) in an 
imprecise manner creating additional diversity (junctional diversity). In addition, extra 
nucleotides can be added during the joining procedure providing further diversity. The 
genetic mechanisms underlying the light-chain diversity are similar except that there are 
no D segments, and therefore the diversity of CDR 3 depends largely upon junctional 
diversity generated during V-J joining (Branden and Tooze, 1991). The light chain V 
genes from the antibodies described in this section were amplified by the light chain back 
primers listed in section 2.4.2.1. The light chain forward primers hybridise the J-element 
and encode three repeats o f the Gly4Ser linker. The heavy chain forward primers hybridise 
within the J region and the back primers encode for the V segments and overlap with the 
Gly-Ser linker. The resulting scFv formation is VL-JL-linker-VH-D-JH (Pliickthun et al., 
1996; Kebber et al., 1997). From the alignment in Figure 5.13, it seems that the light 
chains o f the three antibodies have descended from the same original V and J segments as 
clones D3 and BIO show 100% light chain identity and clone G7 only varies in the first 3 
amino acids (may vary more as no results were obtained for the rest of the chain), a 
substitution o f isoleucine for leucine (possibly a base substitution o f an adenine for a 
cytosine during amplification by PCR) and the presence of a stop codon (indicated by the 
dash highlighted in blue). The presence of the stop codon in the light chain o f clone G7 
may have occurred as the result of the substitution o f a thymine for a cytosine in the codon 
sequence (the codons coding for glutamine (Q) are CAA and CAG while two of the stop 
codons are TAA and TAG) or simply may be a sequencing error. A base substitution of 
thymine for guanine could result in valine being translated instead o f glycine as observed 
in the linker region o f clone D3. This also may be an error in the PCR amplification or
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sequencing. The heavy chain framework and CDR regions o f clone G7 differ significantly 
from that o f the other two clones. Clones BIO and D3, already observed to have identical 
light chains, also contain identical heavy chain framework regions 1 and 2 and CDR 1 and 
2 regions. Considerable differences in identity are observed in the last 18 residues o f the 
framework 3 region as well as the CDR 3 and Framework 4 regions. This observation 
indicates that the diversity between these clones is probably due to D and JH segment 
rearrangements, which encode this region o f the heavy chain domain.
5.3.3.3 Alignment o f the three clones selected from the HT-Listeria monocytogenes library 
after bio-panning
The alignment o f the 3 clones selected from the HT-Listeria monocytogenes antibody 
library is shown in Figure 5.14. From the number o f conserved residues highlighted it is 
clear that there is very little diversity between the clones especially in the heavy chain 
region. On further investigation it is observed that clones D 8 and D l l  are actually the 
same clone and show 100% identity throughout both the light and heavy chain domains. 
Clone D6 has an identical heavy chain domain except for 4 amino acid substitutions in 
framework regions 1 (two amino acids), 2 and 3. The substitutions o f a lysine (K) for a 
glutamine (Q) and a  serine for a proline observed in framework regions one and two, 
could be the result o f  a single base substitution or PCR error, underlining the power of 
combinatorial library production in producing random diversity into a family o f conserved 
residues during amplification o f the variable genes. The remaining two substitutions 
observed would involve at least two base changes as the codons encoding for the 
substituted amino acids are quite different from that o f the conserved amino acids at their 
corresponding positions. The heavy chain CDR regions o f all three clones are identical 
which would lead us to believe that the heavy chain antigen binding potential o f all three 
clones is the same. However, binding o f antigen to the one or more o f the CDR regions is 
also depended on the orientation (i.e. folding o f the protein), which can cause a significant 
increase/decrease in binding. Substitution o f a polar amino acid (serine) for a hydrophobic 
amino acid (proline) and a large amino acid (leucine) for a small amino acid (glycine) as 
observed in the framework regions o f clone D 6, can cause a significant change in CDR 
orientation. A glycine residue in the linker o f clone D 6 has been deleted (indicated by the 
dash and not highlighted) but this should have no significant effect on the association of 
the heavy and light chain domains as only 15 residues or more are needed for proper 
domain association. From the alignment and number o f conserved residues, it is obvious 
that there is very little similarity between the light chain o f clone D6 and the two other 
clones. According to the Kabat scheme for identifying CDR regions, the CDR 1 region is
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always preceded by a cysteine, finishes at a tryptophan residue and is usually 10-17 
residues in length. The light chain sequence o f clone D6 does not contain a cysteine 
residue indicating the start o f CDR1 making if  very difficult to determine the exact 
starting point of the region. The length o f the highlighted region (24 residues) is a  lot 
longer than the expected 10-17 residues in the Kabat scheme. However, with alignment of 
an unsure sequence (clone D6) with a greater number o f known sequences (Figure 5.15 or 
the Kabat database) the CDR regions can be determined more accurately (CDR 1 o f clone 
D6 is actually 15 residues in length as observed in Figure 5.15).
5.3.3.4 Alignment o f all nine clones selected from both antibody libraries
On examination o f the aligned light chain sequences in Figure 5.15, it is evident that there 
is an extremely high level o f similarity between the InlB extract library clones D3, BIO, 
G7 and B12 and the YU-Listeria monocytogenes library clones D 8 and D l l  (actually 
same clone as discussed in section 5.3.3.3). Slight differences are observed between the 
six clones in both framework 1 and framework 3 regions. Multiple residue variations are 
observed the framework 1 region with the exception o f the five amino acids preceding the 
CDR 1 region while slight amino acid substitutions are observed in the second framework 
region, most notably the substitution o f an arginine for a cysteine in clones D 8 and D ll .  
The three CDR regions of all six clones show 100% identity except for two residues in the 
CDR 1 o f clone B12 (indicated by white text) that seem to have been the result o f an 
inversion o f a cysteine-glutamine-tyrosine sequence. The apparent high level o f similarity 
o f the light chain genes examined would indicate that they originated from the same V-J 
gene segments. These finding may indicate that there may have been cross contamination 
o f variable genes prior to domain linking by SOE PCR, which could have occurred from 
purifying both sets o f light chains from the same agarose gel (Figure 5.3). Clone B l, D6 
and G9 show significant variation in both the framework and CDR regions. All aligned 
clones show differing degrees o f variability in both framework and CDR regions, 
especially in the regions encoded by the D-JH segments (CDR H3 and Framework 4). 
Clones B 1 and D 6 possess near identical heavy chains which is also unusual as each clone 
was selected from a different antibody library. This may again indicate some level of 
heavy chain cross contamination and also highlights the ability o f PCR to amplify very 
small concentrations o f contaminating DNA. Slight differences in amino acid structures in 
the framework (1, 2 and 3) and especially CDR (CDR H I) regions o f both clones could 
result in both heavy chains having varied antigen binding abilities.
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Figure 5.12: Anti-InlB scFv gene sequences from the first round o f selection (section 5.3.1) were translated 
into amino acid sequences using the Expasy Translate tool and aligned using the ClustalW multiple 
alignment program. Aligned sequences were imported into Genedoc for further manipulation and 
alignment. The sequences highlighted in black show 100% identity in all three gene sequences. The 
sequences highlighted in grey show identity in 2 out o f  the three sequences while sequences highlighted in 
red and yellow show the light and heavy chain complementarity determining regions (CDR), respectively.
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Figure 5.13: Anti-InlB scFv gene sequences from the second round of selection (section 5.3.2) were 
translated into amino acid sequences using the Expasy Translate tool and aligned using the ClustalW 
multiple alignment program. Aligned sequences were imported into Genedoc for further manipulation 
and alignment. The sequences highlighted in black show 100% identity in all three gene sequences. 
The sequences highlighted in grey show identity in 2 out o f the three sequences while sequences 
highlighted in red and yellow show the light and heavy chain complementarity determining regions 
(CDR), respectively.
—  F r a m e w o r k  1 --------------- C D R  H 1 -  F r a m e w o r k  2  -
160  * 180  * 2 0 0
175
List-D8
List-Dll
List-D6
RT
—  F r a m e w o r k  1
41  
38
42
List-D8
List-Dll
List-D6
-  F r a m e w o r k  2  -  - C D R  L 2  - --------------------- F r a m e w o r k  3 -----------
60 * 80 * 100
List-D8
List-Dll
List-D6
List-D8
List-Dll
List-D6
160
■ F r a m e w o r k  1*
.rE SGGG:.VKPGGS 
SC . Ke&SS
100
f ;
I'AASGFTF : 
I'.Ai1.:? GF T F ;
C D R  H I
-NYAMS— 
-NYAMS-- 
- NYAMS—
2 0 0
173
170
171
List-D8
List-Dll
List-D6
C D R  H 2
*  220  
— S IIS G G S T Y Y P D S V —  
— SX ISG G STY Y PD SV —  
S— SIISG G ST Y Y PD SV —
• F r a m e w o r k  3 ------
2 40  *
K ' T - R F T I  i  F:U! :.AF;MK L . Y L ' j ’ ' 3 £  L  F S : 219
K G R S ' T I  .5E D I J A R N I i L Y L g ! : 2 1 6
K G F . F T I S R D r I3SLR-3 :  217
-  C D R  L 3  -  - F r a m e w o r k  4  -  L in k e r  R e g io n  -
* 120 * 140 *
List-D8
List-Dll
List-D6
Figure 5.14: Anti-Listeria monocytogenes scFvgene sequences from the second round o f  selection (section 
5.3.2) were translated into amino acid sequences using the Expasy Translate tool and aligned using the 
ClustalW multiple alignment program. Aligned sequences were imported into Genedoc for farther 
manipulation and alignment. The sequences highlighted in black show 100% identity in all three gene 
sequences. The sequences highlighted in grey show identity in 2 out o f the three sequences while sequences 
highlighted in red and yellow show the light and heavy chain complementarity determining regions (CDR), 
respectively.
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Figure 5.15: All nine scFv gene sequences from both rounds o f selection (section 5.3.1 and 5.3.2). The 
sequences highlighted in black show 100% identity in all three gene sequences. The sequences highlighted 
in dark grey show identity in 7 or more genes and the sequences highlighted in light grey show identity in 5 
or more genes. Sequences highlighted in red and yellow show the light and heavy chain complementarity 
determining regions (CDR), respectively.
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5.3.4 Homology modelling o f scFv sequences using Swiss-Model and Swiss-PDB viewer
The Protein Data Bank, established at Brookhaven National Laboratories (BNL) in 1971, 
is the single worldwide archive o f structural data o f biological macromolecules, which is 
now managed by the Research Collaboratory for Structural Bioinformatics (RCSB) 
(Berman et al., 2000). The Protein Data Bank contains thousands (21,390 structures at the 
time printing) o f protein structures deposited from research groups throughout the world. 
The accumulation o f such a large collection o f protein structural information can enable 
the 3D structure prediction o f most linear polypeptide sequences. Many web-based 
protein-modelling programs (eg. SWISS-Modcl, 3D-JIGSAW etc.) are available without 
charge where the researcher can deposit their desired linear polypeptide sequence for 
modelling. The modelling program performs a blast search against all the sequences in the 
Protein Data Bank and models the linear sequence with the best blast result. The 
researcher receives the modelling result via e-mail as a  PDB (Protein Data Bank) file, 
which can be then viewed using one of the web based PDB viewer programs (e.g. SWISS- 
PDB-Viewer, Rasmol, Protein Explorer etc.).
Figures 5.16 to 5.18 show illustrations o f clone G9 (section 5.3.3.1), which has been 
modelled by SWISS-Model and viewed using the SWISS-PDB-Viewer. In order to 
illustrate the 3D nature of the antigen-binding domain o f the antibody, several views have 
been presented. A side view o f a ribbon representation o f the scFv antibody is given in 
Figure 5.16, Panel A. Both the heavy and light chain variable domains can be clearly seen 
and are linked by the synthetic Gly4Ser repeats introduced by the VL-forward and VH-back 
primers listed in section 2.4.2.1. Beta sheets are illustrated by flattened arrows with the 
arrow pointing towards the C terminus of the polypeptide chain. Both the linker and the 
loop structures are illustrated as solid lines. Each variable domain consists o f nine Beta 
sheets and no helices (as described in section 1.8). The light chain CDR regions are 
highlighted in red and the heavy chain CDR regions in yellow. All CDR regions are 
labelled for easy identification. Figure 5.16, Panel B shows a front view (where the 
antigen would fit right down on the page, like an egg in an egg cup) o f  the antigen-binding 
region. From this view it can be clearly seen that the CDR L3 and H3 from the centre of 
the antigen-binding site and the other CDR regions form a cup shape around the two 
centre sites. Figure 5.17 Panel A shows an enlarged view of the antigen-binding site while 
Figure 5.17, Panel B illustrates a  more realistic space fill view o f  the scFv with CDR 
regions coloured. The space fill model takes into account the amino acid side chain size 
and properties and estimates the Van der Waals interactions between the residues. A 
reverse view of the antigen-binding site (displayed in space fill) is presented in Figure
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5.18. The antibody framework regions are illustrated as ribbon structures for easier chain 
differentiation and orientation. The framework regions act as foundations for the optimal 
orientation o f the CDR regions for the binding o f antigen.
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Figure 5.16: Homology model of the anti-lnlB scFv antibody clone G9. (A) Side view illustration 
of the scFv showing the confirmation of both domains and (B) front view of the antigen-binding 
surface with labelled CDR regions.
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Figure 5.17: Enlarged front view antigen-binding site of the scFv antibody. (A) Ribbon illustration 
of an enlarged view of the antigen-binding site and (B) a space fill model o f the same view taking 
into account side chain orientation and Van der Waal’s forces.
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Figure 5.18: Reverse view of the antigen-binding site presented in Figures 5.17 (A and B). The 
CDR regions are illustrated in space fill form while the framework regions are illustrated in ribbon 
structure. From this view, it can be seen how the framework regions orientate the CDR regions for 
antigen-binding. Mutations leading to amino acid substitutions in the framework regions can 
potentially alter the conformation of the antibody and increase/decrease the antibodies ability to 
bind its antigen. This view also illustrates that many of the residues found in the CDR regions are 
actually buried in the protein structure and not involved in antigen binding.
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5.3.5 Expression of soluble scFv with the pAK400 vector
Subcloning the scFv antibody genes into pAK400 (Figure 1.12) allows the enhanced 
expression o f soluble scFv antibodies. The scFv gene sequences o f the clones selected in 
sections 5.3.1 and 5.3.2, were subcloned into the pAK400 vector by Sfil restriction 
(section 2.4.2.8) o f the pAKlOO vectors carrying scFv genes (Figure 5.19) and 
transformed into the non-suppressor E. coli strain JM83 (section 2.4.2.11). Clones were 
grown in 2xTY media (section 2.4.3.9) and protein expression induced by 1 mM IPTG. 
The supernatant and cytoplasmic extracts o f each clone were assayed by ELISA (section 
2.4.3.10) for determination o f antibody expression. However, subcloning the scFv genes 
into pAK400 did not result in the expression o f  soluble antibody. Varying the expression 
times and temperatures failed to have any effect on solublisation o f the antibodies. A 
number strategies have been reported in the literature for the solublisation o f scFv 
antibodies. Antibodies can be solublised using denaturing buffers such as those containing 
urea or guanidine hydrochloride and refolded by continuous dialysis (Park et al., 2000a) 
or after affinity purification (Casalvilla et al., 1999). Antibody solubility can also be 
increased by the co-expression o f a gene encoding a molecular chaperone protein. 
Hayhurst and Harris, (1999) successfully increased the solubility o f a single chain 
antibody (scAb) by co-expressing the E. coli skp chaperone gene. Hayhurst et al. (2003), 
also used the strategy o f co-expressing the skp chaperone gene with scFv antibodies that 
they produced using the system designed by Krebber et al. (1997a). These authors also 
expressed the antibodies fused to human kappa light chain constant domain with and 
without co-expression skp chaperone gene. It was found that even though co-expressing 
the scFv antibody with the skp gene or expression o f the antibody fused to  a constant 
domain (scAb), increased the levels o f soluble functional antibodies, expression levels 
were still very low. Due to the large signal amplification afforded by the anti-phage 
antibodies against the abundant g8p phage coat protein, phage-displaying scFvs or scAbs 
were still found to be superior ELISA reagents for immunoassays. The purpose o f the 
production o f scFv antibodies to Listeria monocytogenes in this project was for the 
generation o f a  species specific antibody, which could be used, for the detection of 
Listeria monocytogenes by ELISA. Therefore, the tendency of each clone to cross-react 
with other bacterial strains was evaluated (section 5.3.6) before further efforts to solublise 
the antibodies were pursued.
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Figure 5.19: Typical Sfil restriction ofpAKlOO plasmids with scFv gene inserts. The gel shows the 
restriction o f  the pAKlOO vector (4425 bp) containing anti-InlB G9 (lane 1) and B1 (lane 2) scFv 
clones (800 bp). The marker (lane 3) is a Gibco Ikb plus DNA ladder with molecular weights 
indicated. The scFv gene sequences were purified from the gel and ligated into the pAK400 vector 
as described in sections 2.4.2.7 and 2.4,2.9.
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5.3.6 Cross reactivity studies of phage-scFv clones
As discussed in section 5.3.5, the purpose o f the production o f scFv antibodies to Listeria 
monocytogenes in this project was for the generation o f a species-specific antibody, which 
could be used for the detection o f Listeria monocytogenes by ELISA. To evaluate the 
tendency o f each phage-scFv clone to cross-react, each antibody was tested for binding to 
intact Listeria monocytogenes cells, four non-pathogenic strains o f the genus Listeria and 
the phylogenetically-related gram-positive rod, Bacillus subtilis (Vázquez-Boland el al., 
2001). Phage-scFv antibodies were added to ELISA plates coated with 1x10s cells/ml of 
bacterial cells as described in section 2.4.3.11. The absorbance values observed for each 
antibody against the intact cells was recorded as a  percentage o f that observed against 
heat-killed Listeria monocytogenes cells as shown in Table 5.1. Each o f the antibodies 
tested failed to recognise intact Listeria monocytogenes cells to the same degree as heat- 
killed cells. Only clones B1 and B12 showed binding o f greater than 50% of that observed 
for heat-killed cells. Each phage-scFv clone recognised the four non-pathogenic strains of 
the genus Listeria and showed binding equal to or more than that observed to intact 
Listeria monocytogenes 4b. Clone B12 showed greater binding to the four non-pathogenic 
Listeria strains than that observed to heat-treated Listeria monocytogenes. Each phage- 
scFv clone also showed binding to intact B. subtilis cells, which was equal to or greater 
than that observed to intact Listeria monocytogenes cells. From the results presented in 
Table 5.1, solubilising the scFv antibodies will not yield an antibody specific for the 
detection of Listeria monocytogenes. Large naive antibody libraries are available with 
antibody diversities o f greater than 1010 clones that have the potential for generating high 
affinity antibodies that are specific for their target antigen (Vaughan et al., 1996). In 
pursuit o f a species-specific recombinant scFv antibody for the detection o f Listeria 
monocytogenes, a naive human antibody library (described in section 5.1), with an 
antibody diversity o f 1.4 x 1010 clones (Vaughan et a l, 1996), was bio-panned against 
Listeria monocytogenes cells (section 5.4) and purified recombinant Listeria 
monocytogenes invasion-associated proteins, Intcmalin B (InlB) and p60 (section 5.5).
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HT-L.m 4b L. m 4h L. in 6B L. welsh. L. ivan. L. seel B. subtilis
B1 ++++ +++ +++ +++ +++ +++ ++++
G9 ++++ ++ +++ +++ +++ ++ ++++
B12 ++++ +++ +++++ +++++ +++++ +++++ +++
D3 ++++ + +++ ++ +++ ++ ++
BIO ++++ + ++ + ++ ++ +
G7 ++++ + ++ + ++ ++ +
D ll ++++ ++ +++ +++ +++ +++ +++
D8 ++++ ++ +++ +++ +++ +++ +++
D6 ++++ ++ +++++ +++ ++++ +++ ++
Table 5.1: Cross reactivity studies o f  phage-scFv antibodies by ELISA. The binding response 
minus background (wells blocked with milk) was expressed as a percentage o f the binding response 
of each antibody over heat-killed Listeria monocytogenes 4b (HT-L.m 4b). Each antibody was 
tested against intact (not heat killed) Listeria monocytogenes 4b (L. m 4b), intact Listeria innocua 
6B (L. in 6B), intact Listeria welshimeri (L. welsh.), Listeria ivanovii (L. ivan.), Listeria seeligeri 
(L. seel.) and Bacillus subtilis (S. subtilis).
(+) represents 0-24% binding, (++) represents 25-49% binding, (+++) represents 50-74% 
binding, (++ + +) represents 75-100% binding, (+++++) represents >100% binding.
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5.4 Selection of scFv antibodies from a naive human antibody library by bio-panning 
on Nunc immunotubes
A naive human antibody library with a diversity o f 1.4 x 1010 clones (Vaughan et al., 
1996) was donated by Cambridge Antibody Technology Ltd, Cambridge, UK. This 
antibody library was used to select for scFv antibody sequences capable o f binding to 
Listeria monocytogenes cells. Immunotubes were coated with H T -Listeria monocytogenes 
cells and blocked with 5% (w/v) milk marvel as described in section 2.4.4.3. Rescued 
phage displaying scFv particles were added to the immunotube and incubated for 2 hours 
at room temperature. Unbound phage-scFv particles were washed from the tube and phage 
binders eluted as described in section 2.4.4.3. Four rounds o f bio-panning were performed 
against immobilised HT -Listeria monocytogenes cells and a phage ELISA carried out 
from clones selected from rounds 3 and 4 o f bio-panning.
5.4.1 Screening of scFv sequences to Listeria monocytogenes cells by phage ELISA
Ninety-five clones from rounds 3 and 4 o f bio-panning were selected and characterised by 
phage ELISA (Figure 5.20) against immobilised HT-Listeria monocytogenes cell-coated 
ELISA plates. Four clones from the third round o f bio-panning (clones C l l ,  F12, E10 and 
B6) and four clones from the fourth round of bio-panning (G4, F9, D1 and B5) were 
selected and further characterised by inhibition ELISA (Figure 5.21). Phage-scFv 
antibodies from all eight clones were produced in 5 ml cultures over night at 26°C. Phage 
scFv supernatant was incubated with decreasing concentrations o f HT-Listeria 
monocytogenes cells for 30 minutes at 37°C and then added to HT -Listeria monocytogenes 
coated ELISA plate wells as described in section 2.4.4.5. Bound phage scFv antibodies 
were detected with a rabbit anti-bacteriophage Fd antibody and the results plotted in 
Figure 5.21. One of the four clones selected from the third round o f bio-panning (clone 
F12, Figure 5.21, panel A) recognised HT -Listeria monocytogenes cells in solution 
showing a decrease in absorbance with increasing HT -Listeria monocytogenes cell 
concentrations. Clone B5 from the fourth round of bio-panning also recognised HT- 
Listeria monocytogenes cells in solution showing a decrease in absorbance with increasing 
KT-Listeria monocytogenes cell concentrations (Figure 5.21, panel B).
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Figure 5.20: Phage ELISA results after the third and fourth rounds of bio-panning the naive human 
antibody library with HT-Listeria monocytogenes cells. Panel (A) represents the results for the third round 
of selection and panel (B) the results for the fourth round ofselection.
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Figure 5.21: Inhibition ELISA curves from phage-scFv clones selected from both the third and fourth 
rounds of bio-panning. Clones were expressed in 5 ml of 2xTY media overnight at 26’C and incubated 
with decreasing concentrations of heat-treated (HT) Listeria monocytogenes cells for 30 minutes. 
Antibody and cells were then added to ELISA plate wells that had being coated with 1x1 ( f cells/ml 
heat-treated Listeria monocytogenes cells and blocked with 5% (w/v) milk marvel. Clone FI2 from the 
third round of bio-panning (labelled A) and clone B5 from the fourth round of bio-panning showed 
competition with free HT-Listeria monocytogenes cells.
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5.4.2 Determination of antigen specificity of clones F12 and B5 by Western blotting
SDS protein extracts from Listeria monocytogenes 4b cells were prepared as described in 
section 2.4.4 .6 and the extracted proteins separated by SDS-PAGE as outlined in section
2.2.6. The separated proteins were transferred to a nitrocellulose membrane and blocked 
with 5% (w/v) milk marvel solution overnight as discussed in section 2.2.7. The 
nitrocellulose membranes were later probed with the phage-scFv antibody clones F12 and 
B5 (Figure 5.22) and detected with a rabbit anti-bacteriophage Fd antibody. Both phage- 
scFv clones strongly recognised an unknown 38-43 kDa protein band and also produced a 
faint band at approximately 70-80 kDa (Figure 5.22). The identity o f  the 38-43 kDa band 
is currently unknown but it is probable that the faint band found at 70-80 kDa is dimeric 
form o f the unknown protein.
5.4.3 Sequencing and alignment of positive phage-scFv clones
E. coli TGI stocks containing the scFv gene sequences from the clones selected in section
5.4.1 were grown overnight in 5 ml 2xTY containing 1% (w/v) glucose and 100 (J.g/ml 
ampicillin at 37°C. Plasmid DNA was purified according to section (2.4.2.7) and vacuum 
dried. DNA was sent to Kate Duffy at Queens University Belfast, for sequencing. On 
receiving the DNA sequence results, the DNA sequences were translated to amino acid 
sequences using the Expasy translate tool (see section 2.4.3 .8 for web addresses o f 
programs used in this section) and the amino acid sequences were pasted into the 
ClustalW program, a  tool for multiple alignments. The aligned sequences from ClustalW 
were imported into the Genedoc program, for the easy manipulation o f sequence 
alignments. Using the Genedoc program identical residues were automatically identified 
and the CDR regions manually highlighted according to the Kabat scheme for the 
identification o f antibody CDR regions (Figure 5.23). The heavy chain CDR regions are 
highlighted in yellow, the light chain CDR regions in red and the 15 amino acid (5 amino 
acid shorter than the Krebber antibodies shown in section 5.3.3) linker region highlighted 
in dark grey. The polyhistidine tag can be seen at the C terminus o f the light chain region 
(highlighted in green). Upon alignment of both antibodies (clones B5 and F12) it was 
observed that both scFv gene sequences were identical. Therefore, further analysis was 
only carried out with one o f the two antibodies, clone FI 2 .
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Figure 5.22: Western blots o f  clone FI 2 and 135 phage supernatants against Listeria monocytogenes SDS- 
extract. 20 p i o f L  monocytogenes SDS extract (section 2.4.4.6) was analysed by SDS-PAGE gel 
electrophoresis and probed with phage-scFv antibody supernatant by Western blotting. The marker used is 
a Sigma pre-stained marker with molecular weights indicated. Both phage-scFv clones were observed to 
react with ftvo unknown protein bands, a strong 38-43 kDa band and a faint 70-80 kDa.
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Figure 5.23: Alignment ofphage-scFv clones FI 2 and B5 selected from the naive human library against 
Listeria monocytogenes cells. Both clones show 100% identity. Heavy chain CDR regions are highlighted 
in yellow and the light chain regions in red. The 15 amino acid linker region and 6 histidine tag are also 
highlighted.
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The naive human antibody library used to in this section allows the expression o f  soluble 
scFv antibodies without the need for subcloning into an expression vector (see section
1.14). Clone F12 was grown overnight in 2xTY media and soluble scFv antibody 
produced as described in section 2.4.4.9. An anti-fluorescein scFv (clone FITC-E2), first 
described by Vaughan et al. (1996), was donated by Cambridge Antibody Technology and 
used as a positive control in ELISA. A non-competitive ELISA was performed with the 
scFv supernatants and cytoplasmic extracts from both clones to determine the expression 
o f soluble antibody as described in 2.4.3.10. Figure 5.24 shows the binding curves 
observed from the two clones against their respective antigens. The positive clone, clone 
FITC-E2, shows a good response to immobilised FITC-BSA from both antibody 
supernatant and cytoplasmic extract. However, clone F12 supernatant and cytoplasmic 
extract did not yield a measurable signal.
A time course experiment (described in section 2.4.4.11) was carried out with the 
cytoplasmic extract from clone F12 as shown in Figure 5.25. One millilitre aliquots from 
TG I clone F12 cells induced with 1 mM IPTG were taken every hour and centrifuged at 
14,000 rpm for 10 minutes. Cell pellets were resuspended in denaturing buffer (section 
2.4.4.11) and sonicated. Cytoplasmic extracts were electrophoresed by SDS-PAGE and 
the protein bands stained with Coomassie blue as described in section 2.2.6. Clone F12 
scFv bands were observed after 3, 4, and 5 hours of induction but was absent after 20 
hours o f induction indicating that the protein is degraded over time. Figure 5.26 shows a 
W estern blot of clone F12 cytoplasmic extracts probed with an anti-c-myc-HRP-labelled 
monoclonal antibody. ScFv bands can be clearly seen in lanes 1 and 2 (denatured 
cytoplasmic extract at 4 and 5 hours after induction, respectively), corresponding to a size 
o f approximately 29-30 kDa. No band is observed for the denatured extract after 20 hours 
o f induction (lane 3), which corresponds with Figure 5.25. Low levels o f scFv bands were 
observed for native cytoplasmic extracts after 4 and 5 hours o f induction (lanes 7 and 8) 
indicating very low soluble expression of antibody.
5.4.4 Expression of soluble scFv antibodies and characterisation by ELISA and
Western blotting
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1/Antibody dilution
Figure 5.24: Titre o f FI 2 and F1TC-E2 (positive control) supernatant and cytoplasmic extracts. Antibody 
supernatant and cytoplasmic extracts were diluted in PBS and added to ELISA plate wells coated with 
1x10s cells/ml HT-Listeria monocytogenes or 30 pg/ml FITC-BSA. Bound antibodies were detected with an 
anti-c-myc HRP-conjugated monoclonal antibody and absorbance read at 450 nm. The anti-fluorescein 
antibody (clone FITC-E2) produced a good response to immobilised fluorescein-conjugated BSA while 
clone F12 supernatant and cytoplasmic extract did not yield  a response to immobilised HT-Listeria 
monocytogenes cells.
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Figure 5.25: Time course experiment o f  the expression o f scFv antibody from clone FI2. Lanes 2-8 
represent denatured cytoplasmic extracts o f  clone F12 at times 0, 1, 2, 3, 4, 5 and 20 hours after induction 
with 1 mM IPTG as described in section 2.4.4.11. The red arrow indicates the possible scFv bands.
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Figure 5.26: Western Blot o f clone F12 cytoplasmic extract at one-hour intervals. Lane 1, 2 and 3 are 
denatured cytoplasmic extract at time 4, 5 and 20 hours. Lanes 4 and 10 are a Sigma pre-stained marker 
and Lanes 5-9 are native cytoplasmic extracts at time 0, 3, 4, 5, and 20 hours. Panel B shows the blot from 
panel A in black and white for better visualisation o f scFv bands (indicated by the red arrows).
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5.4.5 Evaluation of clone F12 phage-scFv antibodies for use in an Inhibition ELISA
As observed in section 5.4.4, induction of TG I cells containing the F12 scFv gene 
sequence with IPTG, results in the majority o f the antibodies forming inclusion bodies. As 
previously discussed in section 5,3.5, after attempts to increase the soluble expression of 
scFv antibodies, Hayhurst et al. (2003), found that the use o f phage-scFv antibodies 
generated the best binding response in ELISA, probably due to the high copy number of 
the pVIII protein which was detected by the anti-bacteriophage antibody. Phage-scFv 
antibodies were also used to detect Listeria monocytogenes cells in an electrochemical 
immunosensor assay described by Benhar et al. (2001). An inhibition ELISA was 
developed using clone F12 phage-scFv antibodies incubated with decreasing H T -Listeria 
monocytogenes cell concentrations as described in section 2.4.4.5. Phage-scFv antibodies 
were incubated with cell concentrations from 2 x l0 10 to 4 x l0 4 cells/ml as presented in 
Figure 5.27. The inhibition ELISA was repeated using the same phage-scFv antibody 
supernatant over a four-day period. The sensitivity o f the inhibition ELISA decreased 
dramatically overtim e (from approximately 5 x l0 5 cells/ml at Day 1 to 5 -6x l06 cells/ml at 
Day 4) with coefficients o f variance between 12 and 20%. The loss o f sensitivity o f the 
inhibition ELISA is possibly due to the loss o f the scFv antibodies from the surface o f the 
phage. Johns et al. (2000), also reported a loss o f reactivity in ELISA when storing phage 
antibodies for 4 days at 4°C. When analysing fresh phage antibody supernatant and 4 day 
old supernatant by Western blotting, the authors observed almost total cleavage o f the 
scFv antibody from the phage coat protein pill. From this observation and from the loss of 
sensitivity observed in ELISA with the phage-scFv clone F12, the use o f phage-scFv 
antibodies in the development o f a reproducible immunoassay is limited. As described in 
section 5.3.5, refolding o f insoluble inclusion bodies or co-expression o f a molecular 
chaperone protein can help increase the solubility of scFv antibodies. However, when 
assayed against intact cells as described in section 2.4.3.11, clone F12 phage-scFv 
antibodies generated a much decreased signal (over 70% decrease in signal when assayed 
against intact Listeria monocytogenes 4b) and showed no significant increase in reactivity 
to Listeria monocytogenes cells compared to the other bacterial strains tested (Table 5.2).
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Table 5.2: Cross reactivity studies o f phage-scFv clone F12 antibodies by ELISA. The binding 
response minus background (wells blocked with milk) was expressed as a percentage o f the binding 
response o f the antibody over heat-killed Listeria monocytogenes 4b (HT-L.m 4b). The antibody 
was tested against intact (hot heat killed) Listeria monocytogenes 4b (L. m 4b), Listeria innocua 
6B (L. in 6B), Listeria welshimeri (L. welsh.), Listeria ivanovii (L. ivan.), Listeria seeligeri (L. 
seel.) and Bacillus subtilis (S. subtilis).
HT-L.m 4b L. m 4b L. in 6B L. welsh. L. ivan. L. seel B. subtilis
F12 100% 29.0%
_
17.5% 18.4% 20.9% 18% 17.5%
Cell concentration (cells/ml)
Figure 5.27: Interday reproducibility study o f  the anti-HT-Listeria monocytogenes phage-scFv 
antibody clone F12. The antibody supernatant was incubated with decreasing concentrations o f  
HT-Listeria monocytogenes cells as described in section 2.4.4.5. The sensitivity o f the inhibition 
ELISA decreased dramatically over time (from approximately 5x10s cells/ml at Day 1 to 5-6x1 (f  
cells/ml at Day 4) with coefficients o f variance between 12 and 20%. The loss o f  sensitivity of the 
ELISA is possibly due to the loss o f  the scFv antibodies from the surface o f the phage.
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5.5 Selection o f scFv sequences against purified recombinant InlB and p60from a 
naïve human antibody library by bio-panning on Nunc immunotubes
The naïve human antibody library donated by Cambridge Antibody Technology Ltd, 
Cambridge, UK, was used to select for scFv antibody sequences capable o f binding to 
recombinant InlB (rlnlB) and recombinant p60 (rp60). The recombinant proteins were 
purified from E. coli cytoplasmic extracts by immobilised metal affinity chromatography 
(IMAC) as described in section 2.3.9. Immunotubes were coated with 30 |xg/ml o f either 
rlnlB or rp60 protein and blocked with 5% (w/v) milk marvel as described in section 
2.4.4.3. Rescued phage-displaying scFv particles were added to the immunotube and 
incubated for 2 hours at room temperature. Unbound phage-scFv particles were washed 
from the tube and phage binders eluted as described in section 2.4.4.3. Four rounds o f bio­
panning were performed against immobilised recombinant protein and a phage ELISA 
carried out from clones selected from rounds 3 and 4 of bio-panning. Fifteen clones were 
found to react with rlnlB (Table 5.3) and nine clones found to react with rp60 (Table 5.4).
5.5.1 Screening o f supernatant and periplasmic extracts o f selected clones against 
recombinant protein and Listeria monocytogenes cells
As discussed in section 5.4.5, phage-scFv antibodies can be unreliable reagents for the 
development o f a reproducible immunoassay and the selection o f a stable soluble antibody 
is an imperative. The 24 phage-scFv clones selected in Tables 5.3 and 5.4 were expressed 
as soluble scFv antibodies as described in section 2.4.4.9, and screened for reactivity 
against recombinant protein and Listeria monocytogenes cells. Table 5.5 shows the names 
and well positions of each of the clones analysed in Figure 5.28. Only two clones, clones 
G7 and A1 from round 4 of bio-panning against rlnlB, expressed functional scFv 
antibodies in the supernatant. While both clones reacted well with rlnlB, neither clone 
produced a  measurable signal against intact Listeria monocytogenes cells (Figure 5.29, 
panel A). Cytoplasmic extracts from each o f the selected clones were also analysed 
against recombinant protein and Listeria monocytogenes cells (Figure 5.29, panel B). Five 
clones (clone D3 from round 4 o f bio-panning against rp60, clone H I2 from round 3 of 
bio-panning against rlnlB and clones G3, G7 and A1 form round 4 of bio-panning against 
rlnlB) were observed to react with either rp60 or rlnlB . Only one o f the clones, clone D3 
reacted with immobilised Listeria monocytogenes cells as well as protein. In fact, clone 
D3 seemed to react better with immobilised Listeria monocytogenes cells (absorbance of 
1.294) than with immobilised rp60 (absorbance of 0.653), which was unexpected due to 
the high concentration o f immobilised purified recombinant protein. However, with
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further analysis o f this clone, it was observed that the scFv was sticking to the blocking 
solution (milk marvel) and was not actually specific for either rp60 or Listeria 
monocytogenes cells. All four clones (clones G3, G7, H12 and A l)  that recognised 
immobilised rlnlB protein failed to generated a  measurable signal against Listeria 
monocytogenes cells. Clone G7 was observed to react against purified rlnlB protein in 
solution using an inhibition ELISA format (Figure 5.29) and showed good expression of 
scFv antibody in both the supernatant and cytoplasmic extract (Figure 5.28). This clone 
was therefore selected for the development o f an immunoassay to detect InlB protein (and 
therefore indirectly Listeria monocytogenes) as described in section 5.5.2.
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Table 5.3: Number o f clones selected for screening from rounds 3and 4 o f bio-panning against 
recombinant InlB. Out o f 95 clones selected from each round o f  panning 15 clones were positive (5 
from round 3 and 10 from round 4) .
Rounds o f bio­
panning
No. o f clones 
screened
No. o f clones 
positive
3 95 5
4 95 10
Table 5.4: Number o f  clones selected for screening from rounds 3 and 4 o f bio-panning against 
recombinant p60 protein. Out o f  95 clones selected from each round o f  panning 9 clones were 
positive (all nine from round 4).
Rounds of bio­
panning
No. of clones 
screened
No. o f clones 
positive
3 95 0
4 95 9
Table 5.5: Table showing the well positions o f the 24 clones selected from rounds 3 and 4 of 
panning. Each clone was assayed (Figure 5.28) against either rlnlB or rp60 (rows B,C and D) and 
against Listeria monocytogenes cells rows (E, F  and G). The clones highlighted in red were 
selected against rp60 in round 4 o f  panning, the clones highlighted in green and blue were selected 
against rlnlB in rounds 3 and 4 o f panning, respectively. The clone names represent the well 
positions from which they were selected on the phage EIJSA plates.
1 2 3 4 5 6 7 8 9 10 11 12
A - - - - - - - - - - - -
B - A3 E7 C9 G12 H12 G3 B10 C9 A3 - -
C - E1 B9 C6 A10 H10 G7 A12 H12 - - -
I) - C8 E2 D3 A12 - E4 C7 A1 - - -
E - A3 E7 C9 G12 H12 G3 B10 C9 A3 - -
F - E1 B9 C6 A10 H10 G7 A12 H12 - - -
G - C8 E2 D3 A12 - E4 C7 A1 - - -
H - - - - - - - - - - - -
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Figure 5.28: Screening o f selected clone supernatant and cytoplasmic extracts against recombinant 
protein and Listeria monocytogenes cells. Columns B, C and D were coated with either rlnlB or rp60 while 
columns E, F  and G were coated with 1x1 (f  cells/ml intact Listeria monocytogenes cells. Table 5.5 (shown 
previously) shows the names and positions o f each clone assayed in panels A and B..
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Concentration of rlnJB (ng/ml)
Figure 5.29: An inhibition ELISA curve o f done G7 scFv supernatant against decreasing concentrations o f  
rlnlB over wells coated with 20 ng/ml rlnlB. Antibody supernatant was incubated with purified protein for 
30 minutes at 37°C and added to a rlnlB protein coated ELISA in triplicate. The scFv antibody had a limit 
o f  detection o f approximately 300 ng/ml ofpurified recombinant protein.
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5.5.2 Development of an ELISA-based immunoassay for the indirect detection of 
Listeria monocytogenes cells using the anti-InlB clone G7 scFv antibody
Soluble scFv antibodies were generated from the anti-InlB protein clone G7, which 
expressed well in both the culture supernatant and cytoplasmic extract (Figure 5.28). 
Slightly more antibody was secreted into the supernatant than found in the cytoplasmic 
extract, with max antibody production occurring 4-6 hours after induction (Figure 5.30). 
Antibody supernatant was subsequently used in all further analysis o f the antibody due to 
its high concentration o f antibody and ease o f production. To determine the binding 
specificity o f the scFv antibody, E. coli cell lysate containing the recombinant InlB (rlnlB) 
protein and Listeria monocytogenes InlB enriched extract (see section 2.4.4.13) were 
probed with the scFv antibody supernatant by Western blotting. The clone G7 scFv 
supernatant recognised both the recombinant and native forms o f Intemalin B (Figure 
5.31) and generates only a single band when probed against both E. coli cell lysate 
containing the recombinant InlB (rlnlB) protein and L isteria monocytogenes InlB- 
enriched extract.
5.5.3 Intra- and interday studies
Clone G7 scFv antibody supernatant was used to develop an inhibition immunoassay for 
the detection o f InlB protein from Listeria monocytogenes cell protein extracts as 
described in section 2.4.4.14. The assay was performed using eight InlB extract standards, 
assayed in triplicate and repeated over five days. Figure 5.32 shows the average interday 
inhibition ELISA standard curve plotted with a 4 parameter equation using BIAevaluation 
software. To assess the precision o f the assay, the percentage coefficients o f variance, 
standard deviation and percentage accuracy values are presented in Table 5.6 for both the 
inter- and intraday studies. The assay had a linear range o f detection o f between 
approximately 3x106 and 1x10s cells/ml with interday coefficients o f variance of between
3.19 and 7.69%. The percentage accuracies o f the curve ranged from 91.35% to 105.08% 
indicating the 4 parameter function provides an accurate representation o f  the sigmoidal 
relationship between the measured response and the logarithm o f  concentration observed 
for the immunoassay.
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Figure 5.30: Expression o f  ant-InlB scFv antibody (clone G7) in both the cytoplasm and supernatant 
over time. One millilitre samples were taken from the growing culture at one hour intervals and the 
supernatant and cytoplasmic extracts analysed for binding to rlnlB coated ELISA wells. Bound antibody 
was detected using a mouse anti-c-myc-HRP labelled monoclonal antibody.
M  1 2 M  3 4
112 kDa- f  
85 kDa •—  ►
In lB  ► rlnlB -lnlB
f  A.............. 48 kDa  h
^ ------ 32 kDa
I
Figure 5.31: SDS-PAGE and Western blot o f  InlB extract and recombinant InlB using the anti-InlB scFv 
clone G7. Lanes M  represent a Pierce blue Ranger marker with weights indicated. Lanes 1 and 2 show 
InlB extract and rlnlB lysate protein bands, respectively, separated by SDS-PAGE. Lanes 3 and 4 show 
western blots o f  rlnlB lysate and InlB extract, respectively, probed with anti-InlB scFv G7 and detected 
with anti-c-myc-HRP monoclonal antibody.
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Figure 5.32: Inhibition ELISA standard curve for the detection o f  InlB extract using the anti-lnlB 
scFv clone G7. The curve here represents the average values o f  five assays with eight standards 
and each standard assayed in triplicate. The coefficients o f variance, standard deviations and 
percentage accuracies are shown in Table 5.6. The equivalent Listeria monocytogenes cell 
concentrations for each InlB extract dilution was calculated and plotted against the observed 
absorbance values.
Table 5.6: Intra- and interday assay coefficients o f  variation (CVs) and percentage accuracies for  
the anti-lnlB scFv antibody used in the inhibition assay described in section 5.5.3.
INTERDAY INTRADAY
Concentration
(cells/ml)
%
CV
Back-
calculated
concentration.
%
Accuracies
%
CV
Back-
calculated
concentration.
%
Accuracies
1.09 x 10“ 6.08 1.06 x 10“ 102.75 4.05 8.94x10' 118.23
5.47 x 10^ 7.69 5.80x10' 93.90 3.37 5.84x10' 93.24
2.73 x 10' 4.84 2.60 x 10; 105.08 5.33 2.40 x 10' 112.39
1.37 x 107 5.47 1.42 x 107 96.46 5.46 1.46 x 10' 93.06
6.84 x 10* 5.81 6.78 x lO4 100.88 7.28 6.57 x 106 103.96
3.42 x 10° 4.05 3.30 x 106 103.45 5.19 3.40 x 106 100.53
1.71 x 10- 3.19 1.74 x 10s 98.47 6.19 1.77 x 10* 96.31
8.54 x 10i 3.56 9.28 x 10^ 91.35 2.06 9.06 x 105 94.02
n- ’1- ■*i
1 x 1 0 s1 x 1 0 «  1 x 1 0 '  1 x 1 0 *
Equivalent cell concentration (cells/ml)
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5.5.4 Sequencing o f the scFv clone G7 and determination o f the antibody 
complementarity determining regions
Sequencing o f the scFv gene was carried out as described in section 2.4.4.8. The CDR 
regions were determined according to the Kabat scheme for the identification o f antibody 
CDR regions as previously described. Figure 5.33 shows the scFv gene sequence with the 
heavy chain CDR regions highlighted in yellow, the light chain CDR regions highlighted 
in red, the linker region in grey and both affinity tags highlighted in green.
5.5.5 Cross-reactivity studies o f  the scFv
To assess the binding reactivity o f  the scFv antibody clone G7 against non-pathogenic 
strains o f bacteria, cross reactivity studies were performed as described in section 
2.4.4.15. Figure 5.34 shows a  SDS-PAGE gel o f the Tris-Cl protein extracts from each 
bacterial strain examined (Panel A) and a Western blot o f each extract probed with the 
clone G7 scFv antibody supernatant (Panel B). Only one distinct band was observed 
representing binding to the InlB protein, indicating that the scFv antibody supernatant 
does not react with Tris-Cl extracts from the non -Listeria monocytogenes strains tested. 
The clone G7 scFv antibody supernatant was also examined for binding to each extract in 
an inhibition ELISA format as described in section 2.4.4.15. As presented in Table 5.7, the 
scFv antibody supernatant from clone G7 did not react with any o f the strains tested with 
less than four percent cross-reactivity observed from each strain as determined by ELISA.
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------------------F r a m e w o r k  1 -------------------------  C D R H )  — F r a m e w o r k  2 -
* 2 0  * 4 0  * 6
SC FV -G 7 : E VQLVQS GPEVKKPGTSVKVS CNAS GYTF S— N F G IS— WVRQAPGQGLEWMG— W IN P  : 53
C D R H 2   F r a m e w o r k s ----------------- c d r  H 3
0 * 8 0  * 1 0 0  * 1 
s c F v - G 7  : K T G G S N IA Q R L — QGRVTMTRDT SITIVYMDLIGLTSDDTAIYYCAR— T R IG D T Y G S Y  : 10  0
- F r a m e w o r k  4  - —  L i n k e r  R e g i o n  —  F r a m e w o r k  1 ------------
2 0  *  1 4 0  * 1 6 0  *
s c F v - G 7  : YFDY--WGKGT LVTVS S — GGGGSGGGGSGGGGS— QSVLTQPASVSGSPGQSITISC- : 1 6 0
 C D R  L i   — F r a m e w o r k 2 —  - C D R  L 2 -  — F r a m e w o r k 3  —
1 8 0  *  2 0 0  *  2 2 0  *
SCFV-G 7 : —I  GTS S L > V G . ' _ : ' — WYQQHPGKAPKLMIY—  EGSKRPS- -GVSNRF SGSKSGNTAS : 2 1 2
2 4 0  * 2 6 0  -  _ _ _ _ _
s c F v - G 7  : LTISGLQAEDEADYYC— 0SYTTRSTR\!—  FGGGTKLTVLGAAA--HHHHHH(— GAA—  : 2 6 1
C D R  L 3  — — F r a m e w o r k 4 — H is  t a g -  —o fC n
C-MYC TAG -
s c F v -G 7  : EQKLISEEDL : 2 7 1
Figure 5.33: The anti-lnlB scFv antibody(clone G7) amino acid sequence. The framework, regions are 
shown not highlighted while the complementarity determining regions are highlighted in yellow and red 
representing the heavy and light chain CDR regions, respectively. The fifteen amino acid glycine-serine 
repeat linker region is shown highlighted in grey. Antibodies expressed in the pCantabô vector contain a 6 
x histidines tag and a c-myc peptide tag for the purification and detection of the scFv antibody. Both 
affinity tags are shown highlighted in green.
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Figure 5.34: SDS-PAGE and Western blot analysis o f  Tris-Cl protein extracts from various bacteria. 
Panel A shows extracts from L. monocytogenes (lane I), L. innocua 6a (lane 2), L. innocua 6b (lane 3), L. 
ivanovii (lane 4), L. welshimeri (lane 5), L. seeligeri (lane 6), B. subtilis (lane 7) and E. coli (lane 8). Panel 
B shows a western blot o f each extract shown in panel A probed with the anti-lnlB scFv clone G7 and 
detected with anti-c-myc-HRP monoclonal antibody. A Pierce Blue Ranger pre-stained molecular weight 
marker (section 2.2.6) was used (lanes M) and the molecular weights indicated.
Table 5.7: Percentage cross reactivities o f the anti-lnlB scFv antibody with various bacteria using 
the inhibition ELISA format described in section 2.4.4.15.
Organism %  Cross reactivity
L. innocua 6a Neg.
L. innocua 6b 3.52
L. welshimeri 3.79
L. seeligeri 1.62
L. ivanovii Neg.
B. subtilis Neg.
E. coli Neg.
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5.6. Discussion
A detailed description o f the generation o f two antibody libraries developed from the 
spleens o f  mice immunised with heat-treated Listeria monocytogenes cells and InlB 
protein extract is presented in this chapter. Phagc-scFv antibodies selected from both 
murine antibody libraries and a naive human antibody library were characterised by SDS- 
PAGE, W estern blotting and ELISA. Selected scFv antibody genes were sequenced and 
the complementarity determining regions identified.
The method used in section 5.2 to develop scFv antibody libraries from the spleen cells of 
mice, was described by Krebber el al. (1997a). Splenomic mRNA from immunised mice 
with an antibody titre o f over 1/50,000 for their respective immunogens, was isolated and 
used as a  template for cDNA synthesis. Variable domain genes were amplified from the 
cDNA template, by primers incorporating all mouse VH, V*. and VK sequences collected in 
the Kabat data base (Kabat et al., 1991), combined with some additional extended primer 
sets (Kettleborough et al, 1993; 0rum  et al., 1993 and Zhou et al., 1994). Good 
amplification o f variable light and heavy chain genes (Figure 5.3 and 5.4) was achieved 
and single chain Fv fragments were assembled in the orientation V l-(G4S)4-Vh (where VH 
and VL are the variable heavy and light chains domains, respectively, and (G4S)4 is the 20 
amino acid linker region) by a two fragment Splice by Overlap Extension PCR. A PCR 
Optimizer™ kit from Invitrogen was used to determine the optimal buffer composition for 
the SOE PCR. From Figure 5.5 and 5.6. a buffer composition o f 7.5 mM MgCl2, pH 9.0 
(buffer E) was determined to be optimal for both SOE PCR reactions. Purified pAKlOO 
plasmid and SOE PCR product were restricted with the Sfil restriction enzyme allowing 
directional cloning in to the vector. Sfil cuts DNA containing a sequence of 
GGCCNNNNNGGCC where N can be any nucleotide. Krebber et al. (1997a), designed 
the plasmid to contain two different Sfil sites (one site with N  nucleotides which hybridise 
the variable light chain DNA and another site which can hybridise the variable heavy 
chain DNA) allowing the directional cloning o f scFv sequences with a  single enzyme. 
Ligated pAKlOO-scFv gene sequences were originally transformed into Stratagene 
supercompetent E. coli XL-1 Blue cells but less than ten colonies were observed after 
transformation. The transformation efficiency o f supercompetent cells is severely affected 
by changes in temperature and the cells could have been damaged during delivery. High 
efficiency E. coli XL-1 Blue cells were therefore produced as described in section 
2.4.2.10, and two antibody libraries o f approximately 5-6 x 103 transformants produced. 
The size o f the generated antibody libraries were very small with a library size o f between 
106 and 108 transformants expected. However, due to the pre-immunised nature o f the 
splenomic cells, which contain highly specific mRNA for production o f antibodies to
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Listeria monocytogenes cells and InlB extract, low levels o f efficiency may in fact 
produce specific scFv antibodies.
Nine phage-scFv clones, six from the InlB extract library and three from the Listeria 
monocytogenes library were selected that rcacted with HT- Listeria monocytogenes cells 
in ELISA (sections 5.3.1 and 5.3.2). Alignment of the nine clones revealed that two o f the 
clones (clones D8 and D l l )  were actually the same clone, while the diversity between 
each of the remaining clones varied, with a number o f clones showing significant 
similarities. The high degree of similarity between clones selected from two different 
libraries would indicate that there may have been cross contamination o f DNA prior to 
domain linking by SOE PCR. The Polymerase Chain Reaction is a  very sensitive 
technique and the presence o f trace amounts o f contaminating DNA can be easily be 
amplified. A homology model o f one o f the selected clones (clone G9) was produced and 
various views o f the antigen binding domain presented. The homology model illustrated 
the importance of the CDR 3 regions o f the antibody and showed how not all residues of 
the CDR regions are involved in antigen binding. Subcloning the selected scFv genes into 
the pAK400 vector failed to produce soluble scFv antibodies (section 5.3.5). Before 
pursuing the strategies discussed in section 5.3.5 for the solublisation o f scFv antibodies, 
the tendency o f each clone to cross-react with bacterial strains was evaluated in section
5.3.6. Each o f the antibodies tested failed to recognise intact Listeria monocytogenes cells 
to the same degree as heat-killed cells. Also, each phage-scFv clone recognised the four 
non-pathogenic strains o f the genus Listeria and the Gram positive bacterium B. subtilis, 
showing binding equal to or more than that observed to intact Listeria monocytogenes 4b 
cells.
In pursuit of a species-specific recombinant scFv antibody, a naive human antibody 
library, with an antibody diversity o f 1.4 x 1010 clones (Vaughan et al., 1996), was bio­
panned against Listeria monocytogenes cells (section 5.4) and purified recombinant 
Listeria monocytogenes invasion associated proteins, Intemalin B (InlB) and p60 (section 
5.5). Four rounds o f bio-panning were performed with H T -Listeria monocytogenes cells 
and two clones selected that recognised HT -Listeria monocytogenes cells in an inhibition 
ELISA format. Both clones recognised an unknown 38-43 kDa Listeria monocytogenes 
associated protein as observed in Figure 5.22. Sequencing o f the scFv genes sequences 
revealed that both clones were in fact the same clone. The naive human antibody library 
used in section 5.4 allows the expression o f soluble scFv antibodies without the need for 
subcloning into an expression vector. However, induction o f scFv expression with 1 mM 
IPTG failed to generate soluble antibody. A Western blot o f cytoplasmic extracts from the 
scFv clone at various times after induction was performed. Single chain Fv fragment
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bands were observed at 3 and 4 hours after induction in the denatured cytoplasmic extracts 
indicating that the majority o f the scFv gene product is expressed as insoluble inclusion 
bodies. The use of phage-scFv antibodies in the development o f an inhibition 
immunoassay for the detection of HT-Listeria monocytogenes cells was subsequently 
evaluated. Phage-scFv antibodies were incubated with cell concentrations from 2x1010 to 
4x l0 4 cells/ml as presented in Figure 5.27. The ELISA was repeated using the same 
phage-scFv antibody supernatant over a  four-day period and the sensitivity o f the ELISA 
observed to decrease dramatically with time (from approximately 5x10s cells/ml at Day 1 
to 5-6x106 cells/ml at Day 4) with coefficients o f variance between 12 and 20%. The loss 
o f sensitivity o f the inhibition ELISA is thought to be due to the loss o f the scFv 
antibodies from the surface o f the phage, which was also observed by Johns, et al. (2000). 
When assayed against intact cells as described in section 2.4.3.11, clone F12 phage-scFv 
antibodies generated a much decreased signal (over 70% decrease in signal when assayed 
against intact Listeria monocytogenes 4b) and showed no significant increase in reactivity 
to Listeria monocytogenes cells compared to the other bacterial strains tested (Table 5.2).
In order to refine the specificity o f scFv antibodies capable o f reacting with Listeria 
monocytogenes cells, the naive human antibody library was bio-panned with purified 
recombinant InlB (rlnlB) and recombinant p60 (rp60). The recombinant proteins were 
purified from E. coli cytoplasmic extracts by immobilised metal affinity chromatography 
(IMAC) as described in chapter in chapter 4. After 4 rounds o f bio-panning with each 
protein, fifteen clones were selected that reacted with rlnlB (Table 5.3) and nine clones 
selected that reacted with rp60 (Table 5.4). The 24 phage-scFv clones selected were 
expressed as soluble scFv antibodies as described in section 2.4.4.9, and screened for 
reactivity against recombinant protein and Listeria monocytogenes cells. Only two clones, 
clones G7 and A l from round 4 o f bio-panning against rlnlB, expressed functional scFv 
antibodies in the supernatant, while the cytoplasmic extracts o f five clones (clone D3 form 
round 4 o f bio-panning against rp60, clone H12 from round 3 o f bio-panning against rlnlB 
and clones G3, G7 and A l form round 4 o f bio-panning against rlnlB) were observed to 
react with either rp60 or rlnlB protein. Only one o f the clones, clone D3, seemed to react 
with immobilised Listeria monocytogenes cells, however this was later observed to  be 
non-specific binding of the scFv antibody to the blocking solution. Clone G7 was 
observed to react against purified rlnlB protein in solution using an inhibition ELISA 
format (Figure 5.29) and showed good expression o f scFv antibody in both the supernatant 
and cytoplasmic extract (Figure 5.28). Therefore, it was selected for the development of 
an immunoassay to detect InlB protein (and therefore indirectly Listeria monocytogenes) 
as described in section 5.5.2.
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An inhibition immunoassay for the detection of InlB protein from Listeria monocytogenes 
cell Tris-Cl extracts was developed as described in section 2.4.4.14. The assay was plotted 
with a 4 parameter equation using BIAevaluation software and had a linear range of 
detection o f between approximately 3 x l0 6 and 1x10s cells/ml. Interday coefficients of 
variance o f between 3.19 and 7.69% were observed which is well within the 20% limit 
reported by Findlay et al. (2000). The percentage accuracies o f the curve ranged from 
91.35% to 105.08% which indicates that the fitted four parameter equation provides an 
accurate representation o f the sigmoidal relationship between the measured response and 
the logarithm of concentration observed for the immunoassay. These results show that this 
anti-InlB antibody generates an accurate, specific and reproducible assay. Demonstration of 
specificity o f an immunoassay for the antigen of interest is critical as most immunoassays 
are not preceded by extraction o f the antigen from the matrix of interest. To assess the 
binding reactivity o f the scFv antibody clone G7 against non-pathogenic strains of 
bacteria, cross reactivity studies were performed as described in section 2.4.4.15. The 
scFv clone G7 recognised a single band, representing that o f the Listeria monocytogenes 
InlB protein when probed by Western blotting against Tris-Cl extracts from each bacterial 
strain examined. No significant cross reactivity with the tested Tris-Cl extracts was 
observed in ELISA indicating the antibody has the potential to specifically detect Listeria 
monocytogenes cells.
To summarise, two antibody libraries were successfully generated from the spleens o f 
mice immunised with Listeria monocytogenes cells and InlB protein extract. However, the 
small size o f the libraries can reduce the possibility of selecting high affinity soluble scFv 
antibodies to their targets. Phage-scFv antibodies were selected from both murine 
antibody libraries as well as from a naive human antibody library. Isolation of specific 
phage clones does not guarantee that you will get soluble scFv expression, as antibody 
libraries, and in particular immune libraries are riddled with "truncated" clones, some with 
internal amber stop codons or with frameshifts (personal communication with Prof. Itai 
Benhar, Tel-Aviv University, Israel). A soluble scFv antibody was selected from the naive 
human antibody library that recognised the Intemalin B protein. To our knowledge, this 
antibody is the second recombinant anti -Listeria monocytogenes scFv antibody reported in 
the literature (Benhar et al., 2001 reported using a  phage displayed scFv antibody) and 
first anti -Listeria scFv antibody used in soluble form. An inhibition immunoassay was 
developed with the scFv supernatant that had a limit of detection o f approximately 3 x 106 
cells/ml. The immunoassay showed excellent precision with CV values less that 8% and 
showed no significant cross reactivity with the bacterial strains studied.
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Development of a biosensor-based assay for the 
detection of Listeria monocytogenes using surface
plasmon resonance
Chapter 6
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6.1 Introduction
Biosensors offer the potential o f rapid, accurate and sensitive detection o f  analytes (e.g. 
bacteria, proteins and DNA). Surface plasmon resonance biosensors allow the label free 
detection o f biomolecular interactions in “real-time”. The pioneers of SPR-based bio 
sensing were Pharmacia BiosensorAB, now BIAcore AB, who launched the original 
BIAcore system in 1990 (Liedberg et al., 1995). BIAcore’s detection principle relies on 
surfacc plasmon resonance (SPR), an electron charge density wave phenomenon that 
arises at the surface o f a metallic film when light is reflected at the film under certain 
conditions (see section 1.17 for a more detailed description o f SPR). Resonance occurs as 
a result of energy and momentum being transformed from incident photons into surface 
plasmons, and is sensitive to the refractive index of the medium on the opposite side o f the 
film from the reflected light (Anon., 2001). In a typical BIAcore immunoassay, a ligand, 
usually an antibody, is chemically attached to a sensor chip surface, consisting o f a thin 
metal film applied to a  glass surface. When the sensor is exposed to a sample containing 
the specific analyte (e.g. Intemalin B), the binding o f the analyte to the antibody causes a 
change in the angle o f reflected light at the metal surface, which is measured by the 
BIAcore instrument. The size o f the shift is proportional to the quantity o f the analyte in 
the sample.
The work described in this chapter a BIAcore 3000 instrument was used to detect Listeria 
monocytogenes cells in various assay formats. Two polyclonal antibodies, an anti -Listeria 
monocytogenes antibody and an anti-InlB extract antibody (described in chapter 3), were 
used to directly detect Listeria monocytogenes cells while the anti-InlB scFv antibody 
described in chapter 5, was used to detect Listeria monocytogenes InlB extract and, 
therefore, indirectly to detect Listeria monocytogenes cells.
A subtractive inhibition assay was developed to rapidly detect Listeria monocytogenes 
cells in solution using the anti -Listeria monocytogenes polyclonal antibody described in 
chapter 3. Antibody was incubated with various concentrations o f Listeria monocytogenes 
cells and free unbound antibody separated from bound antibody by centrifugation. By 
removing cells and bound antibody from solution with a  stepwise centrifugation step 
(gradually increasing the centrifugation speed in small increments), free unbound antibody 
could be detected by an immobilised anti-Fab antibody on the sensor chip surface. A 
decrease in free antibody concentration was observed with increasing Listeria 
monocytogenes cell concentrations. A calibration curve was constructed by plotting the 
average (n=3) change in response for each Listeria monocytogenes cell concentration
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A polyclonal antibody against InlB extract (also described in chapter 3), was used to 
develop a  direct inhibition assay to accurately dctect Listeria monocytogenes cells in 
solution. Protein G-purified antibody was incubated with various concentrations of 
Listeria monocytogenes cells and subsequently injected over a recombinant InlB 
(described in chapter 4) immobilised CM5 sensor chip surface. A decrease in antibody 
binding response was observed with increasing Listeria monocytogenes cell 
concentrations and a standard curve generated. Intra- and interday assay variability studies 
were carried out to evaluate the precision and reproducibility o f the assay.
An anti-InlB single chain Fv fragment antibody (clone G7 described in section 5.5.2), was 
used to develop an inhibition assay to indirectly detect Listeria monocytogenes. Antibody 
incubated with InlB extract from a known concentration of Listeria monocytogenes cells, 
was injected over a recombinant InlB protein immobilised sensor chip surface. The 
decrease in binding response observed with increasing InlB extract concentrations was 
recorded and standard curve against equivalent Listeria monocytogenes cell numbers 
(equivalent cell numbers at each InlB extract concentration). However, the choice of 
sensor chip used for the assay had to be evaluated as the Intemalin B protein was observed 
to non-specifically bind to the dextran matrix due to the strong electrostatic interactions 
between the negatively charged dextran surface and the cationic protein. It was also 
observed that the InlB protein also non-specifically bound the dextran free flat 
carboxymethylated surface of the BIAcore pioneer C l sensor chip. Nevertheless, the 
observed non-specific binding to the flat carboxymethylated surface o f the C 1 sensor chip 
could be eliminated by over-activation o f the sensor chip surfacc following 
immobilisation o f the recombination InlB with subsequent capping o f unreacted groups 
with 1M ethylene diamine, pH 8.5 (described in section 6.4.1.5). Activation o f the 
carboxymethylated surface under normal conditions (section 2.5.2) usually results in the 
activation o f only 40% of the carboxyl groups on the surface (personal communication 
with John Butler, BIAcore AB, UK.). Over-activation (activation for double the time) of 
the sensor chip surface, followed by capping with ethylene diamine (instead of 
ethanolamine), allows the formation of an amine surface, increasing the overall pH o f  the 
surface.
standard against the known concentration of Listeria monocytogenes cells used in each
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6.2 Indirect detection of Listeria monocytogenes with an anti-Listeria monocytogenes 
polyclonal antibody using a subtractive inhibition assay
The BIAcore biosensor is a commercial biosensor based on the phenomenon o f surface 
plasmon resonance (SPR) (Quinn and O ’Kennedy, 1999). The objective o f this study was 
to develop a new “real-time” subtractive inhibition assay to detect low numbers o f Listeria 
monocytogenes cells in solution using a  BIAcore 3000 biosensor as described in Figure 
6.1. By removing cells and bound antibody from solution with a stepwise centrifugation 
step, free unbound antibody could be detected by an immobilised anti-rabbit Fab antibody 
on the sensor chip surface. A decrease in free antibody concentration was observed with 
increasing Listeria monocytogenes cell concentrations. Removing the cells and bound 
antibody by gradually increasing the centrifugation speed was the key to the success o f the 
experiment. Centrifugation at 3000 rpm without the gradual increase in speed (results not 
shown) seemed to shear the antibodies from the cells, possibly due to the high centrifugal 
forces, resulting in no inhibition o f antibody being observed. Removing cells and antibody 
by centrifugation as shown in this section, is relatively quick, easy and will allow the 
detection o f cells in more complex and viscous matrices which may cause problems for 
other reported methods o f cell removal such as filtration (Haines and Patel, 1995). In this 
section a polyclonal rabbit anti-whole Listeria monocytogenes cell antibody (described in 
chapter 3) was mixed with various concentrations o f heat-killed Listeria monocytogenes 
cells and free antibody detected using a polyclonal goat anti-rabbit Fab antibody 
immobilised on the sensor chip surface.
6.2.1 Preconcentration of the goat anti-rabbit Fab antibody on to the CMS sensor chip 
surface
Low ionic strength buffers, such as 10 mM sodium acetate, allow the electrostatic 
adsorption o f positively charged proteins (proteins in low ionic buffer at a pH below the 
proteins pi) to the negatively charged dextran surface, maximising “preconcentration” of 
protein to the sensor surface for subsequent immobilisation and thus, increasing the 
potential yield of immobilised ligand. To maximise the preconcentration o f the goat anti­
rabbit Fab antibody to the CM dextran surface, 50 fxg/ml o f antibody, diluted in 10 mM 
sodium acetate buffer at various pH increments (Figure 6.2) were injected over a  blank 
CM dextran surface and the degree o f preconcentration recorded. From Figure 6.2, 
optimal antibody preconcentration was observed in sodium acetate buffer, pH 4.3, which 
was used for all subsequent immobilisations o f the goat anti-rabbit Fab antibody.
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Figure 6.1: Illustration o f the subtractive inhibition assay used to indirectly detect Listeria monocytogenes 
cells using a BIAcore 3000 instrument.
(A) Various concentrations of Listeria monocytogenes cells are incubated with an cmti-Listeria 
monocytogenes antibody for twenty minutes as described in section 2.5.4.
(B) Cells and cell bound antibodies are separated from unbound antibody by centrifugation in a stepwise 
manner, gradually increasing the centrifugation speed at one minute intervals.
(C) Unbound antibody (supernatant) is carefully removed and later detected using a goat anti-rabbit Fab 
antibody immobilised on a BIAcore CM5 sensor surface (panel F).
(D) A goat anti-rabbit Fab antibody is immobilised on the surface of a CMS chip as described in section 
2.5.2.
(E) The surface regeneration conditions are optimised and the surface binding capacity determined for a 
number ofbinding-regeneration cycles.
(F) Antibody supernatants from (C) above are passed over the anti-Fab immobilised surface and the 
response observed.
(G) A sensorgram of increasing free antibody concentrations with decreasing Listeria monocytogenes cell 
numbers is observed and a standard curve plotted.
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Figure 6.2: Typical preconcentration of the goat anti-rabbit Fab antibody to the CM-dextran sensor chip 
surface. Solutions o f 50 pg/ml o f antibody in 10 mM sodium acetate buffer at various pH increments 
(indicated on the sensorgram shown here) were passed over an inactivated CM-dextran surface at 10 
fj/minute for a period of 2 minutes. The low ionic strength o f the acetate buffer favours the electrostatic 
attraction between the negatively charged dextran layer and the positively charged protein (i.e. below its 
isoelectric point). The degree ofpreconcentration was measured from the response prior to the end of each 
sample injection with the ionic strength of the HBS running buffer (150 mM) sufficient for the removal of 
electrostatically attracted antibody jrom the surface. The optimal pH for the immobilisation o f the anti­
rabbit Fab antibody onto the CM-dextran chip surface was observed to be pH 4.3.
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6.2.2 Immobilisation of antibody on to the CM dextran sensor chip surface
Immobilisation o f ligand to a CM5 sensor chip surface involves activation o f the surface, 
followed by ligand prcconcentration/immobilisation and finally, surface deactivation. 
Even though there are a wide variety o f immobilisation chemistries available for the 
coupling of ligands to the CM dextran surface, depending on the residues available for 
coupling, the most commonly employed strategy is the use o f EDC (N-ethyl-N1- 
(dimethylaminopropyl)carbodiimide) and NHS (N-hydroxysuccinimide) chemistry. Using 
the carbodiimide EDC, the CM dextran carboxyl groups can be transformed into active 
ester functional groups in the presence o f NHS. The surface NHS esters can then react 
with suitable amino groups in the protein and the surface deactivated or “capped” by the 
injection of 1M ethanolamine hydrochloride (pH 8.5), which also serves to remove non- 
covalently bound protein by reducing the electrostatic attraction between the protein and 
the CM-dextran.
Immobilisation of the goat anti-rabbit Fab antibody to the dextran surface was performed 
as described in section 2.5.2. 50 fag/ml o f goat anti-rabbit Fab antibody, diluted in sodium 
acetate buffer, pH 4.3, was injected over the EDC/NHS activated sensor chip surface for 
45 minutes at 5 [il/minute. Unreacted sites were blocked with a 7 minute injection o f 1M 
ethanolamine hydrochloride (pH 8.5) at 5 [il/minute. Approximately 23,000 RU of 
antibody was immobilised on the surface (Figure 6.3).
To assess the non-specific binding of the anti -Listeria monocytogenes polyclonal antibody 
to the CM dextran surface, antibody was sequentially injected over the immobilised anti­
rabbit Fab antibody surface and a  blank CM-dextran surface (Figure 6.4) and the change 
in response following injection recorded. Injection o f anti -Listeria monocytogenes 
polyclonal antibody over both surfaces resulted in approximately 900 response units of 
binding to immobilised anti-Fab surface while negligible binding was observed to the 
blank surface.
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Figure 6.3: Typical immobilisation o f  the goat anti-rabbit Fab antibody onto a CM dextran chip surface.
(1) HBS buffer is initially passed over the sensor chip surface and the baseline response recorded.
(2) The CM dextran surface is then activated with 0.05 M  NHS/0.2 M E D C  mixture resulting in a large 
increase in SPR signal due primarily to a bulk refractive index change.
(3) HBS buffer is again passed over the now activated surface and a small increase in the baseline is 
observed.
(4) A 50 fJg/ml solution o f antibody diluted in 10 mM sodium acetate buffer, pH  4.3, is then passed over 
the activated surface for a period o f 45 minutes.
(5) HBS buffer is again passed over the surface and the amount o f  bound ligand recorded.
(6) Deactivation o f  the surface NHS-esters is performed by injecting 1M ethanolamine, pH  8.5 over the
surface for 7 minutes, which also serves to elute non-covalently bound antibody.
(7) Approximately 23,000 RU o f goat anti-rabbit Fab antibody remain bound to the surface after the
immobilisation procedure.
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Figure 6.4: Overlays plot showing the simultaneous injection o f the anti-Listeria monocytogenes polyclonal 
antibody over a goat anti-rabbit Fab antibody immobilised surface (—) and a blank CM dextran surface 
(—). Protein G affinity- purified anti-Listeria monocytogenes antibody (1/300 dilution) was simultaneously 
injected over an anti-rabbit Fab antibody> surface and a blank CM dextran surface for 2 minutes at 10 
/M/minute. No significant binding to the blank surface was observed while approximately 900 RU  o f  anti- 
Listeria monocytogenes antibod}' was captured on the immobilised anti-rabbit Fab surface. Bound 
antibody could be dissociated with a 30 second pulse o f  20 mM NaOH and the baseline restored with the 
injection o f FIBS running buffer over the surface.
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6.2.3 Regeneration studies of the immobilised anti-Fab antibody surface
Regeneration conditions affect the performance and life-time o f the sensor chip surface 
and therefore optimum regeneration is essential for the analysis o f large numbers of 
samples, to evaluate the reproducibility o f each measurement and to reduce the cost of the 
assay. The binding capacity of the anti-rabbit Fab antibody immobilised surface was 
determined by a series o f binding and surface regeneration sequences to assess at which 
point the binding capacity deviated outside the desired performance range o f <20% 
suggested by W ong et al. (1997). Protein G affinity-purified anti -Listeria monocytogenes 
antibody was injected over the immobilised antibody surface for 90 seconds at 10 
fil/minute and the surface regenerated with 30 seconds pulses of 20 mM HC1 and 20 mM 
NaOH. The binding-regeneration cycles were repeated for 60 cycles resulting in less than 
13% decrease in binding capacity from the first to the last cycle studied (Figure 6.5). The 
immobilised anti-Fab surface studied in this section went through over 100 binding cycles 
over a two week period before a significant (<20% original binding capacity) decrease in 
binding capacity was observed.
6.2.4 Development of a subtractive inhibition assay for the detection of Listeria 
monocytogenes cells
To determine the working range of the inhibition assay, serial dilutions o f Listeria 
monocytogenes cells in PBS were incubated with the anti -Listeria monocytogenes 
polyclonal antibody as described in section 2.5.4. The samples containing unbound 
antibody (stepwise centrifugation supernatant) were then passed over the surface of the 
sensor chip immobilised with the goat anti-rabbit Fab antibody in random order, followed 
by regeneration o f the surface using a 30 second pulses o f 20 mM HC1 and 20 mM NaOH. 
A typical overlay plot demonstrating the decrease in binding of the anti -Listeria 
monocytogenes polyclonal antibody to the immobilised anti-Fab antibody surface with 
increasing Listeria monocytogenes cell concentrations is presented in Figure 6.6. A 
calibration curve was constructed by plotting the average (n=3) change in response for 
each Listeria monocytogenes cell standard against the known concentration o f Listeria 
monocytogenes cells used in each run. The range o f detection for the anti -Listeria 
monocytogenes antibody was found to be between 1 x 108 and 1 x 106 cells/ml (Figure 
6.7).
In order to determine the accuracy and the intermediate precision o f the subtractive 
BIAcore Inhibition immunoassay, intra- and interday assay variability studies were
2 2 2
performed. Three sets o f standards were prepared and incubated with antibody before 
being assayed. The results obtained from intra- and interday assay studies are shown in 
Table 6.1. The coefficients o f variation (CV's) were determined to assess the precision o f 
the analytical method, expressing standard deviation as a percent function o f the mean.
These values ranged from 0.59 to 4.80% and 0.14 to 4.00% as observed for the intra- and 
interday studies, respectively, indicating that the assay had a very good degree o f 
precision. The percentage accuracies values obtained in the linear part o f the interday 
assay (Table 6.1) indicate the fitted four parameter curve provides an accurate 
representation of the measured response in the linear range o f  the assay (percentage 
accuracy values from 92 to 108%).
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Figure 6.5: Regeneration study o f  the binding capacity o f the immobilised anti-Fab antibody surface. A 90 
second injection o f 10 pg/ml Protein G affinity-purified anti-Listeria monocytogenes polyclonal antibody 
was passed over the immobilised anti-rabbit Fab antibody sensor surface and bound antibody regenerated 
with a 30 second pulse o f 20 mM HCl followed by a 30 second pulse o f 20 mM NaOH. The binding- 
regeneration cycle was repeated for 60 cycles and the degree o f  binding plotted as shown. The binding 
capacity decreased by 13% from the first binding-regeneration cycle to the last cycle studies (cycle 60) 
which is within the limit o f <20% suggested by Wong et al. (1997).
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Figure 6.6: Overlay plot demonstrating the decrease in binding of affinity purified anti-Listeria 
monocytogenes polyclonal antibod)/ to the immobilised anti-Fab antibody surface with increasing Listeria 
monocytogenes cell concentrations. (A) shows the normalised baselines o f each sensorgram when HBS is 
injected over the sensor chip surface, (B) shows the binding of increasing jree antibody with decreasing 
Listeria monocy>togenes cel! concentrations, while (C) shows the base line shift when buffer is passed over 
the surface after each sample injection. The concentration of Listeria monocytogenes cells used in each 
binding cycle is indicated beside each sensorgram.
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Figure 6.7: Interday assay calibration curve for the anti-Listeria monocytogenes antibody. A 1/250 
dilution of the anti-Listeria monocytogenes antibody was incubated with various Listeria 
monocytogenes cell concentrations and unbound antibody injected over an immobilised anti-rabbit 
Fab antibody surface as described in section 2.5.4 .A  4-parameter equation was fitted to the data 
set using BIAevaluation 3.1 software. The inter-assay means and coefficients of variation are 
tabulated in Table 6.1. Each point on the curve is the mean of three replicate measurements 
analysed over three days.
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Table 6.1: Intra- and interday assay coefficients o f variation (CV's) and percentage accuracies for 
the anti-Listeria monocytogenes polyclonal antibody used in the subtractive inhibition assay 
described in section 2.5.4. Coefficients o f variance (a quantitative measure o f precision) was 
calculated using the equation % CV= (S.D./Mean) x 100 where for intraday studies, the standard 
deviation (S.D.) is computed from replicate (3 replicates) analyses within a single validation run 
and for intermediate precision (interday), the S.D. is computed from replicate (3 replicates) 
analyses over 3 validation runs on 3 separate days. The rows with a “ represent that no value 
could be obtained as the data point did not fit the calibration curve.
Intraday Interday
Concentration
(cells/ml)
Back-
calculated
concentration
(cells/ml)
CV's
%
%
Accuracies
Back-
calculated
concentration
(cells/ml)
CV's
%
%
Accuracies
1 x 1010 1.29 xlO9 1.60 187 4.23 x 109 4.00 158
lx l O 9 - 0.59 - 1.12 x 1010 0.14 -
1 x 10* 9.36 xlO7 1.18 106 9.73 x 107 2.49 103
5 x 107 4.85 x 107 0.89 103 4.61 xlO7 2.79 108
lx 107 9.17 xlO6 3.53 108 1.02 x 107 0.18 98
5 x 106 6.44 x 106 1.01 71 5.41 x 10s 2.63 92
l x l O 6 2.57 x 105 4.80 174 4.52 x 10s 1.50 155
1x10s 3.30 xlO4 3.52 167 2.10 x 105 2.74 -
1x10“ 4.06 x 105 1.42 - 2.19 xlO5 3.26 -
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6.3 Direct detection o f Listeria monocytogenes with an anti-InlB extract polyclonal 
antibody
The polyclonal anti-InlB extract antibody presented in chapter 3 was also used in the 
development o f BIAcore inhibition assay (Figure 6 .8) to  detect Listeria monocytogenes 
cells as described in section 2.5.5. Immobilised metal affinity chromatography (IMAC)- 
purified recombinant Intemalin B (InlB) protein (described in chapter 4) was immobilised 
on the a CMS sensor chip surfacc (section 6.3.2) and protein G-purified anti-InlB extract 
antibody, incubated with decreasing concentrations o f H T -Listeria monocytogenes cells, 
injected over the surfacc. The shift in binding response after each injection was recorded 
and the results presented in section 6.3.4.
6.3.1 Preconcentration of the purified recombinant InlB protein on to the CM dextran 
sensor chip surface
As described in section 6.2.1, low ionic strength buffers, such as 10 mM sodium acetate, 
allow the electrostatic adsorption o f positively charged proteins to the negatively charged 
CM dextran CM5 sensor chip surface. To determine the degree o f preconcentration of 
purified recombinant InlB protein to the sensor chip surface prior to immobilisation, 50 
fig/ml o f recombinant InlB protein diluted in sodium acetate buffer (pH 3.9 to 5.0) was 
injected over a blank CM5 sensor chip surface and the degree o f binding recorded. 
However, due to the high isoelectric point o f the InlB protein (pi -10.2) the protein has an 
overall positive charge in the BIAcore running buffer (HBS buffer, pH 7.4, containing 10 
mM HEPES, 150 mM NaCl, 3.4 M EDTA, and 0.05% (v/v) Tween 20) and does not 
dissociate from the sensor chip surface. Figure 6.9 shows a sensorgram o f  the 
preconcentration o f the recombinant InlB protein diluted in 10 mM sodium acetate buffer, 
pH 4.6, to a blank CM5 sensor chip surface. From the sensorgram it can be seen that after 
a 30 second injection of recombinant InlB protein in sodium acetate buffer, pH 4.6, 
approximately 16,000 RU of protein is electrostatically bound to the sensor chip surface 
(labelled B on the sensorgram). After an eight minute injection o f HBS buffer over the 
surface (labelled C on the sensorgram) approximately 12,000 RU of protein still remains 
electrostatically bound to the CM dextran surface which is only removed by the injection 
of 20 mM NaOH (labelled D on the sensorgram). Due to the very high electrostatic 
binding observed in Figure 6.9, subsequent immobilisations were performed in sodium 
acetate buffer pH 4.6 without further evaluation of preconcentration at different pH 
increments.
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Figure 6.8: Illustration o f  the BIAcore inhibition assay used to detect Listeria monocytogenes cells with 
the polyclonal anti-InlB extract antibody.
(A) Purified recombinant InlB (rlnlB) protein is immobilised on the surface o f a CMS chip as described in 
section 2.5.2.
(B) The surface regeneration conditions are optimised and the surface binding capacity determined for a 
number ofbinding-regeneration cycles.
(C) Various concentrations o f Listeria monocytogenes cells are incubated with an anti-InlB extract 
antibody for twenty minutes as described in section 2.5.5.
(D) Antibody and cells from (C) above are passed over the rlnlB immobilised surface and the response 
observed.
(E) A sensorgram o f increasing free antibody concentrations with decreasing Listeria monocytogenes cell 
numbers is observed and a standard curve plotted.
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Figure 6.9: Sensorgram representing the preconcentration of purified recombinant InlB protein on to a 
blank CM dextran sensor surface.
(A) Sensorgram baseline with running buffer (HBS buffer) injected over a blank surface.
(B) 30 second injection of SO /Jg/ml recombinant MB protein in sodium acetate buffer. pH 4.6.
(C) 8 minute injection of HBS running buffer over the blank surface.
(D) Dissociation o f electrostatically bound recombinant InlB protein by the injection with 20 mM NaOII.
(E) Injection of HBS running buffer over the surface returns the baseline to its original value.
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6.3.2 Immobilisation of the recombinant InlB protein on to the CM dextran sensor chip 
surface
Purified recombinant InlB protein was immobilised onto the CM dextran surface of a 
CM5 sensor chip as described in section 2.5.2. 50 fig/ml o f affinity-purified recombinant 
InlB protein, diluted in sodium acetate buffer, pH 4.6, was injected over the EDC/NHS 
activated sensor chip surface for 45 minutes at 5 fil/minute. Unreacted sites were blocked 
with a 7 minute injection of 1M ethanolamine hydrochloride (pH 8.5) at a rate o f 5 
fil/minute. Approximately 10,000 RU o f recombinant InlB was successfully immobilised 
on the surface as shown in Figure 6.10.
6.3.3 Regeneration studies of a rlnlB immobilised surface with a polyclonal anti-InlB 
antibody
The binding capacity o f the recombinant InlB immobilised surface was determined by a 
series of binding and surface regeneration sequences to assess at which point the binding 
capacity deviated outside the desired performance range o f <20% suggested by Wong et 
al. (1997). Protein G affinity-purified anti-InlB extract antibody was injected over the 
immobilised recombinant InlB surface for 2 minutes at 10 (j,l/minute and the surfacc 
regenerated with a 30 second pulse o f 20 mM NaOH. The binding-regeneration cycles 
were repeated for 45 cycles resulting in less than 2% decrease in binding capacity from 
the first to the last cycle studied (Figure 6.11). The immobilised recombinant InlB surfacc 
studied in this section went through over 200 binding cycles over a one month period 
before a significant (<20% original binding capacity) decrease in binding capacity was 
observed.
6.3.4 Development of a BIAcore inhibition assay for the detection of Listeria
monocytogenes
As described in Figure 6.11, the first injection of antibody in each cycle resulted in a 
decrease in observed binding response and therefore an inhibition assay was developed by 
discarding the first value in each cycle and taking an average o f the remaining three 
replicates. To determine the working range o f  the inhibition assay, serial dilutions of 
Listeria monocytogenes cells in PBS were incubated with the anti-InlB extract polyclonal 
antibody as described in section 2.5.5. The samples containing antibody and Listeria 
monocytogenes cells were passed over the surface of the sensor chip immobilised with 
purified recombinant InlB protein in random order and the binding response recorded.
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Surface bound antibody was regenerated from the surface using a 30 second pulse of 
20 mM NaOH. A typical overlay plot demonstrating the decrease in binding o f the anti- 
InlB polyclonal antibody to the immobilised recombinant InlB surface with increasing 
Listeria monocytogenes cell concentrations is presented in Figure 6.12. A calibration 
curve was constructed by plotting the average (n=3) change in response for each Listeria 
monocytogenes cell standard against the known concentration o f Listeria monocytogenes 
cells used in each run. The range o f detection for the anti-InlB extract antibody was found 
to be between approximately 1 x 108 and 2 x  105 cells/ml (Figure 6.13).
In order to determine the accuracy and the intermediate precision o f the presented 
BIAcore inhibition immunoassay, intra- and interday assay variability studies were 
performed. Three sets of standards were prepared and incubated with antibody before 
being assayed. The results obtained from intra- and interday assay studies are shown in 
Table 6.2. The coefficients o f variation (CV's) were determined to assess the precision of 
the analytical method, expressing standard deviation as a percent function o f the mean. 
These values ranged from 0.53 to 4.55% and 2.98 to 7.70% as observed for the intra- and 
interday studies, respectively, indicating that the assay had a very good degree of 
precision. The percentage accuracies values obtained in the linear part of the interday 
assay (Table 6.2) indicate the fitted four parameter curve provides an accurate 
representation o f the measured response in the linear range o f the assay (percentage 
accuracy values from 93 to 108%).
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Figure 6.10: Sensorgram showing the immobilisation o f  recombinant InlB protein to a CM5 sensor chip 
surface.
(A) HBS buffer is initially passed over the sensor chip surface and the baseline response recorded. The 
CM dextran surface is then activated with 0.05 MNHS/0.2 M ED C mixture resulting in a large increase in 
SPR signal due primarily to a bulk refractive index change. HBS buffer is again passed over the now 
activated surface and a small increase in the baseline is observed.
(B)A 50 pg/ml solution o f  purified recombinant InlB protein diluted in 10 mM sodium acetate buffer, pH
4.6, is then passed over the activated surface for a period o f  45 minutes.
(C) Deactivation o f  the surface NHS-esters is performed by injecting 1M ethanolamine, pH  8.5, over the 
surface for  7 minutes, which also serves to elute non-covalently bound antibody. Approximately 10,000 RU  
o f recombinant InlB protein remained bound to the surface after the described immobilisation procedure.
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Figure 6.11: Bar chart showing 45 binding-regeneration cycles o f  the polyclonal anti-InlB extract 
antibody to the recombinant InlB immobilised surface. Nine cycles o f five 2 minute injections o f a 1/30 
dilution o f purified anti-InlB extract antibody were injected over the recombinant InlB immobilised sensor 
chip surface and regenerated with a 30 second pulse o f  20 mM NaOH. A large decrease in binding o f  
antibody to the immobilised recombinant InlB surface was observed for the first injection o f  each o f the 
nine binding cycles (shown in grey on the presented bar chart). This seemed to be a phenomenon o f the 
BIAcore instrument when the program changes cycles, as it was also observed in Figures 6.5 (4 cycles of 
15 injections) and 6.20 (4 cycles o f  10 injections) which used different ligands and number o f binding 
cycles. According to BIAcore, the pattern observed could be due to the fact that there is a time error in sthe 
switch valve indicator and effectively what is seen in the first injection is the loss o f a small fraction of 
injected sample, (personal communication with Ron Wolbert, Application Specialist, BIAcore International 
SA). Excluding the first injection in each cycle, the binding capacity decreased by less than 2% over the 45 
antibody injections, indicating that the surface can be reproducibly regenerated and is suitable for the 
development o f an inhibition assay using the described antibody. The sensor surface went through greater 
than 200 regenerations before a significant (>20%) decrease in binding capacity was observed.
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Figure 6.12: Overlay plot demonstrating the decrease in binding o f affinity purified anti-InlB extract 
polyclonal antibody to the immobilised recombinant InlB surface with increasing Listeria monocytogenes 
cell concentrations.
(A) Shows the normalised baselines of each sensorgram when HBS is injected over the sensor chip 
surface.
(B) Shows the binding of increasing free antibody with decreasing Listeria monocytogenes cell 
concentrations.
(C) Shows the base line shift when buffer is passed over the surface after each sample injection. The 
concentration o f Listeria monocytogenes cells used in each binding cycle is indicated beside each 
sensorgram.
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Figure 6.13: Interday assay calibration curve for the anti-lnlB extract antibody. A 1/30 dilution o f the anti- 
InlB extract antibody was incubated with various Listeria monocytogenes cell concentrations injected over 
an immobilised recombinant InlB surface as described in section 2.5.5. A 4-parameter equation was fitted 
to the data set using BlAevaluation 3.1 software. The inter-assay means and coefficients o f  variance are 
tabulated in Table 6.2. Each point on the curve is the mean o f three replicate measurements analysed over- 
three days.
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Table 6.2: Intra- and interday assay coefficients o f variation (CV's) and percentage accuracies for 
the anti-InlB extract polyclonal antibody used the BIAcore inhibition assay described in section 
2.5.5. Coefficients o f  variance (a quantitative measure ofprecision) was calculated using the 
equation % CV= (S.D./Mean) x 100 where for intraday studies, the standard deviation (S.D.) is 
computed from replicate (3 replicates) analyses within a single validation run andfor intermediate 
precision (interday), the S.D. is computedfrom replicate (3 replicates) analyses over 3 validation 
runs on 3 separate days. The rows with a " represent that no value could be obtained as the data 
point did not fit the calibration curve.
Intraday Interday
Concentration
(cells/ml)
Back-
calculated
concentration
(cells/ml)
CV’s
%
%
Accuracies
Back-
calculated
concentration
(cells/ml)
CV's
%
%
Accuracies
1.00 x 10s 1.04 x 108 0.53 95.85 9.73 x 107 5.53 102.69
2.00 x 107 1.96 x 107 1.35 101.88 2.13 x 107 7.70 93.59
4.00 x 106 4.00 x 106 2.88 100.06 3.66 x lO6 6.23 108.61
8.00 x 10s 8.28 x 105 4.55 96.50 8.34 xlO5 2.45 95.79
1.60 x 10s 1.40 x 105 3.12 112.67 2.08 x 105 4.91 70.30
3.20 x 104 8.69 x 103 4.30 172.85 1.99 x 104 3.23 137.94
6.40 x 103 - 3.29 - 1.86 x 103 2.98 170.86
1.28 x 103 4.15 x 104 2.35 - 4.04 x 103 3.60 -
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6.4 Indirect detection of Listeria monocytogenes with an anti-InlB recombinant single 
chain Fv fragment antibody
As described in section 5.5.2, a human single chain Fv (scFv) fragment antibody capable 
of binding the Listeria monocytogenes invasion-associated protein, Intemalin B (InlB), 
was selected from a naive human antibody library. However, the antibody did not 
recognise Listeria monocytogenes cells indicating that it may bind the protein in a region 
that is associated with the Listeria monocytogenes cell membrane (e.g. in the glycine- 
tryptophan repeat region). To overcome this problem, InlB protein was extracted from the 
cell membrane as described in section 2.2.1.2, and used in an inhibition ELISA (Figure
6.14) to indirectly detect Listeria monocytogenes cells (sections 2.4.4.14 and 5.5,2). In this 
section, a BIAcore inhibition assay was developed using the responses obtained from the 
injection of the anti-TnlB scFv antibody incubated with decreasing Listeria monocytogenes 
InlB enriched extract, over an immobilised recombinant InlB sensor chip surface.
6.4.1 Evaluation of various sensor chip surface chemistries
BIAcore CM5, C l, NTA and HPA sensor chips were evaluated for their possible use in 
the development o f an inhibition assay to detect Listeria monocytogenes InlB extracts in 
solution.
6.4.1.1 Evaluation o f a CM5 sensor chip
A BIAcore sensor chip surface consists o f a glass support on which a gold film has been 
deposited. For most applications the gold layer is covered with a non-crosslinked 
carboxylated dextran hydrogel coupled through an alkyl thiol linker layer. The BIAcore 
CM5 sensor chip is a general purpose chip, with an extremely stable carboxymethylated 
dextran surface allowing high binding capacities and coupling via a wide range of 
chemistries.
To evaluate the use o f the CM5 sensor chip for the development o f an assay to detect 
Listeria monocytogenes InlB extract, approximately 10,000 response units of recombinant 
InlB protein were immobilised on the CM dextran surface as described in section 2.5.2. 
Dilutions of InlB extract and anti-InlB scFv antibody were then passed over the surface 
and the change in response recorded. Figure 6.15 shows the response change observed 
from a 1 minute injection of a 1/5 dilution o f InlB extract in PBS over a recombinant InlB 
immobilised CM5 sensor chip surface. 2875 RU of InlB extract remained non-specifically
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bound to the sensor chip surface upon re-injection o f HBS running buffer over the surface. 
The magnitude o f non-specific binding far exceeded that o f the specific binding o f the 
anti-InlB scFv antibody (253 RU) to the recombinant InlB surface indicating that the CM5 
sensor chip surface is not suitable for the development o f the described assay. As 
described in section 6.3.1, Intemalin B has a very high p i and is positively charged in 
acidic or neutral buffers, resulting in electrostatic interactions between the protein and the 
negatively charged carboxymethylated dextran matrix. Figure 6.16 shows the injection of 
InlB extract over a recombinant InlB CM5 sensor surface in PBS containing different salt 
concentrations. From the sensorgram it can be seen that buffers with a NaCl concentration 
o f 0.5 M eliminate the electrostatic interactions between the sensor surface and the InlB 
protein. However, at these NaCl concentrations, binding o f the anti-InlB scFv antibody to 
InlB is also hindered (results not shown) and therefore a more suitable sensor chip system 
is required.
6.4.1.2 Evaluation o f a NTA sensor chip
The BIAcore NTA chip contains pre-immobilised nitrilotriacetic acid (NTA) on the 
dextran layer. The NTA chip chelates metal ions such as Ni2+, leaving coordination sites 
free for binding histidines residues in recombinant proteins tagged with polyhistidine. The 
NTA chip controls the orientation of the ligand component for optimal site exposure and 
allows the single regeneration o f the sensor surface with EDTA.
To investigate the possible use o f the BIAcore NTA chip for use in the described assay, 
the NTA surface was activated with NiCl2 and the anti-InlB scFv antibody immobilised 
(1139.6 RU) to the surface via its polyhistidine tag as shown in Figure 6.17. Listeria 
monocytogenes InlB extract was then passed over the anti-InlB antibody immobilised 
surface resulting in 304 RU of extract binding to the immobilised antibody surface. The 
surface was regenerated with 100 mM EDTA and the same concentration o f InlB extract 
passed over a now blank NTA surface. 303.8 RU of InlB extract (Figure 6.17) remained 
bound to the blank NTA-dextran sensor chip surface upon addition o f HBS which was 
equivalent to that observed over the anti-InlB scFv antibody surface. The observed results 
indicate that BIAcore sensor chips containing a dextran layer should not be used when 
trying to detect positively charged proteins, such as InlB.
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Figure 6.14: Illustration o f the BIAcore inhibition assay used to indirectly detect Listeria monocytogenes 
cells with the anti-InlB scFv antibody.
(A) Purified recombinant InlB (rlnlB') protein is immobilised on the surface o f a CMS chip as described in 
section 2.5.2.
(B) The surface regeneration conditions are optimised and the surface binding capacity determined for a 
number ofbinding-regeneration cycles.
(C) Various concentrations o f Listeria monocytogenes InlB extracts are incubated with an anti-InlB scFv 
antibody as described in section 2.5.6.
(D) Antibody and extract from (C) above are passed over the rlnlB immobilised surface and the response 
observed.
(E) A sensorgram o f increasing free antibody concentrations with decreasing Listeria monocytogenes cell 
numbers is observed and a standard curve plotted.
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Figure 6.15: Sensorgram showing the injection o f  Listeria monocytogene s-enriched InlB extract and anti- 
InlB scFv antibody over a recombinant InlB immobilised CM5 sensor chip surface. The numbers indicated 
on the sensorgram represent:
(1) HBS buffer injected over the recombinant InlB surface.
(2) 1 minute injection o f a 1/5 dilution o f the InlB extract in PBS.
(3) HBS buffer injected over the recombinant InlB surface. The baseline difference between (1) and (3) 
represents the amount o f InlB extract (2875.1 RU) that is electrostatically bound to the sensor chip surface.
(4) 30 second injection o f  20 mMNaOH followed by HBS injected over the surface.
(5) 30 second injection o f a 1/4 dilution o f  anti-InlB scFv antibody supernatant in PBS.
(6) HBS buffer injected over the recombinant InlB surface. The baseline difference between (4) and (6) 
represents the amount o f  antibody (253.3 RU) that is bound to the recombinant InlB-immobilised sensor 
chip surface.
(7) 30 second injection o f  20 mMNaOH followed by HBS injected over the surface.
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Figure 6.16: Sensorgram showing the effect o f  NaCl concentration o f  the binding o f  Listeria 
monocytogenes InlB extract to a recombinant M B  immobilised CM5 sensor chip surface. The numbers 
indicated on the sensorgram represent the following:
(1) A 2 minute injection o f  a 1/20 dilution o f  InlB extract in PBS containing 0.5 M N aCl (-73.8 RU  change 
in baseline).
(2) HBS buffer injected over the recombinant InlB surface.
(3) A 2 minute injection o f  a 1/20 dilution o f InlB extract in normal PBS (0.15 M  NaCl; 1154.1 RU o f  
extract non-specifically bound to the recombinant InlB surface).
(4) HBS buffer injected over the recombinant InlB surface.
(5) Surface regenerated with a 2 minute injection o f PBS containing 0.5 MNaCl.
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Figure 6.17: Sensorgram showing the injection o f  Listeria monocytogene s-enriched InlB extract and anti- 
InlB scFv antibody over a recombinant InlB-immobilised NTA sensor chip surface. The numbers indicated 
on the sensorgram represent:
(1) The NTA sensor chip, on which nitrilotriacetic acid is covalently linked to a carboxy-methylated 
dextran matrix, was activated with a pulse o f  NiCl2, forming a chelating complex with NTA which binds 
polyhistidine peptides.
(2)5  minute injection o f an anti-InlB scFv antibody (1139.6 RU o f antibody immobilised).
(3) FIBS buffer injected over the scFv immobilised surface followed by an injection o f a 1/50 dilution o f  
InlB extract leaving 304. O R U of extract bound to the immobilised scFv antibody surface.
(4) + (5) Regeneration o f the immobilised scFv antibody surface with 100 mM EDTA solution resulting in 
the chelating o f the Ni2+ and subsequently releasing histidines bound peptides from the NTA surface.
(6) IIBS buffer injected over the regeneration NTA surface followed by an injection o f a 1/50 dilution o f  
InlB extract leaving 303.8 RU o f  extract bound to the blank surface.
(7) 1 minute injection o f  100 mM EDTA removes non-specijically bound material.
(8) The NTA surface was again activated with a pulse ofNiCl2, forming a chelating complex with NTA.
(9) A 1 minute injection o f a 1/50 dilution o f  InlB extract leaving 387.4 RU o f extract bound to the 
activated NTA surface.
(10) Regeneration o f  the activated NTA surface with a 100 mM EDTA solution.
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6.4.1.3 Evaluation o fa  Cl sensor chip
The BIAcore C l sensor chip has a carboxymethylated surface that supports the same 
immobilisation chemistry as CM dextran surfaces but lacks the dextran matrix, The 
surface lacks the hydrophilic character and has a much lower immobilisation capacity than 
the CM dextran chips. However, the chip is useful in cases where the dextran matrix 
interferes with the interaction being studied.
A sensorgram showing the injection o f Listeria monocytogenes enriched InlB extract and 
anti-InlB scFv antibody over a recombinant InlB immobilised C l sensor chip surface is 
shown in Figure 6.18. Recombinant InlB was immobilised on the sensor chip surface as 
described in section 2.5.2 and anti-InlB scFv antibody subsequently injected over the 
sensor chip surface. A 6 minute injection o f a 1/6 dilution o f anti-InlB scFv antibody in 
PBS resulted in a baseline shift of 642.3 RU. However, injection o f a 1/3 dilution of InlB 
extract incubated with an equal volume anti-InlB antibody resulted in a  much higher 
baseline shift o f  1749.9 RU. Also a 6 minute injection o f a  1/6 dilution o f InlB extract in 
PBS resulted in a baseline shift o f 1806 RU indicating that the InlB extract non- 
specifically binds to the sensor chip surface. This result was not expected as the chip 
contains no dextran layer. However, the surface is still carboxymethylated, even though it 
has a slightly more hydrophobic nature (lacks the hydrophilic character o f the dextran 
layer) which could possibly result in the non-specific binding o f the positively charged 
membrane associated InlB protein. Under these conditions, the BIAcore C l sensor chip 
does not provide a feasible surface for the development o f an inhibition assay to detect 
InlB cxtract.
6.4.1.4 Evaluation o f a HPA sensor chip
The BIAcore HPA chip surface is composed o f long-chain alkanethiol molecules that 
form a flat, quasi-crystalline hydrophobic surface for working with membrane-associated 
ligands. The hydrophobic surface is inherently “sticky” and will adsorb a large variety of 
molecules and proteins and therefore can be used to mimic ELISA conditions, such as 
those used in section 5.5.2. Figure 6.19 shows the injection o f Listeria monocytogenes 
enriched InlB extract and anti-InlB scFv antibody over a recombinant InlB-immobilised 
HPA sensor chip surface. Recombinant InlB protein was hydrophobically absorbed to the 
sensor chip surfacc by injecting 50 (xg/ml o f recombinant InlB protein over a clean HPA 
chip surface for 100 minutes at 5 [xl/minute and blocked with 50 ng/ml o f ovalbumin for 
20 minutes at 5 [xl/minute. As presented in Figure 6.19, injection o f InlB extract incubated
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with anti-InlB scFv antibody (71.3 RU) resulted in a decrease in observed response 
compared to that observed from same concentration of antibody diluted in PBS (149 RU). 
The inhibition observed indicates that hydrophobically absorbing the recombinant InlB 
protein to the sensor surface followed by blocking (mimicking ELISA) could potentially 
be used for the generation o f an inhibition assay with both the anti-InlB scFv antibody and 
InlB extract. However, when the injection o f both samples (antibody-extract and antibody 
in PBS) was repeated over the surface (Figure 6.19, labelled 3-6) the binding capacity of 
the surface decreased drastically limiting the feasibility o f the use o f the HPA chip surface 
for used in a development o f an accurate and cost effective immunoassay.
6.4.1.5 Reduction o f the overall negative charge o f a Cl sensor chip surface by over­
activation o f the surface carboxyl groups and capping with ethylene diamine
As concluded in sections 6.4.1.1 and 6.4.1.2, BIAcore sensor chips containing a 
carboxymethylated dextran surface are not suitable for use with highly positively charged 
proteins such as InlB due to  the high electrostatic interactions observed. However, the 
BIAcore C l chip (section 6.4.1.3) containing no dextran layer also displayed electrostatic 
interactions between the InlB protein and the carboxymethylated flat surface resulting in 
high undesirable non-specific binding. In order to attempt to decrease the overall negative 
charge on the sensor chip surface, the surface was over-activated with a double injection 
o f EDC/NHS (according to BIAcore, standard activation procedures only activate 
approximately 40% of the carboxyl groups on the surfacc) and the surface capped with 1 
M  ethylene diamine, pH 8.5, after immobilisation o f the recombinant InlB protein. Figure
6.20 shows a sensorgram o f the injection o f the anti-InlB scFv antibody and InlB extract 
over an recombinant InlB immobilised C l sensor chip surface that has been over-activated 
with two 7 minute injections o f EDC/NHS and capped with 1 M ethylene diamine, pH  8.5. 
A 1 minute injection o f anti-InlB antibody over the recombinant InlB immobilised surface 
resulted in a baseline shift o f 796.8 RU units compared to 131.9 RU observed from a 1/5 
dilution o f InlB extract incubated with the same concentration o f antibody over the same 
surface (Figure 6.20). This result indicates the potential o f the described recombinant InlB 
surface for use in the development o f an assay to detect InlB extract using the anti-InlB 
scFv antibody.
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Figure 6.18:: Sensorgram showing the injection o f  Listeria monocytogenes-enriched InlB extract and anti- 
InlB scFv antibody over a recombinant InlB immobilised C l sensor chip surface. The numbers indicated on 
the sensorgram represent:
(1) HBS buffer injected over the recombinant InlB surface followed by a short injection o f 20 mM NaOH.
(2) 6 minute injection o f 1/6 dilution o f  the anti-InlB scFv antibody supernatant over an immobilised 
recombinant InlB surface (642.3 RU o f  antibody bound).
(3) HBS buffer injected over the recombinant InlB surface followed by a short injection o f 20 mM NaOH.
(4) 6 minute injection o f 1/3 dilution o f  the anti-InlB scFv antibody supernatant incubated with a 1/3 
dilution o f  InlB extract over an immobilised recombinant InlB surface (1749.9 RU o f antibody/InlB extract 
bound).
(5) HBS buffer injected over the recombinant InlB surface followed by a short injection o f  20 mM NaOH.
(6) 6 minute injection o f a 1/6 dilution o f InlB extract over an immobilised recombinant InlB surface 
(1806. ORU of InlB extract bound).
(7) HBS buffer injected over the recombinant InlB surface followed by a short injection o f 20 mM NaOH.
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Figure 6.19:: Sensorgram showing the injection o f Listeria monocytogenes-enriched In IB extract and anti- 
InlB scFv antibody over a recombinant InlB-immobilised HP A sensor chip surface. The numbers indicated 
on the sensorgram represent:
(1) 2.5 minute injection o f  a 1/3 dilution o f  scFv antibody incubated with a 1/5 dilution o f  InlB extract 
resulting in a baseline shift o f  71.3 response units. The surface is regenerated with a 30 second pulse o f  20 
mM NaOII.
(2) 2.5 minute injection o f a 1/3 dilution ofscFv antibody incubated with an equal volume o f  PBS resulting 
in a baseline shift o f  149.0 response units. The surface is regenerated with a 30 second pulse o f 20 mM  
NaOH.
(3) Injection o f (1) repeated resulting in a baseline shift o f  48.1 response units.
(4) Injection o f (2) repeated resulting in a baseline shift o f  115.5 response units.
(5) Injection o f  (2) and (4) repeated resulting in a baseline shift o f  81.8 response units.
(6) Injection o f  (1) and (3) repeated resulting in a baseline shift o f  50.9 response units.
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Figure 6.20: Sensorgram showing the injection o f  the anti-InlB scFv antibody and InIB extract over an 
recombinant M B  immobilised C l sensor chip surface that has been over-activated with hw  7 minute 
injections o f EDC/NHS and capped with ethylene diamine instead o f ethanolamine. The numbers 
indicated on the sensorgram represent:
(1) HBS buffer injected over the recombinant InIB surface.
(2) 30 second injection o f  20 mMNaOH.
(3) HBS buffer injected over the recombinant M B  surface.
(4)1 minute injection o f a 1/2 dilution o f the anti-InlB scFv culture supernatant in PBS.
(5) HBS buffer injected over the recombinant M B  surface. The difference baseline between (3) and (5) 
indicates the amount o f  antibody bound to the immobilised InIB surface (796.8 RU).
(6) 30 second injection o f  20 mMNaOH.
(7) HBS buffer injected over the recombinant InIB surface.
(8) Injection o f the scFv antibody incubated with a 1/5 dilution o f  InlB extract diluted in PBS injected 
over the recombinant InlB immobilised surface. The difference in baseline between (7) and (9) indicates 
the amount o f antibody bound to the recombinant InlB immobilised surface (131.9 RU).
(9) HBS buffer injected over the recombinant InlB surface.
(10) 30 second injection o f 20 mMNaOH.
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6.4.2 Immobilisation of recombinant InlB protein on to a BIAcore C l sensor chip 
surface
Purified recombinant InlB protein was immobilised onto the carboxymethylated surface o f 
a C l sensor chip as briefly described in section 6 .4.1.5. 50 pg/ml o f affinity-purified 
recombinant InlB protein, diluted in sodium acetate buffer, pH 4.6, was injected over the 
EDC/NHS over-activated sensor chip surface for 45 minutes at 5 (¿l/minute. Unreacted 
sites were blocked with a 7 minute injection o f 1M ethylene diamine (pH 8.5) at 5 
fil/minute. Approximately 1,100 RU of recombinant InlB was successfully immobilised 
on the surface as shown in Figure 6.21.
6.4.3 Regeneration studies of the anti-InlB scFv antibody
The binding capacity o f the recombinant InlB immobilised surface was determined by a 
series of binding and surface regeneration sequences to assess at which point the binding 
capacity deviated outside the desired performance range o f <20% suggested by Wong et 
al. (1997). Anti-InlB scFv antibody was injected over the immobilised antibody surface 
for 2 minutes at 10 p.I/minute and the surface regenerated with a 30 second pulse o f 20 
mM NaOH. The binding-regeneration cycles were repeated for 40 cycles resulting in a 
decrease of approximately 20% in binding capacity from the first to the last cycle studied 
(Figure 6.22). This result indicates that the surface can be used for up to 40 binding- 
regeneration cycles before the decrease binding capacity exceeds the desired performance 
range suggested by W ong et al. (1997).
6.4.4 Development o f a BIAcore inhibition assay for the indirect detection of Listeria 
monocytogenes using an anti-InlB scFv antibody
To determine the working range o f the inhibition assay, serial dilutions o f Listeria 
monocytogenes InlB extracts in PBS were incubated with the anti-InlB scFv antibody as 
described in section 2.5.6. The samples containing antibody and Listeria monocytogenes 
InlB extract were passed over the surface o f the sensor chip immobilised with purified 
recombinant InlB protein in random order and the binding response recorded. Surface 
bound antibody was removed from the surface using a 30 second pulse o f 20 mM NaOH. 
A typical overlay plot demonstrating the decrease in binding o f the anti-InlB scFv 
antibody to the immobilised recombinant InlB surface with increasing Listeria 
monocytogenes InlB extract concentrations is presented in Figure 6.23. A calibration 
curve was constructed by plotting the average (n=3) change in response for each Listeria
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monocytogenes InlB extract standard against the known equivalent concentration o f 
Listeria monocytogenes cells used in each run. The range o f detection for the anti -Listeria 
monocytogenes antibody was found to be between approximately 6.6 x  10s and 2 x 107 
cells/ml (Figure 6.24). The limit o f detection (approximately 2 x 107 cells/ml) observed in 
Figure 6.24 is approximately 10 fold higher than that observed in ELISA (2 x 106 cells/ml) 
with the same antibody (section 5.5.3, Figure 5.32) which was not expected.
In order to determine the accuracy and the intermediate precision o f the presented 
BIAcore Inhibition immunoassay, intra- and interday assay variability studies were 
performed. Three sets o f standards were prepared and incubated with antibody before 
being assayed. The results obtained from intra- and interday assay studies are shown in 
Table 6.3. The coefficients o f variation (CV's) were determined to assess the precision of 
the analytical method, expressing standard deviation as a  percent function o f the mean. 
These values ranged from 0.46 to 5.62% and 1.41 to 9.58% as observed for the intra- and 
interday studies, respectively, indicating that the assay had a very good degree of 
precision. The percentage accuracies values obtained in the linear part o f the interday 
assay (Table 6.3) indicate the fitted four parameter curve provides an accurate 
representation o f the measured response in the linear range o f  the assay (percentage 
accuracy values from 94.46 to 106.84%).
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Figure 6.21: Sensorgram showing the immobilisation o f  recombinant lnlB protein to a C l sensor chip 
surface by over-activation o f  the carboxymethylated surface followed by capping o f the unreacted groups 
with 1M ethylene diamine, pH  8.5 instead o f 1M ethanolamine at the same pH.
(A) HBS buffer is initially passed over the sensor chip surface and the baseline response recorded. The 
carboxymethylated surface is then activated with 0.05 M  NHS/0.2 M  EDC mixture resulting in a large 
increase in SPR signal due primarily to a bulk refractive index change. HBS buffer is again passed over 
the now activated surface and a small increase in the baseline is observed.
(B) Purified recombinant InlB protein (50 pg/ml) diluted in 10 mM sodium acetate buffer, pH  4.6, is then 
passed over the activated surface for a period o f 45 minutes.
(C) Deactivation o f  the surface NHS-esters is performed by injecting 1M ethylene diamine, pH  8.5, over 
the surface for 7 minutes, which also serves to elute non-covalently bound antibody. Approximately 1100 
RU o f recombinant InlB protein remained bound to the surface after the described immobilisation 
procedure.
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Figure 6.22: Bar chart showing 40 binding-regeneration cycles o f  the anti-InlB scFv antibody to the 
recombinant InlB immobilised C l sensor chip surface. Four cycles o f  ten 2 minute injections o f  a 1/10 
dilution o f  anti-InlB scFv antibody supernatant were injected over the recombinant InlB immobilised 
sensor chip surface and regenerated with a 30 second pulse o f  20 mMNaOH. A large decrease in binding 
of antibody to the immobilised recombinant InlB surface was observed for the first injection o f  each o f  the 
four binding cycles (shown in grey on the presented bar chart). As previously discussed, this pattern could 
be due to the fact that the matrix swells when in contact with different pHs, and effectively what is seen in 
the first injection is a conditioning o f  the matrix. Excluding the first injection in each cycle, the binding 
capacity decreased by approximately 20% over the 40 antibody injections which is just within the limits 
described by Wonget. al. (1997).
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Figure 6.23: Overlay/ plot demonstrating the decrease in binding of anti-InlB scFv antibody to the 
immobilised recombinant InIB surface with increasing Listeria monocytogenes MB extract concentrations.
(A) Shows the normalised baselines of each sensorgrarn when HBS is injected over the sensor chip surface 
after a brief injection o f 20 mM NaOH.
(B) Shows the binding of increasing free antibod'y with decreasing Listeria monocytogenes InIB extract 
concentrations.
(C) Shows the base line shift when buffer is passed over the surface after each sample injection.
(D) Slum's an enlarged view of (C) with the equivalent concentration of Listeria monocytogenes cells used 
in each binding cycle indicated beside each sensorgrarn.
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Figure 6.24: Interday assay calibration curve fo r  the anti-InlB scFv antibody based SPR assay. A 1/5 
dilution o f  the anti-InlB extract antibody wav incubated with various Listeria monocytogenes cell 
concentrations injected over an immobilised recombinant InlB surface as described in section 2.5.6. A 4- 
parameter equation was fitted  to the data set using BIAevaluation 3.1 software. The inter-assay means and 
coefficients o f  variance are tabulated in Table 6.3. Each point on the curve is the mean o f  three replicate 
measurement* analysed over three days.
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Table 6.3: Intra- and interday assay coefficients o f variation (CV's) and percentage accuracies for  
the anti-lnlB scFv antibody used the BlAcore inhibition assay described in section 2.5.6. 
Coefficients o f  variance (a quantitative measure ofprecision) was calculated using the equation % 
CV= (S.D./Mean) x  100. For intraday studies, the standard deviation (S.D.) is computed from  
replicate (3 replicates) analyses within a single validation run, while fo r  intermediate precision 
(interday), the S.D. is computed from replicate (3 replicates) analyses over 3 validation runs on 3 
separate days.
Intraday Interday
C oncen tra tion
(ce lls /m l)
B ack-
ca lcu la ted
concen tra tion
(ce lls /m l)
C V ’s
%
%
A ccuracies
B ack-
ca lcu la ted
concen tra tion
(ce lls /m l)
C V 's
%
%
Accuracies
6.67 x 108 6.36 x 10s 1.17 104.65 6.59 x 108 9.06 101.22
4.44 x 108 4.58 x 108 0.59 96.93 4.47 x 108 1.41 99.43
2.96 x 108 2.88 x 108 1.65 102.61 2.94 x 108 9.13 100.62
1.98 x 10s 2.19 xlO8 0.72 89.45 2.06 x 108 9.25 95.74
1.32 x 108 1.19 x 108 1.15 109.74 1.23 x 108 9.58 106.94
8.78 x 107 8.72 x 107 0.46 100.69 9.23 x 107 7.86 94.92
5.85 x 107 5.79 x 107 5.62 101.02 5.82 x 107 2.44 100.54
3.90 x 107 4.61 x 107 1.57 81.91 4.12 x 107 6.64 94.46
2.60 x 107 2.96 x 107 1.41 86.04 2.11 xlO7 2.31 118.86
1.74 x 107 7.69 x 106 5,25 155.79 1.98 x 107 4.22 86.10
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6.5 Discussion
This chapter describes the development o f three BIAcore assays to detect Listeria  
monocytogenes using both polyclonal and recombinant single chain Fv fragment 
antibodies. Each of the three assays described, was developed using a BIAcore 3000 
instrument and intra- and intcrday studies carried out to determine the precision and 
reproducibility o f each assay. A 4-parameter equation was fitted to each standard curve 
using BIAevaluation software and the percentage accuracies calculated.
The polyclonal anti -Listeria monocytogenes antibody described in chapter 3 was used to 
develop a subtractive inhibition assay for the detection of Listeria m onocytogenes cells 
(section 6.2). As described in section 2.5.4, by removing cells and bound antibody from 
solution with a stepwise centrifugation step, free unbound antibody could be detected by 
an immobilised anti-rabbit Fab antibody on the sensor chip surface. To maximise the 
preconcentration of the anti-rabbit Fab antibody to the CM5 sensor chip surface, 50 (xg/ml 
of antibody, diluted in 10 mM sodium acetate buffer at various pH increments (Figure 6.2) 
were injected over a blank CM dextran surface and the degree o f preconcentration 
recorded. The optimal antibody concentration was observed in sodium acetate pH 4.3 
buffer, which was used for all subsequent immobilisations o f the anti-rabbit Fab antibody. 
Approximately 23,000 response units (RU) o f anti-rabbit Fab antibody were immobilised 
(Figure 6.3) on the surface o f a CM5 sensor chip surface using EDC and NHS chemistry 
as described in section 2.5.2. Regeneration studies were carried out on the immobilised 
anti-rabbit Fab antibody surface to evaluate the performance and lifetime of the sensor 
chip surface. Binding regeneration cycles were repeated for 60 cycles (Figure 6.5) 
resulting in less than 13% decrease in binding capacity from the first to the last cycle 
studied which is well within the limits suggested by Wong et al. (1997). An important part 
o f any immunoassay is the cost of the assay. A stable sensor chip surface not only 
provides the bases for the production of an accurate immunoassay but also can reduce the 
overall cost o f the assay by allowing multiple samples to run over the same assay surface. 
The immobilised anti-Fab surface studied in section 6.2.3, went through over 100 binding 
cycles over a two week period before a significant (<20% original binding capacity) 
decrease in binding capacity was observed.
To determine the working range of the assay, samples containing unbound antibody 
(stepwise centrifugation supernatant) were injected over the anti-rabbit Fab antibody 
immobilised surface in random order (Figure 6.6) and a calibration curve constructed. The 
range o f detection o f the anti -Listeria m onocytogenes antibody was found to be between 1
255
X  108 and 1 x 106 cells/ml (Figure 6.7) which is equivalent to that observed in ELISA for 
the same antibody (Figure 3.9). Intra- and interday assay variability studies were 
performed to determine the accuracy and the intermediate precision of the subtractive 
inhibition assay. The percentage coefficients o f variation (CV’s) values ranged from 0.59 
to 4.80% and 0.14 to 4.00% as observed for the intra- and interday studies, respectively, 
indicating that the assay had a very good degree o f precision. These coefficients of 
variation values were significantly lower than those observed in ELISA (Table 3.2) due to 
the automated nature o f the BIAcore biosensor system. The percentage accuracies 
obtained in the linear part of the interday assay (Table 6.1) indicate the fitted 4-parameter 
curve provides an accurate representation o f the measured response in the linear range of 
the assay.
Section 6.3 describes the development of an inhibition assay for the direct detection of 
Listeria monocytogenes using the anti-InlB extract polyclonal antibody described in 
chapter 3. Protein G-purified anti-InlB extract antibody, incubated with decreasing 
concentrations o f Listeria monocytogenes cells, was injectcd over an IMAC purified 
recombinant Intemalin B protein (described in chapter 4) immobilised CM5 sensor chip 
surface. Prior to immobilisation, the degree of preconcentration of the recombinant InlB 
protein to the sensor chip surface was determined. As described in section 6.3.1 the 
recombinant InlB protein electrostatically bound the sensor chip surface and could only be 
removed with an injection of 20 mM NaOH. Due to the high electrostatic interactions 
observed, subsequent immobilisations of the recombinant InlB protein were performed in 
sodium acetate buffer, pH 4.6. Approximately 10,000 RU of recombinant InlB was 
successfully immobilised on the surface o f a CM5 sensor chip as shown in Figure 6.9. 
Regeneration studies, involving 45 binding-regeneration cycles were performed and a 
decrease o f less than 2% in binding capacity from the first to the last cycle observed. This 
result indicates that the surface is very stable and should provide an accurate platform for 
the development o f an assay to detect Listeria monocytogenes cells. However, it was also 
observed that the first injection o f each assay cycle was significantly lower than 
subsequent injections containing the same sample (Figure 6.11). According to BIAcore 
this pattern could be due to the fact that there is a time error in the instruments switch 
valve indicator and was is observed in actually a reduction in injected sample volume. 
Therefore, an inhibition assay was developed by discarding the first value in each cycle 
and taking an average o f the remaining three replicates. The range o f detection for the 
anti-InlB extract antibody was found to be between approximately 1 x 10s and 1-2 x 105 
cells/ml as shown in Figure 6.13. The observed limit o f detection was approximately 10 
fold lower than that observed in ELISA with the same antibody (Figure 3.7) highlighting
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the sensitivity o f the BIAcore 3000 automated biosensor. The intra- and interday assay 
coefficients of variation values were determined to assess the precision o f the analytical 
method. These values ranged from 0.53 and 4.55% and 2.98 and 7.70% as observed for 
the intra- and interday studies respectively. The percentage accuracies of the assay 
indicate that the fitted 4-parameter equation provides an accurate representation o f the 
measured response in the linear range o f the assay. Overall the assay showed good 
sensitivity and the sensor chip surface was very stable over the number o f cycles studied.
A BIAcore inhibition assay was also developed to indirectly detect Listeria  
m onocytogenes using the anti-InlB scFv antibody described in section 5.5.2. However, the 
antibody did not recognise Listeria m onocytogenes cells indicating that it may be specific 
for a region o f the protein which is involved in the association o f the protein to the 
Listeria m onocytogenes cell membrane. Therefore, InlB protein was extracted from the 
Listeria monocytogenes cell surface as described in section 2.2.1.2, and used to develop a 
BIAcore inhibition assay using the responses obtained from the injection of the anti-InlB 
scFv antibody incubated with decreasing concentrations o f  Listeria  monocytogenes InlB 
extract over an immobilised recombinant InlB sensor chip surface. Due to the cationic 
nature o f the InlB protein, various BIAcore sensor chips were evaluated for use in the 
described assay. It was observed that the InlB extract seemed to non-specifically bind to 
the dextran surface o f the CM5 and NTA sensor chips (sections 6.4.1.1 and 6.4.1.2) 
limiting their use for further development. It was observed that high salt concentrations 
(Figure 6.15) could eliminate the electrostatic interactions o f the cationic InlB protein to 
the anionic surfaces but such high salt concentrations also seriously hindered the binding 
of the recombinant scFv antibody to the sensor surface. In order to mimic ELISA 
conditions, recombinant InlB protein was adsorbed onto the surface o f a HPA chip as 
described in section 6.2.1.4. As presented in Figure 6.19, an injection o f InlB extract 
incubated with anti-InlB scFv antibody (71.3 RU) resulted in a decrease in observed 
response compared to that observed from same concentration o f antibody diluted in PBS 
(149 RU). However, when the injection of both samples (antibody-extract and antibody in 
PBS) was repeated over the surface (Figure 6.19, labelled 3-6) the binding capacity o f the 
surface decreased drastically limiting the feasibility o f the use o f the HPA chip surface for 
used in a development o f an accurate and cost effective immunoassay.
Using the standard EDC/NHS immobilisation procedure (section 5.5.2), the Listeria  
monocytogenes InlB extract was also observed to non-specifically bind to the flat 
carboxymethylated surface o f a C l sensor chip (section 6.4.1.3). In order to decrease the 
overall negative charge on the sensor surface, the surface was over-activated with a double
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injection o f  EDC/NHS and recombinant InlB immobilised followed by capping with 1M 
ethylene diamine, pH 8.5. A 1 minute injection of anti-InlB scFv antibody over the 
recombinant InlB immobilised surface resulted in a baseline shift o f 796.8 RU units 
compared to 131.9 RU observed from a 1/5 dilution of InlB extract incubated with the 
same concentration of antibody indicating the potential o f the described method in the 
development o f an assay to detect InlB extract using the anti-InlB scFv antibody.
The binding capacity o f the recombinant InlB immobilised surface was determined by a 
series o f binding and surface regeneration sequences to assess at which point the binding 
capacity deviated outside the desired performance range o f <20% suggested by Wong et 
al. (1997). 40 binding-regeneration cycles were performed resulting in a decrease of 
approximately 20% in binding capacity from the first to the last cycle studied (Figure 
6.22). This finding indicates that the surface can be used for only 40 binding-regeneration 
cycles before the decrease binding capacity exceeds the desired performance range. 
Therefore, an assay developed using this method will not be cost effective (only 160 
samples per chip can be performed) and will lack the accuracy observed from assays with 
more stable surfaces such as in section 6.3. However, as a number o f sensor chips had 
already been evaluated and because the antibody had shown good specificity towards 
Listeria  monocytogenes cells (section 5.5.5), it was decided that the development o f an 
assay using the described surface could still be a valuable tool for the species-specific 
detection o f Listeria  monocytogenes even if  not cost effective. A calibration curve was 
constructed by plotting the average (n=3) change in response for each Listeria  
monocytogenes InlB extract standard against the known equivalent concentration o f  
Listeria m onocytogenes cells used in each run. The range o f detection for the anti -Listeria 
monocytogenes antibody was found to be between approximately 6.6 x 10s and 2 x  107 
cells/ml (Figure 6.24). The limit o f detection (approximately 2 x 107 cells/ml) observed in 
Figure 6.24 is approximately 10 fold higher than that observed in ELISA (2 x 106 cells/ml) 
with the same antibody (section 5.5.3, Figure 5.32) which was not expected. The 
coefficients of variation (CV's) were determined to assess the precision o f the analytical 
method, expressing standard deviation as a percent function o f the mean. These values 
ranged from 0.46 to 5.62% and 1.41 to 9.58% as observed for the intra- and interday 
studies, respectively, indicating that the assay had a good degree o f precision. Even with 
the automated nature o f the BIAcore instrument, the observed coefficient o f variation 
values were still slightly higher than those obtained in ELISA for the same antibody 
(section 5.5.3), which is probably due to the unstable nature o f  the sensor chip surface. 
The percentage accuracies values obtained in the linear part o f the interday assay (Table
6.3) indicate the fitted four parameter curve provides an accurate representation of the
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measured response in the linear range of the assay (percentage accuracy values from 94 .46
to 106.84%).
To summarise, three BIAcore inhibition assays were developed with two polyclonal 
antibodies described in chapter 3 and with an scFv antibody described in chapter 5. The 
three assays described use novel formats for the SPR-based detection of Listeria  
monocytogenes and may have wider applications for the study o f other bacteria and large 
molecules. In terms of sensitivity and reproducibility the inhibition assay developed with 
the anti-InlB antibody proved to be the most sensitive assay (Limit o f detection of 
approximately 2 x 105 cells/ml) and could be regenerated over 200 times before 
significant decrease in binding capacity was observed. This assay proved more sensitive 
than the other SPR-based detection formats for microorganisms discussed in section 1.18 
and was further characterised in terms of reproducibility and accuracy (Intra- and interday 
assay variability studies performed). In general, the stability o f the sensor surface depends 
on the immobilised ligand with non-protein molecules such as carbohydrate or haptens 
like progesterone (3600 regeneration cycles, Gillis et al. 2003) being most stable. 
According to BIAcore (personnel communication with John Butler, BIAcore application 
specialist) protein immobilised sensor surface tend to stable for between 100 and 200 
regeneration cycles. The described anti-InlB polyclonal inhibition assay was stable for 
over 200 regeneration cycles which compares very well with other protein immobilised 
surfaces such as that described by Rasooly, 2001 (70 regenerations). However, as 
described in section 3.2.7, both the anti-InlB extract and anti -Listeria monocytogenes 
polyclonal antibodies are not species specific and cross react with a number o f the other 
members o f  the genus Listeria  (Table 3.5). On the other hand, the BIAcore assay 
developed with the anti-InlB scFv antibody, was not as sensitive nor as cost effective as 
the anti-InlB extract polyclonal antibody based assay but it was shown to specifically bind 
Listeria monocytogenes InlB extract (section 5.5.5). Therefore, depending on the desired 
assay requirements (e.g. species or genus-specific detection or low cost assay) the 
BIAcore assays described in this chapter can be reliably and accurately used to monitor 
the interaction o f anti -Listeria m onocytogenes related antibodies and cells in “real-time”.
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Chapter 7 
Overall Conclusions
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7.1 Overall conclusions
The aim of this thesis was to develop an immunoassay for the rapid and specific detection 
of Listeria  monocytogenes cells. The strategy used involved the production and 
characterisation o f polyclonal and recombinant single chain Fv antibody fragments to 
Listeria  monocytogenes cells and invasion-associated proteins. The Listeria  
monocytogenes invasion-associated proteins, Intemalin B (InlB) and p60, were cloned into 
E. coli and expressed in the cytoplasm of the cells. IMAC purified InlB and p60 proteins 
were used in the selection of recombinant scFv antibodies from a naive human antibody 
library. Antibodies, were characterised by ELISA, SDS-PAGE and Western blotting and 
used in the development of a biosensor-based immunoassay for the detection of Listeria  
monocytogenes.
Chapter 3 describes the production and characterisation o f two polyclonal antibodies 
generated against H T-Listeria monocytogenes cells and InlB protein extract. Antibodies 
were crudely purified by saturated ammonium sulphate precipitation and further purified 
by protein G affinity chromatography. Purified IgG was used for the development of an 
inhibition ELISA to detect Listeria monocytogenes cells. Inhibition ELIS As were 
developed with both antibodies in PBS and chocolate milk. As discussed in chapter 3, 
chocolate milk was reported to have been the source o f a Listeria m onocytogenes food 
poisoning outbreak in Illinois in 1994. Intra- and interday studies were performed to 
evaluate the precision and reproducibility o f each assay developed. Assays developed with 
both antibodies proved to be accurate and reproducible with intra- and interday 
coefficients o f variation of typically less than 10-12%. Cross reactivity studies were 
performed with both antibodies against a number o f bacterial strains. Two methods for 
evaluating the percentage cross reactivity o f each antibody were evaluated in section 
3 .2.7. The observed percentage cross reactivity of each antibody was calculated by using a 
ratio o f concentrations (Figure 3.15) and a ratio of observed inhibition (Figure 3.16) 
yielding large differences in calculated percentage cross reactivity values. Both antibodies 
discussed were observed to cross react with the other Listeria  strains to different degrees 
indicating that neither antibody can be used for the specific detection of Listeria  
monocytogenes cells from a heterogeneous population o f bacterial cells. However, it was 
discussed that by varying the assay format, and by utilising either o f the antibodies as a 
capture antibody in conjunction with a detection antibody with a more refined specificity 
(monoclonal antibody), both antibodies have great potential to be valuable reagents for the 
development of an immunoassay for the reliable detection of Listeria  m onocytogenes cells 
from a mixed population. Both antibodies were successfully further utilised for the
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identification of Listeria monocytogenes recombinant invasion-associated proteins 
(chapter 4) and for the rapid genus-specific detection of Listeria  cells using surfacc 
plasmon resonance (SPR) described in chapter 6.
The availability of large quantities o f Listeria  m onocytogenes-specific  antigen is a 
prerequisite for the generation of species specific anti -Listeria m onocytogenes antibodies. 
Chapter 4 describes the expression and purification o f the Listeria  m onocytogenes 
invasion-associated proteins, Intemalin B (InlB) and p60, in E. coli XL10 Gold cells. 
Genomic DNA was extracted from Listeria m onocytogenes cells and the InlB and p60 
gene sequences amplified by PCR using specific primer sequences. Amplified gene 
products were cloned into a TA cloning vector (Invitrogen) and subsequently sub-cloned 
into the pQE-60 expression vector (QIAgen). InlB and p60 gene products were expressed 
in E. coli XL 10 Gold cells and purified by immobilised metal affinity chromatography 
(IMAC). Purified protein was characterised by SDS-PAGE and the immunoreactivity of 
each protein with anti-Listeria m onocytogenes antibodies determined. As discussed in 
section 4.3, both the recombinant p60 (rp60) and recombinant InlB (rlnlB) proteins could 
be specifically detected with monoclonal antibodies raised against the native form of the 
protein and against the fused 6xHis tag, indicating that both proteins can be used for the 
generation o f Listeria  monocytogenes-specific antibodies. This result also indicates that 
the 6xHis tag is not hidden in the protein structure and no proteolytic activity has occurred 
at the C-terminus o f the protein. The detection of both recombinant proteins by ELISA 
(Figure 4.15 and 4.16) shows the immunoreactivity of the recombinant proteins in native 
conditions and indicates that both proteins can be used in the development o f a specific 
immunoassay or for the generation o f specific antibodies by immunisation or by bio­
panning of a combinatorial antibody library.
The selection o f  single chain Fv (scFv) fragment antibodies from a naive human antibody 
library and from two murine antibody libraries generated from the spleens o f mice 
immunised with Listeria monocytogenes cells and InlB protein extract is described in 
chapter 5. Two antibody libraries were produced using the system described by Krebber et 
al. (1997a) and nine phage-scFv antibodies selected against Listeria m onocytogenes cells. 
All nine scFv genes were sequenced, aligned and examined for cross reactivity with a 
number o f bacterial strains. All nine phage-scFv antibodies showed tendencies to cross 
react with the other bacterial strains tested and therefore were not further characterised.
A naive human antibody library, with an antibody diversity of 1.4 x 1010 clones (Vaughan 
et al., 1996), was bio-panned against Listeria  monocytogenes cells (section 5.4) and
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purified recombinant Listeria monocytogenes invasion associated proteins, Internalin B 
(InlB) and p60 (section 5.5). Two clones were selected when bio-panned with Listeria  
monocytogenes that recognised W T-Listeria m onocytogenes cells in an inhibition ELISA 
format. Sequencing o f the scFv genes sequences revealed that both clones were in fact the 
same clone. When assayed against intact cells as described in section 2.4.3.11, the phage- 
scFv antibody generated a much decreased signal (over 70% decrease in signal when 
assayed against intact Listeria m onocytogenes 4b) and showed no significant increase in 
reactivity to Listeria monocytogenes cells compared to the other bacterial strains tested.
In order to refine the specificity o f scFv antibodies capable o f reacting with Listeria  
monocytogenes cells, the naive human antibody library was also bio-panned with purified 
recombinant InlB (rlnlB) and recombinant p60 (rp60). Twenty four phage-scFv clones 
were selected and expressed as soluble scFv antibodies and screened for reactivity against 
recombinant protein and Listeria m onocytogenes cells. Only two clones expressed 
functional scFv antibodies in the supernatant, while the cytoplasmic extracts o f five clones 
were observed to react with either rp60 or rlnlB protein. One scFv antibody (clone G7) 
was observed to react against purified rlnlB protein in solution using an inhibition ELISA 
format and showed good expression o f scFv antibody in both the supernatant and 
cytoplasmic extract. Therefore, it was selected for the development o f an immunoassay to 
detect InlB protein (and therefore indirectly Listeria  monocytogenes) as described in 
section 5.5.2. The generated inhibition assay showed good intra- and interday coefficients 
of variation values, and the scFv antibody did not cross react with the bacterial strains 
examined.
Chapter 6 describes the generation of three biosensor-based immunoassays using the two 
polyclonal antibodies and the anti-InlB scFv antibody described in chapters 3 and 5, 
respectively. The polyclonal anti -Listeria m onocytogenes antibody was used to develop a 
subtractive inhibition BIAcore assay to detected Listeria  cells. An anti-rabbit Fab antibody 
was immobilised on the surface of a CM5 sensor chip and used to detect free rabbit 
polyclonal m ti-L isteria  monocytogenes antibodies. Decreasing concentrations o f Listeria  
monocytogenes cells were incubated with anti -Listeria m onocytogenes antibody, and 
unbound antibody removed by centrifugation. Gradually increasing the centrifugation 
speed in a stepwise manner allowed the separation of cells with bound antibody from free 
unbound antibody. Antibody supernatant was passed over the immobilised anti-rabbit Fab 
surface and decrease in free antibody observed with increasing cell concentrations. The 
sensor surface proved to be stable for over 100 binding cycles, with the developed assay
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proving accurate and reproducible with intra- and interday coefficient o f variation values 
less than 5% obtained.
An inhibition assay for the direct detection o f Listeria  m onocytogenes was also developed 
using the anti-InlB extract polyclonal antibody described in chapter 3. Protein G-purified 
anti-lnlB extract antibody was incubated with decreasing concentrations o f Listeria  
monocytogenes cells for 1 hour at 37°C as described in section 2.5.5. Antibody and cells 
were then injected over a CM5 sensor chip surface that had been previously immobilised 
with IMAC-purified recombinant Intemalin B protein (described in chapter 4). 
Regeneration studies, involving 45 binding-regeneration cycles were performed and a 
decrease o f less than 2% in binding capacity from the first to the last cycle observed. This 
result indicated that the surface was very stable and should provide an accurate platform 
for the development o f an assay to detect Listeria  monocytogenes cells. Percentage 
coefficient of variation values o f less than 8% were observed for the intra- and interday 
assay variability studies. Overall the assay showed good sensitivity (better than other 
reported SPR-based assays for microorganisms described in section 1.18) and the sensor 
chip surface was very stable (200 regeneration cycles compared to 70 cycles reported by 
Rasooly, 2001) over the number o f cycles studied.
A BIAcore inhibition assay was also developed to indirectly detect Listeria  
monocytogenes using the anti-InlB scFv antibody described in section 5.5.2. InlB protein 
was extracted from the cell membrane of Listeria  m onocytogenes cells and used to 
develop a BIAcore inhibition assay. An anti-InlB scFv antibody incubated with decreasing 
concentrations o f Listeria  monocytogenes InlB extract was injected over an immobilised 
recombinant InlB sensor chip surface and the change in observed response recorded. 
Various sensor chips and immobilisation procedures were evaluated as the InlB extract 
was observed to non-specifically bind to the negatively charged dextran surface. Over 
activation o f the surface of a Cl sensor chip, containing no dextran layer, and capping 
with ethylene diamine was deduced to be the best approach for the preparation o f an 
immunoassay to detect the cationic InlB extract. The assay surface was not as stable as the 
previously described assays as the surface could be used for only 40 binding-regeneration 
cycles before the decrease binding capacity exceeded the desired performance range of 
20%. The coefficients o f variation (CV's) were determined to assess the precision o f the 
analytical method, with intra- and interday assays values o f less than 10% obtained, 
indicating that the assay had a good degree of precision.
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Overall, the work described in this thesis involved the generation o f polyclonal and 
recombinant scFv antibodies to Listeria m onocytogenes cells and invasion-associated 
protein. Antibodies were purified and characterised by ELISA, SDS-PAGE and Western 
blotting. The Listeria monocytogenes invasion associated proteins, InlB and p60, were 
cloned and expressed in E. coli providing an available o f pure antigen for the selection of 
protein specific antibodies and for use in immunoassay development. Three BIAcore 
inhibition assays were developed with two polyclonal antibodies described in chapter 3 
and with an scFv antibody described in chapter 5.
An evaluation o f the literature for detection o f Listeria monocytogenes reveals three main 
detection platforms which can differ in sensitivity, robustness and confirmation time. 
Cultural methods such as described by Scotter et al. (2001a,b), have proven to be the 
“gold standard” for the detection of Listeria  monocytogenes. However, cultural methods 
can be too time consuming, taking up to a week in some cases to yield confirmation of a 
result. Nucleic acid-based and immunological-based detection systems have become more 
widely used in recent years (see Table 1.3 for list o f recent nucleic acid-based assays for 
the detection of Listeria monocytogenes and Tables 1.4 and 1.6 for a list o f antibody-based 
detection platforms for Listeria monocytogenes). Nucleic acid-based detection systems 
have been reported to be extremely sensitive with detection limits o f less than 10 cfu/ml 
units reported by a number o f research groups (Kaclikova et al., 2003; Hein et al., 2001 
and O’Connor et al., 2000). When compared with immunological detection systems such 
as those presented in Table 1.6 or discussed in section 1.18, nucleic acid-based assays 
have proven more sensitive. However, a direct comparison of sensor-based and nucleic- 
based detection systems is not so clear cut. Nucleic acid-based detection can be sensitive 
to a number of environmental contaminants present in food therefore pre-enrichment of 
sample is required before sample analysis. The reported limits o f detection listed in Table
1.6 for recent optical and electrochemical sensor-based detection systems for Listeria  
monocytogenes are falsely high compared to reported nucleic acid-based systems (Table
1.3) as no pre-enrichment is reported. Pre-enrichment o f large food samples (e.g. current 
regulations for the need to detect 1 cell in 25g o f food) is required to isolate the desired 
target and realistically is a prerequisite for both nucleic-acid and immunological-based 
detection o f microorganisms. In conjunction with sensitivity, important assay criteria for 
the detection o f a target analyte are speed, cost and complexity. Detection o f pathogens in 
“real-time” after sample enrichment can drastically shorten assay time, a requirement for 
the routine quality control o f semi-perishable foods. With the exception of real-time PCR, 
nucleic-acid-based and most immunological detection methods (with the exception of 
dipstick type assays) still require several hours to yield results after enrichment. Real-time
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biosensor-based systems are generally more robust and less complex than nucleic acid- 
based systems and can be used for multiple sample analysis (over 200 cycles observed 
with the anti-InlB polyclonal antibody) allowing the “on-site” detection of pathogens with 
“unskilled” personnel at low cost. Therefore, the choice o f a suitable detection method for 
Listeria m onocytogenes will depend on factors such as the sensitivity need (PCR tend to 
be slightly more sensitive than biosensor-based systems and will therefore require shorter 
enrichment times), complexity (immunoassay-based systems tend to be more user-friendly 
than nucleic acid-based systems and therefore can be performed with “unskilled” 
personnel), enrichment steps (both nucleic acid-based and immunological-based assays 
require enrichment to accurately detect low numbers of pathogens in large food samples), 
robustness (nucleic acid-based systems are sensitive to environmental contaminants are 
only suitable for laboratory-based detection while handheld antibody-sensor systems or 
dipstick type assays can used for field testing) and cost (will depend on the specific format 
used). Therefore, depending on the desired assay requirements (e.g. species or genus- 
specific detection) the BIAcore assays described in this thesis can be reliably and 
accurately used to monitor the interaction o f anti -Listeria monocytogenes related 
antibodies and cells in “real-time”.
The work presented in this thesis could be further developed by transferring the described 
BIAcore assays to a miniature and portable SPR sensor platform, such as the Spreeta SPR 
biosensor, for use in environment testing. Ligand fishing using magnetic particles coated 
with anti-Listeria  antibodies (such as the anti-whole Listeria  m onocytogenes cell 
polyclonal antibody) could be used to capture and concentrate low numbers o f Listeria  
monocytogenes cells from large sample volumes. Using antibody engineering techniques 
such as those described in section 1.15, the described anti-InlB scFv antibody could be 
affinity maturated to increase its sensitivity and stability, enhancing its capabilities for the 
indirect detection o f Listeria monocytogenes cells.
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